TCGA-24-1474-01.12	122	0_HALLMARK_G2M_CHECKPOINT	174	40	0.0000000000000000000000000
TCGA-04-1365-01.6	150	0_HALLMARK_G2M_CHECKPOINT	174	42	0.0000000000000000000000000
TCGA-24-1556-01.19	120	0_HALLMARK_G2M_CHECKPOINT	174	38	0.0000000000000000000000000
TCGA-10-0933-01.2	97	0_HALLMARK_G2M_CHECKPOINT	174	35	0.0000000000000000000000000
TCGA-13-0893-01.4	112	0_HALLMARK_G2M_CHECKPOINT	174	34	0.0000000000000000000000000
TCGA-04-1365-01.6	150	0_HALLMARK_E2F_TARGETS	169	37	0.0000000000000000000000000
TCGA-24-1556-01.19	120	0_HALLMARK_E2F_TARGETS	169	34	0.0000000000000000000000000
TCGA-13-0916-01.11	92	0_HALLMARK_E2F_TARGETS	169	31	0.0000000000000000000000000
TCGA-24-1474-01.12	122	0_HALLMARK_E2F_TARGETS	169	34	0.0000000000000000000000000
TCGA-24-1463-01.5	130	0_HALLMARK_G2M_CHECKPOINT	174	35	0.0000000000000000000000000
TCGA-13-0924-01.5	68	0_HALLMARK_G2M_CHECKPOINT	174	28	0.0000000000000000000000000
TCGA-24-2293-01.3	33	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000000000000000000000
TCGA-24-1424-01.4	80	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000000000000000
TCGA-13-1497-01.7	59	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000000000000000
TCGA-24-1556-01.19	120	2_CELL_CYCLE_GO_0007049	265	38	0.0000000000000000000000000
TCGA-13-0916-01.11	92	0_HALLMARK_G2M_CHECKPOINT	174	30	0.0000000000000000000000000
TCGA-25-1322-01.15	93	0_HALLMARK_G2M_CHECKPOINT	174	30	0.0000000000000000000000000
TCGA-25-2398-01.5	81	2_COLLAGEN	23	16	0.0000000000000000000000001
TCGA-13-0893-01.4	112	0_HALLMARK_E2F_TARGETS	169	31	0.0000000000000000000000001
TCGA-24-1474-01.12	122	2_CELL_CYCLE_GO_0007049	265	37	0.0000000000000000000000002
TCGA-13-1492-01.2	162	0_HALLMARK_E2F_TARGETS	169	35	0.0000000000000000000000002
TCGA-04-1365-01.6	150	2_CELL_CYCLE_GO_0007049	265	40	0.0000000000000000000000002
TCGA-24-1474-01.12	122	2_CELL_CYCLE_PROCESS	163	31	0.0000000000000000000000005
TCGA-59-2350-01.1	62	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000000000005
TCGA-23-2078-01.15	105	0_HALLMARK_G2M_CHECKPOINT	174	30	0.0000000000000000000000006
TCGA-04-1365-01.6	150	2_CELL_CYCLE_PROCESS	163	33	0.0000000000000000000000012
TCGA-09-2051-01.26	142	0_HALLMARK_G2M_CHECKPOINT	174	33	0.0000000000000000000000017
TCGA-13-0910-01.3	71	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000000000017
TCGA-25-2042-01.3	63	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	25	0.0000000000000000000000019
TCGA-25-2391-01.2	64	0_HALLMARK_G2M_CHECKPOINT	174	25	0.0000000000000000000000027
TCGA-04-1331-01.5	90	0_HALLMARK_G2M_CHECKPOINT	174	28	0.0000000000000000000000029
TCGA-10-0938-01.2	102	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000000000000059
TCGA-25-1322-01.15	93	2_CELL_CYCLE_GO_0007049	265	32	0.0000000000000000000000107
TCGA-25-1626-01.2	86	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	27	0.0000000000000000000000232
TCGA-24-2280-01.10	58	2_COLLAGEN	23	14	0.0000000000000000000000263
TCGA-13-0893-01.4	112	2_CELL_CYCLE_GO_0007049	265	34	0.0000000000000000000000297
TCGA-13-0804-01.5	78	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000000000303
TCGA-10-0933-01.2	97	2_CELL_CYCLE_GO_0007049	265	32	0.0000000000000000000000496
TCGA-25-2391-01.2	64	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000000000498
TCGA-24-1549-01.21	158	0_HALLMARK_G2M_CHECKPOINT	174	33	0.0000000000000000000000709
TCGA-24-1463-01.5	130	2_CELL_CYCLE_PROCESS	163	30	0.0000000000000000000000859
TCGA-25-1322-01.15	93	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000000000000953
TCGA-24-1474-01.12	122	1_KEGG_CELL_CYCLE	114	26	0.0000000000000000000001085
TCGA-10-0933-01.2	97	2_CELL_CYCLE_PROCESS	163	27	0.0000000000000000000001227
TCGA-59-2350-01.1	62	1_KEGG_CELL_CYCLE	114	21	0.0000000000000000000001563
TCGA-36-1576-01.8	124	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	30	0.0000000000000000000001720
TCGA-13-0924-01.5	68	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000000002814
TCGA-10-0938-01.2	102	2_CELL_CYCLE_GO_0007049	265	32	0.0000000000000000000003023
TCGA-13-0893-01.4	112	2_CELL_CYCLE_PROCESS	163	28	0.0000000000000000000003879
TCGA-13-0804-01.5	78	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000000004317
TCGA-24-2262-01.25	141	0_HALLMARK_G2M_CHECKPOINT	174	31	0.0000000000000000000004860
TCGA-24-2293-01.3	33	2_COLLAGEN	23	12	0.0000000000000000000007557
TCGA-09-1665-01.16	131	0_HALLMARK_G2M_CHECKPOINT	174	30	0.0000000000000000000008405
TCGA-24-1424-01.4	80	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000000008918
TCGA-13-0910-01.3	71	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000000009486
TCGA-24-2019-01.10	192	0_HALLMARK_E2F_TARGETS	169	34	0.0000000000000000000013651
TCGA-10-0938-01.2	102	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000000000015224
TCGA-24-1556-01.19	120	1_KEGG_CELL_CYCLE	114	25	0.0000000000000000000019436
TCGA-24-1556-01.19	120	2_CELL_CYCLE_PROCESS	163	28	0.0000000000000000000031297
TCGA-24-2019-01.10	192	0_HALLMARK_G2M_CHECKPOINT	174	34	0.0000000000000000000037784
TCGA-24-1434-01.3	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	25	0.0000000000000000000044483
TCGA-24-1474-01.12	122	2_CELL_CYCLE_PHASE	146	27	0.0000000000000000000046714
TCGA-04-1342-01.12	104	0_HALLMARK_G2M_CHECKPOINT	174	27	0.0000000000000000000061055
TCGA-24-1463-01.5	130	2_CELL_CYCLE_GO_0007049	265	34	0.0000000000000000000071785
TCGA-13-0723-01.8	50	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000000000000000078030
TCGA-10-0933-01.2	97	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000000000083359
TCGA-25-1626-01.2	86	2_EXTRACELLULAR_REGION_PART	269	29	0.0000000000000000000090354
TCGA-13-0894-01.9	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000000000147333
TCGA-24-1551-01.15	87	1_KEGG_CELL_CYCLE	114	22	0.0000000000000000000152385
TCGA-25-1322-01.15	93	2_CELL_CYCLE_PROCESS	163	25	0.0000000000000000000238998
TCGA-04-1331-01.5	90	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000000245594
TCGA-24-1428-01.9	90	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000000245594
TCGA-04-1348-01.6	81	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000000355351
TCGA-59-2354-01.2	44	2_COLLAGEN	23	12	0.0000000000000000000443903
TCGA-09-2044-01.4	83	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000000685940
TCGA-24-0970-01.6	94	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000000816260
TCGA-25-2398-01.5	81	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000000000842741
TCGA-61-2000-01.11	69	1_KEGG_CELL_CYCLE	114	20	0.0000000000000000000908971
TCGA-04-1365-01.6	150	2_CELL_CYCLE_PHASE	146	28	0.0000000000000000000922925
TCGA-13-0920-01.9	82	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000000000000001018279
TCGA-10-0933-01.2	97	2_CELL_CYCLE_PHASE	146	24	0.0000000000000000001123042
TCGA-25-2396-01.6	42	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000000000001190163
TCGA-25-2391-01.2	64	2_CELL_CYCLE_GO_0007049	265	25	0.0000000000000000001301658
TCGA-25-2398-01.5	81	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	19	0.0000000000000000001594279
TCGA-09-2044-01.4	83	1_KEGG_CELL_CYCLE	114	21	0.0000000000000000001706350
TCGA-24-1470-01.7	76	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000000000001795018
TCGA-13-0723-01.8	50	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000000001798316
TCGA-23-1118-01.5	50	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000000001798316
TCGA-13-1509-01.9	117	0_HALLMARK_G2M_CHECKPOINT	174	27	0.0000000000000000001885843
TCGA-13-1404-01.13	117	0_HALLMARK_G2M_CHECKPOINT	174	27	0.0000000000000000001885843
TCGA-24-1474-01.12	122	2_MITOTIC_CELL_CYCLE	134	25	0.0000000000000000002217125
TCGA-24-1557-01.13	106	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000002248939
TCGA-25-2398-01.5	81	2_EXTRACELLULAR_MATRIX	85	19	0.0000000000000000002620187
TCGA-10-0938-01.2	102	2_CELL_CYCLE_PROCESS	163	25	0.0000000000000000002984411
TCGA-24-1470-01.7	76	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000000003580206
TCGA-24-1614-01.5	86	1_KEGG_CELL_CYCLE	114	21	0.0000000000000000003885438
TCGA-24-2280-01.10	58	2_EXTRACELLULAR_MATRIX_PART	51	15	0.0000000000000000004257911
TCGA-57-1993-01.8	52	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000000004663675
TCGA-24-1428-01.9	90	2_CELL_CYCLE_GO_0007049	265	28	0.0000000000000000004686139
TCGA-24-2280-01.10	58	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	17	0.0000000000000000004909092
TCGA-24-2293-01.3	33	2_EXTRACELLULAR_MATRIX_PART	51	13	0.0000000000000000005622000
TCGA-24-1463-01.5	130	2_CELL_CYCLE_PHASE	146	26	0.0000000000000000005768955
TCGA-24-1549-01.21	158	2_CELL_CYCLE_PROCESS	163	29	0.0000000000000000006437079
TCGA-13-1492-01.2	162	0_HALLMARK_G2M_CHECKPOINT	174	30	0.0000000000000000006447607
TCGA-24-2280-01.10	58	2_EXTRACELLULAR_MATRIX	85	17	0.0000000000000000007629940
TCGA-25-1626-01.2	86	2_EXTRACELLULAR_REGION	346	30	0.0000000000000000007984484
TCGA-24-1603-01.3	69	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000000008380603
TCGA-24-1563-01.15	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	25	0.0000000000000000010791939
TCGA-24-1428-01.9	90	1_KEGG_CELL_CYCLE	114	21	0.0000000000000000011055335
TCGA-09-2051-01.26	142	0_HALLMARK_E2F_TARGETS	169	28	0.0000000000000000012722889
TCGA-23-1110-01.7	299	0_HALLMARK_G2M_CHECKPOINT	174	38	0.0000000000000000012723713
TCGA-61-1995-01.4	102	0_HALLMARK_G2M_CHECKPOINT	174	25	0.0000000000000000015913467
TCGA-31-1959-01.7	101	2_EXTRACELLULAR_REGION_PART	269	29	0.0000000000000000015976438
TCGA-24-2262-01.25	141	2_CELL_CYCLE_GO_0007049	265	33	0.0000000000000000016113546
TCGA-24-1463-01.5	130	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000000016974288
TCGA-25-2398-01.5	81	2_EXTRACELLULAR_MATRIX_PART	51	16	0.0000000000000000017045167
TCGA-13-0887-01.6	47	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000000000017211942
TCGA-13-0730-01.8	83	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000000000017371472
TCGA-24-1549-01.21	158	0_HALLMARK_E2F_TARGETS	169	29	0.0000000000000000018718661
TCGA-36-1577-01.14	168	0_HALLMARK_G2M_CHECKPOINT	174	30	0.0000000000000000019557650
TCGA-09-2051-01.26	142	2_CELL_CYCLE_GO_0007049	265	33	0.0000000000000000020485524
TCGA-24-2293-01.3	33	2_EXTRACELLULAR_REGION_PART	269	19	0.0000000000000000022130608
TCGA-24-2261-01.2	87	2_CELL_CYCLE_PROCESS	163	23	0.0000000000000000024435442
TCGA-04-1365-01.6	150	2_MITOTIC_CELL_CYCLE	134	26	0.0000000000000000027155860
TCGA-04-1356-01.1	71	2_CELL_CYCLE_GO_0007049	265	25	0.0000000000000000027175495
TCGA-24-1469-01.6	123	2_CELL_CYCLE_GO_0007049	265	31	0.0000000000000000027469789
TCGA-25-2042-01.3	63	2_EXTRACELLULAR_REGION_PART	269	24	0.0000000000000000028423779
TCGA-13-1505-01.13	60	2_COLLAGEN	23	12	0.0000000000000000028947974
TCGA-13-0730-01.8	83	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000000034522515
TCGA-61-2095-01.1	32	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000000000000000036304066
TCGA-13-0924-01.5	68	2_CELL_CYCLE_PROCESS	163	21	0.0000000000000000040190001
TCGA-13-0804-01.5	78	2_CELL_CYCLE_PROCESS	163	22	0.0000000000000000040258217
TCGA-25-1628-01.2	118	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000043987673
TCGA-04-1364-01.3	163	0_HALLMARK_E2F_TARGETS	169	29	0.0000000000000000046966869
TCGA-24-1557-01.13	106	2_CELL_CYCLE_GO_0007049	265	29	0.0000000000000000047187152
TCGA-13-1492-01.2	162	1_KEGG_CELL_CYCLE	114	25	0.0000000000000000049991625
TCGA-61-2095-01.1	32	2_EXTRACELLULAR_MATRIX	85	14	0.0000000000000000051968364
TCGA-24-2293-01.3	33	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000000000000000062623468
TCGA-13-1494-01.4	65	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000000000062956984
TCGA-23-1122-01.11	77	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000000066340532
TCGA-24-1549-01.21	158	2_CELL_CYCLE_GO_0007049	265	34	0.0000000000000000068507563
TCGA-13-1509-01.9	117	2_CELL_CYCLE_GO_0007049	265	30	0.0000000000000000073931537
TCGA-13-2060-01.10	86	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000000084915372
TCGA-24-2293-01.3	33	2_EXTRACELLULAR_MATRIX	85	14	0.0000000000000000089626058
TCGA-25-2398-01.5	81	2_EXTRACELLULAR_REGION_PART	269	26	0.0000000000000000092801096
TCGA-36-1570-01.2	36	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000000000094129631
TCGA-10-0938-01.2	102	2_CELL_CYCLE_PHASE	146	23	0.0000000000000000095049239
TCGA-59-2363-01.3	89	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000000000101524054
TCGA-13-0897-01.2	61	1_KEGG_CELL_CYCLE	114	18	0.0000000000000000105835822
TCGA-24-2261-01.2	87	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000000113651291
TCGA-13-1506-01.5	113	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000116434832
TCGA-04-1365-01.6	150	1_KEGG_CELL_CYCLE	114	24	0.0000000000000000140673371
TCGA-13-0916-01.11	92	2_CELL_CYCLE_GO_0007049	265	27	0.0000000000000000153378494
TCGA-13-1492-01.2	162	2_CELL_CYCLE_GO_0007049	265	34	0.0000000000000000161047961
TCGA-13-0924-01.5	68	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000000000168095300
TCGA-24-1563-01.15	100	2_EXTRACELLULAR_REGION_PART	269	28	0.0000000000000000178396667
TCGA-24-0975-01.6	78	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000000000000199358184
TCGA-09-1665-01.16	131	2_CELL_CYCLE_GO_0007049	265	31	0.0000000000000000209819450
TCGA-23-1023-01.1	93	2_CELL_CYCLE_GO_0007049	265	27	0.0000000000000000210835805
TCGA-25-1635-01.6	129	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000000230355964
TCGA-24-1463-01.5	130	2_MITOTIC_CELL_CYCLE	134	24	0.0000000000000000233697028
TCGA-24-1556-01.19	120	2_CELL_CYCLE_PHASE	146	24	0.0000000000000000263523469
TCGA-24-1428-01.9	90	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000000266011764
TCGA-13-0923-01.5	53	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000000000268105773
TCGA-13-1404-01.13	117	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000291050493
TCGA-23-2078-01.15	105	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000323615099
TCGA-13-0804-01.5	78	2_CELL_CYCLE_GO_0007049	265	25	0.0000000000000000391341334
TCGA-23-1110-01.7	299	0_HALLMARK_E2F_TARGETS	169	36	0.0000000000000000399706422
TCGA-24-1557-01.13	106	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000412114023
TCGA-25-1326-01.11	119	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000453767893
TCGA-61-2095-01.1	32	2_EXTRACELLULAR_REGION_PART	269	18	0.0000000000000000478524052
TCGA-24-2261-01.2	87	2_CELL_CYCLE_GO_0007049	265	26	0.0000000000000000494353933
TCGA-23-2078-01.15	105	2_CELL_CYCLE_GO_0007049	265	28	0.0000000000000000510324945
TCGA-25-1633-01.1	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000000000516200574
TCGA-59-2350-01.1	62	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000000531532392
TCGA-25-2042-01.3	63	2_EXTRACELLULAR_REGION	346	25	0.0000000000000000612706567
TCGA-25-1322-01.15	93	1_KEGG_CELL_CYCLE	114	20	0.0000000000000000664283346
TCGA-61-2095-01.1	32	2_COLLAGEN	23	10	0.0000000000000000780604138
TCGA-13-0905-01.7	160	0_HALLMARK_G2M_CHECKPOINT	174	28	0.0000000000000000881564690
TCGA-13-0893-01.4	112	2_CELL_CYCLE_PHASE	146	23	0.0000000000000000931975886
TCGA-13-0906-01.5	66	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000001216497928
TCGA-24-2261-01.2	87	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000001274911151
TCGA-10-0933-01.2	97	1_KEGG_CELL_CYCLE	114	20	0.0000000000000001636734345
TCGA-24-2019-01.10	192	2_CELL_CYCLE_PROCESS	163	29	0.0000000000000001899574773
TCGA-04-1342-01.12	104	2_CELL_CYCLE_PROCESS	163	23	0.0000000000000002045329399
TCGA-13-1509-01.9	117	2_CELL_CYCLE_PROCESS	163	24	0.0000000000000002071009094
TCGA-13-0916-01.11	92	2_CELL_CYCLE_PROCESS	163	22	0.0000000000000002143108550
TCGA-36-1574-01.10	152	2_CELL_CYCLE_GO_0007049	265	32	0.0000000000000002172164587
TCGA-10-0938-01.2	102	2_M_PHASE	94	19	0.0000000000000002362901116
TCGA-24-2262-01.25	141	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000002489951934
TCGA-24-1548-01.8	141	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000002489951934
TCGA-23-2078-01.15	105	2_CELL_CYCLE_PROCESS	163	23	0.0000000000000002581508277
TCGA-24-2293-01.3	33	2_EXTRACELLULAR_REGION	346	19	0.0000000000000002739331011
TCGA-23-1117-01.11	99	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000002809932832
TCGA-36-1574-01.10	152	0_HALLMARK_G2M_CHECKPOINT	174	27	0.0000000000000002878102572
TCGA-61-1995-01.4	102	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000000002958950440
TCGA-04-1356-01.1	71	2_CELL_CYCLE_PROCESS	163	20	0.0000000000000002991749351
TCGA-13-0903-01.11	77	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000000000003035038862
TCGA-24-1603-01.3	69	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000003305129535
TCGA-61-2000-01.11	69	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000003305129535
TCGA-24-1470-01.7	76	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000000003450369243
TCGA-24-1474-01.12	122	2_M_PHASE	94	20	0.0000000000000003454188981
TCGA-36-1574-01.10	152	1_KEGG_CELL_CYCLE	114	23	0.0000000000000003681134589
TCGA-23-1118-01.5	50	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000000004468560038
TCGA-24-2290-01.3	70	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000004557312696
TCGA-24-2035-01.8	102	2_EXTRACELLULAR_REGION_PART	269	27	0.0000000000000004562144807
TCGA-10-0938-01.2	102	1_KEGG_CELL_CYCLE	114	20	0.0000000000000004762146257
TCGA-09-1669-01.10	81	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000000005230657508
TCGA-25-1322-01.15	93	2_CELL_CYCLE_PHASE	146	21	0.0000000000000005238634114
TCGA-13-0905-01.7	160	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000005288061633
TCGA-24-1548-01.8	141	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000005322343191
TCGA-24-1614-01.5	86	2_CELL_CYCLE_GO_0007049	265	25	0.0000000000000005778425372
TCGA-59-2350-01.1	62	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000000006375200179
TCGA-24-1435-01.12	115	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000000000006534897480
TCGA-13-0920-01.9	82	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000000006925568853
TCGA-25-2396-01.6	42	2_CELL_CYCLE_GO_0007049	265	19	0.0000000000000007215374325
TCGA-25-1635-01.6	129	0_HALLMARK_G2M_CHECKPOINT	174	25	0.0000000000000007652070583
TCGA-59-2354-01.2	44	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000000000000008152829827
TCGA-25-2391-01.2	64	2_CELL_CYCLE_PROCESS	163	19	0.0000000000000008249995848
TCGA-24-1470-01.7	76	1_KEGG_CELL_CYCLE	114	18	0.0000000000000008732996939
TCGA-04-1356-01.1	71	2_CELL_CYCLE_PHASE	146	19	0.0000000000000008749081876
TCGA-04-1348-01.6	81	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000000000009725794014
TCGA-24-0975-01.6	78	2_EXTRACELLULAR_REGION_PART	269	24	0.0000000000000009808950904
TCGA-57-1993-01.8	52	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000000010232996794
TCGA-13-0910-01.3	71	2_CELL_CYCLE_GO_0007049	265	23	0.0000000000000010415247634
TCGA-04-1356-01.1	71	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000011294443385
TCGA-24-1103-01.5	73	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000011559725302
TCGA-24-1425-01.1	61	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000000011621320832
TCGA-59-2354-01.2	44	2_EXTRACELLULAR_MATRIX	85	14	0.0000000000000011642678066
TCGA-23-1023-01.1	93	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000011844573753
TCGA-04-1365-01.6	150	2_M_PHASE	94	21	0.0000000000000011893635933
TCGA-13-1404-01.13	117	2_CELL_CYCLE_GO_0007049	265	28	0.0000000000000012244710617
TCGA-24-1556-01.19	120	2_MITOTIC_CELL_CYCLE	134	22	0.0000000000000012501242695
TCGA-61-1736-01.2	54	0_HALLMARK_E2F_TARGETS	169	18	0.0000000000000013197032959
TCGA-24-1552-01.5	54	0_HALLMARK_E2F_TARGETS	169	18	0.0000000000000013197032959
TCGA-13-0791-01.35	80	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000000013447091611
TCGA-24-1470-01.7	76	2_CELL_CYCLE_PROCESS	163	20	0.0000000000000013450994541
TCGA-13-0807-01.8	46	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000000016429339716
TCGA-13-0723-01.8	50	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000000016673018855
TCGA-09-2044-01.4	83	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000000000016962032033
TCGA-24-1469-01.6	123	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000017240905880
TCGA-31-1959-01.7	101	2_EXTRACELLULAR_REGION	346	29	0.0000000000000018833388721
TCGA-04-1364-01.3	163	0_HALLMARK_G2M_CHECKPOINT	174	27	0.0000000000000019124081814
TCGA-25-1322-01.15	93	2_MITOTIC_CELL_CYCLE	134	20	0.0000000000000019164094999
TCGA-04-1362-01.4	35	1_KEGG_CELL_CYCLE	114	14	0.0000000000000019386725926
TCGA-24-1614-01.5	86	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000000020443760072
TCGA-13-1505-01.13	60	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000000000000024968309647
TCGA-10-0933-01.2	97	2_M_PHASE	94	18	0.0000000000000025184993552
TCGA-24-2035-01.8	102	2_EXTRACELLULAR_REGION	346	29	0.0000000000000025455187287
TCGA-13-0920-01.9	82	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000000025701650041
TCGA-24-2261-01.2	87	2_CELL_CYCLE_PHASE	146	20	0.0000000000000026720812077
TCGA-13-1488-01.17	109	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000028956295993
TCGA-24-2271-01.3	44	2_COLLAGEN	23	10	0.0000000000000029574329597
TCGA-13-0924-01.5	68	1_KEGG_CELL_CYCLE	114	17	0.0000000000000032495711999
TCGA-13-0893-01.4	112	1_KEGG_CELL_CYCLE	114	20	0.0000000000000033952971333
TCGA-24-2280-01.10	58	2_EXTRACELLULAR_REGION_PART	269	21	0.0000000000000035260235169
TCGA-13-1505-01.13	60	2_EXTRACELLULAR_MATRIX	85	15	0.0000000000000036578418475
TCGA-13-1497-01.7	59	2_CELL_CYCLE_GO_0007049	265	21	0.0000000000000039094279644
TCGA-24-1603-01.3	69	2_CELL_CYCLE_PROCESS	163	19	0.0000000000000040667819553
TCGA-61-2109-01.13	122	2_CELL_CYCLE_GO_0007049	265	28	0.0000000000000040857649396
TCGA-13-1506-01.5	113	1_KEGG_CELL_CYCLE	114	20	0.0000000000000040860105946
TCGA-24-1424-01.4	80	2_CELL_CYCLE_PROCESS	163	20	0.0000000000000041150578033
TCGA-24-1556-01.19	120	2_REGULATION_OF_CELL_CYCLE	160	23	0.0000000000000041370519859
TCGA-13-0887-01.6	47	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000000000000042004869321
TCGA-61-2095-01.1	32	2_EXTRACELLULAR_REGION	346	18	0.0000000000000045341844003
TCGA-13-1505-01.13	60	2_EXTRACELLULAR_MATRIX_PART	51	13	0.0000000000000045791571414
TCGA-24-2019-01.10	192	2_CELL_CYCLE_GO_0007049	265	34	0.0000000000000046512183307
TCGA-13-0910-01.3	71	2_MITOTIC_CELL_CYCLE	134	18	0.0000000000000046753010158
TCGA-10-0933-01.2	97	2_MITOTIC_CELL_CYCLE	134	20	0.0000000000000046833093181
TCGA-59-2354-01.2	44	2_EXTRACELLULAR_MATRIX_PART	51	12	0.0000000000000047731919079
TCGA-13-0893-01.4	112	2_MITOTIC_CELL_CYCLE	134	21	0.0000000000000050829602607
TCGA-24-0975-01.6	78	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	16	0.0000000000000052068072006
TCGA-25-2398-01.5	81	2_EXTRACELLULAR_REGION	346	26	0.0000000000000054968896324
TCGA-13-1506-01.5	113	2_CELL_CYCLE_GO_0007049	265	27	0.0000000000000055650952338
TCGA-24-1557-01.13	106	2_CELL_CYCLE_PROCESS	163	22	0.0000000000000058273835279
TCGA-13-1410-01.9	115	1_KEGG_CELL_CYCLE	114	20	0.0000000000000058843995767
TCGA-13-0887-01.6	47	1_KEGG_CELL_CYCLE	114	15	0.0000000000000059773282979
TCGA-13-0804-01.5	78	2_CELL_CYCLE_PHASE	146	19	0.0000000000000061892465750
TCGA-13-0890-01.2	48	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000000000000064015693014
TCGA-13-1506-01.5	113	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000068559513981
TCGA-04-1342-01.12	104	2_CELL_CYCLE_GO_0007049	265	26	0.0000000000000070971996100
TCGA-13-0910-01.3	71	1_KEGG_CELL_CYCLE	114	17	0.0000000000000072710078264
TCGA-04-1365-01.6	150	2_CHROMOSOME	102	21	0.0000000000000072951092116
TCGA-13-0910-01.3	71	2_CELL_CYCLE_PROCESS	163	19	0.0000000000000074011469814
TCGA-24-0975-01.6	78	2_EXTRACELLULAR_MATRIX	85	16	0.0000000000000078251512791
TCGA-04-1342-01.12	104	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000083600727449
TCGA-13-1404-01.13	117	1_KEGG_CELL_CYCLE	114	20	0.0000000000000084130441641
TCGA-04-1356-01.1	71	2_M_PHASE	94	16	0.0000000000000084857236860
TCGA-13-0916-01.11	92	2_CELL_CYCLE_PHASE	146	20	0.0000000000000088063159018
TCGA-24-1603-01.3	69	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000000091792575599
TCGA-61-2109-01.13	122	2_CELL_CYCLE_PROCESS	163	23	0.0000000000000093944355703
TCGA-13-1494-01.4	65	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000000000000094081882776
TCGA-13-0924-01.5	68	2_CELL_CYCLE_PHASE	146	18	0.0000000000000096880365786
TCGA-36-1576-01.8	124	2_EXTRACELLULAR_REGION_PART	269	28	0.0000000000000097190416741
TCGA-25-1324-01.3	42	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000000100812454776
TCGA-24-2280-01.10	58	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000000108934470671
TCGA-24-1469-01.6	123	2_CELL_CYCLE_PROCESS	163	23	0.0000000000000113894356399
TCGA-59-2350-01.1	62	2_CELL_CYCLE_PROCESS	163	18	0.0000000000000115158247834
TCGA-24-0979-01.5	41	2_CELL_CYCLE_GO_0007049	265	18	0.0000000000000124537365154
TCGA-13-1494-01.4	65	2_EXTRACELLULAR_MATRIX	85	15	0.0000000000000137691228606
TCGA-13-1497-01.7	59	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000000138993022340
TCGA-24-1563-01.15	100	2_EXTRACELLULAR_REGION	346	28	0.0000000000000159510219075
TCGA-13-0890-01.2	48	2_CELL_CYCLE_GO_0007049	265	19	0.0000000000000160319814245
TCGA-25-2396-01.6	42	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000000162116650014
TCGA-13-0894-01.9	118	2_COLLAGEN	23	12	0.0000000000000165735169299
TCGA-30-1891-01.4	84	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	16	0.0000000000000185702244879
TCGA-04-1525-01.7	52	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000000187919043004
TCGA-24-2298-01.7	138	2_EXTRACELLULAR_REGION_PART	269	29	0.0000000000000196422338733
TCGA-25-1635-01.6	129	2_CELL_CYCLE_GO_0007049	265	28	0.0000000000000199644211539
TCGA-24-2262-01.25	141	2_CELL_CYCLE_PROCESS	163	24	0.0000000000000204329129234
TCGA-13-0727-01.1	29	0_HALLMARK_E2F_TARGETS	169	14	0.0000000000000207170949838
TCGA-09-1659-01.5	51	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000000000000212422089892
TCGA-13-0910-01.3	71	2_CELL_CYCLE_PHASE	146	18	0.0000000000000227339127621
TCGA-24-2289-01.6	53	2_COLLAGEN	23	10	0.0000000000000229796881431
TCGA-25-1326-01.11	119	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000233729923201
TCGA-24-1469-01.6	123	1_KEGG_CELL_CYCLE	114	20	0.0000000000000236013159615
TCGA-09-2051-01.26	142	2_CELL_CYCLE_PROCESS	163	24	0.0000000000000242374207625
TCGA-13-1488-01.17	109	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000245081963503
TCGA-24-0975-01.6	78	2_EXTRACELLULAR_REGION	346	25	0.0000000000000259526475905
TCGA-31-1953-01.6	53	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000000272439844285
TCGA-24-0970-01.6	94	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000000000276947541193
TCGA-24-0979-01.5	41	1_KEGG_CELL_CYCLE	114	14	0.0000000000000277409153717
TCGA-30-1891-01.4	84	2_EXTRACELLULAR_MATRIX	85	16	0.0000000000000278748850029
TCGA-04-1331-01.5	90	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000000284111821511
TCGA-24-1463-01.5	130	2_M_PHASE	94	19	0.0000000000000287150812074
TCGA-30-1891-01.4	84	2_COLLAGEN	23	11	0.0000000000000292178524251
TCGA-61-2000-01.11	69	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000000000000296690099389
TCGA-04-1364-01.3	163	1_KEGG_CELL_CYCLE	114	22	0.0000000000000306796852721
TCGA-04-1525-01.7	52	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000000000000310628220825
TCGA-25-1322-01.15	93	2_M_PHASE	94	17	0.0000000000000322365303735
TCGA-23-1122-01.11	77	1_KEGG_CELL_CYCLE	114	17	0.0000000000000324679338012
TCGA-24-1105-01.8	52	1_KEGG_CELL_CYCLE	114	15	0.0000000000000339162308796
TCGA-25-2401-01.5	119	2_EXTRACELLULAR_REGION_PART	269	27	0.0000000000000343614405423
TCGA-25-2391-01.2	64	1_KEGG_CELL_CYCLE	114	16	0.0000000000000348944763109
TCGA-13-0916-01.11	92	1_KEGG_CELL_CYCLE	114	18	0.0000000000000350314962891
TCGA-24-1428-01.9	90	2_REGULATION_OF_CELL_CYCLE	160	20	0.0000000000000352825347571
TCGA-25-2396-01.6	42	1_KEGG_CELL_CYCLE	114	14	0.0000000000000411990994161
TCGA-25-1324-01.3	42	1_KEGG_CELL_CYCLE	114	14	0.0000000000000411990994161
TCGA-24-1549-01.21	158	2_MITOTIC_CELL_CYCLE	134	23	0.0000000000000413461608010
TCGA-61-2109-01.13	122	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000419859673163
TCGA-13-0923-01.5	53	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000000000000450111260511
TCGA-24-1103-01.5	73	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000000000461445112262
TCGA-61-2113-01.15	99	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000000470886290742
TCGA-09-1665-01.16	131	2_CELL_CYCLE_PROCESS	163	23	0.0000000000000498565414240
TCGA-24-1469-01.6	123	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000508440853363
TCGA-13-0730-01.8	83	2_CELL_CYCLE_GO_0007049	265	23	0.0000000000000534088087548
TCGA-09-2044-01.4	83	2_CELL_CYCLE_GO_0007049	265	23	0.0000000000000534088087548
TCGA-13-1404-01.13	117	2_CELL_CYCLE_PROCESS	163	22	0.0000000000000552018329365
TCGA-24-1434-01.3	82	2_EXTRACELLULAR_REGION_PART	269	23	0.0000000000000553395364549
TCGA-13-1512-01.2	113	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000555765385093
TCGA-13-0924-01.5	68	2_MITOTIC_CELL_CYCLE	134	17	0.0000000000000556366054943
TCGA-57-1582-01.26	174	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000590235856798
TCGA-13-0906-01.5	66	1_KEGG_CELL_CYCLE	114	16	0.0000000000000599080449792
TCGA-24-1416-01.4	38	0_HALLMARK_E2F_TARGETS	169	15	0.0000000000000600375212135
TCGA-13-0900-01.8	90	2_COLLAGEN	23	11	0.0000000000000649862230465
TCGA-04-1530-01.2	90	2_COLLAGEN	23	11	0.0000000000000649862230465
TCGA-24-1614-01.5	86	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000724026601909
TCGA-24-1463-01.5	130	1_KEGG_CELL_CYCLE	114	20	0.0000000000000732455927996
TCGA-59-2354-01.2	44	2_EXTRACELLULAR_REGION_PART	269	18	0.0000000000000769040486980
TCGA-10-0934-01.11	145	2_IMMUNE_RESPONSE	206	26	0.0000000000000830128700477
TCGA-13-1512-01.2	113	1_KEGG_CELL_CYCLE	114	19	0.0000000000000848548560385
TCGA-61-2102-01.7	172	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000924329614360
TCGA-57-1583-01.20	185	1_KEGG_PATHWAYS_IN_CANCER	323	35	0.0000000000000945360311862
TCGA-24-1105-01.8	52	2_CELL_CYCLE_GO_0007049	265	19	0.0000000000000959255187184
TCGA-61-2012-01.6	78	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000001032108111775
TCGA-13-1512-01.2	113	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000001051241920106
TCGA-24-1435-01.12	115	2_CELL_CYCLE_GO_0007049	265	26	0.0000000000001051863240666
TCGA-04-1530-01.2	90	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000001058440900429
TCGA-09-1665-01.16	131	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000001137712484794
TCGA-13-0730-01.8	83	1_KEGG_CELL_CYCLE	114	17	0.0000000000001271738072656
TCGA-13-2060-01.10	86	2_CELL_CYCLE_GO_0007049	265	23	0.0000000000001276957808604
TCGA-24-1603-01.3	69	1_KEGG_CELL_CYCLE	114	16	0.0000000000001300835513821
TCGA-25-1319-01.10	69	1_KEGG_CELL_CYCLE	114	16	0.0000000000001300835513821
TCGA-13-0906-01.5	66	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000001315905990186
TCGA-24-1556-01.19	120	2_M_PHASE	94	18	0.0000000000001364584638467
TCGA-23-1122-01.11	77	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000000001381750571223
TCGA-61-2113-01.15	99	1_KEGG_CELL_CYCLE	114	18	0.0000000000001400899077140
TCGA-13-0723-01.8	50	2_CELL_CYCLE_PROCESS	163	16	0.0000000000001467296374512
TCGA-25-1628-01.2	118	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000001474931934832
TCGA-61-2000-01.11	69	2_CELL_CYCLE_GO_0007049	265	21	0.0000000000001581773705355
TCGA-13-0730-01.8	83	2_CELL_CYCLE_PROCESS	163	19	0.0000000000001830334951902
TCGA-24-2035-01.8	102	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000001876805451744
TCGA-04-1530-01.2	90	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000001894538749944
TCGA-23-1117-01.11	99	2_COLLAGEN	23	11	0.0000000000001948187680450
TCGA-24-2019-01.10	192	2_CELL_CYCLE_PHASE	146	25	0.0000000000001973141381316
TCGA-61-2095-01.1	32	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000000001976275346051
TCGA-13-1481-01.3	78	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000002004943366594
TCGA-25-2396-01.6	42	2_CELL_CYCLE_PROCESS	163	15	0.0000000000002076502170491
TCGA-13-1494-01.4	65	2_COLLAGEN	23	10	0.0000000000002078062479014
TCGA-09-1659-01.5	51	2_CELL_CYCLE_PROCESS	163	16	0.0000000000002106648356156
TCGA-24-2019-01.10	192	2_M_PHASE	94	21	0.0000000000002160426033891
TCGA-24-1563-01.15	100	2_COLLAGEN	23	11	0.0000000000002186403135378
TCGA-13-0893-01.4	112	2_REGULATION_OF_CELL_CYCLE	160	21	0.0000000000002187901637411
TCGA-24-0979-01.5	41	0_HALLMARK_E2F_TARGETS	169	15	0.0000000000002350137212878
TCGA-10-0938-01.2	102	2_MITOTIC_CELL_CYCLE	134	19	0.0000000000002618510814954
TCGA-24-1417-01.14	94	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000002639322461806
TCGA-13-0791-01.35	80	1_KEGG_SMALL_CELL_LUNG_CANCER	83	15	0.0000000000002718250324314
TCGA-13-0910-01.3	71	2_M_PHASE	94	15	0.0000000000002861443071931
TCGA-24-2019-01.10	192	2_MITOTIC_CELL_CYCLE	134	24	0.0000000000002871648567936
TCGA-36-1574-01.10	152	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000002914857140138
TCGA-23-1117-01.11	99	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	16	0.0000000000002970569370061
TCGA-24-1549-01.21	158	2_CELL_CYCLE_PHASE	146	23	0.0000000000002992919258117
TCGA-57-1993-01.8	52	2_CELL_CYCLE_PROCESS	163	16	0.0000000000002998228107792
TCGA-13-0791-01.35	80	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000000003008350722540
TCGA-24-1424-01.4	80	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000003207199701595
TCGA-10-0934-01.11	145	2_IMMUNE_SYSTEM_PROCESS	283	29	0.0000000000003241919836023
TCGA-09-1666-01.28	109	1_KEGG_PATHWAYS_IN_CANCER	323	27	0.0000000000003312108248395
TCGA-24-0979-01.5	41	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000000003660615326537
TCGA-59-2348-01.14	123	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000003730182374210
TCGA-61-2109-01.13	122	1_KEGG_CELL_CYCLE	114	19	0.0000000000003779364119660
TCGA-23-1117-01.11	99	2_CELL_CYCLE_PROCESS	163	20	0.0000000000003780666434050
TCGA-24-2262-01.25	141	1_KEGG_CELL_CYCLE	114	20	0.0000000000003794562786420
TCGA-09-0369-01.9	109	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000003821171370466
TCGA-23-2078-01.15	105	2_COLLAGEN	23	11	0.0000000000003823628632142
TCGA-13-1506-01.5	113	2_CELL_CYCLE_PROCESS	163	21	0.0000000000003905547706816
TCGA-24-1434-01.3	82	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000000000004027647665687
TCGA-31-1959-01.7	101	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	16	0.0000000000004145711143767
TCGA-04-1343-01.7	50	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000004220799532592
TCGA-23-1117-01.11	99	2_EXTRACELLULAR_MATRIX	85	16	0.0000000000004445510818112
TCGA-24-1418-01.16	84	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000004634052609732
TCGA-24-1417-01.14	94	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000004714511456652
TCGA-24-1434-01.3	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000000000004870411613001
TCGA-24-2035-01.8	102	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	16	0.0000000000004883919712297
TCGA-25-1635-01.6	129	2_CELL_CYCLE_PROCESS	163	22	0.0000000000004894239895255
TCGA-61-2102-01.7	172	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000004954104115889
TCGA-36-1576-01.8	124	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	17	0.0000000000005524034118582
TCGA-04-1362-01.4	35	0_HALLMARK_E2F_TARGETS	169	14	0.0000000000005647940808505
TCGA-24-1435-01.12	115	2_CELL_CYCLE_PROCESS	163	21	0.0000000000005688695246315
TCGA-57-1583-01.20	185	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000005824742554920
TCGA-24-1434-01.3	82	2_EXTRACELLULAR_MATRIX	85	15	0.0000000000005874492315885
TCGA-31-1959-01.7	101	2_EXTRACELLULAR_MATRIX	85	16	0.0000000000006201628483030
TCGA-24-2280-01.10	58	2_EXTRACELLULAR_REGION	346	21	0.0000000000006211074849857
TCGA-13-1482-01.7	62	1_KEGG_CELL_CYCLE	114	15	0.0000000000006377864378577
TCGA-61-1995-01.4	102	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000006550152239574
TCGA-13-0897-01.2	61	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000000000006586716912968
TCGA-13-0916-01.11	92	2_MITOTIC_CELL_CYCLE	134	18	0.0000000000006901188170978
TCGA-61-1995-01.4	102	2_CELL_CYCLE_PROCESS	163	20	0.0000000000007015232959741
TCGA-59-2348-01.14	123	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000007019330698299
TCGA-24-2035-01.8	102	2_EXTRACELLULAR_MATRIX	85	16	0.0000000000007304451054757
TCGA-13-2060-01.10	86	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000007429840537030
TCGA-04-1365-01.6	150	2_DNA_METABOLIC_PROCESS	218	26	0.0000000000008144571477695
TCGA-61-2095-01.1	32	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000000000008214524695916
TCGA-36-1576-01.8	124	2_EXTRACELLULAR_REGION	346	29	0.0000000000008303728790037
TCGA-24-2298-01.7	138	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000008318798449162
TCGA-13-0760-01.12	93	2_CELL_CYCLE_GO_0007049	265	23	0.0000000000008471032871100
TCGA-36-1576-01.8	124	2_EXTRACELLULAR_MATRIX	85	17	0.0000000000008471735009878
TCGA-23-1023-01.1	93	2_M_PHASE	94	16	0.0000000000008492338912259
TCGA-13-0893-01.4	112	2_M_PHASE	94	17	0.0000000000008661579036834
TCGA-13-1412-01.8	113	2_COLLAGEN	23	11	0.0000000000008838742554291
TCGA-13-1494-01.4	65	2_EXTRACELLULAR_REGION_PART	269	20	0.0000000000009215437731875
TCGA-24-1428-01.9	90	2_CELL_CYCLE_PROCESS	163	19	0.0000000000009278944829558
TCGA-24-2293-01.1	22	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000000009688069402637
TCGA-25-1628-01.2	118	2_CELL_CYCLE_PROCESS	163	21	0.0000000000009857731445798
TCGA-13-0891-01.18	125	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000010036705773043
TCGA-13-0804-01.5	78	1_KEGG_CELL_CYCLE	114	16	0.0000000000010700414172924
TCGA-13-0792-01.8	64	1_KEGG_CELL_CYCLE	114	15	0.0000000000010718783981845
TCGA-23-1110-01.7	299	0_HALLMARK_ALLOGRAFT_REJECTION	190	33	0.0000000000010898116132132
TCGA-59-2350-01.1	62	2_CELL_CYCLE_PHASE	146	16	0.0000000000011557294282513
TCGA-24-0970-01.6	94	1_KEGG_CELL_CYCLE	114	17	0.0000000000011796819430174
TCGA-13-0886-01.1	45	0_HALLMARK_E2F_TARGETS	169	15	0.0000000000012011959899845
TCGA-24-1435-01.12	115	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000012054489314220
TCGA-24-1549-01.21	158	2_M_PHASE	94	19	0.0000000000012174081017793
TCGA-24-1434-01.3	82	2_EXTRACELLULAR_REGION	346	24	0.0000000000012236883700773
TCGA-13-0804-01.5	78	2_M_PHASE	94	15	0.0000000000012927205712853
TCGA-13-0900-01.8	90	2_EXTRACELLULAR_MATRIX_PART	51	13	0.0000000000013008907662699
TCGA-24-2289-01.6	53	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000013302945260151
TCGA-09-1659-01.5	51	2_CELL_CYCLE_GO_0007049	265	18	0.0000000000013369463295365
TCGA-30-1891-01.4	84	2_EXTRACELLULAR_REGION_PART	269	22	0.0000000000013785926047806
TCGA-59-2354-01.2	44	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000000013793635853082
TCGA-24-0975-01.6	78	2_COLLAGEN	23	10	0.0000000000014369780495594
TCGA-25-2396-01.6	42	2_CELL_CYCLE_PHASE	146	14	0.0000000000014521344925594
TCGA-10-0934-01.11	145	0_HALLMARK_ALLOGRAFT_REJECTION	190	24	0.0000000000014740600294233
TCGA-36-1574-01.10	152	2_CELL_CYCLE_PROCESS	163	23	0.0000000000015166648883437
TCGA-61-2092-01.12	209	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	27	0.0000000000015215623493895
TCGA-13-0791-01.35	80	1_KEGG_CELL_CYCLE	114	16	0.0000000000016444729326112
TCGA-24-1422-01.10	56	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	13	0.0000000000016478815198491
TCGA-09-2050-01.18	196	1_KEGG_CELL_CYCLE	114	22	0.0000000000016786880690513
TCGA-61-1736-01.2	54	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000016968097709962
TCGA-24-1552-01.5	54	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000016968097709962
TCGA-13-0791-01.35	80	2_CELL_CYCLE_PROCESS	163	18	0.0000000000016973204262539
TCGA-13-1509-01.9	117	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000017401940245677
TCGA-04-1530-01.2	90	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000000000017523343975689
TCGA-24-1470-01.7	76	2_CELL_CYCLE_PHASE	146	17	0.0000000000018847015545625
TCGA-13-0903-01.11	77	2_CELL_CYCLE_GO_0007049	265	21	0.0000000000019172033365114
TCGA-04-1342-01.12	104	2_CELL_CYCLE_PHASE	146	19	0.0000000000019793602296427
TCGA-13-0919-01.5	50	2_COLLAGEN	23	9	0.0000000000019889670382480
TCGA-57-1993-01.8	52	2_CELL_CYCLE_GO_0007049	265	18	0.0000000000019939573470277
TCGA-25-2391-01.2	64	2_CELL_CYCLE_PHASE	146	16	0.0000000000020121871818880
TCGA-24-1616-01.2	38	2_CELL_CYCLE_GO_0007049	265	16	0.0000000000020230361726355
TCGA-04-1348-01.6	81	1_KEGG_CELL_CYCLE	114	16	0.0000000000020291435705163
TCGA-09-1669-01.10	81	1_KEGG_CELL_CYCLE	114	16	0.0000000000020291435705163
TCGA-13-0890-01.2	48	2_CELL_CYCLE_PROCESS	163	15	0.0000000000021047557194974
TCGA-04-1331-01.5	90	2_CELL_CYCLE_PHASE	146	18	0.0000000000021659908789933
TCGA-24-2298-01.7	138	2_EXTRACELLULAR_REGION	346	30	0.0000000000021788880929227
TCGA-25-1628-01.2	118	2_CELL_CYCLE_GO_0007049	265	25	0.0000000000022089542346777
TCGA-24-1548-01.8	141	2_CELL_CYCLE_GO_0007049	265	27	0.0000000000022499866527586
TCGA-24-1422-01.10	56	2_EXTRACELLULAR_MATRIX	85	13	0.0000000000022820737718337
TCGA-24-2262-01.25	141	2_REGULATION_OF_CELL_CYCLE	160	22	0.0000000000023111962244699
TCGA-23-2078-01.15	105	2_CELL_CYCLE_PHASE	146	19	0.0000000000023855622571838
TCGA-24-1434-01.3	82	2_COLLAGEN	23	10	0.0000000000024307387554914
TCGA-36-1576-01.8	124	2_COLLAGEN	23	11	0.0000000000025379421709066
TCGA-04-1530-01.2	90	2_EXTRACELLULAR_MATRIX	85	15	0.0000000000025517514110199
TCGA-24-2271-01.3	44	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000000000026328602425442
TCGA-13-0920-01.9	82	2_CELL_CYCLE_PROCESS	163	18	0.0000000000027148755220591
TCGA-13-0807-01.8	46	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000000027269035914682
TCGA-61-2109-01.13	122	2_CELL_CYCLE_PHASE	146	20	0.0000000000030249450392256
TCGA-13-0894-01.9	118	2_EXTRACELLULAR_REGION_PART	269	25	0.0000000000031457159029798
TCGA-13-1488-01.17	109	1_KEGG_PATHWAYS_IN_CANCER	323	26	0.0000000000032989444141685
TCGA-24-2290-01.3	70	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000034665999820814
TCGA-23-1123-01.7	70	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000034665999820814
TCGA-24-2298-01.7	138	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	17	0.0000000000035008108264549
TCGA-24-2271-01.3	44	2_EXTRACELLULAR_MATRIX	85	12	0.0000000000035541177353215
TCGA-13-0890-01.2	48	2_MITOTIC_CELL_CYCLE	134	14	0.0000000000036163355188678
TCGA-13-1489-01.11	118	1_KEGG_CELL_CYCLE	114	18	0.0000000000036289707126058
TCGA-13-0890-01.2	48	0_HALLMARK_E2F_TARGETS	169	15	0.0000000000036355218350817
TCGA-13-0885-01.6	44	1_KEGG_CELL_CYCLE	114	13	0.0000000000036633552888837
TCGA-24-1549-01.21	158	1_KEGG_CELL_CYCLE	114	20	0.0000000000036798045928579
TCGA-23-1117-01.11	99	2_CELL_CYCLE_GO_0007049	265	23	0.0000000000037367243601746
TCGA-23-1023-01.1	93	2_CELL_CYCLE_PHASE	146	18	0.0000000000040032459359176
TCGA-13-1495-01.22	101	1_KEGG_CELL_CYCLE	114	17	0.0000000000041822183089802
TCGA-13-1501-01.12	101	1_KEGG_CELL_CYCLE	114	17	0.0000000000041822183089802
TCGA-09-2050-01.18	196	1_KEGG_PATHWAYS_IN_CANCER	323	34	0.0000000000042252627882221
TCGA-23-1120-01.10	57	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000044402832034867
TCGA-61-1919-01.9	87	2_COLLAGEN	23	10	0.0000000000045172464235149
TCGA-24-2290-01.3	70	1_KEGG_CELL_CYCLE	114	15	0.0000000000045678606741201
TCGA-23-1123-01.7	70	1_KEGG_CELL_CYCLE	114	15	0.0000000000045678606741201
TCGA-23-2079-01.14	85	1_KEGG_CELL_CYCLE	114	16	0.0000000000045685776107352
TCGA-13-0924-01.5	68	2_M_PHASE	94	14	0.0000000000046028637507174
TCGA-13-0793-01.8	97	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000000000046415919711284
TCGA-24-0979-01.5	41	2_CELL_CYCLE_PROCESS	163	14	0.0000000000046916220907575
TCGA-24-1424-01.4	80	2_CELL_CYCLE_PHASE	146	17	0.0000000000047496745973880
TCGA-24-1614-01.5	86	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000000000047859520389286
TCGA-24-0979-01.5	41	2_M_PHASE	94	12	0.0000000000048110314276182
TCGA-24-2261-01.2	87	2_MITOTIC_CELL_CYCLE	134	17	0.0000000000048904076574751
TCGA-23-1120-01.10	57	1_KEGG_CELL_CYCLE	114	14	0.0000000000051648157481638
TCGA-25-2396-01.6	42	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000000053315916368434
TCGA-25-1633-01.1	71	2_EXTRACELLULAR_REGION	346	22	0.0000000000053374340649492
TCGA-24-2298-01.7	138	2_EXTRACELLULAR_MATRIX	85	17	0.0000000000053536606785507
TCGA-13-0910-01.3	71	2_MITOSIS	71	13	0.0000000000053737388545936
TCGA-13-0894-01.9	118	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	16	0.0000000000053819427067662
TCGA-24-0968-01.9	71	1_KEGG_CELL_CYCLE	114	15	0.0000000000057342258530803
TCGA-24-1422-01.10	56	2_COLLAGEN	23	9	0.0000000000059660861797490
TCGA-13-0760-01.12	93	1_KEGG_PATHWAYS_IN_CANCER	323	24	0.0000000000060479469943327
TCGA-23-1031-01.17	142	1_KEGG_PATHWAYS_IN_CANCER	323	29	0.0000000000061985556883218
TCGA-59-2348-01.14	123	2_CELL_CYCLE_GO_0007049	265	25	0.0000000000062041893175560
TCGA-25-1633-01.1	71	2_EXTRACELLULAR_REGION_PART	269	20	0.0000000000062879607446968
TCGA-23-2078-01.15	105	2_M_PHASE	94	16	0.0000000000063536382850474
TCGA-13-1492-01.2	162	2_CELL_CYCLE_PROCESS	163	23	0.0000000000063656842346758
TCGA-13-0910-01.3	71	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	13	0.0000000000065201999548750
TCGA-24-0968-01.9	71	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000066228774878290
TCGA-59-2354-01.2	44	2_EXTRACELLULAR_REGION	346	18	0.0000000000066234365971150
TCGA-13-2060-01.10	86	2_CELL_CYCLE_PROCESS	163	18	0.0000000000066741330728487
TCGA-24-2261-01.2	87	1_KEGG_CELL_CYCLE	114	16	0.0000000000067432319608965
TCGA-09-1669-01.10	81	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000069186341662964
TCGA-13-1497-01.7	59	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000000069205440579448
TCGA-61-2109-01.13	122	1_KEGG_PATHWAYS_IN_CANCER	323	27	0.0000000000069733643457793
TCGA-13-0891-01.18	125	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000070363389661695
TCGA-13-0807-01.8	46	1_KEGG_CELL_CYCLE	114	13	0.0000000000070387511464209
TCGA-25-1623-01.7	111	2_EXTRACELLULAR_REGION_PART	269	24	0.0000000000072383384633575
TCGA-24-1603-01.3	69	2_CELL_CYCLE_PHASE	146	16	0.0000000000073809938735953
TCGA-13-0905-01.7	160	2_CELL_CYCLE_GO_0007049	265	28	0.0000000000073951431751629
TCGA-13-0760-01.12	93	2_CELL_PROLIFERATION_GO_0008283	436	27	0.0000000000076196354277598
TCGA-13-1512-01.2	113	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000079223618093244
TCGA-13-0894-01.9	118	2_EXTRACELLULAR_MATRIX	85	16	0.0000000000080233427551204
TCGA-23-2078-01.15	105	2_MITOTIC_CELL_CYCLE	134	18	0.0000000000080786384399483
TCGA-04-1525-01.7	52	2_CELL_CYCLE_PROCESS	163	15	0.0000000000081304199325816
TCGA-13-1497-01.7	59	1_KEGG_CELL_CYCLE	114	14	0.0000000000087501086632024
TCGA-04-1331-01.5	90	2_MITOTIC_CELL_CYCLE	134	17	0.0000000000089150299339700
TCGA-24-1103-01.5	73	1_KEGG_CELL_CYCLE	114	15	0.0000000000089373711851912
TCGA-24-1563-01.15	100	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000000000090546854437947
TCGA-13-0897-01.2	61	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000091621689383336
TCGA-36-1571-01.6	109	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000099032548274298
TCGA-09-0369-01.9	109	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000099032548274298
TCGA-04-1362-01.4	35	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000000000104248937154430
TCGA-13-1412-01.8	113	2_EXTRACELLULAR_REGION_PART	269	24	0.0000000000111172794390753
TCGA-04-1331-01.5	90	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000000000112202364092505
TCGA-04-1362-01.4	35	2_CELL_CYCLE_GO_0007049	265	15	0.0000000000117239478233948
TCGA-04-1331-01.5	90	1_KEGG_CELL_CYCLE	114	16	0.0000000000118640465467802
TCGA-04-1530-01.2	90	1_KEGG_CELL_CYCLE	114	16	0.0000000000118640465467802
TCGA-23-1117-01.11	99	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000119548582124996
TCGA-13-1505-01.13	60	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000119848762208773
TCGA-24-1556-01.19	120	2_CHROMOSOME	102	17	0.0000000000120564092511298
TCGA-04-1364-01.3	163	2_CELL_CYCLE_GO_0007049	265	28	0.0000000000121295511700491
TCGA-24-1427-01.4	83	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000121424778912768
TCGA-13-1482-01.7	62	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000121601018532504
TCGA-13-0890-01.2	48	2_CELL_CYCLE_PHASE	146	14	0.0000000000122438971171277
TCGA-59-2363-01.3	89	2_DNA_METABOLIC_PROCESS	218	20	0.0000000000125994761652711
TCGA-09-1665-01.16	131	2_CELL_CYCLE_PHASE	146	20	0.0000000000126003710822810
TCGA-23-1117-01.11	99	2_CELL_CYCLE_PHASE	146	18	0.0000000000127842805119287
TCGA-24-1563-01.15	100	2_EXTRACELLULAR_MATRIX	85	15	0.0000000000131589903122737
TCGA-24-0970-01.6	94	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000131717385476694
TCGA-25-1324-01.3	42	2_CELL_CYCLE_GO_0007049	265	16	0.0000000000136959396737184
TCGA-24-2019-01.10	192	1_KEGG_CELL_CYCLE	114	21	0.0000000000137459138176896
TCGA-24-1435-01.12	115	2_CELL_CYCLE_PHASE	146	19	0.0000000000138486271025188
TCGA-36-1580-01.1	65	2_EXTRACELLULAR_REGION_PART	269	19	0.0000000000147091013746562
TCGA-13-1494-01.4	65	1_KEGG_FOCAL_ADHESION	195	17	0.0000000000147288757395978
TCGA-30-1891-01.4	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000152094580070037
TCGA-23-1116-01.7	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000152094580070037
TCGA-23-1032-01.16	250	0_HALLMARK_G2M_CHECKPOINT	174	28	0.0000000000152199746461430
TCGA-13-1483-01.3	66	2_CELL_CYCLE_GO_0007049	265	19	0.0000000000152888330403944
TCGA-04-1331-01.5	90	2_CELL_CYCLE_PROCESS	163	18	0.0000000000156277636704852
TCGA-13-1488-01.17	109	1_KEGG_CELL_CYCLE	114	17	0.0000000000157799631990787
TCGA-13-1494-01.4	65	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000000158331200901051
TCGA-25-1623-01.7	111	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000160014871446927
TCGA-24-1474-01.12	122	2_CHROMOSOME	102	17	0.0000000000160198742961242
TCGA-24-1474-01.12	122	2_MITOSIS	71	15	0.0000000000161940555060106
TCGA-24-2288-01.12	112	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000171433479925603
TCGA-23-2079-01.14	85	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000171538178480917
TCGA-13-1495-01.22	101	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000176309285761413
TCGA-23-1118-01.5	50	2_CELL_CYCLE_GO_0007049	265	17	0.0000000000179335391558026
TCGA-24-1474-01.12	122	2_REGULATION_OF_CELL_CYCLE	160	20	0.0000000000184739270860982
TCGA-24-1616-01.2	38	1_KEGG_CELL_CYCLE	114	12	0.0000000000185624399114979
TCGA-04-1365-01.6	150	2_MITOSIS	71	16	0.0000000000185666816118815
TCGA-13-1509-01.9	117	2_CELL_CYCLE_PHASE	146	19	0.0000000000192661303648769
TCGA-13-1404-01.13	117	2_CELL_CYCLE_PHASE	146	19	0.0000000000192661303648769
TCGA-25-2401-01.5	119	2_EXTRACELLULAR_REGION	346	27	0.0000000000198296846085803
TCGA-24-1474-01.12	122	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	15	0.0000000000202374360569383
TCGA-23-1023-01.1	93	1_KEGG_CELL_CYCLE	114	16	0.0000000000204321290145724
TCGA-61-2113-01.15	99	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000000206044315403885
TCGA-23-1023-01.1	93	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000000000206489288064656
TCGA-31-1959-01.7	101	2_COLLAGEN	23	10	0.0000000000213129391726213
TCGA-24-1105-01.8	52	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000000217009630775391
TCGA-09-2050-01.18	196	0_HALLMARK_G2M_CHECKPOINT	174	25	0.0000000000229785729244404
TCGA-04-1365-01.6	150	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	16	0.0000000000235513609241785
TCGA-13-0723-01.8	50	1_KEGG_CELL_CYCLE	114	13	0.0000000000235812886596901
TCGA-23-1118-01.5	50	1_KEGG_CELL_CYCLE	114	13	0.0000000000235812886596901
TCGA-24-2035-01.8	102	2_COLLAGEN	23	10	0.0000000000235997394805581
TCGA-25-1626-01.2	86	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000000000241157616668361
TCGA-30-1891-01.4	84	2_EXTRACELLULAR_REGION	346	23	0.0000000000249707340001055
TCGA-36-1577-01.14	168	2_CELL_CYCLE_GO_0007049	265	28	0.0000000000269842630327806
TCGA-25-1326-01.11	119	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000272274548164056
TCGA-23-1023-01.1	93	2_CELL_CYCLE_PROCESS	163	18	0.0000000000287338340302421
TCGA-31-1953-01.6	53	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000000297882344152728
TCGA-24-2271-01.3	44	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000000000301268362063672
TCGA-25-1628-01.2	118	2_EXTRACELLULAR_REGION_PART	269	24	0.0000000000312085723249346
TCGA-24-2289-01.6	53	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000000000312750389740155
TCGA-59-2348-01.14	123	2_CELL_CYCLE_PROCESS	163	20	0.0000000000312831106805857
TCGA-04-1362-01.4	35	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000000000313495296463967
TCGA-24-1557-01.13	106	2_CELL_PROLIFERATION_GO_0008283	436	28	0.0000000000337376514059668
TCGA-31-1959-01.7	101	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000337685513229419
TCGA-25-1626-01.2	86	2_EXTRACELLULAR_MATRIX	85	14	0.0000000000341511059486011
TCGA-24-0979-01.5	41	2_CELL_CYCLE_PHASE	146	13	0.0000000000343100899165651
TCGA-24-0970-01.6	94	2_CELL_CYCLE_PROCESS	163	18	0.0000000000350192850360663
TCGA-13-0795-01.9	67	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000000355294590549953
TCGA-24-1466-01.15	82	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0000000000365247656347701
TCGA-04-1525-01.7	52	2_CELL_CYCLE_GO_0007049	265	17	0.0000000000380045192766927
TCGA-13-1496-01.13	120	1_KEGG_PATHWAYS_IN_CANCER	323	26	0.0000000000394454393862926
TCGA-13-0890-01.2	48	2_M_PHASE	94	12	0.0000000000401049758153009
TCGA-24-2271-01.3	44	2_EXTRACELLULAR_REGION_PART	269	16	0.0000000000412387019976041
TCGA-13-1506-01.5	113	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000000000418866575716245
TCGA-24-2289-01.6	53	2_EXTRACELLULAR_MATRIX	85	12	0.0000000000421435769231052
TCGA-24-1603-01.3	69	2_MITOTIC_CELL_CYCLE	134	15	0.0000000000426569948648645
TCGA-13-1494-01.4	65	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000000437587788484126
TCGA-24-1557-01.13	106	2_CELL_CYCLE_PHASE	146	18	0.0000000000448041582147131
TCGA-25-1633-01.1	71	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	13	0.0000000000456582883760602
TCGA-13-1492-01.2	162	2_REGULATION_OF_CELL_CYCLE	160	22	0.0000000000459799874460590
TCGA-13-0900-01.8	90	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000000000467247671872910
TCGA-57-1583-01.20	185	2_CELL_CYCLE_GO_0007049	265	29	0.0000000000467574066251587
TCGA-36-1580-01.1	65	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000479167918886788
TCGA-36-1570-01.2	36	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000000000482910759284766
TCGA-24-1469-01.6	123	2_CELL_CYCLE_PHASE	146	19	0.0000000000499165080341903
TCGA-13-0889-01.4	37	0_HALLMARK_E2F_TARGETS	169	13	0.0000000000500559363098405
TCGA-13-0886-01.1	45	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000000523889836679192
TCGA-13-0905-01.7	160	2_CELL_CYCLE_PROCESS	163	22	0.0000000000524022277098511
TCGA-61-2109-01.13	122	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000538039234141320
TCGA-23-1117-01.11	99	2_M_PHASE	94	15	0.0000000000539640236338938
TCGA-24-2262-01.25	141	2_CELL_CYCLE_PHASE	146	20	0.0000000000540410823157232
TCGA-13-0923-01.5	53	1_KEGG_CELL_CYCLE	114	13	0.0000000000542587925159507
TCGA-04-1530-01.2	90	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000550760522730327
TCGA-59-2351-01.5	31	1_KEGG_CELL_CYCLE	114	11	0.0000000000564594366007658
TCGA-24-2019-01.10	192	2_MITOSIS	71	17	0.0000000000565989477436937
TCGA-13-1509-01.9	117	2_MITOTIC_CELL_CYCLE	134	18	0.0000000000581415345131366
TCGA-09-2044-01.4	83	2_CELL_CYCLE_PROCESS	163	17	0.0000000000590971226506733
TCGA-13-1412-01.8	113	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000000000591974712504184
TCGA-13-0884-01.11	68	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000595997616819861
TCGA-23-1027-01.8	68	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000595997616819861
TCGA-04-1514-01.6	91	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000610728486297373
TCGA-25-1633-01.1	71	2_EXTRACELLULAR_MATRIX	85	13	0.0000000000630420720422547
TCGA-61-1998-01.14	105	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000000641436657273147
TCGA-25-2401-01.5	119	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000645578427884906
TCGA-13-0905-01.7	160	1_KEGG_CELL_CYCLE	114	19	0.0000000000650997062401445
TCGA-13-1495-01.22	101	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000655782886363384
TCGA-13-1501-01.12	101	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000655782886363384
TCGA-13-0900-01.8	90	2_EXTRACELLULAR_MATRIX	85	14	0.0000000000661156004179066
TCGA-04-1356-01.1	71	2_MITOTIC_CELL_CYCLE	134	15	0.0000000000672098887070523
TCGA-13-0727-01.1	29	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000000695247831729088
TCGA-24-1552-01.5	54	1_KEGG_CELL_CYCLE	114	13	0.0000000000707511392411932
TCGA-24-2019-01.10	192	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	17	0.0000000000727917291951000
TCGA-24-2030-01.8	161	1_KEGG_CELL_CYCLE	114	19	0.0000000000730962210535100
TCGA-13-0889-01.4	37	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000000000732686967299272
TCGA-13-0807-01.8	46	2_CELL_CYCLE_GO_0007049	265	16	0.0000000000737435900742540
TCGA-23-1027-01.8	68	1_KEGG_CELL_CYCLE	114	14	0.0000000000741271838581783
TCGA-04-1348-01.6	81	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000762602780418305
TCGA-09-1669-01.10	81	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000762602780418305
TCGA-13-1405-01.4	69	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000764048365827416
TCGA-13-1410-01.9	115	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000000768695925443416
TCGA-24-1552-01.5	54	2_CELL_CYCLE_GO_0007049	265	17	0.0000000000776502256639899
TCGA-04-1364-01.3	163	2_CELL_CYCLE_PROCESS	163	22	0.0000000000777231288265683
TCGA-04-1530-01.2	90	2_EXTRACELLULAR_REGION_PART	269	21	0.0000000000792861458915032
TCGA-24-1418-01.16	84	1_KEGG_CELL_CYCLE	114	15	0.0000000000816066274632296
TCGA-13-1412-01.8	113	2_EXTRACELLULAR_MATRIX	85	15	0.0000000000858060700303687
TCGA-13-0791-01.35	80	2_CELL_CYCLE_PHASE	146	16	0.0000000000900483069335601
TCGA-24-1548-01.8	141	1_KEGG_CELL_CYCLE	114	18	0.0000000000902443101862983
TCGA-61-1995-01.4	102	1_KEGG_CELL_CYCLE	114	16	0.0000000000931094056958299
TCGA-23-1123-01.7	70	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000975276954742895
TCGA-04-1365-01.6	150	2_REGULATION_OF_CELL_CYCLE	160	21	0.0000000000999901695543570
TCGA-04-1365-01.6	150	2_NON_MEMBRANE_BOUND_ORGANELLE	476	34	0.0000000001005919968958478
TCGA-04-1365-01.6	150	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	34	0.0000000001005919968958478
TCGA-09-2051-01.26	142	1_KEGG_CELL_CYCLE	114	18	0.0000000001023387213913434
TCGA-13-1404-01.13	117	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000001066344128653576
TCGA-13-1409-01.6	122	2_SIGNAL_TRANSDUCTION	1442	53	0.0000000001069752159991574
TCGA-25-1623-01.7	111	0_HALLMARK_E2F_TARGETS	169	19	0.0000000001081360866744600
TCGA-24-1614-01.5	86	2_CELL_CYCLE_PROCESS	163	17	0.0000000001104264319132426
TCGA-04-1342-01.12	104	2_MITOTIC_CELL_CYCLE	134	17	0.0000000001110367108773820
TCGA-10-0938-01.2	102	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000000001128187198591642
TCGA-04-1342-01.12	104	2_M_PHASE	94	15	0.0000000001149134121597373
TCGA-25-2401-01.5	119	2_COLLAGEN	23	10	0.0000000001153727294824001
TCGA-13-1494-01.4	65	2_EXTRACELLULAR_REGION	346	20	0.0000000001163951267869989
TCGA-36-1580-01.1	65	2_EXTRACELLULAR_REGION	346	20	0.0000000001163951267869989
TCGA-57-1583-01.20	185	2_CELL_CYCLE_PROCESS	163	23	0.0000000001195532590720442
TCGA-04-1356-01.1	71	0_HALLMARK_E2F_TARGETS	169	16	0.0000000001239727334339533
TCGA-25-1320-01.4	71	0_HALLMARK_E2F_TARGETS	169	16	0.0000000001239727334339533
TCGA-59-2351-01.5	31	0_HALLMARK_E2F_TARGETS	169	12	0.0000000001287549012402335
TCGA-25-2401-01.5	119	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000000001299428844722800
TCGA-24-2262-01.25	141	2_MITOTIC_CELL_CYCLE	134	19	0.0000000001306805476267966
TCGA-23-1110-01.7	299	2_CELL_CYCLE_GO_0007049	265	36	0.0000000001356917741541351
TCGA-13-0920-01.9	82	2_CELL_CYCLE_PHASE	146	16	0.0000000001358118042118689
TCGA-24-1556-01.19	120	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	12	0.0000000001365740398130741
TCGA-13-1481-01.3	78	2_COLLAGEN	23	9	0.0000000001394338817991026
TCGA-36-1574-01.10	152	1_KEGG_P53_SIGNALING_PATHWAY	66	15	0.0000000001396330592689296
TCGA-24-1469-01.6	123	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000000001399216909945634
TCGA-13-0724-01.21	71	1_KEGG_CELL_CYCLE	114	14	0.0000000001405287987053870
TCGA-61-1919-01.9	87	1_KEGG_CELL_CYCLE	114	15	0.0000000001407786506080500
TCGA-13-1506-01.5	113	2_CELL_CYCLE_PHASE	146	18	0.0000000001429542004429341
TCGA-24-1469-01.6	123	2_MITOTIC_CELL_CYCLE	134	18	0.0000000001430257502615701
TCGA-23-1110-01.7	299	1_KEGG_CELL_CYCLE	114	24	0.0000000001459818579692375
TCGA-36-1577-01.14	168	2_CELL_CYCLE_PROCESS	163	22	0.0000000001471246264228752
TCGA-09-2051-01.26	142	2_MITOTIC_CELL_CYCLE	134	19	0.0000000001491040577201450
TCGA-23-1024-01.3	24	0_HALLMARK_E2F_TARGETS	169	11	0.0000000001492885870966278
TCGA-24-1105-01.8	52	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000001542388019281869
TCGA-24-2290-01.3	70	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000001546260251076956
TCGA-23-1123-01.7	70	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000001546260251076956
TCGA-13-1481-01.3	78	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	13	0.0000000001650485619152609
TCGA-13-0730-01.8	83	2_CELL_CYCLE_PHASE	146	16	0.0000000001660544718656494
TCGA-23-1117-01.11	99	2_EXTRACELLULAR_MATRIX_PART	51	12	0.0000000001693763424138511
TCGA-23-1120-01.10	57	2_CELL_CYCLE_PHASE	146	14	0.0000000001735070924874117
TCGA-24-2261-01.2	87	2_M_PHASE	94	14	0.0000000001736048818091195
TCGA-13-0886-01.1	45	1_KEGG_CELL_CYCLE	114	12	0.0000000001837977928967796
TCGA-25-1623-01.7	111	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000001852325147092316
TCGA-25-2401-01.5	119	2_EXTRACELLULAR_MATRIX	85	15	0.0000000001881237490242822
TCGA-29-2427-01.10	116	0_HALLMARK_ALLOGRAFT_REJECTION	190	20	0.0000000001900169271990528
TCGA-24-1425-01.1	61	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000000001931195976898274
TCGA-24-1422-01.10	56	2_EXTRACELLULAR_REGION_PART	269	17	0.0000000001963827423819906
TCGA-25-1320-01.4	71	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000001964540226897181
TCGA-25-1326-01.11	119	2_CELL_CYCLE_PROCESS	163	19	0.0000000002072025155516275
TCGA-25-1324-01.3	42	2_CELL_CYCLE_PROCESS	163	13	0.0000000002073176724717862
TCGA-25-1322-01.15	93	2_MITOSIS	71	13	0.0000000002115197103185399
TCGA-13-1410-01.9	115	0_HALLMARK_E2F_TARGETS	169	19	0.0000000002116707361311940
TCGA-23-1120-01.10	57	2_CELL_CYCLE_GO_0007049	265	17	0.0000000002132416933210474
TCGA-24-1418-01.16	84	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000000002175092974734726
TCGA-13-0906-01.5	66	2_CELL_CYCLE_GO_0007049	265	18	0.0000000002250379357596944
TCGA-13-1481-01.3	78	2_EXTRACELLULAR_MATRIX	85	13	0.0000000002275721609239919
TCGA-24-2289-01.6	53	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000000002284505274805667
TCGA-13-1495-01.22	101	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000000002334802917698196
TCGA-36-1574-01.10	152	2_CELL_CYCLE_PHASE	146	20	0.0000000002344293202719773
TCGA-61-2109-01.13	122	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000002349601440021323
TCGA-24-2293-01.3	33	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000002356873686404765
TCGA-13-0900-01.8	90	1_KEGG_CELL_CYCLE	114	15	0.0000000002377374139003178
TCGA-09-1659-01.5	51	0_HALLMARK_E2F_TARGETS	169	14	0.0000000002457212926992076
TCGA-13-1501-01.12	101	0_HALLMARK_E2F_TARGETS	169	18	0.0000000002470923000217749
TCGA-24-1551-01.15	87	0_HALLMARK_E2F_TARGETS	169	17	0.0000000002472875012965382
TCGA-25-1322-01.15	93	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	13	0.0000000002560866997637799
TCGA-24-1425-01.1	61	2_EXTRACELLULAR_MATRIX	85	12	0.0000000002598214318247450
TCGA-57-1583-01.20	185	0_HALLMARK_E2F_TARGETS	169	23	0.0000000002637956369800889
TCGA-13-0923-01.5	53	2_CELL_CYCLE_PROCESS	163	14	0.0000000002677589055873700
TCGA-13-0903-01.11	77	2_CELL_CYCLE_PROCESS	163	16	0.0000000002731265184194558
TCGA-24-1469-01.6	123	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000002739125476885425
TCGA-25-1635-01.6	129	1_KEGG_CELL_CYCLE	114	17	0.0000000002813571089869685
TCGA-04-1331-01.5	90	2_M_PHASE	94	14	0.0000000002832497913663550
TCGA-24-1463-01.5	130	2_COLLAGEN	23	10	0.0000000002848849057204481
TCGA-24-1556-01.19	120	2_MITOSIS	71	14	0.0000000002907921815945859
TCGA-25-2396-01.6	42	2_M_PHASE	94	11	0.0000000002913399785922516
TCGA-36-1576-01.8	124	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000000002914207286095012
TCGA-31-1959-01.7	101	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000002924485221250488
TCGA-04-1338-01.7	85	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000002943471304467633
TCGA-13-0804-01.5	78	2_MITOTIC_CELL_CYCLE	134	15	0.0000000002952124194357905
TCGA-24-1614-01.5	86	2_CELL_CYCLE_PHASE	146	16	0.0000000002984824466740829
TCGA-04-1338-01.7	85	2_COLLAGEN	23	9	0.0000000003118581384289266
TCGA-36-1577-01.14	168	0_HALLMARK_E2F_TARGETS	169	22	0.0000000003145690013529297
TCGA-13-0714-01.9	51	2_COLLAGEN	23	8	0.0000000003162199834545242
TCGA-13-0916-01.11	92	2_DNA_METABOLIC_PROCESS	218	19	0.0000000003165050341196395
TCGA-23-1117-01.11	99	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000003165326077277849
TCGA-25-1322-01.15	93	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000003166465538489356
TCGA-25-2398-01.5	81	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000003233953595700312
TCGA-24-2030-01.8	161	1_KEGG_P53_SIGNALING_PATHWAY	66	15	0.0000000003292473637577649
TCGA-24-1105-01.8	52	0_HALLMARK_E2F_TARGETS	169	14	0.0000000003310887398187164
TCGA-23-1122-01.11	77	2_CELL_CYCLE_GO_0007049	265	19	0.0000000003402571350194215
TCGA-13-1407-01.11	220	0_HALLMARK_G2M_CHECKPOINT	174	25	0.0000000003406557803259369
TCGA-25-1626-01.2	86	2_COLLAGEN	23	9	0.0000000003478411985517103
TCGA-57-1993-01.8	52	2_MITOTIC_CELL_CYCLE	134	13	0.0000000003492236583334684
TCGA-24-1556-01.19	120	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	14	0.0000000003571869738863189
TCGA-24-0975-01.6	78	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000003614454122515424
TCGA-13-1412-01.8	113	2_EXTRACELLULAR_REGION	346	25	0.0000000003659377052940679
TCGA-10-0933-01.2	97	2_MITOSIS	71	13	0.0000000003711833778516550
TCGA-36-1570-01.2	36	1_KEGG_CELL_CYCLE	114	11	0.0000000003809618606337252
TCGA-13-0916-01.11	92	2_M_PHASE	94	14	0.0000000003885782300090544
TCGA-24-1425-01.1	61	2_EXTRACELLULAR_REGION	346	19	0.0000000003887615822304162
TCGA-13-0760-01.12	93	1_KEGG_CELL_CYCLE	114	15	0.0000000003936134651541037
TCGA-13-1510-01.20	82	1_KEGG_PATHWAYS_IN_CANCER	323	21	0.0000000003978762926348529
TCGA-23-1027-01.8	68	2_CELL_CYCLE_GO_0007049	265	18	0.0000000003979428999927908
TCGA-24-2035-01.8	102	2_CHEMOKINE_ACTIVITY	40	11	0.0000000004033658501745682
TCGA-13-1507-01.8	101	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000004116423392031672
TCGA-13-1501-01.12	101	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000004116423392031672
TCGA-24-1422-01.10	56	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000000004122337892780920
TCGA-13-0760-01.12	93	2_CELL_CYCLE_PROCESS	163	17	0.0000000004314762597806429
TCGA-23-1032-01.16	250	0_HALLMARK_E2F_TARGETS	169	26	0.0000000004356045093293227
TCGA-13-1492-01.2	162	2_DNA_METABOLIC_PROCESS	218	24	0.0000000004364420921673263
TCGA-24-1424-01.4	80	2_MITOTIC_CELL_CYCLE	134	15	0.0000000004379162537866050
TCGA-13-0791-01.35	80	2_MITOTIC_CELL_CYCLE	134	15	0.0000000004379162537866050
TCGA-09-1665-01.16	131	2_MITOTIC_CELL_CYCLE	134	18	0.0000000004399084903277323
TCGA-10-0933-01.2	97	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	13	0.0000000004492129092844181
TCGA-24-1548-01.8	141	2_CELL_CYCLE_PROCESS	163	20	0.0000000004594043056969522
TCGA-24-1417-01.14	94	1_KEGG_CELL_CYCLE	114	15	0.0000000004637208289946804
TCGA-24-2035-01.8	102	2_LOCOMOTORY_BEHAVIOR	86	14	0.0000000004729671658131853
TCGA-24-0982-01.3	34	0_HALLMARK_E2F_TARGETS	169	12	0.0000000004776036258464007
TCGA-23-1027-01.8	68	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000000004818945927107593
TCGA-25-1324-01.3	42	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000000004845414602683412
TCGA-25-1633-01.1	71	0_HALLMARK_COAGULATION	125	14	0.0000000005171748661573609
TCGA-24-1417-01.14	94	2_CELL_CYCLE_PROCESS	163	17	0.0000000005190057217371531
TCGA-24-2298-01.7	138	2_COLLAGEN	23	10	0.0000000005233315225226224
TCGA-25-2396-01.6	42	2_MITOTIC_CELL_CYCLE	134	12	0.0000000005235914901366550
TCGA-25-1319-01.10	69	2_CELL_CYCLE_GO_0007049	265	18	0.0000000005250166028914311
TCGA-24-1435-01.12	115	2_M_PHASE	94	15	0.0000000005290639866124079
TCGA-24-2030-01.8	161	2_CELL_CYCLE_GO_0007049	265	26	0.0000000005325265736698882
TCGA-13-0889-01.4	37	1_KEGG_CELL_CYCLE	114	11	0.0000000005367104872349788
TCGA-24-2035-01.8	102	2_CHEMOKINE_RECEPTOR_BINDING	41	11	0.0000000005463890152931094
TCGA-24-1436-01.1	49	1_KEGG_CELL_CYCLE	114	12	0.0000000005664205184461677
TCGA-24-2254-01.3	49	1_KEGG_CELL_CYCLE	114	12	0.0000000005664205184461677
TCGA-13-1481-01.3	78	2_EXTRACELLULAR_REGION_PART	269	19	0.0000000005748333686225714
TCGA-23-1117-01.11	99	2_EXTRACELLULAR_REGION_PART	269	21	0.0000000005981874870372081
TCGA-13-0723-01.8	50	2_CELL_CYCLE_PHASE	146	13	0.0000000006136540140034935
TCGA-24-1435-01.12	115	2_MITOTIC_CELL_CYCLE	134	17	0.0000000006189246659803620
TCGA-24-2288-01.12	112	2_CELL_CYCLE_GO_0007049	265	22	0.0000000006277974117635904
TCGA-24-1428-01.9	90	2_CELL_CYCLE_PHASE	146	16	0.0000000006289855378820012
TCGA-04-1348-01.6	81	2_CELL_CYCLE_PROCESS	163	16	0.0000000006325441874096967
TCGA-09-1669-01.10	81	2_CELL_CYCLE_PROCESS	163	16	0.0000000006325441874096967
TCGA-24-1434-01.3	82	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000006405438962682994
TCGA-13-0920-01.9	82	2_MITOTIC_CELL_CYCLE	134	15	0.0000000006422481879076985
TCGA-24-1435-01.12	115	1_KEGG_CELL_CYCLE	114	16	0.0000000006466876001129781
TCGA-13-0885-01.6	44	0_HALLMARK_E2F_TARGETS	169	13	0.0000000006545519949478149
TCGA-10-0933-01.2	97	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000006546466191748336
TCGA-24-0982-01.3	34	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000006782327445528609
TCGA-13-1509-01.9	117	2_M_PHASE	94	15	0.0000000006860208833145721
TCGA-36-1576-01.8	124	0_HALLMARK_COAGULATION	125	17	0.0000000006871989509682356
TCGA-09-2044-01.4	83	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000000007060517251180334
TCGA-13-0800-01.9	124	0_HALLMARK_ALLOGRAFT_REJECTION	190	20	0.0000000007064823179767820
TCGA-10-0938-01.2	102	2_MITOSIS	71	13	0.0000000007236983632210270
TCGA-25-1626-01.2	86	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000007238836631117908
TCGA-09-2051-01.26	142	2_CELL_CYCLE_PHASE	146	19	0.0000000007340104087166733
TCGA-24-2262-01.25	141	2_M_PHASE	94	16	0.0000000007365135781086193
TCGA-13-0897-01.2	61	2_CELL_CYCLE_GO_0007049	265	17	0.0000000007412414818030790
TCGA-25-2398-01.5	81	1_KEGG_FOCAL_ADHESION	195	17	0.0000000007590601536826365
TCGA-23-1117-01.11	99	2_MITOTIC_CELL_CYCLE	134	16	0.0000000007622802121528812
TCGA-13-0889-01.4	37	2_CELL_CYCLE_GO_0007049	265	14	0.0000000007686502266310103
TCGA-24-1463-01.5	130	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000007702423013786518
TCGA-13-0730-01.8	83	2_MITOTIC_CELL_CYCLE	134	15	0.0000000007746179148335357
TCGA-23-1023-01.1	93	0_HALLMARK_E2F_TARGETS	169	17	0.0000000007861318667584012
TCGA-24-1549-01.21	158	2_MITOSIS	71	15	0.0000000007895417999363891
TCGA-13-0900-01.8	90	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000007950288516684129
TCGA-25-1319-01.10	69	2_CELL_CYCLE_PROCESS	163	15	0.0000000007990889322877802
TCGA-13-1492-01.2	162	2_CELL_CYCLE_PHASE	146	20	0.0000000008014032876311947
TCGA-23-1120-01.10	57	2_CELL_CYCLE_PROCESS	163	14	0.0000000008075544952025453
TCGA-30-1891-01.4	84	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000008430484246341229
TCGA-13-1509-01.9	117	1_KEGG_CELL_CYCLE	114	16	0.0000000008519746057498077
TCGA-13-0903-01.11	77	2_CELL_CYCLE_PHASE	146	15	0.0000000008686424804508934
TCGA-36-1576-01.8	124	0_HALLMARK_E2F_TARGETS	169	19	0.0000000008707487839778579
TCGA-10-0938-01.2	102	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	13	0.0000000008753982571761954
TCGA-24-1463-01.5	130	2_MITOSIS	71	14	0.0000000008970475285304818
TCGA-24-1422-01.10	56	2_EXTRACELLULAR_REGION	346	18	0.0000000009137436922527462
TCGA-13-0923-01.5	53	2_CELL_CYCLE_GO_0007049	265	16	0.0000000009257507993420746
TCGA-25-1623-01.7	111	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000000009403696944395848
TCGA-24-1434-01.3	82	1_KEGG_FOCAL_ADHESION	195	17	0.0000000009404700169283015
TCGA-24-1425-01.1	61	2_EXTRACELLULAR_REGION_PART	269	17	0.0000000009466444100380718
TCGA-10-0934-01.11	145	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	24	0.0000000009505932398491321
TCGA-25-1628-01.2	118	2_MITOTIC_CELL_CYCLE	134	17	0.0000000009566597643785940
TCGA-61-2002-01.1	118	1_KEGG_CELL_CYCLE	114	16	0.0000000009759170514528569
TCGA-36-1571-01.6	109	0_HALLMARK_E2F_TARGETS	169	18	0.0000000009768384685516958
TCGA-24-1549-01.21	158	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	15	0.0000000009831099986770004
TCGA-13-1512-01.2	113	2_CELL_CYCLE_PROCESS	163	18	0.0000000009910999316987785
TCGA-13-0889-01.4	37	2_CELL_CYCLE_PROCESS	163	12	0.0000000009979764595781795
TCGA-24-2290-01.3	70	2_CELL_CYCLE_PROCESS	163	15	0.0000000010020320007953196
TCGA-13-0717-01.6	103	2_CELL_CYCLE_GO_0007049	265	21	0.0000000010185918450322182
TCGA-25-1628-01.2	118	2_EXTRACELLULAR_REGION	346	25	0.0000000010422483511278061
TCGA-13-0894-01.9	118	2_EXTRACELLULAR_REGION	346	25	0.0000000010422483511278061
TCGA-13-1497-01.7	59	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000010471014239045468
TCGA-24-0968-01.9	71	1_KEGG_OOCYTE_MEIOSIS	105	13	0.0000000010617958699696791
TCGA-04-1525-01.7	52	2_CELL_CYCLE_PHASE	146	13	0.0000000010695277724219211
TCGA-57-1993-01.8	52	2_CELL_CYCLE_PHASE	146	13	0.0000000010695277724219211
TCGA-13-0760-01.12	93	2_CELL_CYCLE_PHASE	146	16	0.0000000010727757170671255
TCGA-24-1463-01.5	130	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	14	0.0000000011007636190697376
TCGA-59-2350-01.1	62	2_M_PHASE	94	12	0.0000000011106426710683103
TCGA-24-1556-01.19	120	2_CHROMOSOMAL_PART	78	14	0.0000000011484463667959476
TCGA-24-2289-01.6	53	2_EXTRACELLULAR_REGION_PART	269	16	0.0000000011670014868307601
TCGA-13-0800-01.9	124	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	12	0.0000000012021212026359508
TCGA-13-0899-01.1	28	0_HALLMARK_E2F_TARGETS	169	11	0.0000000012072879068159641
TCGA-13-0727-01.1	29	1_KEGG_CELL_CYCLE	114	10	0.0000000012240468744477188
TCGA-57-1993-01.8	52	1_KEGG_CELL_CYCLE	114	12	0.0000000012293918847894315
TCGA-24-1424-01.4	80	2_M_PHASE	94	13	0.0000000012313656952871477
TCGA-13-0916-01.11	92	2_CHROMOSOME	102	14	0.0000000012456460334538571
TCGA-61-1919-01.9	87	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000012562731916988478
TCGA-24-1417-01.14	94	2_CELL_CYCLE_PHASE	146	16	0.0000000012759946547563763
TCGA-24-0970-01.6	94	2_CELL_CYCLE_PHASE	146	16	0.0000000012759946547563763
TCGA-61-2109-01.13	122	2_M_PHASE	94	15	0.0000000012856014462041693
TCGA-25-1623-01.7	111	2_EXTRACELLULAR_MATRIX	85	14	0.0000000013250524169812181
TCGA-13-0900-01.8	90	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000013288267570522239
TCGA-23-1120-01.10	57	0_HALLMARK_E2F_TARGETS	169	14	0.0000000013329698341982905
TCGA-13-1497-01.7	59	2_CELL_CYCLE_PROCESS	163	14	0.0000000013547859770265336
TCGA-23-1032-01.16	250	2_CELL_CYCLE_PROCESS	163	25	0.0000000013826942847963428
TCGA-13-1507-01.8	101	1_KEGG_CELL_CYCLE	114	15	0.0000000013846390572198828
TCGA-25-2393-01.5	140	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000013969906836978144
TCGA-13-0923-01.5	53	2_CELL_CYCLE_PHASE	146	13	0.0000000013985542126852444
TCGA-10-0937-01.9	40	1_KEGG_CELL_CYCLE	114	11	0.0000000014080512639023719
TCGA-13-1408-01.1	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000014228138280516684
TCGA-24-1616-01.2	38	2_CELL_CYCLE_PROCESS	163	12	0.0000000014370318404909752
TCGA-24-1425-01.1	61	2_COLLAGEN	23	8	0.0000000014418172769699793
TCGA-24-1474-01.12	122	2_CHROMOSOMAL_PART	78	14	0.0000000014484049688871134
TCGA-59-2348-01.14	123	2_M_PHASE	94	15	0.0000000014525786265628804
TCGA-13-0894-01.9	118	2_EXTRACELLULAR_MATRIX_PART	51	12	0.0000000014530288113683151
TCGA-25-1324-01.3	42	2_CELL_CYCLE_PHASE	146	12	0.0000000014760573091939900
TCGA-13-0800-01.9	124	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000014816554646517483
TCGA-24-1558-01.12	174	1_KEGG_PATHWAYS_IN_CANCER	323	29	0.0000000015245373726928404
TCGA-24-2261-01.2	87	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000000015262111241874613
TCGA-25-1633-01.1	71	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000000015350694356488341
TCGA-23-1124-01.17	107	1_KEGG_PATHWAYS_IN_CANCER	323	23	0.0000000015617998981197826
TCGA-04-1365-01.6	150	2_CHROMOSOMAL_PART	78	15	0.0000000015843867390176778
TCGA-25-2391-01.2	64	2_M_PHASE	94	12	0.0000000016615309288403279
TCGA-23-1027-01.8	68	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000016643727370127949
TCGA-24-1614-01.5	86	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	15	0.0000000016681176835663923
TCGA-61-2109-01.13	122	2_MITOTIC_CELL_CYCLE	134	17	0.0000000016763596839846202
TCGA-25-2404-01.5	58	0_HALLMARK_E2F_TARGETS	169	14	0.0000000017301212371743272
TCGA-24-1413-01.6	34	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000000017384852522267026
TCGA-13-1501-01.12	101	2_CELL_CYCLE_PROCESS	163	17	0.0000000017770166567950502
TCGA-23-1110-01.7	299	2_CELL_CYCLE_PROCESS	163	27	0.0000000017955945426536640
TCGA-04-1362-01.4	35	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000000017957484162736817
TCGA-04-1530-01.2	90	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000018445367612136309
TCGA-25-2399-01.16	103	2_COLLAGEN	23	9	0.0000000018554552608004843
TCGA-13-0717-01.6	103	1_KEGG_CELL_CYCLE	114	15	0.0000000018626860493478685
TCGA-25-2399-01.16	103	1_KEGG_CELL_CYCLE	114	15	0.0000000018626860493478685
TCGA-24-1466-01.15	82	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0000000019099747995488276
TCGA-25-1623-01.7	111	2_EXTRACELLULAR_REGION	346	24	0.0000000019182413263617517
TCGA-04-1338-01.7	85	1_KEGG_CELL_CYCLE	114	14	0.0000000019289852631702007
TCGA-24-2035-01.8	102	2_BEHAVIOR	138	16	0.0000000019626267094184621
TCGA-61-1736-01.2	54	1_KEGG_CELL_CYCLE	114	12	0.0000000020026424600514306
TCGA-13-0887-01.6	47	2_CELL_CYCLE_GO_0007049	265	15	0.0000000020061009796342184
TCGA-13-0723-01.8	50	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000000020134890903226332
TCGA-24-2271-01.3	44	2_EXTRACELLULAR_REGION	346	16	0.0000000020561601226144749
TCGA-24-1614-01.5	86	2_REGULATION_OF_KINASE_ACTIVITY	138	15	0.0000000020718462898568405
TCGA-61-2000-01.11	69	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000020930323928399293
TCGA-25-1322-01.15	93	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000021492210624616646
TCGA-23-1023-01.1	93	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000021492210624616646
TCGA-59-2350-01.1	62	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000021916995466250750
TCGA-24-1616-01.2	38	0_HALLMARK_E2F_TARGETS	169	12	0.0000000022165708007019080
TCGA-25-1628-01.2	118	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000000022238493356020572
TCGA-24-1557-01.13	106	2_MITOTIC_CELL_CYCLE	134	16	0.0000000022876376819923458
TCGA-23-2079-01.14	85	2_CELL_CYCLE_GO_0007049	265	19	0.0000000023314141546441373
TCGA-13-1408-01.1	45	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000000023942289132429469
TCGA-13-1411-01.7	96	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000024087397665737779
TCGA-13-0791-01.35	80	1_KEGG_PATHWAYS_IN_CANCER	323	20	0.0000000024597931091391575
TCGA-25-1626-01.2	86	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	19	0.0000000025490355132814679
TCGA-23-1118-01.5	50	2_CELL_CYCLE_PROCESS	163	13	0.0000000025593456999488833
TCGA-04-1343-01.7	50	2_CELL_CYCLE_PROCESS	163	13	0.0000000025593456999488833
TCGA-24-1614-01.5	86	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	15	0.0000000025642711471995943
TCGA-61-2102-01.7	172	2_CELL_CYCLE_GO_0007049	265	26	0.0000000026059046863844985
TCGA-24-1614-01.5	86	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	10	0.0000000026174476960420379
TCGA-13-0894-01.9	118	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000026410655062165159
TCGA-10-0933-01.2	97	2_CHROMOSOME	102	14	0.0000000026460679586439542
TCGA-36-1576-01.8	124	2_EXTRACELLULAR_MATRIX_PART	51	12	0.0000000026501145959440881
TCGA-24-1428-01.9	90	2_MITOTIC_CELL_CYCLE	134	15	0.0000000026820454969612057
TCGA-24-1470-01.7	76	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000000027465859106376585
TCGA-20-0991-01.12	166	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	25	0.0000000027617065074559621
TCGA-09-2044-01.4	83	2_CELL_CYCLE_PHASE	146	15	0.0000000027683396054508029
TCGA-13-1483-01.3	66	2_COLLAGEN	23	8	0.0000000027922226429465868
TCGA-24-1557-01.13	106	1_KEGG_CELL_CYCLE	114	15	0.0000000028710704051352007
TCGA-61-2102-01.7	172	1_KEGG_CELL_CYCLE	114	18	0.0000000029453367702766526
TCGA-25-1319-01.10	69	2_CELL_CYCLE_PHASE	146	14	0.0000000029765544241481576
TCGA-13-1497-01.7	59	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000000030402393032167532
TCGA-04-1338-01.7	85	2_EXTRACELLULAR_REGION_PART	269	19	0.0000000030463441698688181
TCGA-13-0916-01.11	92	2_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0000000030901245787193116
TCGA-13-0916-01.11	92	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0000000030901245787193116
TCGA-04-1356-01.1	71	1_KEGG_CELL_CYCLE	114	13	0.0000000031290657623272313
TCGA-25-1628-01.2	118	2_EXTRACELLULAR_MATRIX	85	14	0.0000000031291911810373613
TCGA-24-1416-01.4	38	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000031414604578325444
TCGA-24-1616-01.2	38	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000031414604578325444
TCGA-13-2060-01.10	86	2_M_PHASE	94	13	0.0000000032408072507972260
TCGA-13-0800-01.9	124	2_IMMUNE_RESPONSE	206	20	0.0000000032593136679112056
TCGA-24-0968-01.9	71	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000032713050996591499
TCGA-36-1571-01.6	109	2_CELL_CYCLE_GO_0007049	265	21	0.0000000032738204975702681
TCGA-13-1488-01.17	109	2_CELL_CYCLE_GO_0007049	265	21	0.0000000032738204975702681
TCGA-13-1404-01.13	117	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	11	0.0000000034141358851307199
TCGA-13-0755-01.6	16	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000034300447450820743
TCGA-25-1320-01.4	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000035578317187099785
TCGA-13-0924-01.5	68	2_MITOSIS	71	11	0.0000000035628712476353980
TCGA-61-1919-01.9	87	0_HALLMARK_E2F_TARGETS	169	16	0.0000000035834781978988061
TCGA-04-1331-01.5	90	2_MITOSIS	71	12	0.0000000035934450077825891
TCGA-57-1582-01.26	174	1_KEGG_CELL_CYCLE	114	18	0.0000000035955244323709785
TCGA-24-1551-01.15	87	2_CELL_CYCLE_GO_0007049	265	19	0.0000000036408896762035219
TCGA-24-2035-01.8	102	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	11	0.0000000036718345483836141
TCGA-24-2290-01.3	70	2_CELL_CYCLE_PHASE	146	14	0.0000000036720039523972420
TCGA-23-1123-01.7	70	2_CELL_CYCLE_PHASE	146	14	0.0000000036720039523972420
TCGA-25-1623-01.7	111	2_COLLAGEN	23	9	0.0000000036957334303558488
TCGA-24-1424-01.4	80	2_DNA_METABOLIC_PROCESS	218	17	0.0000000037893662441605195
TCGA-04-1525-01.7	52	2_M_PHASE	94	11	0.0000000037910339655210391
TCGA-57-1993-01.8	52	2_M_PHASE	94	11	0.0000000037910339655210391
TCGA-20-0990-01.17	133	1_KEGG_PATHWAYS_IN_CANCER	323	25	0.0000000038148378443536728
TCGA-25-1628-01.2	118	2_CELL_CYCLE_PHASE	146	17	0.0000000039803146381239530
TCGA-24-1436-01.1	49	2_CELL_CYCLE_GO_0007049	265	15	0.0000000039989611451299493
TCGA-13-1405-01.4	69	2_COLLAGEN	23	8	0.0000000040476202785351203
TCGA-59-2350-01.1	62	2_MITOTIC_CELL_CYCLE	134	13	0.0000000040525093894389317
TCGA-13-1501-01.12	101	2_CELL_CYCLE_PHASE	146	16	0.0000000040564368852325666
TCGA-04-1356-01.1	71	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	14	0.0000000041045584872873235
TCGA-24-2030-01.8	161	2_REGULATION_OF_CELL_CYCLE	160	20	0.0000000041087751675593231
TCGA-13-0924-01.5	68	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000000041819914482880227
TCGA-04-1331-01.5	90	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	12	0.0000000042791316898423747
TCGA-24-1603-01.3	69	2_M_PHASE	94	12	0.0000000042831975257494867
TCGA-24-1614-01.5	86	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	15	0.0000000043063078673045493
TCGA-24-1552-01.5	54	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000000043256365146004054
TCGA-23-1023-01.1	93	2_MITOTIC_CELL_CYCLE	134	15	0.0000000044138655572232679
TCGA-61-2113-01.15	99	2_CELL_CYCLE_GO_0007049	265	20	0.0000000044312074754235451
TCGA-24-1105-01.8	52	2_CELL_CYCLE_PROCESS	163	13	0.0000000044455623512797278
TCGA-25-1326-01.11	119	2_CELL_CYCLE_PHASE	146	17	0.0000000045833661508082775
TCGA-24-0982-01.3	34	2_CELL_CYCLE_GO_0007049	265	13	0.0000000046019183683895577
TCGA-13-0900-01.8	90	1_KEGG_FOCAL_ADHESION	195	17	0.0000000046946314688328371
TCGA-61-1995-01.4	102	2_CELL_CYCLE_PHASE	146	16	0.0000000047484393480911153
TCGA-13-2060-01.10	86	2_CELL_CYCLE_PHASE	146	15	0.0000000047652191750099890
TCGA-25-1627-01.4	75	0_HALLMARK_E2F_TARGETS	169	15	0.0000000049959935768610461
TCGA-25-2404-01.5	58	1_KEGG_CELL_CYCLE	114	12	0.0000000050016913270938294
TCGA-24-2290-01.3	70	2_M_PHASE	94	12	0.0000000051277944622310287
TCGA-23-1123-01.7	70	2_M_PHASE	94	12	0.0000000051277944622310287
TCGA-25-1633-01.1	71	2_COLLAGEN	23	8	0.0000000051355900210575878
TCGA-13-0884-01.11	68	2_CELL_CYCLE_GO_0007049	265	17	0.0000000052041982757624932
TCGA-13-0723-01.8	50	2_MITOTIC_CELL_CYCLE	134	12	0.0000000052213165964747267
TCGA-04-1343-01.7	50	2_MITOTIC_CELL_CYCLE	134	12	0.0000000052213165964747267
TCGA-13-1409-01.6	122	0_HALLMARK_ALLOGRAFT_REJECTION	190	19	0.0000000053766793966315050
TCGA-61-2109-01.13	122	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	11	0.0000000054385566254814601
TCGA-04-1343-01.7	50	2_CELL_CYCLE_GO_0007049	265	15	0.0000000055708862470163935
TCGA-23-1028-01.18	93	1_KEGG_PATHWAYS_IN_CANCER	323	21	0.0000000056992645420281348
TCGA-04-1356-01.1	71	2_MITOSIS	71	11	0.0000000058470131547602882
TCGA-61-2094-01.6	63	0_HALLMARK_E2F_TARGETS	169	14	0.0000000059025338802728064
TCGA-24-1563-01.15	100	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000060380051029944890
TCGA-04-1332-01.2	25	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000000060921944405653756
TCGA-13-0900-01.8	90	0_HALLMARK_E2F_TARGETS	169	16	0.0000000062004906737332876
TCGA-61-1998-01.14	105	0_HALLMARK_E2F_TARGETS	169	17	0.0000000062100285094309201
TCGA-13-1506-01.5	113	2_MITOTIC_CELL_CYCLE	134	16	0.0000000063274638679943787
TCGA-36-1571-01.6	109	2_CELL_CYCLE_PROCESS	163	17	0.0000000064432774220493546
TCGA-20-0990-01.17	133	1_KEGG_CELL_CYCLE	114	16	0.0000000064686455105843626
TCGA-25-1628-01.2	118	2_COLLAGEN	23	9	0.0000000064778295750624786
TCGA-13-0891-01.18	125	2_CELL_CYCLE_GO_0007049	265	22	0.0000000064816067298970049
TCGA-13-0905-01.7	160	2_CELL_CYCLE_PHASE	146	19	0.0000000065028749686874967
TCGA-04-1346-01.10	75	1_KEGG_CELL_CYCLE	114	13	0.0000000065499350363285506
TCGA-25-1627-01.4	75	1_KEGG_CELL_CYCLE	114	13	0.0000000065499350363285506
TCGA-13-1507-01.8	101	2_CELL_CYCLE_GO_0007049	265	20	0.0000000065680328978223240
TCGA-13-1408-01.1	45	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000065891887499308883
TCGA-13-0919-01.5	50	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000000066344226794667806
TCGA-10-0938-01.2	102	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000066438003514915628
TCGA-04-1337-01.2	31	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000000066691571237703580
TCGA-23-1032-01.16	250	2_CELL_CYCLE_PHASE	146	23	0.0000000067186240505233611
TCGA-09-1659-01.5	51	2_MITOTIC_CELL_CYCLE	134	12	0.0000000067463128854874844
TCGA-31-1959-01.7	101	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000067494918235052530
TCGA-04-1356-01.1	71	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000000068610359288187038
TCGA-24-1474-01.12	122	2_DNA_METABOLIC_PROCESS	218	20	0.0000000068668852104516663
TCGA-24-1425-01.1	61	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000068914882796930225
TCGA-13-0906-01.5	66	2_CELL_CYCLE_PROCESS	163	14	0.0000000071067903785363263
TCGA-04-1364-01.3	163	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000000071067903785363263
TCGA-13-1492-01.2	162	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	19	0.0000000071834615536024365
TCGA-25-1628-01.2	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000072857490497040076
TCGA-13-0903-01.11	77	0_HALLMARK_E2F_TARGETS	169	15	0.0000000074951293011197860
TCGA-24-1552-01.5	54	2_CELL_CYCLE_PROCESS	163	13	0.0000000075305121984188705
TCGA-24-2035-01.8	102	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000075357845373773831
TCGA-24-0982-01.3	34	1_KEGG_CELL_CYCLE	114	10	0.0000000076198271474872156
TCGA-04-1346-01.10	75	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000076496166994609438
TCGA-59-2348-01.14	123	2_CELL_CYCLE_PHASE	146	17	0.0000000079492978940796148
TCGA-09-2053-01.14	121	2_COLLAGEN	23	9	0.0000000081517919996223894
TCGA-25-1626-01.2	86	0_HALLMARK_COAGULATION	125	14	0.0000000082578926846338967
TCGA-24-1556-01.19	120	2_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0000000083557567415745367
TCGA-24-1556-01.19	120	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0000000083557567415745367
TCGA-13-1408-01.1	45	2_EXTRACELLULAR_MATRIX	85	10	0.0000000084195555211456424
TCGA-13-0924-01.5	68	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000085106241616167882
TCGA-24-2281-01.10	107	0_HALLMARK_E2F_TARGETS	169	17	0.0000000085264773427461444
TCGA-25-2042-01.3	63	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000000087403477521444955
TCGA-25-2396-01.6	42	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000000088169703007515177
TCGA-61-2104-01.15	95	1_KEGG_PATHWAYS_IN_CANCER	323	21	0.0000000088528445113477798
TCGA-04-1364-01.3	163	2_CELL_CYCLE_PHASE	146	19	0.0000000090930752117117872
TCGA-09-2050-01.18	196	2_CELL_CYCLE_GO_0007049	265	27	0.0000000091237060192945421
TCGA-61-2109-01.13	122	1_KEGG_WNT_SIGNALING_PATHWAY	149	17	0.0000000096938754319932308
TCGA-13-0897-01.2	61	2_CELL_CYCLE_PHASE	146	13	0.0000000098211335344270191
TCGA-13-1505-01.13	60	2_EXTRACELLULAR_REGION_PART	269	16	0.0000000098335621708301457
TCGA-24-0982-01.3	34	2_CELL_CYCLE_PROCESS	163	11	0.0000000098604618190829875
TCGA-57-1583-01.20	185	2_CELL_CYCLE_PHASE	146	20	0.0000000099128723683822998
TCGA-25-1322-01.15	93	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000000099963259012941674
TCGA-23-2078-01.15	105	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000104156134138953960
TCGA-04-1336-01.28	106	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0000000104827281579867320
TCGA-24-1417-01.14	94	2_M_PHASE	94	13	0.0000000105173436803369270
TCGA-24-1603-01.3	69	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000105224908872392340
TCGA-61-2000-01.11	69	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000105224908872392340
TCGA-13-0730-01.8	83	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000000106237966656402850
TCGA-23-1116-01.7	84	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000000106650303142285930
TCGA-04-1530-01.2	90	2_EXTRACELLULAR_REGION	346	21	0.0000000108071128653111060
TCGA-36-1570-01.2	36	2_CELL_CYCLE_GO_0007049	265	13	0.0000000108983919248334530
TCGA-23-1120-01.10	57	2_M_PHASE	94	11	0.0000000111199890052406780
TCGA-10-0933-01.2	97	2_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0000000112422249754825730
TCGA-10-0933-01.2	97	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0000000112422249754825730
TCGA-04-1332-01.2	25	0_HALLMARK_E2F_TARGETS	169	10	0.0000000112569092924996690
TCGA-13-0912-01.2	55	1_KEGG_MELANOMA	71	10	0.0000000112598733626892530
TCGA-24-1463-01.5	130	2_CHROMOSOME	102	15	0.0000000113360446208342530
TCGA-25-2042-01.3	63	2_EXTRACELLULAR_MATRIX	85	11	0.0000000114354779588075730
TCGA-04-1332-01.2	25	1_KEGG_CELL_CYCLE	114	9	0.0000000115687886643712310
TCGA-24-1603-01.3	69	2_CHROMOSOME	102	12	0.0000000115844216242332440
TCGA-13-1404-01.13	117	2_M_PHASE	94	14	0.0000000116141228064679880
TCGA-24-1464-01.7	62	1_KEGG_CELL_CYCLE	114	12	0.0000000116381909090212760
TCGA-13-0883-01.3	23	2_CELL_CYCLE_GO_0007049	265	11	0.0000000116653453915087690
TCGA-13-1483-01.3	66	0_HALLMARK_E2F_TARGETS	169	14	0.0000000116673349115729780
TCGA-24-1616-01.2	38	2_CELL_CYCLE_PHASE	146	11	0.0000000116809496104054140
TCGA-09-2051-01.26	142	2_M_PHASE	94	15	0.0000000121872371865541280
TCGA-04-1338-01.7	85	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000000123315912991631760
TCGA-59-2363-01.3	89	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0000000125108762765643110
TCGA-36-1580-01.1	65	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000000125268319217466210
TCGA-24-1474-01.12	122	2_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0000000128397051544667360
TCGA-24-1474-01.12	122	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0000000128397051544667360
TCGA-24-1466-01.15	82	2_REGULATION_OF_CELL_PROLIFERATION	265	18	0.0000000128545059740086910
TCGA-24-2290-01.3	70	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000129628097187452600
TCGA-23-1123-01.7	70	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000129628097187452600
TCGA-09-2044-01.4	83	2_MITOTIC_CELL_CYCLE	134	14	0.0000000130430854387513430
TCGA-24-1614-01.5	86	2_DNA_METABOLIC_PROCESS	218	17	0.0000000131514191961365830
TCGA-13-1408-01.1	45	2_COLLAGEN	23	7	0.0000000133562976609562340
TCGA-36-1575-01.9	193	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	26	0.0000000134447066759748860
TCGA-13-0791-01.35	80	0_HALLMARK_E2F_TARGETS	169	15	0.0000000134591319389653870
TCGA-36-1574-01.10	152	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000134821774308974950
TCGA-61-2000-01.11	69	2_CELL_CYCLE_PROCESS	163	14	0.0000000135736059761379170
TCGA-04-1336-01.28	106	2_CELL_PROLIFERATION_GO_0008283	436	25	0.0000000137130306604912370
TCGA-24-1470-01.7	76	2_M_PHASE	94	12	0.0000000142448173721038640
TCGA-23-1116-01.7	84	2_EXTRACELLULAR_MATRIX	85	12	0.0000000142837227536344690
TCGA-25-1326-01.11	119	2_MITOTIC_CELL_CYCLE	134	16	0.0000000142971122051612300
TCGA-36-1580-01.1	65	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000143385022784190140
TCGA-31-1953-01.6	53	2_CELL_CYCLE_GO_0007049	265	15	0.0000000143453800872595950
TCGA-13-0905-01.7	160	2_MITOTIC_CELL_CYCLE	134	18	0.0000000143847373762045090
TCGA-13-1409-01.6	122	2_IMMUNE_SYSTEM_PROCESS	283	22	0.0000000145157458553959390
TCGA-13-0795-01.9	67	0_HALLMARK_E2F_TARGETS	169	14	0.0000000145227916655168390
TCGA-23-1118-01.5	50	2_CELL_CYCLE_PHASE	146	12	0.0000000145803777986076860
TCGA-04-1343-01.7	50	2_CELL_CYCLE_PHASE	146	12	0.0000000145803777986076860
TCGA-25-1326-01.11	119	2_M_PHASE	94	14	0.0000000146975985414825200
TCGA-13-0804-01.5	78	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000000151823761143799480
TCGA-59-2363-01.3	89	1_KEGG_DNA_REPLICATION	32	9	0.0000000153412988216628350
TCGA-10-0933-01.2	97	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000000153682302476202910
TCGA-13-0804-01.5	78	2_MICROTUBULE_CYTOSKELETON	117	13	0.0000000155096964236195170
TCGA-04-1517-01.4	44	0_HALLMARK_E2F_TARGETS	169	12	0.0000000157352494671770630
TCGA-24-1417-01.14	94	2_CELL_CYCLE_GO_0007049	265	19	0.0000000157448883260237200
TCGA-04-1356-01.1	71	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000159130359699417420
TCGA-13-0910-01.3	71	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000159130359699417420
TCGA-24-1427-01.4	83	2_CELL_CYCLE_GO_0007049	265	18	0.0000000160062883497388120
TCGA-04-1364-01.3	163	0_HALLMARK_ALLOGRAFT_REJECTION	190	21	0.0000000160247726627864830
TCGA-36-1580-01.1	65	2_EXTRACELLULAR_MATRIX	85	11	0.0000000163831336523572350
TCGA-61-1919-01.9	87	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000000163932582259923930
TCGA-13-0760-01.12	93	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000164574498578664860
TCGA-09-2050-01.18	196	1_KEGG_SMALL_CELL_LUNG_CANCER	83	16	0.0000000164600587617936250
TCGA-04-1338-01.7	85	2_EXTRACELLULAR_MATRIX	85	12	0.0000000165124993577857730
TCGA-23-1123-01.7	70	2_CELL_CYCLE_PROCESS	163	14	0.0000000167164994699693540
TCGA-13-0903-01.11	77	2_M_PHASE	94	12	0.0000000167388479850589940
TCGA-25-1319-01.10	69	2_MITOTIC_CELL_CYCLE	134	13	0.0000000173334631437584210
TCGA-13-1483-01.3	66	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000173783539761492580
TCGA-25-1635-01.6	129	2_CELL_CYCLE_PHASE	146	17	0.0000000174733097963805950
TCGA-20-0991-01.12	166	1_KEGG_PATHWAYS_IN_CANCER	323	27	0.0000000174821677324815950
TCGA-61-1995-01.4	102	2_MITOTIC_CELL_CYCLE	134	15	0.0000000177007758669349110
TCGA-24-2288-01.12	112	0_HALLMARK_E2F_TARGETS	169	17	0.0000000182781407122922940
TCGA-13-0807-01.8	46	2_CELL_CYCLE_PROCESS	163	12	0.0000000183339467426519950
TCGA-30-1891-01.4	84	1_KEGG_FOCAL_ADHESION	195	16	0.0000000184640391465817330
TCGA-59-2350-01.1	62	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000000186098185545792720
TCGA-24-1427-01.4	83	2_COLLAGEN	23	8	0.0000000187176544055285960
TCGA-09-1659-01.5	51	2_CELL_CYCLE_PHASE	146	12	0.0000000188165566628646280
TCGA-24-1418-01.16	84	2_CELL_CYCLE_GO_0007049	265	18	0.0000000198653541674315430
TCGA-24-2030-01.8	161	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000199195607434043300
TCGA-23-2079-01.14	85	2_CELL_CYCLE_PROCESS	163	15	0.0000000199891880985705990
TCGA-36-1570-01.2	36	2_CELL_CYCLE_PROCESS	163	11	0.0000000201001643923512570
TCGA-61-2102-01.7	172	2_CELL_CYCLE_PROCESS	163	20	0.0000000202302235641378380
TCGA-13-0800-01.9	124	2_IMMUNE_SYSTEM_PROCESS	283	22	0.0000000203622772694672630
TCGA-13-0919-01.5	50	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000204804224029471500
TCGA-23-1110-01.7	299	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	14	0.0000000206211717891169980
TCGA-23-1116-01.7	84	2_COLLAGEN	23	8	0.0000000206585429843651350
TCGA-13-0916-01.11	92	1_KEGG_DNA_REPLICATION	32	9	0.0000000208295225169712150
TCGA-13-1408-01.1	45	2_EXTRACELLULAR_REGION_PART	269	14	0.0000000210324000420586640
TCGA-25-1630-01.10	35	0_HALLMARK_E2F_TARGETS	169	11	0.0000000210503786081079930
TCGA-10-0926-01.2	45	0_HALLMARK_E2F_TARGETS	169	12	0.0000000211275857854008270
TCGA-13-0920-01.9	82	1_KEGG_CELL_CYCLE	114	13	0.0000000215170073523672040
TCGA-61-1919-01.9	87	2_EXTRACELLULAR_MATRIX	85	12	0.0000000219425813364320890
TCGA-13-0885-01.6	44	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000222347682385457390
TCGA-25-1319-01.10	69	0_HALLMARK_E2F_TARGETS	169	14	0.0000000222438641972133810
TCGA-13-1507-01.8	101	2_CELL_CYCLE_PROCESS	163	16	0.0000000223843747264706590
TCGA-13-1495-01.22	101	2_CELL_CYCLE_PROCESS	163	16	0.0000000223843747264706590
TCGA-25-1623-01.7	111	0_HALLMARK_COAGULATION	125	15	0.0000000224050963392636270
TCGA-09-0366-01.5	32	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0000000224239467500347430
TCGA-24-1469-01.6	123	2_M_PHASE	94	14	0.0000000232296582344157270
TCGA-23-2078-01.15	105	2_MITOSIS	71	12	0.0000000234646060655576160
TCGA-13-1412-01.8	113	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000235542546486077020
TCGA-24-1427-01.4	83	0_HALLMARK_E2F_TARGETS	169	15	0.0000000235572511618874330
TCGA-57-1583-01.20	185	2_CELL_PROLIFERATION_GO_0008283	436	33	0.0000000236682013186867940
TCGA-59-2348-01.14	123	2_MITOTIC_CELL_CYCLE	134	16	0.0000000239812016109942190
TCGA-13-1512-01.2	113	2_CELL_CYCLE_PHASE	146	16	0.0000000240244058433258060
TCGA-24-1105-01.8	52	2_CELL_CYCLE_PHASE	146	12	0.0000000241406653299913180
TCGA-23-1110-01.7	299	2_IMMUNE_SYSTEM_PROCESS	283	34	0.0000000242064552451459440
TCGA-13-0887-01.6	47	2_CELL_CYCLE_PROCESS	163	12	0.0000000242561258170924360
TCGA-24-1416-01.4	38	2_CELL_CYCLE_GO_0007049	265	13	0.0000000242885628314721670
TCGA-13-0714-01.9	51	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000252962518992390790
TCGA-13-1510-01.20	82	1_KEGG_PANCREATIC_CANCER	70	11	0.0000000255088341356728380
TCGA-13-0919-01.5	50	2_EXTRACELLULAR_MATRIX	85	10	0.0000000261441918156836690
TCGA-24-1416-01.4	38	1_KEGG_CELL_CYCLE	114	10	0.0000000263858422866846320
TCGA-13-0791-01.35	80	2_M_PHASE	94	12	0.0000000267844387456438120
TCGA-13-1501-01.12	101	2_M_PHASE	94	13	0.0000000269350756132657440
TCGA-23-2078-01.15	105	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	12	0.0000000279007304092830940
TCGA-61-2088-01.7	150	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	19	0.0000000283000208851992640
TCGA-24-1428-01.9	90	2_DNA_METABOLIC_PROCESS	218	17	0.0000000284572083223052490
TCGA-13-0906-01.5	66	2_CELL_CYCLE_PHASE	146	13	0.0000000286328451568295690
TCGA-13-0891-01.18	125	2_M_PHASE	94	14	0.0000000290208412747978970
TCGA-61-2101-01.2	38	2_EXTRACELLULAR_REGION_PART	269	13	0.0000000293476285804202740
TCGA-61-2088-01.7	150	2_CHEMOKINE_ACTIVITY	40	11	0.0000000293989037023403500
TCGA-04-1348-01.6	81	2_CELL_CYCLE_PHASE	146	14	0.0000000299702243039958850
TCGA-13-0920-01.9	82	2_MITOSIS	71	11	0.0000000299766909644008080
TCGA-13-0804-01.5	78	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000000301007866399720750
TCGA-13-0804-01.5	78	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000000301007866399720750
TCGA-13-0717-01.6	103	1_KEGG_ASTHMA	30	9	0.0000000305006106513587320
TCGA-13-0795-01.9	67	1_KEGG_CELL_CYCLE	114	12	0.0000000307266462712287050
TCGA-24-1422-01.10	56	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000308613092588653220
TCGA-13-0897-01.2	61	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000000317342480991194430
TCGA-24-1616-01.2	38	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000000318989895464946390
TCGA-13-0714-01.9	51	2_EXTRACELLULAR_MATRIX	85	10	0.0000000322855594146321940
TCGA-04-1338-01.7	85	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000000322855594146322070
TCGA-04-1525-01.7	52	1_KEGG_CELL_CYCLE	114	11	0.0000000326048610820017150
TCGA-13-1405-01.4	69	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000330822028296890170
TCGA-24-1436-01.1	49	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000000333679974484854300
TCGA-24-1469-01.6	123	1_KEGG_PATHWAYS_IN_CANCER	323	23	0.0000000333974914110434090
TCGA-23-2079-01.14	85	0_HALLMARK_E2F_TARGETS	169	15	0.0000000337634511730790370
TCGA-13-0905-01.7	160	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000338402055879343900
TCGA-25-2042-01.3	63	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000000349173193307390690
TCGA-10-0933-01.2	97	0_HALLMARK_MITOTIC_SPINDLE	175	16	0.0000000351028872856515780
TCGA-13-0920-01.9	82	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000000351376081912707940
TCGA-24-1427-01.4	83	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000359246666687454740
TCGA-13-0920-01.9	82	2_M_PHASE	94	12	0.0000000362422747090889890
TCGA-25-1626-01.2	86	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000000363886939062576700
TCGA-04-1332-01.2	25	2_CELL_CYCLE_GO_0007049	265	11	0.0000000365848551884748730
TCGA-13-1512-01.2	113	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000372382909490227010
TCGA-61-1919-01.9	87	2_CELL_CYCLE_GO_0007049	265	18	0.0000000372657639511326400
TCGA-13-0899-01.1	28	1_KEGG_CELL_CYCLE	114	9	0.0000000379489638893071200
TCGA-13-1507-01.8	101	0_HALLMARK_E2F_TARGETS	169	16	0.0000000389778579038776040
TCGA-09-2051-01.26	142	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000000390385650637938300
TCGA-61-2088-01.7	150	2_CHEMOKINE_RECEPTOR_BINDING	41	11	0.0000000396360334383154290
TCGA-13-0897-01.2	61	2_CELL_CYCLE_PROCESS	163	13	0.0000000402050242594656890
TCGA-25-2401-01.5	119	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000000417208437163250890
TCGA-13-1512-01.2	113	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	10	0.0000000424251458408831520
TCGA-25-2042-01.3	63	0_HALLMARK_COAGULATION	125	12	0.0000000429484706190432160
TCGA-13-1489-01.11	118	0_HALLMARK_E2F_TARGETS	169	17	0.0000000433265473159982470
TCGA-36-1575-01.9	193	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	21	0.0000000438315177912013660
TCGA-24-1425-01.1	61	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000000439334405244826570
TCGA-25-1635-01.6	129	2_M_PHASE	94	14	0.0000000447594341479641520
TCGA-13-0727-01.1	29	2_CELL_CYCLE_PROCESS	163	10	0.0000000452208591397213500
TCGA-25-2404-01.5	58	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000000463994600960780660
TCGA-13-1496-01.13	120	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000471030221560479950
TCGA-61-1919-01.9	87	2_EXTRACELLULAR_REGION_PART	269	18	0.0000000478628042237275010
TCGA-24-2298-01.7	138	0_HALLMARK_COAGULATION	125	16	0.0000000485812190309639220
TCGA-24-2262-01.25	141	2_MITOSIS	71	13	0.0000000488444710166559550
TCGA-04-1542-01.4	141	1_KEGG_MELANOMA	71	13	0.0000000488444710166559550
TCGA-36-1575-01.9	193	0_HALLMARK_INFLAMMATORY_RESPONSE	170	21	0.0000000491303926743365380
TCGA-24-2281-01.10	107	1_KEGG_CELL_CYCLE	114	14	0.0000000495692890878373250
TCGA-13-1481-01.3	78	2_EXTRACELLULAR_REGION	346	19	0.0000000497054878836806090
TCGA-13-0916-01.11	92	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000000501864519248127850
TCGA-13-1410-01.9	115	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	10	0.0000000506373390189642580
TCGA-13-0903-01.11	77	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000508781484042989390
TCGA-23-1122-01.11	77	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000508781484042989390
TCGA-13-0893-01.4	112	2_MITOSIS	71	12	0.0000000509833108632971450
TCGA-25-2401-01.5	119	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000514707211779960780
TCGA-61-2000-01.11	69	2_CELL_CYCLE_PHASE	146	13	0.0000000520188185252877130
TCGA-04-1365-01.6	150	0_HALLMARK_MITOTIC_SPINDLE	175	19	0.0000000525947371565301350
TCGA-25-2401-01.5	119	1_KEGG_FOCAL_ADHESION	195	18	0.0000000530481887439477600
TCGA-13-0717-01.6	103	0_HALLMARK_E2F_TARGETS	169	16	0.0000000530672026935553680
TCGA-13-1495-01.22	101	2_CELL_CYCLE_PHASE	146	15	0.0000000534316049794756450
TCGA-24-2289-01.6	53	2_EXTRACELLULAR_REGION	346	16	0.0000000542024975191289320
TCGA-13-1411-01.7	96	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000000542102613923489380
TCGA-09-1665-01.16	131	2_M_PHASE	94	14	0.0000000552718555677056320
TCGA-13-0899-01.1	28	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000000577076908112149650
TCGA-10-0931-01.12	59	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000000585688487157756010
TCGA-24-2262-01.25	141	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	13	0.0000000588546096839712680
TCGA-09-2050-01.18	196	0_HALLMARK_E2F_TARGETS	169	21	0.0000000589312581440897900
TCGA-23-2079-01.14	85	2_CELL_CYCLE_PHASE	146	14	0.0000000592478390736160310
TCGA-13-0720-01.5	32	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0000000600988105995563100
TCGA-23-1030-01.10	58	2_CELL_CYCLE_GO_0007049	265	15	0.0000000602161464048955150
TCGA-13-0893-01.4	112	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	12	0.0000000605801738917378340
TCGA-25-2391-01.2	64	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000000607713112768106830
TCGA-13-1411-01.7	96	2_COLLAGEN	23	8	0.0000000617725470067545500
TCGA-13-0891-01.18	125	2_CELL_CYCLE_PROCESS	163	17	0.0000000622528333707008700
TCGA-36-1574-01.10	152	2_MITOTIC_CELL_CYCLE	134	17	0.0000000626640099763457130
TCGA-24-2035-01.8	102	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	19	0.0000000627296689435503070
TCGA-24-1470-01.7	76	2_MITOTIC_CELL_CYCLE	134	13	0.0000000629712135951369760
TCGA-24-2262-01.25	141	2_CELL_PROLIFERATION_GO_0008283	436	28	0.0000000631895631204604750
TCGA-10-0934-01.11	145	2_LOCOMOTORY_BEHAVIOR	86	14	0.0000000636014730837704040
TCGA-24-1436-01.1	49	0_HALLMARK_E2F_TARGETS	169	12	0.0000000637092489329212190
TCGA-09-0369-01.9	109	1_KEGG_CELL_CYCLE	114	14	0.0000000640520859284972950
TCGA-24-1560-01.2	29	0_HALLMARK_E2F_TARGETS	169	10	0.0000000648517697486347570
TCGA-13-0897-01.2	61	2_MITOTIC_CELL_CYCLE	134	12	0.0000000656461262080183070
TCGA-24-2290-01.3	70	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000000657475610487820270
TCGA-13-0893-01.4	112	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000000660070794913470830
TCGA-24-2030-01.8	161	2_CELL_PROLIFERATION_GO_0008283	436	30	0.0000000668191623131610800
TCGA-61-2104-01.15	95	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000000676905646206360890
TCGA-04-1356-01.1	71	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	14	0.0000000678644274219668320
TCGA-13-0900-01.8	90	2_CELL_CYCLE_GO_0007049	265	18	0.0000000680682609145034640
TCGA-04-1530-01.2	90	2_CELL_CYCLE_GO_0007049	265	18	0.0000000680682609145034640
TCGA-13-1492-01.2	162	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	11	0.0000000681520769315170570
TCGA-24-1434-01.3	82	0_HALLMARK_COAGULATION	125	13	0.0000000705041352178838410
TCGA-24-1616-01.2	38	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000000711393037891265990
TCGA-13-1497-01.7	59	2_DNA_METABOLIC_PROCESS	218	14	0.0000000717565255064699800
TCGA-24-1424-01.4	80	2_CHROMOSOME	102	12	0.0000000718158861202440650
TCGA-36-1571-01.6	109	2_M_PHASE	94	13	0.0000000723603404956175160
TCGA-13-1411-01.7	96	2_EXTRACELLULAR_MATRIX	85	12	0.0000000724324681365314810
TCGA-24-1551-01.15	87	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000729184766603912730
TCGA-61-1919-01.9	87	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000729184766603912730
TCGA-25-1634-01.4	75	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	11	0.0000000730630093522293640
TCGA-09-2044-01.4	83	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000000740514328986011050
TCGA-09-2053-01.14	121	2_EXTRACELLULAR_MATRIX	85	13	0.0000000744767801327760100
TCGA-24-1614-01.5	86	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	17	0.0000000746905232348979130
TCGA-24-1548-01.8	141	2_CELL_CYCLE_PHASE	146	17	0.0000000747019216211855160
TCGA-13-0903-01.11	77	2_MITOTIC_CELL_CYCLE	134	13	0.0000000748581053328213780
TCGA-09-0369-01.9	109	2_DNA_METABOLIC_PROCESS	218	18	0.0000000752155640899459620
TCGA-24-2293-01.1	22	2_CELL_CYCLE_PROCESS	163	9	0.0000000752967869723741110
TCGA-24-0970-01.6	94	2_MITOTIC_CELL_CYCLE	134	14	0.0000000753348007098461890
TCGA-23-1117-01.11	99	2_EXTRACELLULAR_REGION	346	21	0.0000000758691616694592840
TCGA-13-1407-01.11	220	0_HALLMARK_E2F_TARGETS	169	22	0.0000000764637428332434030
TCGA-24-1549-01.21	158	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000000783336788221961430
TCGA-13-1492-01.2	162	2_CELL_PROLIFERATION_GO_0008283	436	30	0.0000000785628899526755660
TCGA-24-0979-01.5	41	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000000801711031064894320
TCGA-13-1410-01.9	115	2_CELL_CYCLE_GO_0007049	265	20	0.0000000804440854091569550
TCGA-04-1347-01.15	187	2_IMMUNE_SYSTEM_PROCESS	283	26	0.0000000824677035141604100
TCGA-04-1343-01.7	50	0_HALLMARK_E2F_TARGETS	169	12	0.0000000825404113399625680
TCGA-13-1492-01.2	162	2_M_PHASE	94	15	0.0000000827155350430270550
TCGA-09-1669-01.10	81	2_CHROMOSOME	102	12	0.0000000835611818272680660
TCGA-13-0751-01.2	51	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0000000840108448083343280
TCGA-24-1614-01.5	86	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	15	0.0000000850039103300520950
TCGA-13-0791-01.35	80	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000874405664808372140
TCGA-13-0886-01.1	45	2_CELL_CYCLE_PHASE	146	11	0.0000000898372704162443640
TCGA-09-1659-01.5	51	2_M_PHASE	94	10	0.0000000900046060503919270
TCGA-13-0905-01.7	160	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000000918767911233279890
TCGA-24-0982-01.3	34	2_CELL_CYCLE_PHASE	146	10	0.0000000919398979197332670
TCGA-23-1110-01.7	299	2_IMMUNE_RESPONSE	206	28	0.0000000926505628483342810
TCGA-13-1498-01.13	104	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000962394966237437250
TCGA-04-1542-01.4	141	1_KEGG_PATHWAYS_IN_CANCER	323	24	0.0000000963099323331831080
TCGA-13-1512-01.2	113	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000000979028124175786200
TCGA-13-1506-01.5	113	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000000979028124175786200
TCGA-09-1665-01.16	131	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000990963948932417340
TCGA-24-1103-01.5	73	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000001013123975274361000
TCGA-13-0890-01.2	48	2_MITOSIS	71	9	0.0000001016992058410287600
TCGA-13-1498-01.13	104	2_CELL_CYCLE_GO_0007049	265	19	0.0000001021184595383653400
TCGA-24-1563-01.15	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000001025204183339792400
TCGA-13-0883-01.3	23	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000001030970802757192400
TCGA-13-0919-01.5	50	2_EXTRACELLULAR_REGION_PART	269	14	0.0000001040389071915728800
TCGA-09-2049-01.8	96	0_HALLMARK_ALLOGRAFT_REJECTION	190	16	0.0000001041317964785133300
TCGA-25-1633-01.1	71	0_HALLMARK_ANGIOGENESIS	32	8	0.0000001044231664380370500
TCGA-25-2391-01.2	64	2_CHROMOSOME	102	11	0.0000001048133846180639700
TCGA-04-1342-01.12	104	0_HALLMARK_MITOTIC_SPINDLE	175	16	0.0000001049839777014887100
TCGA-13-1409-01.6	122	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	20	0.0000001060472716855976400
TCGA-24-1466-01.15	82	1_KEGG_BLADDER_CANCER	42	9	0.0000001064820925783794000
TCGA-25-1324-01.3	42	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000001070472531991698700
TCGA-13-1492-01.2	162	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000001075247564622834600
TCGA-24-1614-01.5	86	2_REGULATION_OF_MOLECULAR_FUNCTION	286	18	0.0000001079294234622580900
TCGA-23-1032-01.16	250	2_CELL_CYCLE_GO_0007049	265	29	0.0000001079327861008392500
TCGA-10-0937-01.9	40	0_HALLMARK_E2F_TARGETS	169	11	0.0000001079610914359084700
TCGA-13-0889-01.4	37	2_M_PHASE	94	9	0.0000001081224110454224100
TCGA-13-0916-01.11	92	2_MITOSIS	71	11	0.0000001085127910903545500
TCGA-24-2280-01.10	58	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000001110818211854955800
TCGA-25-1635-01.6	129	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000001113947101516431900
TCGA-23-1028-01.18	93	1_KEGG_CELL_CYCLE	114	13	0.0000001121242528321173700
TCGA-24-1428-01.9	90	2_M_PHASE	94	12	0.0000001123148542985838100
TCGA-24-2288-01.12	112	2_CELL_CYCLE_PROCESS	163	16	0.0000001131446536330634000
TCGA-13-1481-01.3	78	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000001135703731794705800
TCGA-13-0751-01.2	51	2_CELL_CYCLE_GO_0007049	265	14	0.0000001144449555848250400
TCGA-13-1482-01.7	62	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000001145994978798713900
TCGA-13-1506-01.5	113	2_M_PHASE	94	13	0.0000001150535923342671500
TCGA-13-0791-01.35	80	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	11	0.0000001152347600627229100
TCGA-24-1552-01.5	54	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000001153252508753035300
TCGA-13-0891-01.18	125	2_CELL_CYCLE_PHASE	146	16	0.0000001153733034757492700
TCGA-13-0890-01.2	48	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0000001157939069687743900
TCGA-13-1496-01.13	120	1_KEGG_MELANOMA	71	12	0.0000001161520938774121700
TCGA-13-1483-01.3	66	2_CELL_CYCLE_PROCESS	163	13	0.0000001162276468562031000
TCGA-13-0807-01.8	46	2_CELL_CYCLE_PHASE	146	11	0.0000001165234520312969200
TCGA-25-2391-01.2	64	2_MITOTIC_CELL_CYCLE	134	12	0.0000001193758699387322600
TCGA-13-1497-01.7	59	2_CELL_CYCLE_PHASE	146	12	0.0000001193878226692534400
TCGA-25-1633-01.1	71	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000001205123966275330600
TCGA-24-1603-01.3	69	2_MITOSIS	71	10	0.0000001205123966275330600
TCGA-13-0900-01.8	90	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000001209302950827240900
TCGA-13-0792-01.8	64	0_HALLMARK_E2F_TARGETS	169	13	0.0000001215246054021029200
TCGA-61-1998-01.14	105	2_CELL_CYCLE_GO_0007049	265	19	0.0000001215814533077720500
TCGA-23-1023-01.1	93	2_MITOSIS	71	11	0.0000001223489069499185500
TCGA-13-1492-01.2	162	0_HALLMARK_APOPTOSIS	150	18	0.0000001223943168542807800
TCGA-13-0761-01.6	75	1_KEGG_CELL_CYCLE	114	12	0.0000001235113216324650800
TCGA-13-0920-01.9	82	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000001238127820818941100
TCGA-13-0919-01.5	50	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000001243794300437426400
TCGA-20-0990-01.17	133	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000001266850120644512300
TCGA-13-0724-01.21	71	2_CELL_CYCLE_GO_0007049	265	16	0.0000001269267173667554100
TCGA-25-1320-01.4	71	2_CELL_CYCLE_GO_0007049	265	16	0.0000001269267173667554100
TCGA-24-0968-01.9	71	2_CELL_CYCLE_GO_0007049	265	16	0.0000001269267173667554100
TCGA-13-0916-01.11	92	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000001270705062506227000
TCGA-24-1435-01.12	115	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000001285018869861729600
TCGA-13-0900-01.8	90	2_CELL_CYCLE_PHASE	146	14	0.0000001319540454431904000
TCGA-24-1549-01.21	158	0_HALLMARK_MITOTIC_SPINDLE	175	19	0.0000001322839631210665700
TCGA-61-2113-01.15	99	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0000001329020417555237700
TCGA-13-1404-01.13	117	2_MITOTIC_CELL_CYCLE	134	15	0.0000001339304360078282000
TCGA-09-2045-01.1	9	2_AGING	10	4	0.0000001344311714685381600
TCGA-13-0923-01.5	53	2_M_PHASE	94	10	0.0000001351331248608724300
TCGA-24-1603-01.3	69	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000001391522095773806600
TCGA-13-1482-01.7	62	2_COLLAGEN	23	7	0.0000001411297040019778300
TCGA-61-2109-01.13	122	2_MITOSIS	71	12	0.0000001413484912773916000
TCGA-24-2293-01.1	22	0_HALLMARK_MITOTIC_SPINDLE	175	9	0.0000001427861303486022700
TCGA-23-1023-01.1	93	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000001432588467101926800
TCGA-24-1603-01.3	69	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000001466043583860642100
TCGA-24-1603-01.3	69	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000001466043583860642100
TCGA-23-2079-01.14	85	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000001481906650705097600
TCGA-23-1110-01.7	299	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	18	0.0000001483035669452633200
TCGA-09-0369-01.9	109	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	15	0.0000001486750886689814600
TCGA-61-1995-01.4	102	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000001487277607689313300
TCGA-13-0887-01.6	47	2_CELL_CYCLE_PHASE	146	11	0.0000001501328462240935300
TCGA-13-0755-01.6	16	2_CELL_CYCLE_GO_0007049	265	9	0.0000001528945020938357000
TCGA-24-1470-01.7	76	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000001531306660481630900
TCGA-10-0930-01.5	60	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0000001555363060014315600
TCGA-59-2348-01.14	123	2_MITOSIS	71	12	0.0000001557191906543363300
TCGA-24-1474-01.12	122	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000001558220609825255900
TCGA-04-1347-01.15	187	2_IMMUNE_RESPONSE	206	22	0.0000001566980212580745400
TCGA-25-2042-01.3	63	2_COLLAGEN	23	7	0.0000001585345628548133800
TCGA-25-1320-01.4	71	2_EXTRACELLULAR_REGION_PART	269	16	0.0000001588343734321457400
TCGA-23-2078-01.15	105	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000001590220192490483300
TCGA-09-1659-01.5	51	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0000001600567366123715900
TCGA-36-1570-01.2	36	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000001604774957661480900
TCGA-13-0899-01.1	28	2_CELL_CYCLE_GO_0007049	265	11	0.0000001635420405196127700
TCGA-13-0800-01.9	124	1_KEGG_ASTHMA	30	9	0.0000001652810998532102800
TCGA-10-0926-01.2	45	1_KEGG_CELL_CYCLE	114	10	0.0000001659407542497304600
TCGA-04-1365-01.6	150	2_SPINDLE	35	10	0.0000001662604410768417600
TCGA-13-0760-01.12	93	2_M_PHASE	94	12	0.0000001667300686532466500
TCGA-57-1583-01.20	185	2_MITOTIC_CELL_CYCLE	134	18	0.0000001677007633789916200
TCGA-61-2109-01.13	122	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	12	0.0000001677896892533249000
TCGA-04-1365-01.6	150	2_NUCLEUS	1110	47	0.0000001684882224886747800
TCGA-13-0903-01.11	77	1_KEGG_CELL_CYCLE	114	12	0.0000001702893925258111000
TCGA-13-0755-01.6	16	0_HALLMARK_E2F_TARGETS	169	8	0.0000001710126060446112600
TCGA-23-1122-01.11	77	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000001750335436061743800
TCGA-20-0991-01.12	166	0_HALLMARK_ALLOGRAFT_REJECTION	190	20	0.0000001779047227548068600
TCGA-24-2261-01.2	87	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000001834435655024042500
TCGA-59-2348-01.14	123	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	12	0.0000001848303931577811300
TCGA-24-1427-01.4	83	2_CELL_CYCLE_PROCESS	163	14	0.0000001885443341675940400
TCGA-24-0970-01.6	94	2_M_PHASE	94	12	0.0000001895904674297451200
TCGA-61-2012-01.6	78	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000001897189773839469900
TCGA-25-1628-01.2	118	1_KEGG_CELL_CYCLE	114	14	0.0000001905088607890796100
TCGA-04-1525-01.7	52	2_MITOTIC_CELL_CYCLE	134	11	0.0000001921861705050072700
TCGA-04-1364-01.3	163	2_MITOTIC_CELL_CYCLE	134	17	0.0000001924411773015366600
TCGA-13-0793-01.8	97	1_KEGG_CELL_CYCLE	114	13	0.0000001934284345256119600
TCGA-61-2113-01.15	99	2_CELL_CYCLE_PROCESS	163	15	0.0000001943855058538814800
TCGA-23-1031-01.17	142	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	133	16	0.0000001956637612959707300
TCGA-24-1103-01.5	73	2_CELL_CYCLE_GO_0007049	265	16	0.0000001987405037823662900
TCGA-36-1580-01.1	65	2_COLLAGEN	23	7	0.0000001988933748236188000
TCGA-61-2012-01.6	78	1_KEGG_CELL_CYCLE	114	12	0.0000001992383659887000000
TCGA-25-1628-01.2	118	2_M_PHASE	94	13	0.0000002002482496251986800
TCGA-13-0885-01.6	44	2_CELL_CYCLE_GO_0007049	265	13	0.0000002003235777183890100
TCGA-13-1409-01.6	122	2_IMMUNE_RESPONSE	206	18	0.0000002034936017846277100
TCGA-24-1424-01.4	80	2_DNA_DEPENDENT_DNA_REPLICATION	46	9	0.0000002038977033007824800
TCGA-13-1507-01.8	101	2_MITOTIC_CELL_CYCLE	134	14	0.0000002038998546297035600
TCGA-13-1501-01.12	101	2_MITOTIC_CELL_CYCLE	134	14	0.0000002038998546297035600
TCGA-23-2079-01.14	85	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000002048052888633568900
TCGA-20-0991-01.12	166	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	18	0.0000002061883800098930500
TCGA-04-1362-01.4	35	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000002104008526346119100
TCGA-24-2298-01.7	138	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000002112853586950927600
TCGA-04-1365-01.6	150	2_CONDENSED_CHROMOSOME	26	9	0.0000002113185059611566800
TCGA-23-2078-01.15	105	2_EXTRACELLULAR_MATRIX	85	12	0.0000002120988834575319900
TCGA-25-1322-01.15	93	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000002133766783875382600
TCGA-25-1326-01.11	119	1_KEGG_CELL_CYCLE	114	14	0.0000002137624989363062100
TCGA-23-1124-01.17	107	2_EXTRACELLULAR_REGION_PART	269	19	0.0000002217808496601504300
TCGA-24-1418-01.16	84	2_CELL_CYCLE_PROCESS	163	14	0.0000002229115855674164500
TCGA-09-2050-01.18	196	2_CELL_CYCLE_PROCESS	163	20	0.0000002241639538575522600
TCGA-04-1347-01.15	187	0_HALLMARK_ALLOGRAFT_REJECTION	190	21	0.0000002259016107172581800
TCGA-13-1487-01.3	79	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000002273898166063674300
TCGA-24-0982-01.3	34	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000002286488978488768500
TCGA-61-1995-01.4	102	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000002309960332952822800
TCGA-13-1403-01.9	71	1_KEGG_FOCAL_ADHESION	195	14	0.0000002313744089856082100
TCGA-13-1512-01.2	113	2_COLLAGEN	23	8	0.0000002326841095380257700
TCGA-13-0889-01.4	37	2_CELL_CYCLE_PHASE	146	10	0.0000002347610222272402700
TCGA-24-1556-01.19	120	1_KEGG_DNA_REPLICATION	32	9	0.0000002356590554961415500
TCGA-24-1549-01.21	158	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000002382227154080259100
TCGA-13-0923-01.5	53	2_MITOTIC_CELL_CYCLE	134	11	0.0000002396219210498446600
TCGA-24-0968-01.9	71	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000002426994815788254100
TCGA-10-0926-01.2	45	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000002429836388761729300
TCGA-23-1117-01.11	99	2_MITOSIS	71	11	0.0000002442174089537842100
TCGA-13-1496-01.13	120	2_CELL_PROLIFERATION_GO_0008283	436	25	0.0000002461708749736501700
TCGA-04-1338-01.7	85	2_EXTRACELLULAR_REGION	346	19	0.0000002491503818525894100
TCGA-23-1116-01.7	84	2_EXTRACELLULAR_REGION_PART	269	17	0.0000002501563211276362800
TCGA-24-1428-01.9	90	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000002502008685100853300
TCGA-25-1626-01.2	86	2_EXTRACELLULAR_SPACE	192	15	0.0000002504991019395196800
TCGA-24-2281-01.10	107	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000002517979231585927900
TCGA-13-0727-01.1	29	2_CELL_CYCLE_GO_0007049	265	11	0.0000002569929681077384000
TCGA-61-2088-01.7	150	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	11	0.0000002577324799826243500
TCGA-30-1891-01.4	84	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000002598162418274806000
TCGA-23-1110-01.7	299	2_CELL_CYCLE_PHASE	146	23	0.0000002619887272023665100
TCGA-24-2035-01.8	102	2_RESPONSE_TO_CHEMICAL_STIMULUS	252	18	0.0000002638233146027265100
TCGA-10-0933-01.2	97	2_MICROTUBULE_CYTOSKELETON	117	13	0.0000002694734678820395200
TCGA-13-1411-01.7	96	2_EXTRACELLULAR_REGION_PART	269	18	0.0000002703098491129203700
TCGA-24-1413-01.6	34	1_KEGG_CELL_CYCLE	114	9	0.0000002713048914244070800
TCGA-24-1616-01.2	38	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000002717896942600822400
TCGA-23-2079-01.14	85	2_MITOTIC_CELL_CYCLE	134	13	0.0000002734193244170577500
TCGA-24-1474-01.12	122	1_KEGG_DNA_REPLICATION	32	9	0.0000002736592742788430800
TCGA-13-0886-01.1	45	2_CELL_CYCLE_GO_0007049	265	13	0.0000002747267267943206700
TCGA-23-1022-01.10	170	0_HALLMARK_ALLOGRAFT_REJECTION	190	20	0.0000002750102087283742600
TCGA-23-1110-01.7	299	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	18	0.0000002753068488968545700
TCGA-25-2391-01.2	64	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0000002758202385719085000
TCGA-25-2391-01.2	64	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0000002758202385719085000
TCGA-13-1492-01.2	162	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	19	0.0000002763872453990315700
TCGA-13-0792-01.8	64	2_CELL_CYCLE_GO_0007049	265	15	0.0000002776265395554600900
TCGA-04-1347-01.15	187	2_EXTRACELLULAR_REGION	346	28	0.0000002797068921386486600
TCGA-24-1614-01.5	86	2_INTERPHASE	62	10	0.0000002823859544550434800
TCGA-61-1919-01.9	87	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000002831648285634351900
TCGA-23-1117-01.11	99	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000002857874528944201900
TCGA-23-1110-01.7	299	2_MITOTIC_CELL_CYCLE	134	22	0.0000002918338372818713700
TCGA-04-1348-01.6	81	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000002932751070907662800
TCGA-13-0910-01.3	71	2_REGULATION_OF_MITOSIS	36	8	0.0000002933485597399040600
TCGA-24-1463-01.5	130	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000002937881031611586500
TCGA-04-1332-01.2	25	2_CELL_CYCLE_PROCESS	163	9	0.0000002958412052794422200
TCGA-24-1426-01.7	63	1_KEGG_APOPTOSIS	85	10	0.0000002959770372782008600
TCGA-13-0886-01.1	45	2_CELL_CYCLE_PROCESS	163	11	0.0000002970541223756509100
TCGA-09-2050-01.18	196	0_HALLMARK_KRAS_SIGNALING_UP	148	19	0.0000003020191401459889900
TCGA-13-1501-01.12	101	2_MITOSIS	71	11	0.0000003043431668888063200
TCGA-24-0979-01.5	41	2_MITOTIC_CELL_CYCLE	134	10	0.0000003062476616658388500
TCGA-13-1404-01.13	117	2_COLLAGEN	23	8	0.0000003083170958590571600
TCGA-13-0916-01.11	92	2_CHROMOSOMAL_PART	78	11	0.0000003118742133974073000
TCGA-13-0717-01.6	103	0_HALLMARK_ALLOGRAFT_REJECTION	190	16	0.0000003122388415209995100
TCGA-13-0807-01.8	46	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000003147293280195447700
TCGA-24-2261-01.2	87	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000003159358086238589800
TCGA-24-2261-01.2	87	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000003159358086238589800
TCGA-24-2262-01.25	141	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000003181649649168799600
TCGA-13-2060-01.10	86	2_MITOTIC_CELL_CYCLE	134	13	0.0000003182653913916664100
TCGA-24-1614-01.5	86	2_MITOTIC_CELL_CYCLE	134	13	0.0000003182653913916664100
TCGA-36-1575-01.9	193	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	15	0.0000003200750931086373500
TCGA-24-1425-01.1	61	1_KEGG_PPAR_SIGNALING_PATHWAY	63	9	0.0000003219497620301318500
TCGA-13-0765-01.4	54	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0000003223192454953574200
TCGA-24-1548-01.8	141	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000003243210653213882100
TCGA-24-1614-01.5	86	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0000003309366299181363600
TCGA-25-1623-01.7	111	2_CELL_CYCLE_GO_0007049	265	19	0.0000003319614694230897300
TCGA-24-1466-01.15	82	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000003321996509101451800
TCGA-23-1023-01.1	93	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000003375220954059422800
TCGA-31-1959-01.7	101	1_KEGG_FOCAL_ADHESION	195	16	0.0000003400447429990650000
TCGA-23-1024-01.3	24	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000003453512262491554900
TCGA-13-1501-01.12	101	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000003560780092424150900
TCGA-24-2290-01.3	70	2_MITOTIC_CELL_CYCLE	134	12	0.0000003597959413821151700
TCGA-61-2101-01.2	38	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0000003598629678305681700
TCGA-24-1551-01.15	87	2_CELL_CYCLE_PROCESS	163	14	0.0000003633025165842162500
TCGA-13-0714-01.9	51	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000003665175082844696500
TCGA-61-2088-01.7	150	1_KEGG_PATHWAYS_IN_CANCER	323	24	0.0000003667182633370823600
TCGA-23-1024-01.3	24	1_KEGG_CELL_CYCLE	114	8	0.0000003710937974780874000
TCGA-25-1324-01.3	42	2_M_PHASE	94	9	0.0000003720789627746026600
TCGA-36-1576-01.8	124	1_KEGG_CELL_CYCLE	114	14	0.0000003740609877732671100
TCGA-13-1403-01.9	71	2_COLLAGEN	23	7	0.0000003765517528773939700
TCGA-25-1320-01.4	71	2_COLLAGEN	23	7	0.0000003765517528773939700
TCGA-09-2044-01.4	83	1_KEGG_DNA_REPLICATION	32	8	0.0000003767198990598153500
TCGA-04-1362-01.4	35	2_CELL_CYCLE_PROCESS	163	10	0.0000003791574848449684000
TCGA-13-1512-01.2	113	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000003807047388551999800
TCGA-24-2262-01.25	141	1_KEGG_SMALL_CELL_LUNG_CANCER	83	13	0.0000003817937905530463000
TCGA-20-0991-01.12	166	1_KEGG_MELANOMA	71	13	0.0000003854009812618376900
TCGA-20-0990-01.17	133	1_KEGG_MELANOMA	71	12	0.0000003917682755267648200
TCGA-24-1558-01.12	174	1_KEGG_CELL_CYCLE	114	16	0.0000003987161345959969600
TCGA-13-1498-01.13	104	2_CELL_CYCLE_PROCESS	163	15	0.0000003998231327172077000
TCGA-10-0928-01.6	70	0_HALLMARK_E2F_TARGETS	169	13	0.0000004001344303468409900
TCGA-13-0887-01.6	47	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000004049515373473408900
TCGA-24-1557-01.13	106	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000004050538588195255100
TCGA-36-1574-01.10	152	2_M_PHASE	94	14	0.0000004149839828008139800
TCGA-61-2095-01.1	32	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000004154289549375253700
TCGA-13-0804-01.5	78	2_MITOSIS	71	10	0.0000004228633502258483000
TCGA-13-0894-01.9	118	1_KEGG_FOCAL_ADHESION	195	17	0.0000004235096792431132400
TCGA-13-1494-01.4	65	1_KEGG_CELL_CYCLE	114	11	0.0000004238762553587947100
TCGA-09-1665-01.16	131	2_NON_MEMBRANE_BOUND_ORGANELLE	476	27	0.0000004250627614751679900
TCGA-09-1665-01.16	131	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	27	0.0000004250627614751679900
TCGA-09-1669-01.10	81	2_CELL_CYCLE_PHASE	146	13	0.0000004312167935960006300
TCGA-13-1481-01.3	78	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000004314387045662484200
TCGA-13-1505-01.13	60	2_EXTRACELLULAR_REGION	346	16	0.0000004322445343046054300
TCGA-13-1496-01.13	120	1_KEGG_GLIOMA	62	11	0.0000004342698727822468300
TCGA-23-1026-01.5	65	2_EXTRACELLULAR_REGION_PART	269	15	0.0000004344152869527063400
TCGA-09-1666-01.28	109	1_KEGG_PROSTATE_CANCER	87	12	0.0000004376133120577101100
TCGA-61-2009-01.1	46	2_CATION_BINDING	165	11	0.0000004387248935023070700
TCGA-10-0934-01.11	145	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000004416590843509695400
TCGA-13-1507-01.8	101	2_M_PHASE	94	12	0.0000004472131311344544300
TCGA-13-1495-01.22	101	2_M_PHASE	94	12	0.0000004472131311344544300
TCGA-24-1471-01.4	49	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0000004472890215037577300
TCGA-13-1410-01.9	115	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000004558249741699244000
TCGA-04-1350-01.2	130	2_SIGNAL_TRANSDUCTION	1442	49	0.0000004561055342724184700
TCGA-61-1998-01.14	105	2_CELL_CYCLE_PROCESS	163	15	0.0000004595770708403208000
TCGA-61-2113-01.15	99	2_EXTRACELLULAR_REGION_PART	269	18	0.0000004602170656276901300
TCGA-25-1623-01.7	111	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000004795162862180561600
TCGA-24-1563-01.15	100	2_ORGAN_DEVELOPMENT	460	23	0.0000004810781229480567500
TCGA-13-0724-01.21	71	0_HALLMARK_E2F_TARGETS	169	13	0.0000004822935106335618900
TCGA-13-0804-01.5	78	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000004878427700751087900
TCGA-25-2042-01.3	63	2_EXTRACELLULAR_SPACE	192	13	0.0000004880669038787409300
TCGA-23-1032-01.16	250	2_MITOTIC_CELL_CYCLE	134	20	0.0000004907786795801317800
TCGA-57-1582-01.26	174	2_CELL_PROLIFERATION_GO_0008283	436	30	0.0000004943081824150570600
TCGA-13-0897-01.2	61	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000004960299350432837600
TCGA-25-2401-01.5	119	0_HALLMARK_E2F_TARGETS	169	16	0.0000004966007320431545800
TCGA-24-1435-01.12	115	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000004966891771662294400
TCGA-09-1669-01.10	81	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000004973522594581974200
TCGA-09-1669-01.10	81	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000004973522594581974200
TCGA-61-1995-01.4	102	2_M_PHASE	94	12	0.0000005027585993331604400
TCGA-13-1483-01.3	66	1_KEGG_CELL_CYCLE	114	11	0.0000005035558896898810300
TCGA-13-0904-01.6	105	1_KEGG_PATHWAYS_IN_CANCER	323	20	0.0000005040757725417862700
TCGA-13-1512-01.2	113	2_EXTRACELLULAR_MATRIX	85	12	0.0000005069724582430460600
TCGA-13-1405-01.4	69	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000005120828265645502100
TCGA-10-0934-01.11	145	2_CHEMOKINE_ACTIVITY	40	10	0.0000005130266903618297600
TCGA-13-1404-01.13	117	2_CHROMOSOME	102	13	0.0000005135313310254296000
TCGA-13-0890-01.2	48	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000005177416844361274700
TCGA-10-0934-01.11	145	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	18	0.0000005286544562363255600
TCGA-13-1494-01.4	65	1_KEGG_BLADDER_CANCER	42	8	0.0000005339900938367826300
TCGA-61-2113-01.15	99	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000005341400914177124500
TCGA-24-1614-01.5	86	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000005380390480446643200
TCGA-25-2400-01.5	35	0_HALLMARK_E2F_TARGETS	169	10	0.0000005418502771931191700
TCGA-13-0755-01.6	16	1_KEGG_CELL_CYCLE	114	7	0.0000005466654274160769200
TCGA-25-1635-01.6	129	2_MITOTIC_CELL_CYCLE	134	15	0.0000005495370998091183700
TCGA-23-1120-01.10	57	2_MITOTIC_CELL_CYCLE	134	11	0.0000005527966645778965900
TCGA-13-1410-01.9	115	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000005538238550061513900
TCGA-36-1574-01.10	152	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000005544370782644205700
TCGA-10-0933-01.2	97	2_CHROMOSOMAL_PART	78	11	0.0000005585099248305939800
TCGA-10-0933-01.2	97	2_CHROMOSOMEPERICENTRIC_REGION	29	8	0.0000005595442479534141400
TCGA-61-2111-01.16	56	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0000005688870049862123600
TCGA-23-1110-01.7	299	2_CHROMOSOME	102	19	0.0000005723234622740022300
TCGA-10-0928-01.6	70	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000005761378719445867100
TCGA-23-1110-01.7	299	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	30	0.0000005765313482987977600
TCGA-25-2399-01.16	103	0_HALLMARK_E2F_TARGETS	169	15	0.0000005802467042873562200
TCGA-13-0900-01.8	90	2_CELL_CYCLE_PROCESS	163	14	0.0000005806154032330380000
TCGA-23-1032-01.16	250	1_KEGG_MELANOMA	71	15	0.0000005918451516225935500
TCGA-13-1405-01.4	69	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000005927373332806540600
TCGA-24-1548-01.8	141	1_KEGG_PATHWAYS_IN_CANCER	323	23	0.0000005939398168878065200
TCGA-61-2113-01.15	99	1_KEGG_BLADDER_CANCER	42	9	0.0000005960032998485674500
TCGA-24-1434-01.3	82	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0000005999302202140777300
TCGA-61-1728-01.5	45	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000006004735680405467800
TCGA-04-1348-01.6	81	2_M_PHASE	94	11	0.0000006014166919851706400
TCGA-24-1557-01.13	106	1_KEGG_PATHWAYS_IN_CANCER	323	20	0.0000006022545224139089200
TCGA-24-1551-01.15	87	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000006046225796091302500
TCGA-13-1408-01.1	45	2_EXTRACELLULAR_REGION	346	14	0.0000006050547003171099000
TCGA-61-2102-01.7	172	2_DNA_METABOLIC_PROCESS	218	21	0.0000006153019924159065000
TCGA-13-0714-01.9	51	1_KEGG_CELL_CYCLE	114	10	0.0000006256696886970574500
TCGA-09-1659-01.5	51	1_KEGG_CELL_CYCLE	114	10	0.0000006256696886970574500
TCGA-13-0723-01.8	50	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0000006302691136656433900
TCGA-13-1498-01.13	104	2_M_PHASE	94	12	0.0000006329581211332934800
TCGA-61-2003-01.4	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000006386074745034273800
TCGA-57-1582-01.26	174	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000006459248033517673900
TCGA-13-1482-01.7	62	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000006462806895446470500
TCGA-13-2060-01.10	86	1_KEGG_CELL_CYCLE	114	12	0.0000006472320753558314600
TCGA-13-1507-01.8	101	2_CELL_CYCLE_PHASE	146	14	0.0000006477909952047827200
TCGA-04-1346-01.10	75	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0000006490176942728860300
TCGA-04-1365-01.6	150	2_CHROMOSOMEPERICENTRIC_REGION	29	9	0.0000006503996990470083400
TCGA-24-1548-01.8	141	1_KEGG_PANCREATIC_CANCER	70	12	0.0000006534999079338884000
TCGA-04-1365-01.6	150	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000006563210761264076800
TCGA-24-2262-01.25	141	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000006579924208881490100
TCGA-13-1495-01.22	101	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000006590938227631417500
TCGA-10-0934-01.11	145	2_CELL_PROLIFERATION_GO_0008283	436	27	0.0000006613664288739309100
TCGA-13-1498-01.13	104	0_HALLMARK_E2F_TARGETS	169	15	0.0000006676329794536015600
TCGA-24-1426-01.7	63	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000006696179103288941800
TCGA-10-0934-01.11	145	2_CHEMOKINE_RECEPTOR_BINDING	41	10	0.0000006697003610439023100
TCGA-13-1504-01.4	48	2_CELL_CYCLE_GO_0007049	265	13	0.0000006733780256004756300
TCGA-04-1365-01.6	150	2_MICROTUBULE_CYTOSKELETON	117	15	0.0000006750777134449006100
TCGA-10-0938-01.2	102	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	14	0.0000006758852430598595000
TCGA-04-1514-01.6	91	2_CELL_CYCLE_PROCESS	163	14	0.0000006760457899917227400
TCGA-61-2101-01.2	38	2_EXTRACELLULAR_REGION	346	13	0.0000006809270772117619200
TCGA-25-2393-01.5	140	0_HALLMARK_E2F_TARGETS	169	17	0.0000006882392382837852200
TCGA-20-0987-01.19	194	1_KEGG_PATHWAYS_IN_CANCER	323	27	0.0000006923365821250865000
TCGA-04-1350-01.2	130	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0000007011121075108837200
TCGA-24-1466-01.15	82	1_KEGG_MELANOMA	71	10	0.0000007021144803580315400
TCGA-13-1510-01.20	82	1_KEGG_MELANOMA	71	10	0.0000007021144803580315400
TCGA-04-1337-01.2	31	2_EXTRACELLULAR_REGION_PART	269	11	0.0000007021849536214954700
TCGA-13-0884-01.11	68	1_KEGG_CELL_CYCLE	114	11	0.0000007044058133757909300
TCGA-13-0760-01.12	93	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000007114614897927553400
TCGA-24-0966-01.2	18	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0000007122068307352979000
TCGA-13-1501-01.12	101	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000007146604037368702300
TCGA-20-0991-01.12	166	2_CELL_PROLIFERATION_GO_0008283	436	29	0.0000007147688022249526100
TCGA-13-0886-01.1	45	2_M_PHASE	94	9	0.0000007216267744227540700
TCGA-13-0887-01.6	47	2_DNA_METABOLIC_PROCESS	218	12	0.0000007299043071797592900
TCGA-25-1628-01.2	118	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000007327236226915909900
TCGA-25-1635-01.6	129	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000007457070961215176000
TCGA-36-1577-01.14	168	1_KEGG_PATHWAYS_IN_CANCER	323	25	0.0000007506632315800622400
TCGA-23-1030-01.10	58	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000007517732819417126000
TCGA-13-1405-01.4	69	2_EXTRACELLULAR_MATRIX	85	10	0.0000007538757794035547800
TCGA-25-2401-01.5	119	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000007680624081443600500
TCGA-24-1567-01.3	141	0_HALLMARK_E2F_TARGETS	169	17	0.0000007706130223257944900
TCGA-13-1407-01.11	220	0_HALLMARK_ALLOGRAFT_REJECTION	190	22	0.0000007711476370747893300
TCGA-13-0924-01.5	68	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000007745304394677428600
TCGA-10-0938-01.2	102	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000007811387123945633600
TCGA-09-1665-01.16	131	1_KEGG_CELL_CYCLE	114	14	0.0000007848246350675272500
TCGA-13-0730-01.8	83	2_M_PHASE	94	11	0.0000007878188455072229800
TCGA-09-2044-01.4	83	2_M_PHASE	94	11	0.0000007878188455072229800
TCGA-09-0369-01.9	109	2_CELL_CYCLE_PROCESS	163	15	0.0000007900068038829363100
TCGA-24-1557-01.13	106	2_M_PHASE	94	12	0.0000007929263216294173100
TCGA-61-2092-01.12	209	1_KEGG_PATHWAYS_IN_CANCER	323	28	0.0000007960507129956724300
TCGA-04-1347-01.15	187	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	36	0.0000007995654968145704400
TCGA-24-1436-01.1	49	2_CELL_CYCLE_PROCESS	163	11	0.0000008034213236128294600
TCGA-24-1435-01.12	115	2_EXTRACELLULAR_REGION_PART	269	19	0.0000008062293321195505500
TCGA-13-1510-01.20	82	2_SIGNAL_TRANSDUCTION	1442	36	0.0000008080095094876038500
TCGA-24-2030-01.8	161	0_HALLMARK_E2F_TARGETS	169	18	0.0000008094976268915051500
TCGA-13-0899-01.1	28	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000008104804890625845800
TCGA-13-1487-01.3	79	2_COLLAGEN	23	7	0.0000008110348971712973900
TCGA-04-1517-01.4	44	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000008184825897778732700
TCGA-30-1891-01.4	84	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0000008193387510947078100
TCGA-24-1428-01.9	90	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0000008238309824812151900
TCGA-25-2396-01.6	42	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000008251082241727850000
TCGA-23-1118-01.5	50	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000008313280096049528900
TCGA-36-1578-01.10	60	1_KEGG_MELANOMA	71	9	0.0000008347869165593361000
TCGA-23-1031-01.17	142	1_KEGG_MELANOMA	71	12	0.0000008432213045195076700
TCGA-23-1116-01.7	84	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000008501402559480649600
TCGA-24-1428-01.9	90	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000008505763397234793100
TCGA-09-2053-01.14	121	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000008524646104193365200
TCGA-13-1405-01.4	69	2_CELL_CYCLE_GO_0007049	265	15	0.0000008700153512459846400
TCGA-24-1603-01.3	69	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000008732941704425655000
TCGA-24-1556-01.19	120	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000008794110520520244100
TCGA-61-2109-01.13	122	2_REGULATION_OF_MITOSIS	36	9	0.0000008795775327579365600
TCGA-25-1628-01.2	118	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000008817514482643122100
TCGA-61-2104-01.15	95	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000008847303619700204300
TCGA-23-1122-01.11	77	2_CELL_CYCLE_PROCESS	163	13	0.0000008866178772440681600
TCGA-13-0807-01.8	46	2_M_PHASE	94	9	0.0000008898834433466547100
TCGA-36-1580-01.1	65	1_KEGG_FOCAL_ADHESION	195	13	0.0000008956954826223273600
TCGA-24-0979-01.5	41	2_MITOSIS	71	8	0.0000008990945797240130800
TCGA-24-1435-01.12	115	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	11	0.0000009121528781243810500
TCGA-24-1103-01.5	73	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000009142235947633520300
TCGA-13-0920-01.9	82	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0000009219514784325410600
TCGA-13-1504-01.4	48	0_HALLMARK_E2F_TARGETS	169	11	0.0000009324480280111501400
TCGA-24-1416-01.4	38	2_CELL_CYCLE_PROCESS	163	10	0.0000009338656549199235200
TCGA-30-1862-01.13	91	2_EXTRACELLULAR_REGION_PART	269	17	0.0000009406648672043438200
TCGA-13-1512-01.2	113	2_MITOTIC_CELL_CYCLE	134	14	0.0000009439812446566169000
TCGA-24-1556-01.19	120	0_HALLMARK_MITOTIC_SPINDLE	175	16	0.0000009499090095046353000
TCGA-10-0926-01.2	45	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000009565314743466841300
TCGA-13-1498-01.13	104	2_CELL_CYCLE_PHASE	146	14	0.0000009651834578721298000
TCGA-13-0804-01.5	78	2_CHROMOSOME	102	11	0.0000009680485459245979800
TCGA-23-1022-01.10	170	1_KEGG_PATHWAYS_IN_CANCER	323	25	0.0000009706145779141422200
TCGA-10-0928-01.6	70	1_KEGG_CELL_CYCLE	114	11	0.0000009744153535045875200
TCGA-59-2363-01.3	89	1_KEGG_CELL_CYCLE	114	12	0.0000009749589683316350000
TCGA-13-1489-01.11	118	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0000009759028793712390900
TCGA-10-0928-01.6	70	2_CELL_CYCLE_PHASE	146	12	0.0000009811844748574347600
TCGA-31-1950-01.7	105	2_CELL_CYCLE_GO_0007049	265	18	0.0000009867105753544080600
TCGA-04-1346-01.10	75	0_HALLMARK_E2F_TARGETS	169	13	0.0000009877225755116804600
TCGA-24-1470-01.7	76	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000009938223607632102700
TCGA-24-1470-01.7	76	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000009938223607632102700
TCGA-57-1583-01.20	185	1_KEGG_CELL_CYCLE	114	16	0.0000009956374435139019100
TCGA-23-1031-01.17	142	1_KEGG_VEGF_SIGNALING_PATHWAY	72	12	0.0000009989843162770953400
TCGA-10-0934-01.11	145	2_ION_HOMEOSTASIS	105	14	0.0000010027854378091383000
TCGA-24-0979-01.5	41	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0000010083273580988387000
TCGA-04-1356-01.1	71	2_DNA_METABOLIC_PROCESS	218	14	0.0000010169682858923014000
TCGA-25-1623-01.7	111	2_CELL_CYCLE_PROCESS	163	15	0.0000010266839786376718000
TCGA-13-1483-01.3	66	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000010302032767129569000
TCGA-13-0906-01.5	66	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000010302032767129569000
TCGA-13-0807-01.8	46	2_MITOTIC_CELL_CYCLE	134	10	0.0000010486103652070771000
TCGA-23-1110-01.7	299	2_M_PHASE	94	18	0.0000010547040159022863000
TCGA-04-1364-01.3	163	2_M_PHASE	94	14	0.0000010548067382624690000
TCGA-10-0928-01.6	70	2_CELL_CYCLE_GO_0007049	265	15	0.0000010797933482510407000
TCGA-25-1623-01.7	111	1_KEGG_CELL_CYCLE	114	13	0.0000010830554135495249000
TCGA-24-1423-01.5	27	1_KEGG_CELL_CYCLE	114	8	0.0000010869848346822592000
TCGA-10-0926-01.2	45	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000010881083991963051000
TCGA-04-1514-01.6	91	0_HALLMARK_E2F_TARGETS	169	14	0.0000010933333333887804000
TCGA-13-1483-01.3	66	1_KEGG_FOCAL_ADHESION	195	13	0.0000010954163610757661000
TCGA-04-1542-01.4	141	2_SIGNAL_TRANSDUCTION	1442	51	0.0000010957549313314961000
TCGA-13-1488-01.17	109	1_KEGG_FOCAL_ADHESION	195	16	0.0000010977438417453204000
TCGA-61-1998-01.14	105	2_CELL_CYCLE_PHASE	146	14	0.0000010990831913064124000
TCGA-04-1356-01.1	71	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000011040534927379355000
TCGA-25-2396-01.6	42	2_MITOSIS	71	8	0.0000011040534927379508000
TCGA-13-0893-01.4	112	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000011354727561047001000
TCGA-36-1580-01.1	65	0_HALLMARK_COAGULATION	125	11	0.0000011524121591283644000
TCGA-24-2293-01.3	33	1_KEGG_FOCAL_ADHESION	195	10	0.0000011533319334570373000
TCGA-31-1950-01.7	105	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000011567156501889031000
TCGA-04-1336-01.28	106	2_CELL_CYCLE_GO_0007049	265	18	0.0000011589905770258850000
TCGA-24-0980-01.5	44	1_KEGG_BLADDER_CANCER	42	7	0.0000011643981126696890000
TCGA-04-1347-01.15	187	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	37	0.0000011696473067557243000
TCGA-23-1028-01.18	93	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000011818786897989612000
TCGA-13-0760-01.12	93	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000011818786897989612000
TCGA-24-2254-01.3	49	0_HALLMARK_E2F_TARGETS	169	11	0.0000011839250430072458000
TCGA-59-2363-01.3	89	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000011864686084430017000
TCGA-20-0990-01.17	133	2_CELL_CYCLE_GO_0007049	265	20	0.0000012041239443162409000
TCGA-04-1365-01.6	150	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000012118746747468025000
TCGA-13-1492-01.2	162	2_DNA_REPAIR	113	15	0.0000012166924680458102000
TCGA-36-1577-01.14	168	2_CELL_CYCLE_PHASE	146	17	0.0000012184415645685288000
TCGA-25-2396-01.6	42	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0000012380700812326050000
TCGA-13-0761-01.6	75	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0000012474877264875207000
TCGA-13-0904-01.6	105	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000012537309673102912000
TCGA-23-2078-01.15	105	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000012537309673102912000
TCGA-36-1576-01.8	124	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000012539658498782348000
TCGA-24-1435-01.12	115	2_MITOSIS	71	11	0.0000012548438646192577000
TCGA-24-1544-01.7	84	2_COLLAGEN	23	7	0.0000012578426786790884000
TCGA-13-1504-01.4	48	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000012742050290883908000
TCGA-24-2261-01.2	87	2_MITOSIS	71	10	0.0000012747987044762648000
TCGA-23-1022-01.10	170	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	22	0.0000012983372639129117000
TCGA-13-0906-01.5	66	2_M_PHASE	94	10	0.0000013154147516039650000
TCGA-10-0938-01.2	102	2_CHROMOSOME	102	12	0.0000013248390905109992000
TCGA-13-0800-01.9	124	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000013304518887416595000
TCGA-36-1580-01.1	65	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	9	0.0000013478313781800961000
TCGA-23-1027-01.8	68	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000013566952439170282000
TCGA-61-2113-01.15	99	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000013885308031137453000
TCGA-13-1483-01.3	66	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000013893548334380187000
TCGA-24-1556-01.19	120	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0000014022722275666778000
TCGA-24-1549-01.21	158	2_MICROTUBULE_CYTOSKELETON	117	15	0.0000014079852917481203000
TCGA-25-1634-01.4	75	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000014080426153491046000
TCGA-25-1627-01.4	75	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000014186497733958635000
TCGA-25-2400-01.5	35	2_DNA_BINDING	496	14	0.0000014260022563865222000
TCGA-61-1995-01.4	102	2_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0000014371257797205201000
TCGA-61-1995-01.4	102	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0000014371257797205201000
TCGA-13-0905-01.7	160	1_KEGG_PATHWAYS_IN_CANCER	323	24	0.0000014374361403035662000
TCGA-24-2030-01.8	161	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	10	0.0000014400557813732343000
TCGA-04-1365-01.6	150	2_CELL_PROLIFERATION_GO_0008283	436	27	0.0000014609020568934335000
TCGA-24-1435-01.12	115	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000014661442162922036000
TCGA-24-2261-01.2	87	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000014694097935302671000
TCGA-13-0760-01.12	93	0_HALLMARK_E2F_TARGETS	169	14	0.0000014718169000606797000
TCGA-61-2000-01.11	69	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0000015036420874269823000
TCGA-13-1509-01.9	117	2_MITOSIS	71	11	0.0000015122797131936615000
TCGA-04-1542-01.4	141	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	20	0.0000015368880347044448000
TCGA-23-1032-01.16	250	1_KEGG_CELL_CYCLE	114	18	0.0000015403941785509760000
TCGA-24-2035-01.8	102	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	15	0.0000015451147067367402000
TCGA-24-1603-01.3	69	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000015517002901287794000
TCGA-13-1405-01.4	69	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000015517002901287794000
TCGA-23-1110-01.7	299	2_CELL_PROLIFERATION_GO_0008283	436	40	0.0000015663516660222301000
TCGA-13-0887-01.6	47	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000015700678979746354000
TCGA-13-1492-01.2	162	2_MITOTIC_CELL_CYCLE	134	16	0.0000015916433941886813000
TCGA-24-1436-01.1	49	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000016170585210939820000
TCGA-25-2392-01.4	60	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0000016444563836984356000
TCGA-10-0934-01.11	145	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000016485331506905285000
TCGA-04-1365-01.6	150	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	16	0.0000016485331506905285000
TCGA-13-0795-01.9	67	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000016679752999263106000
TCGA-31-1953-01.6	53	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0000016716765279203645000
TCGA-13-0807-01.8	46	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000016728869538342926000
TCGA-13-1509-01.9	117	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000016805958931751019000
TCGA-25-1313-01.2	13	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0000016831565605451460000
TCGA-25-1634-01.4	75	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000017283683270984585000
TCGA-13-0883-01.3	23	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0000017297484967950743000
TCGA-30-1862-01.13	91	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000017346495437078503000
TCGA-36-1576-01.8	124	1_KEGG_PATHWAYS_IN_CANCER	323	21	0.0000017480283797885228000
TCGA-24-1548-01.8	141	2_CELL_PROLIFERATION_GO_0008283	436	26	0.0000017572675465466385000
TCGA-61-2102-01.7	172	2_CELL_CYCLE_PHASE	146	17	0.0000017599410981949386000
TCGA-24-0982-01.3	34	2_M_PHASE	94	8	0.0000017609729329098462000
TCGA-13-1509-01.9	117	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000017665835511377012000
TCGA-23-1123-01.7	70	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000017709392173698571000
TCGA-13-1495-01.22	101	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0000017718403006354784000
TCGA-10-0934-01.11	145	2_CELLULAR_CATION_HOMEOSTASIS	91	13	0.0000017719286349146709000
TCGA-61-2113-01.15	99	2_EXTRACELLULAR_MATRIX	85	11	0.0000018039476691416068000
TCGA-25-1326-01.11	119	2_MITOSIS	71	11	0.0000018161293304286713000
TCGA-36-1571-01.6	109	2_CELL_CYCLE_PHASE	146	14	0.0000018219550493784355000
TCGA-09-2050-01.18	196	2_CELL_CYCLE_PHASE	146	18	0.0000018253640141782899000
TCGA-24-1463-01.5	130	2_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000018302148202978880000
TCGA-24-1463-01.5	130	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000018302148202978880000
TCGA-13-0714-01.9	51	2_EXTRACELLULAR_REGION_PART	269	13	0.0000018532719452743939000
TCGA-25-1321-01.3	33	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	5	0.0000018750018915959478000
TCGA-61-1998-01.7	7	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	4	0.0000018847026728537708000
TCGA-25-2393-01.5	140	1_KEGG_CELL_CYCLE	114	14	0.0000019074438084643416000
TCGA-13-0900-01.8	90	2_M_PHASE	94	11	0.0000019183857962952760000
TCGA-24-1470-01.7	76	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000019254988781259868000
TCGA-13-0916-01.11	92	1_KEGG_PANCREATIC_CANCER	70	10	0.0000019317620866119929000
TCGA-24-1548-01.8	141	2_MITOTIC_CELL_CYCLE	134	15	0.0000019476325178365813000
TCGA-24-1464-01.7	62	2_CELL_CYCLE_GO_0007049	265	14	0.0000019528248398614958000
TCGA-13-0723-01.8	50	2_M_PHASE	94	9	0.0000019588602851280411000
TCGA-04-1343-01.7	50	2_M_PHASE	94	9	0.0000019588602851280411000
TCGA-13-0916-01.11	92	2_MICROTUBULE_CYTOSKELETON	117	12	0.0000019594720203805234000
TCGA-36-1574-01.10	152	0_HALLMARK_ANGIOGENESIS	32	9	0.0000019683137659067798000
TCGA-13-0910-01.3	71	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0000019723209329424206000
TCGA-13-0910-01.3	71	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0000019723209329424206000
TCGA-09-2053-01.14	121	2_EXTRACELLULAR_REGION_PART	269	19	0.0000019737298788169887000
TCGA-20-0991-01.12	166	2_REGULATION_OF_CELL_PROLIFERATION	265	22	0.0000019752274918864852000
TCGA-31-1953-01.6	53	2_CELL_CYCLE_PROCESS	163	11	0.0000019805114431032868000
TCGA-13-0897-01.2	61	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0000019904393237275798000
TCGA-13-1407-01.11	220	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	15	0.0000020106552724409772000
TCGA-24-0968-01.9	71	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000020169625507323246000
TCGA-04-1331-01.5	90	2_REGULATION_OF_MITOSIS	36	8	0.0000020322881726327335000
TCGA-23-2081-01.7	56	2_SKELETAL_DEVELOPMENT	84	9	0.0000020423297893936529000
TCGA-23-1031-01.17	142	2_CELL_PROLIFERATION_GO_0008283	436	26	0.0000020606972411558143000
TCGA-25-1319-01.10	69	2_M_PHASE	94	10	0.0000020689027946192306000
TCGA-24-0975-01.6	78	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	26	0.0000020725275881409583000
TCGA-61-2094-01.6	63	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000020767950794056722000
TCGA-04-1348-01.6	81	2_MITOTIC_CELL_CYCLE	134	12	0.0000020955109164771615000
TCGA-30-1853-01.4	111	2_SIGNAL_TRANSDUCTION	1442	43	0.0000021018775909123620000
TCGA-24-1556-01.19	120	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000021099725461670720000
TCGA-61-2104-01.15	95	1_KEGG_CELL_CYCLE	114	12	0.0000021134894462437467000
TCGA-25-1326-01.11	119	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000021211133846062979000
TCGA-25-2042-01.3	63	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000021230671579708838000
TCGA-25-2398-01.5	81	2_CHEMOKINE_ACTIVITY	40	8	0.0000021351695809536156000
TCGA-25-2399-01.16	103	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000021360434127148445000
TCGA-09-1666-01.28	109	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000021447693016740685000
TCGA-23-1028-01.18	93	1_KEGG_PANCREATIC_CANCER	70	10	0.0000021519472122370069000
TCGA-13-0760-01.12	93	1_KEGG_PANCREATIC_CANCER	70	10	0.0000021519472122370069000
TCGA-13-1494-01.4	65	0_HALLMARK_E2F_TARGETS	169	12	0.0000021711376833587124000
TCGA-25-1627-01.4	75	2_DNA_METABOLIC_PROCESS	218	14	0.0000021831114295254236000
TCGA-24-2035-01.8	102	2_SKELETAL_DEVELOPMENT	84	11	0.0000021913564586150837000
TCGA-04-1338-01.7	85	2_CELL_CYCLE_GO_0007049	265	16	0.0000021930944898035946000
TCGA-61-2113-01.15	99	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000022058995257025996000
TCGA-24-1436-01.1	49	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000022271551048710156000
TCGA-24-2254-01.3	49	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000022271551048710156000
TCGA-59-2351-01.5	31	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000022650490375847613000
TCGA-61-2088-01.7	150	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	58	11	0.0000022670956360140719000
TCGA-24-1463-01.5	130	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000022977790275852025000
TCGA-24-0980-01.5	44	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0000023121713639021431000
TCGA-13-0910-01.3	71	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0000023132376412384383000
TCGA-10-0934-01.11	145	2_CATION_HOMEOSTASIS	93	13	0.0000023367830742635264000
TCGA-13-1487-01.3	79	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000023398842217665742000
TCGA-13-0887-01.6	47	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000023545188969640700000
TCGA-24-1469-01.6	123	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0000023784162458055778000
TCGA-24-1423-01.5	27	2_CELL_CYCLE_GO_0007049	265	10	0.0000023828052452541181000
TCGA-25-1633-01.1	71	2_WOUND_HEALING	46	8	0.0000023833220287756094000
TCGA-23-1124-01.17	107	2_EXTRACELLULAR_REGION	346	20	0.0000024037035598258671000
TCGA-59-2363-01.3	89	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	31	0.0000024238783700320707000
TCGA-61-1736-01.2	54	2_CELL_CYCLE_PROCESS	163	11	0.0000024504510491756279000
TCGA-13-1407-01.11	220	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000024579574298707847000
TCGA-23-1031-01.17	142	1_KEGG_MAPK_SIGNALING_PATHWAY	258	20	0.0000024629575052486379000
TCGA-13-0760-01.12	93	1_KEGG_MELANOMA	71	10	0.0000024846682458902541000
TCGA-13-1489-01.11	118	0_HALLMARK_ALLOGRAFT_REJECTION	190	16	0.0000024879047351385918000
TCGA-23-2079-01.14	85	2_CHROMOSOME	102	11	0.0000024947970936833783000
TCGA-13-0792-01.8	64	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000025155550493473275000
TCGA-20-0991-01.12	166	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	16	0.0000025531457892872942000
TCGA-13-0751-01.2	51	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000025602934068390093000
TCGA-24-2288-01.12	112	2_CELL_CYCLE_PHASE	146	14	0.0000026243247802175715000
TCGA-25-2398-01.5	81	2_CHEMOKINE_RECEPTOR_BINDING	41	8	0.0000026345476837988819000
TCGA-23-1118-01.5	50	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000026368800443460610000
TCGA-25-1322-01.15	93	2_REGULATION_OF_MITOSIS	36	8	0.0000026488897009234549000
TCGA-24-1424-01.4	80	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000026699241378037181000
TCGA-24-1424-01.4	80	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000026699241378037181000
TCGA-13-1484-01.4	70	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0000027066323353577907000
TCGA-23-1123-01.7	70	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0000027066323353577907000
TCGA-09-0369-01.9	109	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	15	0.0000027190150770379899000
TCGA-36-1577-01.14	168	2_MITOTIC_CELL_CYCLE	134	16	0.0000027271142825163649000
TCGA-24-1105-01.8	52	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000027600383028572258000
TCGA-25-2399-01.16	103	2_EXTRACELLULAR_MATRIX	85	11	0.0000027729300700207732000
TCGA-23-1032-01.16	250	1_KEGG_PATHWAYS_IN_CANCER	323	30	0.0000027895900295170184000
TCGA-24-2280-01.10	58	1_KEGG_FOCAL_ADHESION	195	12	0.0000027976614595917562000
TCGA-24-1563-01.15	100	1_KEGG_FOCAL_ADHESION	195	15	0.0000028179585816437666000
TCGA-24-2280-01.10	58	2_SKELETAL_DEVELOPMENT	84	9	0.0000028297714746805029000
TCGA-10-0928-01.6	70	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000028323555158952548000
TCGA-25-1633-01.1	71	1_KEGG_FOCAL_ADHESION	195	13	0.0000028436485626589513000
TCGA-20-0990-01.17	133	1_KEGG_FOCAL_ADHESION	195	17	0.0000028488170205446202000
TCGA-31-1950-01.7	105	2_CELL_PROLIFERATION_GO_0008283	436	22	0.0000028522600697753597000
TCGA-13-1411-01.7	96	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000028527522359096999000
TCGA-13-0717-01.6	103	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000028528009275566511000
TCGA-13-0919-01.5	50	2_EXTRACELLULAR_REGION	346	14	0.0000028785688242307702000
TCGA-25-2391-01.2	64	2_DNA_METABOLIC_PROCESS	218	13	0.0000028888667117194986000
TCGA-61-1919-01.9	87	2_EXTRACELLULAR_REGION	346	18	0.0000029306666720861017000
TCGA-04-1367-01.3	74	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000029446457631199507000
TCGA-13-1405-01.4	69	2_CELL_CYCLE_PROCESS	163	12	0.0000029493979642462620000
TCGA-13-1487-01.3	79	2_EXTRACELLULAR_MATRIX	85	10	0.0000029702352102347031000
TCGA-13-1487-01.3	79	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000029773007641537408000
TCGA-04-1346-01.10	75	2_CELL_CYCLE_GO_0007049	265	15	0.0000030091805755852467000
TCGA-25-1627-01.4	75	2_CELL_CYCLE_GO_0007049	265	15	0.0000030091805755852467000
TCGA-13-0761-01.6	75	2_CELL_CYCLE_GO_0007049	265	15	0.0000030091805755852467000
TCGA-13-1483-01.3	66	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000031103641273889278000
TCGA-13-0893-01.4	112	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000031593900801513904000
TCGA-04-1364-01.3	163	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000031893920029557093000
TCGA-24-2262-01.25	141	2_REGULATION_OF_MITOSIS	36	9	0.0000032107820275419414000
TCGA-13-1407-01.11	220	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000032626393838708102000
TCGA-20-0991-01.12	166	2_SIGNAL_TRANSDUCTION	1442	56	0.0000032675170458689914000
TCGA-13-0717-01.6	103	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000032685216519342003000
TCGA-25-2399-01.16	103	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000032685216519342003000
TCGA-04-1362-01.4	35	2_CELL_CYCLE_PHASE	146	9	0.0000033257107104514019000
TCGA-25-1626-01.2	86	1_KEGG_FOCAL_ADHESION	195	14	0.0000033258597717009859000
TCGA-13-1411-01.7	96	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000033260625946496106000
TCGA-61-1736-01.2	54	2_CELL_CYCLE_GO_0007049	265	13	0.0000033275933562000291000
TCGA-13-0724-01.21	71	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000033590652177894259000
TCGA-13-0791-01.35	80	1_KEGG_COLORECTAL_CANCER	62	9	0.0000033674162338951441000
TCGA-24-1551-01.15	87	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000033842335121306334000
TCGA-10-0934-01.11	145	2_SIGNAL_TRANSDUCTION	1442	51	0.0000033861524479858856000
TCGA-13-1510-01.20	82	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000034015572100648473000
TCGA-24-2035-01.8	102	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	30	0.0000034028438357209014000
TCGA-23-1123-01.7	70	2_MITOSIS	71	9	0.0000034605637694282079000
TCGA-24-1567-01.3	141	2_CELL_CYCLE_GO_0007049	265	20	0.0000034637403627735440000
TCGA-09-2050-01.18	196	2_MITOTIC_CELL_CYCLE	134	17	0.0000034671159158479232000
TCGA-13-1492-01.2	162	1_KEGG_DNA_REPLICATION	32	9	0.0000034680609440194297000
TCGA-24-1424-01.4	80	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0000034982712906907595000
TCGA-24-1614-01.5	86	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	9	0.0000035017263742524336000
TCGA-10-0928-01.6	70	2_CELL_CYCLE_PROCESS	163	12	0.0000035070270759216274000
TCGA-24-2030-01.8	161	2_CELL_CYCLE_PROCESS	163	17	0.0000035134176974150582000
TCGA-13-1412-01.8	113	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0000035379138496864302000
TCGA-10-0934-01.11	145	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	10	0.0000035652821294343791000
TCGA-10-0934-01.11	145	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	10	0.0000035652821294343791000
TCGA-13-1510-01.20	82	1_KEGG_BLADDER_CANCER	42	8	0.0000035699667567277142000
TCGA-13-0800-01.9	124	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000035852341289795713000
TCGA-13-0717-01.6	103	2_CELL_CYCLE_PROCESS	163	14	0.0000036426388144459485000
TCGA-24-1105-01.8	52	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000036557878613378096000
TCGA-23-2078-01.15	105	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000036943730213645541000
TCGA-23-1120-01.10	57	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000037081252052092624000
TCGA-13-1487-01.3	79	1_KEGG_CELL_CYCLE	114	11	0.0000037169052029330699000
TCGA-10-0933-01.2	97	2_REGULATION_OF_MITOSIS	36	8	0.0000037192659204406657000
TCGA-24-1544-01.7	84	2_ORGAN_DEVELOPMENT	460	20	0.0000037218745069029472000
TCGA-13-1404-01.13	117	1_KEGG_PATHWAYS_IN_CANCER	323	20	0.0000037296717166449567000
TCGA-13-1407-01.11	220	2_CELL_CYCLE_GO_0007049	265	25	0.0000037500375902010122000
TCGA-24-1105-01.8	52	2_MITOTIC_CELL_CYCLE	134	10	0.0000037865919134016771000
TCGA-24-1427-01.4	83	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000038402599506405865000
TCGA-24-1563-01.15	100	1_KEGG_CELL_CYCLE	114	12	0.0000038624743589076994000
TCGA-13-1505-01.13	60	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000038723461668558524000
TCGA-13-1505-01.13	60	2_SKELETAL_DEVELOPMENT	84	9	0.0000038723461668558524000
TCGA-13-1411-01.7	96	2_M_PHASE	94	11	0.0000038729942336573558000
TCGA-24-2293-01.1	22	0_HALLMARK_E2F_TARGETS	169	8	0.0000038772453336825213000
TCGA-61-1919-01.9	87	1_KEGG_FOCAL_ADHESION	195	14	0.0000038926641843605655000
TCGA-13-1483-01.3	66	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000039000902627385735000
TCGA-04-1332-01.2	25	2_CELL_CYCLE_PHASE	146	8	0.0000039270893358310943000
TCGA-23-1123-01.7	70	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0000039318768618245411000
TCGA-09-1666-01.28	109	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000039391405498674563000
TCGA-10-0926-01.2	45	2_CELL_CYCLE_GO_0007049	265	12	0.0000039444889466662545000
TCGA-09-2051-01.26	142	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0000039825884597750448000
TCGA-24-1603-01.3	69	1_KEGG_DNA_REPLICATION	32	7	0.0000039940128952119167000
TCGA-61-2113-01.15	99	2_COLLAGEN	23	7	0.0000040427077113389910000
TCGA-24-1471-01.4	49	1_KEGG_MELANOMA	71	8	0.0000040462408298388448000
TCGA-36-1575-01.9	193	2_SIGNAL_TRANSDUCTION	1442	62	0.0000040675701206767199000
TCGA-23-1022-01.10	170	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000041295398263144375000
TCGA-13-0724-01.21	71	2_CELL_CYCLE_PROCESS	163	12	0.0000041579682742906438000
TCGA-25-1320-01.4	71	2_CELL_CYCLE_PROCESS	163	12	0.0000041579682742906438000
TCGA-25-1634-01.4	75	0_HALLMARK_ALLOGRAFT_REJECTION	190	13	0.0000041948698383298070000
TCGA-13-1510-01.20	82	1_KEGG_GLIOMA	62	9	0.0000042123663462336187000
TCGA-24-0975-01.6	78	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0000042150690274101004000
TCGA-61-2088-01.7	150	2_SIGNAL_TRANSDUCTION	1442	52	0.0000042161542556359161000
TCGA-13-1505-01.13	60	1_KEGG_FOCAL_ADHESION	195	12	0.0000042342988699213519000
TCGA-61-1919-01.9	87	2_CELL_CYCLE_PROCESS	163	13	0.0000042544484074797834000
TCGA-09-2049-01.8	96	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000043293183131965235000
TCGA-13-0800-01.9	124	1_KEGG_CELL_CYCLE	114	13	0.0000043425592455785760000
TCGA-10-0934-01.11	145	2_BEHAVIOR	138	15	0.0000043656764375920671000
TCGA-36-1570-01.2	36	2_CELL_CYCLE_PHASE	146	9	0.0000043764192652607617000
TCGA-23-1032-01.16	250	2_M_PHASE	94	16	0.0000043969443626943163000
TCGA-24-1551-01.15	87	1_KEGG_OOCYTE_MEIOSIS	105	11	0.0000043996366319200055000
TCGA-25-2396-01.6	42	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0000044037023630580498000
TCGA-13-1405-01.4	69	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000044731286382583361000
TCGA-13-0885-01.6	44	2_CELL_CYCLE_PROCESS	163	10	0.0000044842529497121327000
TCGA-31-1959-01.7	101	0_HALLMARK_E2F_TARGETS	169	14	0.0000044972988846704002000
TCGA-24-1424-01.4	80	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	12	0.0000044988513451033230000
TCGA-13-0800-01.9	124	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000045130220119939450000
TCGA-04-1331-01.5	90	2_CHROMOSOME	102	11	0.0000046532263161556414000
TCGA-13-1501-01.12	101	2_COLLAGEN	23	7	0.0000046567777879814427000
TCGA-61-2088-01.7	150	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	20	0.0000046682315473364150000
TCGA-13-1496-01.13	120	1_KEGG_FOCAL_ADHESION	195	16	0.0000046823839715535960000
TCGA-24-1103-01.5	73	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000046851272740522449000
TCGA-13-1482-01.7	62	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000047007297017055113000
TCGA-31-1950-01.7	105	2_CELL_CYCLE_PROCESS	163	14	0.0000047143844614636696000
TCGA-24-1436-01.1	49	2_CELL_CYCLE_PHASE	146	10	0.0000047283529413789632000
TCGA-04-1542-01.4	141	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0000047614124425115730000
TCGA-59-2351-01.5	31	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000047660917030085331000
TCGA-04-1343-01.7	50	2_MITOSIS	71	8	0.0000047883561795272849000
TCGA-13-0891-01.18	125	1_KEGG_CELL_CYCLE	114	13	0.0000047981988513311520000
TCGA-24-1427-01.4	83	2_EXTRACELLULAR_MATRIX	85	10	0.0000048710296569332283000
TCGA-57-1582-01.26	174	2_CELL_CYCLE_GO_0007049	265	22	0.0000048794541475119055000
TCGA-61-1736-01.2	54	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000049994044733630438000
TCGA-10-0934-01.11	145	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	20	0.0000050062584971395152000
TCGA-24-1428-01.9	90	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000050072662100794131000
TCGA-36-1577-01.14	168	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000050907615590361738000
TCGA-09-1665-01.16	131	2_MITOSIS	71	11	0.0000050927371493183738000
TCGA-24-1425-01.1	61	1_KEGG_FOCAL_ADHESION	195	12	0.0000051769818834282024000
TCGA-24-2030-01.8	161	2_CELL_CYCLE_PHASE	146	16	0.0000052001669689847362000
TCGA-24-1614-01.5	86	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000052466896352524419000
TCGA-04-1343-01.7	50	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0000053655369467419150000
TCGA-25-2399-01.16	103	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000053683635075001619000
TCGA-10-0934-01.11	145	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000053702956684933349000
TCGA-04-1332-01.2	25	2_M_PHASE	94	7	0.0000054029841299048405000
TCGA-24-1424-01.4	80	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0000054246488881974010000
TCGA-04-1338-01.7	85	2_SKELETAL_DEVELOPMENT	84	10	0.0000054892344323307717000
TCGA-13-1494-01.4	65	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0000054893464594008814000
TCGA-23-1030-01.10	58	2_CELL_CYCLE_PROCESS	163	11	0.0000054922890525866233000
TCGA-23-1032-01.16	250	2_CELL_PROLIFERATION_GO_0008283	436	35	0.0000055391442556651142000
TCGA-23-1123-01.7	70	2_MITOTIC_CELL_CYCLE	134	11	0.0000055447356300603607000
TCGA-57-1583-01.20	185	2_M_PHASE	94	14	0.0000055810096077156516000
TCGA-24-1552-01.5	54	2_MITOTIC_CELL_CYCLE	134	10	0.0000055919561268491627000
TCGA-61-2113-01.15	99	2_CELL_CYCLE_PHASE	146	13	0.0000056032182756104028000
TCGA-13-1507-01.8	101	2_MITOSIS	71	10	0.0000056353059883148017000
TCGA-24-1103-01.5	73	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0000056432128532900287000
TCGA-09-1659-01.5	51	2_MITOSIS	71	8	0.0000056454963416275461000
TCGA-25-1633-01.1	71	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000056454963416275461000
TCGA-24-2293-01.1	22	2_CELL_CYCLE_GO_0007049	265	9	0.0000057331692536382035000
TCGA-24-1548-01.8	141	2_DNA_METABOLIC_PROCESS	218	18	0.0000057339521269238595000
TCGA-61-2009-01.1	46	2_ION_BINDING	210	11	0.0000057426549484901192000
TCGA-36-1575-01.9	193	2_REGULATION_OF_APOPTOSIS	309	25	0.0000057750827139605704000
TCGA-13-1482-01.7	62	2_EXTRACELLULAR_MATRIX	85	9	0.0000058287295795908974000
TCGA-13-1509-01.9	117	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000058645518028399306000
TCGA-09-1665-01.16	131	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000059409884683320103000
TCGA-13-0755-01.6	16	2_REGULATION_OF_CELL_CYCLE	160	7	0.0000059587947966172556000
TCGA-13-0791-01.35	80	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000059791418042589571000
TCGA-25-2042-01.3	63	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000060673973363177748000
TCGA-13-1488-01.17	109	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000060900079674899212000
TCGA-59-2351-01.5	31	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0000060977938481121040000
TCGA-04-1342-01.12	104	1_KEGG_CELL_CYCLE	114	12	0.0000061055040675958884000
TCGA-13-1498-01.13	104	1_KEGG_CELL_CYCLE	114	12	0.0000061055040675958884000
TCGA-13-1489-01.11	118	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000061078287342715973000
TCGA-61-1998-01.14	105	2_COLLAGEN	23	7	0.0000061257258420821520000
TCGA-61-1919-01.9	87	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000061402871748572538000
TCGA-36-1575-01.9	193	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	25	0.0000061718035621553161000
TCGA-13-0911-01.3	47	1_KEGG_CELL_CYCLE	114	9	0.0000061843286347804652000
TCGA-13-0910-01.3	71	2_CHROMOSOME	102	10	0.0000062109768703895205000
TCGA-61-1995-01.4	102	2_MITOSIS	71	10	0.0000062109768703895255000
TCGA-25-1319-01.10	69	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000062337234991362393000
TCGA-04-1514-01.6	91	2_CELL_CYCLE_GO_0007049	265	16	0.0000062424707963087082000
TCGA-30-1862-01.13	91	2_EXTRACELLULAR_REGION	346	18	0.0000062940692373093480000
TCGA-09-1659-01.5	51	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0000063253977292068066000
TCGA-13-1510-01.20	82	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0000063501825408901431000
TCGA-24-1428-01.9	90	1_KEGG_OOCYTE_MEIOSIS	105	11	0.0000063583046837905569000
TCGA-04-1542-01.4	141	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	29	0.0000063630217414546287000
TCGA-24-2271-01.3	44	0_HALLMARK_E2F_TARGETS	169	10	0.0000063748196894542435000
TCGA-24-1427-01.4	83	1_KEGG_CELL_CYCLE	114	11	0.0000063769716051256390000
TCGA-25-1320-01.4	71	2_EXTRACELLULAR_REGION	346	16	0.0000064034821286172737000
TCGA-24-2271-01.3	44	2_SKELETAL_DEVELOPMENT	84	8	0.0000064218754560196437000
TCGA-23-1110-01.7	299	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	12	0.0000064695140297766712000
TCGA-13-1507-01.8	101	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000064867943720351203000
TCGA-23-1023-01.1	93	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000065190792697971724000
TCGA-04-1342-01.12	104	1_KEGG_PANCREATIC_CANCER	70	10	0.0000065208650530574609000
TCGA-04-1530-01.2	90	2_CELL_CYCLE_PROCESS	163	13	0.0000065341991318224033000
TCGA-13-0900-01.8	90	2_EXTRACELLULAR_REGION_PART	269	16	0.0000065515067904686923000
TCGA-13-1488-01.17	109	1_KEGG_PROSTATE_CANCER	87	11	0.0000065771747683606948000
TCGA-13-1412-01.8	113	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000066104920195085616000
TCGA-57-1993-01.8	52	2_MITOSIS	71	8	0.0000066323389991613476000
TCGA-24-1549-01.21	158	2_SPINDLE	35	9	0.0000066989394734117943000
TCGA-61-1998-01.14	105	1_KEGG_CELL_CYCLE	114	12	0.0000068243129906707272000
TCGA-23-2078-01.15	105	1_KEGG_CELL_CYCLE	114	12	0.0000068243129906707272000
TCGA-31-1950-01.7	105	1_KEGG_CELL_CYCLE	114	12	0.0000068243129906707272000
TCGA-61-1919-01.9	87	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000069182399804004931000
TCGA-24-1466-01.15	82	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	21	0.0000069474221909197914000
TCGA-24-0982-01.3	34	1_KEGG_PANCREATIC_CANCER	70	7	0.0000069939952778726896000
TCGA-24-1435-01.12	115	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000070019110758216705000
TCGA-24-1424-01.4	80	2_DOUBLE_STRANDED_DNA_BINDING	30	7	0.0000070277740113103882000
TCGA-36-1580-01.1	65	0_HALLMARK_KRAS_SIGNALING_UP	148	11	0.0000070287851001998363000
TCGA-23-1110-01.7	299	2_MITOSIS	71	15	0.0000070475008197245033000
TCGA-24-1603-01.3	69	2_CHROMOSOMAL_PART	78	9	0.0000071353059665562016000
TCGA-61-1995-01.4	102	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000071487563759853084000
TCGA-30-1862-01.13	91	1_KEGG_FOCAL_ADHESION	195	14	0.0000071514232454363899000
TCGA-13-1483-01.3	66	2_CELL_CYCLE_PHASE	146	11	0.0000072046689103155790000
TCGA-13-1494-01.4	65	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0000072513395109940049000
TCGA-24-1416-01.4	38	2_CELL_CYCLE_PHASE	146	9	0.0000073814288586417880000
TCGA-24-1549-01.21	158	2_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0000074128531999892175000
TCGA-24-1549-01.21	158	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0000074128531999892175000
TCGA-57-1993-01.8	52	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0000074303863010430244000
TCGA-61-1919-01.9	87	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0000074494948255366078000
TCGA-13-0893-01.4	112	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000074666746508854833000
TCGA-13-0755-01.6	16	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0000074914105235085858000
TCGA-04-1342-01.12	104	2_MITOSIS	71	10	0.0000075210672528424286000
TCGA-24-1427-01.4	83	2_CELL_CYCLE_PHASE	146	12	0.0000075230281167471006000
TCGA-13-1483-01.3	66	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0000075327426591716493000
TCGA-13-0890-01.2	48	1_KEGG_CELL_CYCLE	114	9	0.0000075353054638278033000
TCGA-31-1950-01.7	105	0_HALLMARK_E2F_TARGETS	169	14	0.0000075605676070791993000
TCGA-04-1331-01.5	90	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000075667486421212866000
TCGA-61-2092-01.12	209	2_SYSTEM_DEVELOPMENT	694	41	0.0000076135936213456520000
TCGA-36-1576-01.8	124	1_KEGG_FOCAL_ADHESION	195	16	0.0000076248160243642690000
TCGA-13-1488-01.17	109	2_CELL_CYCLE_PROCESS	163	14	0.0000077621395573561342000
TCGA-13-0923-01.5	53	2_MITOSIS	71	8	0.0000077650444794688932000
TCGA-61-2092-01.12	209	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	46	0.0000077797320876048047000
TCGA-24-1431-01.3	57	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000078102559420885065000
TCGA-23-1028-01.18	93	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000078647567105021910000
TCGA-24-1435-01.12	115	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000079754717840595704000
TCGA-61-2092-01.12	209	0_HALLMARK_APOPTOSIS	150	18	0.0000079897137215096233000
TCGA-04-1346-01.10	75	2_CELL_CYCLE_PROCESS	163	12	0.0000079939102696359918000
TCGA-13-0761-01.6	75	2_CELL_CYCLE_PROCESS	163	12	0.0000079939102696359918000
TCGA-23-1030-01.10	58	0_HALLMARK_E2F_TARGETS	169	11	0.0000080507147626777041000
TCGA-04-1347-01.15	187	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	22	0.0000080533978593998620000
TCGA-61-1728-01.5	45	0_HALLMARK_E2F_TARGETS	169	10	0.0000080708331246718328000
TCGA-13-0916-01.11	92	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0000080736506762673987000
TCGA-13-1489-01.11	118	2_IMMUNE_RESPONSE	206	16	0.0000080959408407402778000
TCGA-04-1332-01.2	25	2_REGULATION_OF_CELL_CYCLE	160	8	0.0000081263685107191760000
TCGA-09-2050-01.18	196	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000081275521836433704000
TCGA-24-2293-01.1	22	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0000081346651173290382000
TCGA-13-1512-01.2	113	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000081471842698954461000
TCGA-13-0800-01.9	124	0_HALLMARK_E2F_TARGETS	169	15	0.0000081916984786426495000
TCGA-13-0903-01.11	77	2_MITOSIS	71	9	0.0000082345559133836784000
TCGA-04-1342-01.12	104	2_MICROTUBULE_CYTOSKELETON	117	12	0.0000082447064502430387000
TCGA-13-1407-01.11	220	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000082451994417031291000
TCGA-09-2051-01.26	142	1_KEGG_OOCYTE_MEIOSIS	105	13	0.0000083112493666640085000
TCGA-13-1483-01.3	66	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000083369728518885992000
TCGA-09-2044-01.4	83	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000083369728518887127000
TCGA-36-1575-01.9	193	2_APOPTOSIS_GO	389	28	0.0000084431218004978292000
TCGA-04-1517-01.4	44	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000084594479799617436000
TCGA-10-0933-01.2	97	2_DNA_METABOLIC_PROCESS	218	15	0.0000084895204920170838000
TCGA-24-1614-01.5	86	2_DNA_REPAIR	113	11	0.0000085348208424115708000
TCGA-25-2399-01.16	103	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000085518951990668778000
TCGA-13-0900-01.8	90	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000085955412946005220000
TCGA-24-2030-01.8	161	1_KEGG_PATHWAYS_IN_CANCER	323	23	0.0000086306301024074662000
TCGA-13-0889-01.4	37	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000086402137367285031000
TCGA-23-1110-01.7	299	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	15	0.0000086512054629554370000
TCGA-04-1342-01.12	104	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000086549780718036953000
TCGA-24-1418-01.16	84	2_CELL_CYCLE_PHASE	146	12	0.0000086617034117118975000
TCGA-13-1481-01.3	78	0_HALLMARK_COAGULATION	125	11	0.0000086642776397741086000
TCGA-13-0760-01.12	93	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0000086789472650754434000
TCGA-04-1336-01.28	106	2_REGULATION_OF_CELL_PROLIFERATION	265	17	0.0000086839081745110863000
TCGA-13-0923-01.5	53	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0000086985646613934354000
TCGA-13-0924-01.5	68	2_REGULATION_OF_MITOSIS	36	7	0.0000087213473361315294000
TCGA-13-0897-01.2	61	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000087552029566922052000
TCGA-13-2060-01.10	86	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0000087730502431006435000
TCGA-13-0883-01.3	23	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	8	0.0000088298247925422560000
TCGA-36-1575-01.9	193	2_PROGRAMMED_CELL_DEATH	390	28	0.0000089380106804437373000
TCGA-24-2271-01.3	44	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000089424261030277315000
TCGA-24-1435-01.12	115	2_EXTRACELLULAR_REGION	346	20	0.0000089455263882536438000
TCGA-24-0970-01.6	94	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000089947763752998753000
TCGA-25-2404-01.5	58	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000090103572615433691000
TCGA-24-1435-01.12	115	2_EXTRACELLULAR_MATRIX	85	11	0.0000090683208513549962000
TCGA-04-1336-01.28	106	1_KEGG_MELANOMA	71	10	0.0000090706655737521193000
TCGA-24-2288-01.12	112	2_MITOTIC_CELL_CYCLE	134	13	0.0000090909723083981383000
TCGA-13-1497-01.7	59	2_M_PHASE	94	9	0.0000091302619812641876000
TCGA-10-0933-01.2	97	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000091394957698087256000
TCGA-10-0933-01.2	97	2_CHROMOSOME_SEGREGATION	26	7	0.0000091554882304995806000
TCGA-13-1496-01.13	120	2_CELL_CYCLE_GO_0007049	265	18	0.0000091724696447863323000
TCGA-13-0903-01.11	77	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0000093497979342746303000
TCGA-23-1110-01.7	299	2_REGULATION_OF_CELL_CYCLE	160	22	0.0000093570264550814798000
TCGA-13-0910-01.3	71	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0000093597312294091949000
TCGA-13-0905-01.7	160	1_KEGG_GLIOMA	62	11	0.0000094970888286869486000
TCGA-23-1028-01.18	93	1_KEGG_FOCAL_ADHESION	195	14	0.0000095771129350213065000
TCGA-30-1862-01.13	91	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000095886269116464461000
TCGA-13-0791-01.35	80	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	11	0.0000096146652378128099000
TCGA-24-1435-01.12	115	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000096753223164805358000
TCGA-24-1603-01.3	69	2_REGULATION_OF_MITOSIS	36	7	0.0000096798477370129900000
TCGA-24-1567-01.3	141	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000096827838787799844000
TCGA-04-1347-01.15	187	0_HALLMARK_APOPTOSIS	150	17	0.0000097264428535555097000
TCGA-04-1365-01.6	150	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	24	0.0000097394191334907651000
TCGA-10-0931-01.12	59	0_HALLMARK_E2F_TARGETS	169	11	0.0000097439231409252756000
TCGA-13-1492-01.2	162	1_KEGG_PATHWAYS_IN_CANCER	323	23	0.0000097503864690206564000
TCGA-09-2050-01.18	196	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	10	0.0000097868332445236391000
TCGA-59-2350-01.1	62	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000098392433503213445000
TCGA-25-1322-01.15	93	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0000098538433697282074000
TCGA-25-2398-01.5	81	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	8	0.0000099140836860430030000
TCGA-23-1110-01.7	299	2_SIGNAL_TRANSDUCTION	1442	84	0.0000099651174855949275000
TCGA-61-2092-01.12	209	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	45	0.0000099696073075831497000
TCGA-23-1027-01.8	68	2_CELL_CYCLE_PHASE	146	11	0.0000100154375453820570000
TCGA-59-2354-01.2	44	0_HALLMARK_ANGIOGENESIS	32	6	0.0000100185982883492230000
TCGA-04-1337-01.2	31	2_EXTRACELLULAR_REGION	346	11	0.0000100593500809189640000
TCGA-10-0938-01.2	102	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	14	0.0000100878707713367330000
TCGA-24-2261-01.2	87	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0000101497105134248820000
TCGA-61-1998-01.14	105	2_M_PHASE	94	11	0.0000101704927535212430000
TCGA-24-0970-01.6	94	1_KEGG_OOCYTE_MEIOSIS	105	11	0.0000101704927535212430000
TCGA-61-2095-01.1	32	0_HALLMARK_COAGULATION	125	8	0.0000102090884116253010000
TCGA-61-2012-01.6	78	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0000102192148751187830000
TCGA-13-0791-01.35	80	1_KEGG_PANCREATIC_CANCER	70	9	0.0000102233004416247260000
TCGA-25-2396-01.6	42	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0000102472830902086470000
TCGA-04-1338-01.7	85	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000103296214089110230000
TCGA-13-1483-01.3	66	2_EXTRACELLULAR_MATRIX	85	9	0.0000103296214089110230000
TCGA-13-1488-01.17	109	1_KEGG_PANCREATIC_CANCER	70	10	0.0000103458064746817140000
TCGA-23-1032-01.16	250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000103488237947157090000
TCGA-09-2049-01.8	96	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000103637105550684180000
TCGA-24-2260-01.11	63	2_SIGNAL_TRANSDUCTION	1442	29	0.0000104787119587557290000
TCGA-04-1347-01.15	187	2_ORGAN_DEVELOPMENT	460	30	0.0000105127647716385910000
TCGA-24-1614-01.5	86	2_RESPONSE_TO_STRESS	427	19	0.0000105314827409810360000
TCGA-24-1416-01.4	38	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000105333060317375190000
TCGA-24-1616-01.2	38	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000105333060317375190000
TCGA-24-1474-01.12	122	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000105517937390983820000
TCGA-61-2092-01.12	209	2_ORGAN_DEVELOPMENT	460	32	0.0000105927902364565650000
TCGA-13-1499-01.1	22	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000106440182080268810000
TCGA-13-0760-01.12	93	2_MITOTIC_CELL_CYCLE	134	12	0.0000106843173228667560000
TCGA-10-0926-01.2	45	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000107048692405087590000
TCGA-13-0899-01.1	28	2_CELL_CYCLE_PHASE	146	8	0.0000108515370781315460000
TCGA-13-1496-01.13	120	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000110262427380233060000
TCGA-24-1466-01.15	82	2_CELL_CYCLE_GO_0007049	265	15	0.0000110319330764126520000
TCGA-13-1510-01.20	82	2_REGULATION_OF_CELL_PROLIFERATION	265	15	0.0000110319330764126520000
TCGA-61-2016-01.10	50	1_KEGG_CELL_CYCLE	114	9	0.0000110328222285479890000
TCGA-04-1343-01.7	50	1_KEGG_CELL_CYCLE	114	9	0.0000110328222285479890000
TCGA-25-1326-01.11	119	1_KEGG_OOCYTE_MEIOSIS	105	12	0.0000111982958936533920000
TCGA-59-2351-01.5	31	2_CELL_CYCLE_GO_0007049	265	10	0.0000113435201919936200000
TCGA-04-1525-01.7	52	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000113445042494059770000
TCGA-24-1105-01.8	52	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000113445042494059770000
TCGA-23-1031-01.17	142	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	15	0.0000114209512252046410000
TCGA-10-0934-01.11	145	2_CHEMICAL_HOMEOSTASIS	126	14	0.0000114416435414101680000
TCGA-24-1471-01.4	49	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0000114496316045907910000
TCGA-13-1509-01.9	117	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000114524143498583640000
TCGA-13-1404-01.13	117	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000114524143498583640000
TCGA-24-1416-01.4	38	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0000114711182743277700000
TCGA-13-2060-01.10	86	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000114740920744657840000
TCGA-24-2254-01.3	49	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000115215003738302690000
TCGA-24-1435-01.12	115	2_COLLAGEN	23	7	0.0000116169126853975840000
TCGA-24-1424-01.4	80	2_MITOSIS	71	9	0.0000116279525124083160000
TCGA-13-0791-01.35	80	2_MITOSIS	71	9	0.0000116279525124083160000
TCGA-13-0883-01.4	3	2_MITOCHONDRIAL_RESPIRATORY_CHAIN	19	3	0.0000116541335577144150000
TCGA-25-2396-01.6	42	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0000116586742562265310000
TCGA-25-1633-01.1	71	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	14	0.0000117004045413599700000
TCGA-04-1337-01.2	31	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0000117051670332536380000
TCGA-13-0893-01.4	112	2_REGULATION_OF_MITOSIS	36	8	0.0000117590151554393480000
TCGA-23-2078-01.15	105	0_HALLMARK_MITOTIC_SPINDLE	175	14	0.0000118950551088098860000
TCGA-36-1571-01.6	109	2_MITOSIS	71	10	0.0000119269223752993610000
TCGA-23-1116-01.7	84	2_EXTRACELLULAR_REGION	346	17	0.0000119446011169792520000
TCGA-09-2051-01.26	142	2_MITOSIS	71	11	0.0000119927614667443660000
TCGA-13-0761-01.6	75	0_HALLMARK_E2F_TARGETS	169	12	0.0000120625910710295600000
TCGA-24-1417-01.14	94	2_MITOTIC_CELL_CYCLE	134	12	0.0000121014531267443700000
TCGA-30-1862-01.13	91	2_EXTRACELLULAR_MATRIX	85	10	0.0000121435059828224190000
TCGA-13-1512-01.2	113	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000122652481872130890000
TCGA-24-1470-01.7	76	2_CHROMOSOME	102	10	0.0000122800644356910390000
TCGA-25-2391-01.2	64	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000123524224574086510000
TCGA-23-1027-01.8	68	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0000123555451104790330000
TCGA-13-0893-01.4	112	2_NUCLEUS	1110	36	0.0000123922450919120530000
TCGA-13-0897-01.2	61	2_M_PHASE	94	9	0.0000123970607942282310000
TCGA-09-1666-01.28	109	0_HALLMARK_E2F_TARGETS	169	14	0.0000124185122714472200000
TCGA-61-2000-01.11	69	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0000124960511363423850000
TCGA-04-1331-01.5	90	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0000124993487043204300000
TCGA-24-1565-01.1	16	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0000125129165333108770000
TCGA-13-1407-01.11	220	1_KEGG_CELL_CYCLE	114	16	0.0000125391396954372310000
TCGA-13-1506-01.5	113	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0000126190778890880090000
TCGA-13-1412-01.8	113	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0000126190778890880090000
TCGA-13-1507-01.8	101	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000126264412882725800000
TCGA-13-0755-01.6	16	2_CELL_PROLIFERATION_GO_0008283	436	9	0.0000126753583592777670000
TCGA-09-2049-01.8	96	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000126961903682415940000
TCGA-13-0911-01.3	47	0_HALLMARK_E2F_TARGETS	169	10	0.0000127023104175005500000
TCGA-24-2261-01.2	87	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000127282616315632490000
TCGA-24-1552-01.5	54	2_CELL_CYCLE_PHASE	146	10	0.0000128913060796450100000
TCGA-13-1407-01.11	220	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000129797329943900660000
TCGA-13-0899-01.1	28	2_M_PHASE	94	7	0.0000129892884594579870000
TCGA-10-0937-01.9	40	2_CELL_CYCLE_GO_0007049	265	11	0.0000130535014952351790000
TCGA-24-1551-01.15	87	2_CELL_CYCLE_PHASE	146	12	0.0000130681872589623010000
TCGA-13-1509-01.9	117	2_COLLAGEN	23	7	0.0000131104179762753120000
TCGA-24-1424-01.4	80	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0000131989869145854850000
TCGA-13-0791-01.35	80	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	9	0.0000131989869145854850000
TCGA-13-0791-01.35	80	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0000131989869145854850000
TCGA-25-1318-01.11	46	0_HALLMARK_ANGIOGENESIS	32	6	0.0000132311255773834050000
TCGA-25-2396-01.6	42	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0000132378505581213850000
TCGA-13-0793-01.8	97	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000133220807235623060000
TCGA-09-0369-01.9	109	2_CELL_CYCLE_GO_0007049	265	17	0.0000134610613907802480000
TCGA-59-2348-01.14	123	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000135696150500013360000
TCGA-59-2348-01.14	123	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000135696150500013360000
TCGA-04-1342-01.12	104	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0000135822846766937880000
TCGA-24-1425-01.1	61	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000136170070662166310000
TCGA-10-0938-01.2	102	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000136595310454257690000
TCGA-36-1571-01.6	109	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000137184388967484560000
TCGA-04-1337-01.2	31	2_EXTRACELLULAR_MATRIX	85	7	0.0000138531228856595040000
TCGA-13-1405-01.4	69	1_KEGG_CELL_CYCLE	114	10	0.0000138890363579299540000
TCGA-09-2051-01.26	142	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000139752458709244120000
TCGA-23-1026-01.5	65	2_EXTRACELLULAR_REGION	346	15	0.0000140043231468626610000
TCGA-24-2261-01.2	87	2_MICROTUBULE_CYTOSKELETON	117	11	0.0000140126457748875920000
TCGA-59-2350-01.1	62	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000140931251487497180000
TCGA-23-1120-01.10	57	2_MITOSIS	71	8	0.0000141359613903338540000
TCGA-09-2050-01.18	196	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000141629439875167470000
TCGA-10-0934-01.11	145	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000143553182969481510000
TCGA-61-2088-01.7	150	2_CYTOKINE_ACTIVITY	104	13	0.0000144313484150912810000
TCGA-24-0968-01.9	71	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	9	0.0000145205902432778020000
TCGA-04-1347-01.15	187	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	16	0.0000145346290181156910000
TCGA-13-1411-01.7	96	2_CELL_CYCLE_PROCESS	163	13	0.0000146769588215029210000
TCGA-25-1326-01.11	119	2_COLLAGEN	23	7	0.0000147640486573450650000
TCGA-13-0727-01.1	29	2_CELL_CYCLE_PHASE	146	8	0.0000147910153917851580000
TCGA-13-0800-01.9	124	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0000149886716675426000000
TCGA-23-1110-01.7	299	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	16	0.0000149974798362695900000
TCGA-09-0369-01.9	109	2_M_PHASE	94	11	0.0000151627040802898220000
TCGA-04-1365-01.6	150	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000153038878448686180000
TCGA-23-1028-01.18	93	0_HALLMARK_E2F_TARGETS	169	13	0.0000153243136445179950000
TCGA-13-1411-01.7	96	2_EXTRACELLULAR_REGION	346	18	0.0000154140141451758500000
TCGA-24-1464-01.7	62	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000155488449611236400000
TCGA-13-1482-01.7	62	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000155488449611236400000
TCGA-13-0800-01.9	124	2_CELL_CYCLE_GO_0007049	265	18	0.0000156622309656689670000
TCGA-25-1322-01.15	93	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0000157517904179488850000
TCGA-04-1332-01.2	25	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0000157680613340743400000
TCGA-24-2267-01.8	26	2_AGING	10	4	0.0000158129872964868750000
TCGA-23-1120-01.10	57	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0000158294167526297450000
TCGA-25-2396-01.6	42	2_REGULATION_OF_MITOSIS	36	6	0.0000158693464658523800000
TCGA-24-1466-01.15	82	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	21	0.0000159560121252954690000
TCGA-13-1497-01.7	59	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0000159637973028275900000
TCGA-04-1348-01.6	81	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000160371900391909460000
TCGA-09-1669-01.10	81	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000160371900391909460000
TCGA-04-1514-01.6	91	2_IMMUNE_SYSTEM_PROCESS	283	16	0.0000160397364682332610000
TCGA-61-2008-01.19	70	1_KEGG_CELL_CYCLE	114	10	0.0000160414731919985490000
TCGA-24-1427-01.4	83	2_EXTRACELLULAR_REGION_PART	269	15	0.0000160902582708615490000
TCGA-13-0720-01.5	32	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0000160954310031859860000
TCGA-25-1320-01.4	71	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000161900904575125060000
TCGA-30-1891-01.4	84	0_HALLMARK_ANGIOGENESIS	32	7	0.0000161918325286351600000
TCGA-36-1577-01.14	168	2_M_PHASE	94	13	0.0000162945058384027470000
TCGA-13-0793-01.8	97	2_CELL_CYCLE_GO_0007049	265	16	0.0000163438511306788210000
TCGA-13-0792-01.8	64	2_CELL_CYCLE_PROCESS	163	11	0.0000164061900080481970000
TCGA-24-1416-01.4	38	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000164457768938848350000
TCGA-13-1492-01.2	162	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	15	0.0000165432445914201540000
TCGA-24-1416-01.4	38	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000165492479423155570000
TCGA-13-1404-01.13	117	2_REGULATION_OF_MITOSIS	36	8	0.0000166416567337443570000
TCGA-09-1659-01.5	51	2_MICROTUBULE_CYTOSKELETON	117	9	0.0000166958869212670970000
TCGA-13-0761-01.6	75	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000167858793671582530000
TCGA-25-1318-01.11	46	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0000168593882081180690000
TCGA-10-0930-01.5	60	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000169487620921130190000
TCGA-04-1356-01.1	71	2_DNA_REPAIR	113	10	0.0000169628114127853150000
TCGA-13-0727-01.1	29	2_M_PHASE	94	7	0.0000169842912917353910000
TCGA-61-2113-01.15	99	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000171727513282512320000
TCGA-36-1574-01.10	152	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000171950265379579450000
TCGA-23-1027-01.8	68	2_COLLAGEN	23	6	0.0000172000305856125720000
TCGA-04-1530-01.2	90	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000172409028663211530000
TCGA-25-1628-01.2	118	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000173795423837246620000
TCGA-13-1489-01.11	118	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000173795423837246620000
TCGA-13-0751-01.2	51	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000174012227954703910000
TCGA-24-1557-01.13	106	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000174579883167951180000
TCGA-24-1557-01.13	106	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000174579883167951180000
TCGA-04-1514-01.6	91	1_KEGG_ASTHMA	30	7	0.0000174888049605686460000
TCGA-57-1583-01.20	185	2_MITOSIS	71	12	0.0000175678626239224400000
TCGA-04-1338-01.7	85	0_HALLMARK_ANGIOGENESIS	32	7	0.0000176038836338256910000
TCGA-25-2391-01.2	64	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000176862726609856880000
TCGA-61-2094-01.6	63	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000177130961685095110000
TCGA-13-0911-01.3	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000177873107019476070000
TCGA-13-0727-01.1	29	2_DNA_METABOLIC_PROCESS	218	9	0.0000178206791629288230000
TCGA-24-2267-01.8	26	0_HALLMARK_E2F_TARGETS	169	8	0.0000178216388204645690000
TCGA-61-1995-01.4	102	2_CHROMOSOME	102	11	0.0000179064365248402020000
TCGA-24-1428-01.9	90	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	12	0.0000179400137723534170000
TCGA-13-0793-01.8	97	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000179834331948657690000
TCGA-10-0934-01.11	145	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000180337984582501110000
TCGA-10-0934-01.11	145	2_RESPONSE_TO_VIRUS	42	9	0.0000180337984582501110000
TCGA-24-1551-01.15	87	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0000181683116378596010000
TCGA-13-1411-01.7	96	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000182861645801562430000
TCGA-13-1496-01.13	120	1_KEGG_PROSTATE_CANCER	87	11	0.0000183315193476557260000
TCGA-13-1497-01.7	59	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0000183900918616136440000
TCGA-23-1110-01.7	299	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000184181609978341800000
TCGA-13-1403-01.9	71	1_KEGG_CELL_CYCLE	114	10	0.0000184840908005977920000
TCGA-13-1510-01.20	82	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000185143539044033880000
TCGA-09-0369-01.9	109	2_CELL_CYCLE_PHASE	146	13	0.0000185582637656343350000
TCGA-13-1488-01.17	109	2_CELL_CYCLE_PHASE	146	13	0.0000185582637656343350000
TCGA-13-0804-01.5	78	2_SPINDLE	35	7	0.0000187591044596734120000
TCGA-24-1614-01.5	86	2_M_PHASE	94	10	0.0000187607040674546200000
TCGA-10-0934-01.11	145	1_KEGG_ASTHMA	30	8	0.0000188564702242264430000
TCGA-13-0906-01.5	66	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000189330945421232480000
TCGA-31-1953-01.6	53	1_KEGG_CELL_CYCLE	114	9	0.0000189348264150031270000
TCGA-13-1507-01.8	101	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000190408369580790120000
TCGA-24-1428-01.9	90	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	13	0.0000190826121756194730000
TCGA-13-0792-01.8	64	2_M_PHASE	94	9	0.0000192127852905069640000
TCGA-30-1891-01.4	84	0_HALLMARK_COAGULATION	125	11	0.0000193504434515671570000
TCGA-09-1662-01.6	49	0_HALLMARK_E2F_TARGETS	169	10	0.0000195472625181389250000
TCGA-29-2427-01.10	116	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000196318182994314970000
TCGA-24-1474-01.12	122	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	36	0.0000196853857890377690000
TCGA-24-1425-01.1	61	2_GLYCOSAMINOGLYCAN_BINDING	26	6	0.0000198176376005378380000
TCGA-24-1427-01.4	83	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000199325107999436140000
TCGA-24-0966-01.2	18	2_CELL_CYCLE_GO_0007049	265	8	0.0000199925612588358760000
TCGA-25-1320-01.4	71	2_EXTRACELLULAR_MATRIX	85	9	0.0000200405509000956030000
TCGA-25-2391-01.2	64	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000201328316386952560000
TCGA-13-1492-01.2	162	2_REGULATION_OF_KINASE_ACTIVITY	138	15	0.0000202356837013578360000
TCGA-24-2288-01.12	112	2_M_PHASE	94	11	0.0000202380240718446270000
TCGA-24-1556-01.19	120	2_REGULATION_OF_MITOSIS	36	8	0.0000203427724805825990000
TCGA-13-1482-01.7	62	2_CELL_CYCLE_GO_0007049	265	13	0.0000204146534532681380000
TCGA-13-0916-01.11	92	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0000204356408360315350000
TCGA-61-1995-01.4	102	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000205948538300506110000
TCGA-57-1583-01.20	185	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	12	0.0000207249112611609210000
TCGA-24-1103-01.5	73	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0000208077681151498600000
TCGA-24-1470-01.7	76	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0000209285577934520050000
TCGA-24-2035-01.8	102	2_RECEPTOR_BINDING	331	18	0.0000209843657697647070000
TCGA-04-1347-01.15	187	2_SIGNAL_TRANSDUCTION	1442	59	0.0000210353124422087780000
TCGA-24-1567-01.3	141	1_KEGG_CELL_CYCLE	114	13	0.0000210938265208447970000
TCGA-13-0903-01.11	77	2_REGULATION_OF_MITOSIS	36	7	0.0000211148084427703750000
TCGA-61-2000-01.11	69	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000211261531683327170000
TCGA-13-1497-01.7	59	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0000211375652763839440000
TCGA-57-1993-01.8	52	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000212334898076529010000
TCGA-24-1549-01.21	158	2_CHROMOSOME	102	13	0.0000213405108101471940000
TCGA-25-1634-01.4	75	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000214739131800371170000
TCGA-24-1413-01.6	34	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0000215211991115325220000
TCGA-29-2427-01.10	116	1_KEGG_CELL_CYCLE	114	12	0.0000215306498181469730000
TCGA-23-1023-01.1	93	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0000215525451933325430000
TCGA-24-1548-01.8	141	2_M_PHASE	94	12	0.0000216188946477845000000
TCGA-13-1496-01.13	120	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000216569868650816620000
TCGA-24-2261-01.2	87	1_KEGG_PANCREATIC_CANCER	70	9	0.0000217048866943018050000
TCGA-25-1315-01.7	93	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000218140779661655180000
TCGA-23-1022-01.10	170	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000218202905473996950000
TCGA-24-2267-01.8	26	1_KEGG_GLIOMA	62	6	0.0000219010008814125700000
TCGA-13-0920-01.9	82	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0000219021626039757230000
TCGA-24-1544-01.7	84	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000219411813835201750000
TCGA-13-0723-01.8	50	2_DNA_METABOLIC_PROCESS	218	11	0.0000219769451503224720000
TCGA-23-1118-01.5	50	2_DNA_METABOLIC_PROCESS	218	11	0.0000219769451503224720000
TCGA-13-1507-01.8	101	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000220030570075558580000
TCGA-13-1495-01.22	101	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000220030570075558580000
TCGA-13-1501-01.12	101	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000220030570075558580000
TCGA-24-2035-01.8	102	2_CYTOKINE_ACTIVITY	104	11	0.0000220229245942259400000
TCGA-25-2396-01.6	42	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000220284906911273210000
TCGA-25-1324-01.3	42	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000220284906911273210000
TCGA-04-1514-01.6	91	2_CELL_CYCLE_PHASE	146	12	0.0000220495831083875760000
TCGA-57-1583-01.20	185	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000221610940456929320000
TCGA-13-1487-01.3	79	0_HALLMARK_E2F_TARGETS	169	12	0.0000222264391438656170000
TCGA-13-1512-01.2	113	2_M_PHASE	94	11	0.0000222391196010943900000
TCGA-59-2350-01.1	62	2_DNA_METABOLIC_PROCESS	218	12	0.0000222440152341936050000
TCGA-13-2060-01.10	86	2_MITOSIS	71	9	0.0000222502950499802110000
TCGA-24-1616-01.2	38	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0000223453618799138320000
TCGA-09-2053-01.14	121	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000224715348910828170000
TCGA-04-1347-01.15	187	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	13	0.0000226704027938064650000
TCGA-04-1365-01.6	150	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	41	0.0000227034221807347240000
TCGA-10-0937-01.9	40	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000227247278923033850000
TCGA-13-1411-01.7	96	0_HALLMARK_E2F_TARGETS	169	13	0.0000227483156233719980000
TCGA-13-0793-01.8	97	2_EXTRACELLULAR_MATRIX	85	10	0.0000227486728913643250000
TCGA-13-1494-01.4	65	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000228329351962193580000
TCGA-25-2042-01.3	63	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	13	0.0000229095055134866920000
TCGA-31-1950-01.7	105	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0000230506892686152310000
TCGA-24-1419-01.2	93	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000230981919912917970000
TCGA-25-1315-01.7	93	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000230981919912917970000
TCGA-25-1316-01.2	73	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000231621550839131350000
TCGA-13-1488-01.17	109	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000231665757471072820000
TCGA-24-1474-01.12	122	2_REGULATION_OF_MITOSIS	36	8	0.0000231879881044588570000
TCGA-25-1623-01.7	111	2_CELL_CYCLE_PHASE	146	13	0.0000232157924242503980000
TCGA-23-1123-01.7	70	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000234015128925140520000
TCGA-24-1556-01.19	120	2_DNA_METABOLIC_PROCESS	218	16	0.0000234169672811818590000
TCGA-31-1959-01.7	101	2_EXTRACELLULAR_SPACE	192	14	0.0000235011168078450680000
TCGA-24-0966-01.2	18	0_HALLMARK_E2F_TARGETS	169	7	0.0000235802075920887030000
TCGA-13-1404-01.13	117	2_MITOSIS	71	10	0.0000237983272683465080000
TCGA-24-2293-01.1	22	2_MITOTIC_CELL_CYCLE	134	7	0.0000238108184152493520000
TCGA-09-2045-01.1	9	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0000238741557976144420000
TCGA-13-0885-01.6	44	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	4	0.0000239553975274578880000
TCGA-13-0919-01.5	50	0_HALLMARK_E2F_TARGETS	169	10	0.0000240604351500686210000
TCGA-25-2042-01.3	63	2_GLYCOSAMINOGLYCAN_BINDING	26	6	0.0000241622866154812030000
TCGA-13-1492-01.2	162	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	15	0.0000246655505684797320000
TCGA-36-1575-01.9	193	1_KEGG_APOPTOSIS	85	13	0.0000248011435127864450000
TCGA-13-0905-01.7	160	2_CHROMOSOME	102	13	0.0000248516341539876430000
TCGA-04-1356-01.1	71	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0000250439307772610730000
TCGA-24-1464-01.7	62	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0000250723251248085760000
TCGA-61-2094-01.6	63	2_CELL_CYCLE_GO_0007049	265	13	0.0000250858540780500790000
TCGA-13-2060-01.10	86	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0000252420011513284590000
TCGA-24-1417-01.14	94	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000254046036990214810000
TCGA-13-1483-01.3	66	2_M_PHASE	94	9	0.0000254046036990214810000
TCGA-24-0970-01.6	94	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000254046036990214810000
TCGA-24-1463-01.5	130	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000254767821239504650000
TCGA-57-1583-01.20	185	2_SYSTEM_DEVELOPMENT	694	37	0.0000255231519517213910000
TCGA-61-2113-01.15	99	2_EXTRACELLULAR_REGION	346	18	0.0000256283422211707940000
TCGA-24-1463-01.5	130	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000257277462886046030000
TCGA-13-0923-01.5	53	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000257938750317481930000
TCGA-31-1953-01.6	53	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000257938750317481930000
TCGA-25-1628-01.2	118	2_MITOSIS	71	10	0.0000258483602213868930000
TCGA-13-0894-01.9	118	2_CATION_BINDING	165	14	0.0000258489337173911390000
TCGA-13-0793-01.8	97	0_HALLMARK_E2F_TARGETS	169	13	0.0000258651981519757550000
TCGA-13-0724-01.21	71	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000258814302582458830000
TCGA-24-0968-01.9	71	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000258814302582458830000
TCGA-13-0899-01.1	28	2_CELL_CYCLE_PROCESS	163	8	0.0000258872403278836940000
TCGA-61-2111-01.16	56	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	17	0.0000260199489970255340000
TCGA-04-1347-01.15	187	2_ORGAN_MORPHOGENESIS	122	15	0.0000261123695317216350000
TCGA-24-1558-01.12	174	2_CELL_CYCLE_GO_0007049	265	21	0.0000262805694389127160000
TCGA-59-2351-01.5	31	2_CELL_CYCLE_PHASE	146	8	0.0000264842581682306760000
TCGA-13-0912-01.2	55	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000265102741224983940000
TCGA-24-0979-01.5	41	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000265381551464668020000
TCGA-13-1501-01.12	101	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000267056176938095120000
TCGA-13-0920-01.9	82	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0000267336846224689520000
TCGA-13-0920-01.9	82	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0000267336846224689520000
TCGA-24-1557-01.13	106	2_CHROMOSOME	102	11	0.0000269640002466945530000
TCGA-10-0937-01.9	40	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000269677450282769300000
TCGA-13-0791-01.35	80	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0000270143040780710990000
TCGA-09-1669-01.10	81	2_MITOTIC_CELL_CYCLE	134	11	0.0000272180912495129090000
TCGA-13-1404-01.13	117	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000273518343195048130000
TCGA-23-2072-01.9	74	2_EXTRACELLULAR_REGION_PART	269	14	0.0000274180415355105530000
TCGA-23-1110-01.7	299	2_CHROMOSOMAL_PART	78	15	0.0000275493724576149340000
TCGA-09-1659-01.5	51	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0000276452331046086110000
TCGA-09-1659-01.5	51	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0000276452331046086110000
TCGA-13-1495-01.22	101	2_MITOTIC_CELL_CYCLE	134	12	0.0000277686708729416340000
TCGA-13-0800-01.9	124	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0000278854816896939350000
TCGA-25-2398-01.5	81	2_CYTOKINE_ACTIVITY	104	10	0.0000279334622140959480000
TCGA-09-1665-01.16	131	1_KEGG_PATHWAYS_IN_CANCER	323	20	0.0000280808789361180080000
TCGA-09-1665-01.16	131	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000283121857329880000000
TCGA-13-0905-01.7	160	2_CELL_PROLIFERATION_GO_0008283	436	26	0.0000283235489797066510000
TCGA-25-1322-01.15	93	2_MICROTUBULE_CYTOSKELETON	117	11	0.0000286638493473963660000
TCGA-25-2399-01.16	103	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0000286931525845069100000
TCGA-57-1582-01.26	174	2_DNA_METABOLIC_PROCESS	218	19	0.0000287578901938643750000
TCGA-20-0987-01.19	194	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000288747683539688100000
TCGA-61-2092-01.12	209	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000291756375000925350000
TCGA-04-1346-01.10	75	2_CELL_CYCLE_PHASE	146	11	0.0000291759148531644740000
TCGA-13-0761-01.6	75	2_CELL_CYCLE_PHASE	146	11	0.0000291759148531644740000
TCGA-23-1110-01.7	299	0_HALLMARK_INFLAMMATORY_RESPONSE	170	22	0.0000292655519968110690000
TCGA-13-0751-01.2	51	0_HALLMARK_E2F_TARGETS	169	10	0.0000294711870415445140000
TCGA-13-1512-01.2	113	2_EXTRACELLULAR_REGION_PART	269	17	0.0000294957967828152210000
TCGA-10-0934-01.11	145	1_KEGG_CELL_CYCLE	114	13	0.0000296265945138838600000
TCGA-13-1497-01.7	59	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0000296582017261233240000
TCGA-13-0885-01.6	44	2_CELL_CYCLE_PHASE	146	9	0.0000296693932666872720000
TCGA-25-1628-01.2	118	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000297050981252557110000
TCGA-24-1470-01.7	76	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0000298924593890031910000
TCGA-10-0938-01.2	102	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0000301430568970920650000
TCGA-13-0905-01.7	160	2_CHROMOSOMEPERICENTRIC_REGION	29	8	0.0000304448190565135730000
TCGA-61-2102-01.7	172	2_MITOTIC_CELL_CYCLE	134	15	0.0000305556769610735440000
TCGA-25-1319-01.10	69	2_REGULATION_OF_CELL_CYCLE	160	11	0.0000307738254562257710000
TCGA-25-1324-01.3	42	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000308655277879509270000
TCGA-13-0885-01.6	44	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000309483993182672710000
TCGA-24-0980-01.5	44	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000309483993182672710000
TCGA-04-1361-01.4	27	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0000313639962204885330000
TCGA-24-2281-01.10	107	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0000313669641288339430000
TCGA-13-1498-01.13	104	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0000315247257833132690000
TCGA-13-1496-01.13	120	1_KEGG_CELL_CYCLE	114	12	0.0000317006366311207430000
TCGA-13-0884-01.11	68	2_CELL_CYCLE_PROCESS	163	11	0.0000318719951636755800000
TCGA-23-1027-01.8	68	2_CELL_CYCLE_PROCESS	163	11	0.0000318719951636755800000
TCGA-31-1959-01.7	101	2_CATION_BINDING	165	13	0.0000319117058119236230000
TCGA-25-1322-01.15	93	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	6	0.0000319668168143153140000
TCGA-23-1023-01.1	93	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	6	0.0000319668168143153140000
TCGA-24-1425-01.1	61	2_POLYSACCHARIDE_BINDING	28	6	0.0000321059299359150140000
TCGA-20-0990-01.17	133	2_COLLAGEN	23	7	0.0000321067820875869060000
TCGA-13-2060-01.10	86	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000322326498724096490000
TCGA-09-1666-01.28	109	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0000326841146754448810000
TCGA-24-0979-01.5	41	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0000328718519754332950000
TCGA-13-0884-01.11	68	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000328937182346899010000
TCGA-10-0934-01.11	145	2_CELLULAR_HOMEOSTASIS	115	13	0.0000329675118237564170000
TCGA-04-1365-01.6	150	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	16	0.0000330336286974098130000
TCGA-24-1463-01.5	130	2_EXTRACELLULAR_MATRIX	85	11	0.0000332230291061467570000
TCGA-13-0884-01.11	68	2_M_PHASE	94	9	0.0000332769666167496330000
TCGA-09-2050-01.18	196	1_KEGG_MELANOMA	71	12	0.0000336385919880871640000
TCGA-13-1501-01.12	101	2_EXTRACELLULAR_MATRIX	85	10	0.0000337559256309466850000
TCGA-10-0934-01.11	145	2_CELL_CYCLE_GO_0007049	265	19	0.0000337630159309189260000
TCGA-13-0760-01.12	93	2_AGING	10	5	0.0000339678092860909900000
TCGA-04-1525-01.7	52	2_DNA_METABOLIC_PROCESS	218	11	0.0000341265859143975640000
TCGA-24-1567-01.3	141	0_HALLMARK_ALLOGRAFT_REJECTION	190	16	0.0000343616539484679460000
TCGA-13-0886-01.1	45	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0000344659388250335250000
TCGA-25-2391-01.2	64	0_HALLMARK_MITOTIC_SPINDLE	175	11	0.0000344902772682562170000
TCGA-04-1338-01.7	85	2_CELL_CYCLE_PROCESS	163	12	0.0000346919256074976750000
TCGA-23-2081-01.7	56	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000346995653230033360000
TCGA-61-2111-01.16	56	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000346995653230033360000
TCGA-24-1435-01.12	115	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000354174630076538670000
TCGA-61-2109-01.13	122	1_KEGG_MELANOMA	71	10	0.0000356991924705184030000
TCGA-36-1571-01.6	109	2_CHROMOSOME	102	11	0.0000362365618771882260000
TCGA-61-2101-01.2	38	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000362644142074785410000
TCGA-23-1110-01.7	299	2_DNA_METABOLIC_PROCESS	218	25	0.0000364829371361589440000
TCGA-04-1367-01.3	74	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0000365196065691363700000
TCGA-13-1408-01.1	45	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0000366569180816533530000
TCGA-25-1319-01.10	69	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000370041468175784330000
TCGA-25-1320-01.4	71	1_KEGG_BLADDER_CANCER	42	7	0.0000370090120730904900000
TCGA-13-0910-01.3	71	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000370090120730904900000
TCGA-10-0934-01.11	145	2_RESPONSE_TO_BIOTIC_STIMULUS	96	12	0.0000378200236261776610000
TCGA-13-1405-01.4	69	2_M_PHASE	94	9	0.0000379581761900634660000
TCGA-13-0885-01.6	44	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0000382331305555881210000
TCGA-24-1549-01.21	158	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000382784714852275300000
TCGA-24-1463-01.5	130	2_REGULATION_OF_MITOSIS	36	8	0.0000382896475008914990000
TCGA-24-1419-01.2	93	0_HALLMARK_APOPTOSIS	150	12	0.0000384679803027057130000
TCGA-13-1494-01.4	65	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000384912927399604270000
TCGA-24-1469-01.6	123	2_MITOSIS	71	10	0.0000386289437833077410000
TCGA-24-1436-01.1	49	2_M_PHASE	94	8	0.0000387196861101177010000
TCGA-23-1122-01.11	77	2_CELL_CYCLE_PHASE	146	11	0.0000387621059628850790000
TCGA-13-1498-01.13	104	2_MITOTIC_CELL_CYCLE	134	12	0.0000388402742397407260000
TCGA-13-0714-01.9	51	2_EXTRACELLULAR_REGION	346	13	0.0000388809219498719020000
TCGA-24-1563-01.15	100	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	28	0.0000389785888120001730000
TCGA-57-1582-01.26	174	1_KEGG_PATHWAYS_IN_CANCER	323	23	0.0000390810063270250520000
TCGA-25-2042-01.3	63	2_POLYSACCHARIDE_BINDING	28	6	0.0000391303112349815940000
TCGA-24-1614-01.5	86	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	6	0.0000391886210949079920000
TCGA-04-1517-01.4	44	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0000391973228698130840000
TCGA-25-1322-01.15	93	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	18	0.0000392307936865803070000
TCGA-20-0990-01.17	133	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000397134161436539510000
TCGA-04-1336-01.28	106	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000398852683914681840000
TCGA-23-1031-01.17	142	1_KEGG_GLIOMA	62	10	0.0000399253827465268430000
TCGA-13-1512-01.2	113	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	9	0.0000400398237376590030000
TCGA-04-1364-01.3	163	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000400538071060725250000
TCGA-04-1365-01.6	150	2_DNA_REPAIR	113	13	0.0000400728300965208090000
TCGA-24-1418-01.16	84	2_MITOTIC_CELL_CYCLE	134	11	0.0000402204553003617210000
TCGA-61-2102-01.7	172	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000403111003550767000000
TCGA-04-1542-01.4	141	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0000403297070160974010000
TCGA-13-0889-01.4	37	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0000403346558052772470000
TCGA-24-0975-01.6	78	2_ORGAN_DEVELOPMENT	460	18	0.0000405072925573719410000
TCGA-13-0916-01.11	92	1_KEGG_MELANOMA	71	9	0.0000405620111804729450000
TCGA-24-1556-01.19	120	2_CHROMOSOME_SEGREGATION	26	7	0.0000407013986598233290000
TCGA-13-1411-01.7	96	2_CELL_CYCLE_PHASE	146	12	0.0000408662627442838200000
TCGA-24-1423-01.5	27	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000410906015691244510000
TCGA-04-1517-01.4	44	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000412782989083865000000
TCGA-23-1023-01.1	93	0_HALLMARK_P53_PATHWAY	151	12	0.0000414556906953654130000
TCGA-25-1324-01.3	42	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0000419074037265515500000
TCGA-13-0905-01.7	160	1_KEGG_MELANOMA	71	11	0.0000419643529754601060000
TCGA-13-0905-01.7	160	2_MITOSIS	71	11	0.0000419643529754601060000
TCGA-13-1481-01.3	78	2_SKELETAL_DEVELOPMENT	84	9	0.0000419735355156977780000
TCGA-24-0975-01.6	78	2_SKELETAL_DEVELOPMENT	84	9	0.0000419735355156977780000
TCGA-24-1463-01.5	130	2_EXTRACELLULAR_REGION_PART	269	18	0.0000423588909274897450000
TCGA-24-1424-01.4	80	2_DNA_REPLICATION	82	9	0.0000424560937294929320000
TCGA-24-1556-01.19	120	2_MICROTUBULE_CYTOSKELETON	117	12	0.0000426058746207983490000
TCGA-13-0906-01.5	66	2_MITOTIC_CELL_CYCLE	134	10	0.0000426832152899834570000
TCGA-13-0905-01.7	160	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000427208798865094550000
TCGA-24-1557-01.13	106	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000427368842558296700000
TCGA-13-0807-01.8	46	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000427559784606933610000
TCGA-61-2009-01.1	46	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000427559784606933610000
TCGA-04-1362-01.4	35	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0000429848692253360300000
TCGA-04-1362-01.4	35	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0000429946248150493850000
TCGA-25-1630-01.10	35	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0000429946248150493850000
TCGA-04-1365-01.6	150	1_KEGG_DNA_REPLICATION	32	8	0.0000431018026132960890000
TCGA-10-0928-01.6	70	2_M_PHASE	94	9	0.0000432053261054344350000
TCGA-24-2293-01.1	22	2_CELL_CYCLE_PHASE	146	7	0.0000432478968352366160000
TCGA-24-1471-01.4	49	1_KEGG_GLIOMA	62	7	0.0000432957947915371410000
TCGA-61-1998-01.14	105	2_MITOTIC_CELL_CYCLE	134	12	0.0000433275925138241380000
TCGA-09-1665-01.16	131	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0000434511418768666470000
TCGA-25-1322-01.15	93	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000435621586839580510000
TCGA-25-1322-01.15	93	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000435621586839580510000
TCGA-23-1023-01.1	93	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000435621586839580510000
TCGA-23-1023-01.1	93	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0000435621586839580510000
TCGA-13-1496-01.13	120	0_HALLMARK_E2F_TARGETS	169	14	0.0000437277397519869580000
TCGA-25-1316-01.2	73	1_KEGG_FOCAL_ADHESION	195	12	0.0000439990814731189380000
TCGA-24-1469-01.6	123	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000443711503282958580000
TCGA-23-1028-01.18	93	1_KEGG_MELANOMA	71	9	0.0000446417264948892390000
TCGA-23-1120-01.10	57	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0000450016825624336960000
TCGA-23-1120-01.10	57	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000451291694342604870000
TCGA-24-1431-01.3	57	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000451291694342604870000
TCGA-23-1116-01.7	84	0_HALLMARK_E2F_TARGETS	169	12	0.0000453904953950456010000
TCGA-23-1118-01.5	50	2_M_PHASE	94	8	0.0000457217481720125140000
TCGA-23-1118-01.5	50	2_MITOTIC_CELL_CYCLE	134	9	0.0000458892813722065000000
TCGA-23-1122-01.11	77	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000459459629591339150000
TCGA-13-1489-01.11	118	2_CELL_CYCLE_GO_0007049	265	17	0.0000459480207176642250000
TCGA-61-2012-01.6	78	2_CELL_CYCLE_GO_0007049	265	14	0.0000460030306840629020000
TCGA-24-2024-01.3	55	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0000460076302484543320000
TCGA-24-2267-01.8	26	1_KEGG_PANCREATIC_CANCER	70	6	0.0000460352254752113730000
TCGA-24-1424-01.4	80	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	12	0.0000461087499588553120000
TCGA-10-0930-01.6	9	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	6	0.0000461388884310047470000
TCGA-13-1403-01.9	71	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000465704820232180080000
TCGA-04-1356-01.1	71	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000465704820232180080000
TCGA-13-0724-01.21	71	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000465704820232180080000
TCGA-23-2079-01.14	85	2_CHROMOSOMAL_PART	78	9	0.0000466346305398676410000
TCGA-29-2427-01.10	116	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000466411499992815870000
TCGA-24-2261-01.2	87	2_CHROMOSOME	102	10	0.0000466632995221519640000
TCGA-24-1470-01.7	76	2_MICROTUBULE_CYTOSKELETON	117	10	0.0000467126973114107310000
TCGA-24-2280-01.10	58	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0000473406312135909830000
TCGA-61-2104-01.15	95	1_KEGG_PANCREATIC_CANCER	70	9	0.0000474484101379437120000
TCGA-13-1492-01.2	162	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000476082722628352920000
TCGA-57-1993-01.8	52	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	4	0.0000476763134336517570000
TCGA-23-2078-01.15	105	1_KEGG_FOCAL_ADHESION	195	14	0.0000476859344849248410000
TCGA-04-1361-01.4	27	2_CELL_CYCLE_GO_0007049	265	9	0.0000477553717638783960000
TCGA-04-1514-01.6	91	0_HALLMARK_ALLOGRAFT_REJECTION	190	13	0.0000479576946816405280000
TCGA-31-1959-01.7	101	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000480038101027033450000
TCGA-25-1318-01.11	46	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0000480908924626402090000
TCGA-04-1362-01.4	35	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0000482117924267907130000
TCGA-13-0893-01.4	112	2_CHROMOSOME	102	11	0.0000482526169472201090000
TCGA-04-1542-01.4	141	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	15	0.0000482971725250565730000
TCGA-61-2109-01.13	122	1_KEGG_BASAL_CELL_CARCINOMA	55	9	0.0000483617102623535630000
TCGA-36-1570-01.2	36	2_MITOTIC_CELL_CYCLE	134	8	0.0000486020580510378670000
TCGA-59-2350-01.1	62	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0000488019451149587230000
TCGA-13-0905-01.7	160	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000488153426654423260000
TCGA-61-2088-01.7	150	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	16	0.0000490329308413524510000
TCGA-25-1320-01.4	71	2_M_PHASE	94	9	0.0000490758320449477720000
TCGA-13-0923-01.5	53	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0000493563644826726130000
TCGA-13-0923-01.5	53	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0000493563644826726130000
TCGA-24-2261-01.2	87	2_REGULATION_OF_MITOSIS	36	7	0.0000499386257491757850000
TCGA-13-0911-01.3	47	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000499635128091620870000
TCGA-61-2016-01.10	50	1_KEGG_GLIOMA	62	7	0.0000500872056267861980000
TCGA-04-1347-01.15	187	2_CELL_PROLIFERATION_GO_0008283	436	28	0.0000501408343131368990000
TCGA-13-0910-01.3	71	2_CHROMOSOME_SEGREGATION	26	6	0.0000501930170407484900000
TCGA-04-1364-01.3	163	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000502304833089847710000
TCGA-23-1117-01.11	99	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0000505908393453998870000
TCGA-24-0968-01.9	71	2_CELL_CYCLE_PROCESS	163	11	0.0000509119625974179480000
TCGA-23-1110-01.7	299	1_KEGG_DNA_REPLICATION	32	10	0.0000509954845702262250000
TCGA-61-2102-01.7	172	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000510997747347792930000
TCGA-24-1474-01.12	122	2_MICROTUBULE_CYTOSKELETON	117	12	0.0000513803568877243010000
TCGA-13-0887-01.6	47	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0000516346205873215770000
TCGA-13-1407-01.11	220	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000517387534210692170000
TCGA-13-0899-01.1	28	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000520124158562555280000
TCGA-04-1338-01.7	85	0_HALLMARK_E2F_TARGETS	169	12	0.0000520403660914601490000
TCGA-31-1950-01.7	105	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0000527597288434785720000
TCGA-59-2348-01.14	123	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0000531259834585702200000
TCGA-13-1410-01.9	115	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000532687375907663900000
TCGA-13-1488-01.17	109	1_KEGG_GLIOMA	62	9	0.0000534210978355298820000
TCGA-61-2101-01.2	38	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0000534666756795609670000
TCGA-24-1614-01.5	86	2_KINASE_INHIBITOR_ACTIVITY	22	6	0.0000534933873413652920000
TCGA-61-2111-01.16	56	2_CELL_CYCLE_PROCESS	163	10	0.0000538620582457757840000
TCGA-04-1362-01.4	35	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0000539786092266179220000
TCGA-13-1483-01.3	66	2_EXTRACELLULAR_REGION_PART	269	13	0.0000543085192914928380000
TCGA-13-0807-01.8	46	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000544351808880689040000
TCGA-13-0900-01.8	90	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000544664186559697450000
TCGA-24-2267-01.8	26	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	6	0.0000546562529293178430000
TCGA-24-2298-01.7	138	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000546994697956566000000
TCGA-25-1628-01.2	118	0_HALLMARK_MITOTIC_SPINDLE	175	14	0.0000548791152169432050000
TCGA-23-1031-01.17	142	1_KEGG_FOCAL_ADHESION	195	16	0.0000550263990841480100000
TCGA-13-0807-01.8	46	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0000552664989298539360000
TCGA-24-1424-01.4	80	2_DNA_REPAIR	113	10	0.0000552926435861112690000
TCGA-25-1633-01.1	71	2_ORGAN_DEVELOPMENT	460	17	0.0000553359542852817950000
TCGA-10-0934-01.11	145	2_HOMEOSTATIC_PROCESS	166	15	0.0000554657311158564260000
TCGA-24-0982-01.3	34	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0000555386901484352160000
TCGA-24-1435-01.12	115	0_HALLMARK_COAGULATION	125	12	0.0000556129289741227610000
TCGA-23-1118-01.5	50	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0000556142788871752080000
TCGA-23-1117-01.11	99	2_MICROTUBULE_CYTOSKELETON	117	11	0.0000556928545459007380000
TCGA-13-1488-01.17	109	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000559988910380469300000
TCGA-10-0937-01.9	40	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000560614045018312720000
TCGA-57-1582-01.26	174	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000560614045018312720000
TCGA-59-2348-01.14	123	2_MICROTUBULE_CYTOSKELETON	117	12	0.0000563481791431850920000
TCGA-24-2298-01.7	138	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000566214756866077170000
TCGA-61-2113-01.15	99	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0000572309467643822510000
TCGA-61-2002-01.1	118	2_EXTRACELLULAR_REGION_PART	269	17	0.0000573308296317801260000
TCGA-13-1482-01.7	62	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000577595526727886920000
TCGA-23-1022-01.10	170	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000577698319434473960000
TCGA-23-1028-01.18	93	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0000578129545006926920000
TCGA-13-0893-01.4	112	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0000579317783374951680000
TCGA-23-1031-01.17	142	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	13	0.0000580524935245472310000
TCGA-61-2111-01.16	56	2_CELL_CYCLE_GO_0007049	265	12	0.0000581704677487006190000
TCGA-04-1348-01.6	81	2_DNA_METABOLIC_PROCESS	218	13	0.0000583946782034416050000
TCGA-25-2398-01.5	81	2_SKELETAL_DEVELOPMENT	84	9	0.0000587658489897829930000
TCGA-13-1483-01.3	66	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0000589725380907160990000
TCGA-13-1501-01.12	101	0_HALLMARK_ANGIOGENESIS	32	7	0.0000590974016853543790000
TCGA-13-0916-01.11	92	2_SPINDLE	35	7	0.0000599741937820572870000
TCGA-13-0791-01.35	80	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000601370114520732950000
TCGA-24-1469-01.6	123	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000601875458765121220000
TCGA-24-1424-01.4	80	1_KEGG_CELL_CYCLE	114	10	0.0000601990254982295220000
TCGA-24-1558-01.12	174	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000602286122856652640000
TCGA-13-1404-01.13	117	2_CHROMOSOMAL_PART	78	10	0.0000603163429308340290000
TCGA-24-1557-01.13	106	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0000605954302957297240000
TCGA-24-2293-01.1	22	2_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0000606779687223261870000
TCGA-24-2293-01.1	22	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0000606779687223261870000
TCGA-61-1728-01.5	45	2_MITOSIS	71	7	0.0000611509159750144200000
TCGA-13-0889-01.4	37	2_MITOTIC_CELL_CYCLE	134	8	0.0000612750452632828530000
TCGA-13-0883-01.3	23	2_CELL_CYCLE_PHASE	146	7	0.0000613693592240778810000
TCGA-24-1567-01.3	141	2_IMMUNE_SYSTEM_PROCESS	283	19	0.0000613888251927031930000
TCGA-13-0904-01.6	105	1_KEGG_PROSTATE_CANCER	87	10	0.0000617978866662376560000
TCGA-24-1562-01.4	36	2_AGING	10	4	0.0000619887758129231980000
TCGA-13-0887-01.6	47	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000622084935992719410000
TCGA-25-1634-01.4	75	2_IMMUNE_SYSTEM_PROCESS	283	14	0.0000624025384393525150000
TCGA-36-1575-01.9	193	2_IMMUNE_RESPONSE	206	19	0.0000624470781367061920000
TCGA-13-0884-01.11	68	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000628488161610721080000
TCGA-59-2351-01.5	31	2_CELL_CYCLE_PROCESS	163	8	0.0000628752356311889820000
TCGA-24-1105-01.8	52	2_M_PHASE	94	8	0.0000630544780147239780000
TCGA-61-2101-01.2	38	2_EXTRACELLULAR_MATRIX	85	7	0.0000631957497578674380000
TCGA-24-2035-01.8	102	0_HALLMARK_ANGIOGENESIS	32	7	0.0000633041465718932970000
TCGA-13-1496-01.13	120	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000633967577661043550000
TCGA-13-1506-01.5	113	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0000634400354343627900000
TCGA-09-2049-01.8	96	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000635551493470800150000
TCGA-13-1484-01.4	70	0_HALLMARK_E2F_TARGETS	169	11	0.0000635604345677013040000
TCGA-09-2051-01.26	142	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000648324563655885270000
TCGA-23-1031-01.17	142	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000648324563655885270000
TCGA-13-0791-01.35	80	1_KEGG_ERBB_SIGNALING_PATHWAY	86	9	0.0000648329785229705020000
TCGA-04-1347-01.15	187	0_HALLMARK_INFLAMMATORY_RESPONSE	170	17	0.0000648416730821895100000
TCGA-13-1407-01.11	220	2_IMMUNE_SYSTEM_PROCESS	283	24	0.0000648661124288097370000
TCGA-25-1318-01.11	46	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0000648705320176515930000
TCGA-61-1998-01.14	105	2_EXTRACELLULAR_REGION_PART	269	16	0.0000651174552221811110000
TCGA-23-2078-01.15	105	2_EXTRACELLULAR_REGION_PART	269	16	0.0000651174552221811110000
TCGA-61-2104-01.15	95	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	22	0.0000652209960713249920000
TCGA-24-1560-01.2	29	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000652238489236016040000
TCGA-13-0894-01.9	118	1_KEGG_BLADDER_CANCER	42	8	0.0000652458814920670190000
TCGA-13-0905-01.7	160	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000653305167421952840000
TCGA-24-1560-01.2	29	1_KEGG_CELL_CYCLE	114	7	0.0000655278954894305310000
TCGA-23-1028-01.18	93	2_CELL_CYCLE_GO_0007049	265	15	0.0000655724353359042900000
TCGA-23-1122-01.11	77	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000656269724400104860000
TCGA-13-1487-01.3	79	2_EXTRACELLULAR_REGION_PART	269	14	0.0000658542513796002110000
TCGA-04-1517-01.4	44	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000659845581483184270000
TCGA-13-0885-01.6	44	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000659845581483184270000
TCGA-24-0980-01.5	44	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000659845581483184270000
TCGA-36-1571-01.6	109	2_MITOTIC_CELL_CYCLE	134	12	0.0000662999220830020720000
TCGA-23-1027-01.8	68	2_REGULATION_OF_CELL_PROLIFERATION	265	13	0.0000663185472708071200000
TCGA-13-0924-01.5	68	0_HALLMARK_MITOTIC_SPINDLE	175	11	0.0000666895729456149680000
TCGA-23-1022-01.10	170	2_SIGNAL_TRANSDUCTION	1442	54	0.0000674724703929791740000
TCGA-61-1728-01.5	45	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0000674972819623829340000
TCGA-13-0924-01.5	68	2_CHROMOSOME	102	9	0.0000684832370829436650000
TCGA-25-1625-01.6	38	1_KEGG_ERBB_SIGNALING_PATHWAY	86	7	0.0000685969879059494610000
TCGA-23-2081-01.7	56	2_EXTRACELLULAR_REGION_PART	269	12	0.0000686761271984855810000
TCGA-24-1427-01.4	83	2_EXTRACELLULAR_REGION	346	16	0.0000692536529278159490000
TCGA-24-1567-01.3	141	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000695740220746922890000
TCGA-36-1577-01.14	168	1_KEGG_MELANOMA	71	11	0.0000696490397496152710000
TCGA-25-1326-01.11	119	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000697230214179640780000
TCGA-10-0934-01.11	145	0_HALLMARK_E2F_TARGETS	169	15	0.0000706042339136608510000
TCGA-24-1463-01.5	130	2_CONDENSED_CHROMOSOME	26	7	0.0000710048349540745080000
TCGA-30-1853-01.4	111	2_DEFENSE_RESPONSE	222	15	0.0000714749014700277760000
TCGA-13-0792-01.8	64	2_CELL_CYCLE_PHASE	146	10	0.0000715260624364938340000
TCGA-13-0920-01.9	82	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000715283898410523260000
TCGA-13-0791-01.35	80	1_KEGG_PROSTATE_CANCER	87	9	0.0000718232569123706570000
TCGA-24-0975-01.6	78	1_KEGG_BLADDER_CANCER	42	7	0.0000718626926861707220000
TCGA-24-1431-01.3	57	2_CELL_CYCLE_GO_0007049	265	12	0.0000718641867832029200000
TCGA-04-1338-01.7	85	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000720614033899448740000
TCGA-25-1627-01.4	75	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000722468245534739740000
TCGA-13-0795-01.9	67	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0000722778927884445990000
TCGA-24-1616-01.2	38	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	8	0.0000723227494058288730000
TCGA-25-2398-01.5	81	2_LOCOMOTORY_BEHAVIOR	86	9	0.0000724009298969760560000
TCGA-24-1544-01.7	84	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000729826499110050990000
TCGA-04-1517-01.4	44	1_KEGG_CELL_CYCLE	114	8	0.0000731824648907808790000
TCGA-13-0913-01.5	44	1_KEGG_CELL_CYCLE	114	8	0.0000731824648907808790000
TCGA-13-1512-01.2	113	2_INTERPHASE	62	9	0.0000732982692479777290000
TCGA-04-1336-01.28	106	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000734492791289091620000
TCGA-31-1953-01.6	53	2_M_PHASE	94	8	0.0000736630550224472940000
TCGA-24-1424-01.4	80	2_NUCLEUS	1110	28	0.0000741368130091805360000
TCGA-25-1628-01.2	118	0_HALLMARK_COAGULATION	125	12	0.0000744134772398435710000
TCGA-13-0894-01.9	118	0_HALLMARK_COAGULATION	125	12	0.0000744134772398435710000
TCGA-09-2051-01.26	142	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000744384666393933670000
TCGA-24-2290-01.3	70	2_MITOSIS	71	8	0.0000747428680822915530000
TCGA-13-1484-01.4	70	1_KEGG_MELANOMA	71	8	0.0000747428680822915530000
TCGA-13-1497-01.7	59	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000749614649885269740000
TCGA-10-0931-01.12	59	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0000749614649885269740000
TCGA-25-1623-01.7	111	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000750278188672005130000
TCGA-24-0966-01.2	18	1_KEGG_CELL_CYCLE	114	6	0.0000753767932397999270000
TCGA-25-1318-01.11	46	2_EXTRACELLULAR_REGION_PART	269	11	0.0000756776512064764120000
TCGA-24-1425-01.1	61	0_HALLMARK_ANGIOGENESIS	32	6	0.0000756957043535024430000
TCGA-10-0935-01.2	49	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0000758464619115054830000
TCGA-61-2111-01.16	56	0_HALLMARK_E2F_TARGETS	169	10	0.0000760369149824503360000
TCGA-24-1466-01.15	82	1_KEGG_CELL_CYCLE	114	10	0.0000766563091891920100000
TCGA-13-1510-01.20	82	1_KEGG_CELL_CYCLE	114	10	0.0000766563091891920100000
TCGA-24-1416-01.4	38	2_MITOTIC_CELL_CYCLE	134	8	0.0000766957989622521210000
TCGA-24-1616-01.2	38	2_MITOTIC_CELL_CYCLE	134	8	0.0000766957989622521210000
TCGA-25-2391-01.2	64	2_CHROMOSOMAL_PART	78	8	0.0000771271996745926790000
TCGA-24-2262-01.25	141	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000772568943442921800000
TCGA-04-1331-01.5	90	2_CHROMOSOMAL_PART	78	9	0.0000773911510650383860000
TCGA-13-0730-01.8	83	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000778768223885982180000
TCGA-24-2030-01.8	161	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	37	0.0000778964688353202990000
TCGA-13-0723-01.8	50	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000780572768652063540000
TCGA-24-1603-01.3	69	0_HALLMARK_MITOTIC_SPINDLE	175	11	0.0000780754499805859830000
TCGA-13-1404-01.13	117	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0000784961094817396620000
TCGA-61-2000-01.11	69	2_DNA_METABOLIC_PROCESS	218	12	0.0000787370328938973650000
TCGA-23-1023-01.1	93	2_REGULATION_OF_MITOSIS	36	7	0.0000796614269224123210000
TCGA-24-1436-01.1	49	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000805158121386204840000
TCGA-24-2254-01.3	49	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000805158121386204840000
TCGA-36-1580-01.1	65	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000807671342472536750000
TCGA-36-1574-01.10	152	2_COLLAGEN	23	7	0.0000811000474659190590000
TCGA-13-0886-01.1	45	2_REGULATION_OF_CELL_CYCLE	160	9	0.0000812955772506421970000
TCGA-25-2042-01.3	63	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	21	0.0000817666828344854640000
TCGA-25-2401-01.5	119	0_HALLMARK_COAGULATION	125	12	0.0000818415961159693760000
TCGA-13-0911-01.3	47	2_CELL_CYCLE_GO_0007049	265	11	0.0000826091877062681260000
TCGA-13-0887-01.6	47	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0000826091877062681260000
TCGA-25-1628-01.2	118	2_CHROMOSOME	102	11	0.0000834005763900517710000
TCGA-24-2290-01.3	70	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0000835942419848414800000
TCGA-13-0900-01.8	90	2_MITOTIC_CELL_CYCLE	134	11	0.0000838191669413067170000
TCGA-25-1631-01.6	30	1_KEGG_CELL_CYCLE	114	7	0.0000846248412332874110000
TCGA-24-1603-01.3	69	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0000855157137495490580000
TCGA-04-1367-01.3	74	2_RESPONSE_TO_BIOTIC_STIMULUS	96	9	0.0000855608637364276640000
TCGA-25-1329-01.5	43	0_HALLMARK_E2F_TARGETS	169	9	0.0000856682660058180470000
TCGA-61-1736-01.2	54	2_M_PHASE	94	8	0.0000857740944243910850000
TCGA-24-1552-01.5	54	2_M_PHASE	94	8	0.0000857740944243910850000
TCGA-36-1570-01.2	36	2_M_PHASE	94	7	0.0000858386294201718530000
TCGA-24-1424-01.4	80	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000858489059335427510000
TCGA-61-2109-01.13	122	1_KEGG_MELANOGENESIS	99	11	0.0000862775113205541490000
TCGA-10-0933-01.2	97	2_SPINDLE	35	7	0.0000868042469300171280000
TCGA-04-1336-01.28	106	1_KEGG_CELL_CYCLE	114	11	0.0000871106751262071340000
TCGA-09-2049-01.8	96	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000873286477456493020000
TCGA-13-0904-01.6	105	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0000873815489414990770000
TCGA-04-1362-01.4	35	2_REGULATION_OF_MOLECULAR_FUNCTION	286	10	0.0000876762704773297340000
TCGA-61-2110-01.3	37	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0000877259088752834150000
TCGA-13-0900-01.8	90	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0000878635516446690410000
TCGA-24-1428-01.9	90	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0000878635516446690410000
TCGA-24-2298-01.7	138	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000879241342565746150000
TCGA-61-2104-01.15	95	2_CELL_CYCLE_GO_0007049	265	15	0.0000881099431343416400000
TCGA-61-2104-01.15	95	2_REGULATION_OF_CELL_PROLIFERATION	265	15	0.0000881099431343416400000
TCGA-25-2404-01.5	58	2_CELL_CYCLE_GO_0007049	265	12	0.0000883753530215129350000
TCGA-13-0804-01.5	78	2_CHROMOSOME_SEGREGATION	26	6	0.0000888750764752709050000
TCGA-25-2042-01.3	63	1_KEGG_FOCAL_ADHESION	195	11	0.0000890905664349825390000
TCGA-25-1322-01.15	93	2_CHROMOSOME	102	10	0.0000893278316664906330000
TCGA-24-1551-01.15	87	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	9	0.0000894163257552339980000
TCGA-13-1510-01.20	82	1_KEGG_PROSTATE_CANCER	87	9	0.0000894163257552339980000
TCGA-13-0905-01.7	160	2_M_PHASE	94	12	0.0000895801882949742100000
TCGA-24-1563-01.15	100	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	27	0.0000896609698504128080000
TCGA-09-1659-01.5	51	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000899806493462107290000
TCGA-13-0751-01.2	51	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000899806493462107290000
TCGA-24-1544-01.7	84	2_EXTRACELLULAR_MATRIX	85	9	0.0000901156115073881430000
TCGA-10-0934-01.11	145	2_RESPONSE_TO_OTHER_ORGANISM	66	10	0.0000908826068529130830000
TCGA-13-0717-01.6	103	2_CELL_CYCLE_PHASE	146	12	0.0000912024542468813600000
TCGA-13-0723-01.8	50	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0000912125115438858840000
TCGA-23-2072-01.9	74	2_EXTRACELLULAR_REGION	346	15	0.0000912311694433729960000
TCGA-04-1356-01.1	71	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0000913616509934983060000
TCGA-04-1356-01.1	71	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0000913616509934983060000
TCGA-24-2293-01.1	22	2_M_PHASE	94	6	0.0000915635691714950820000
TCGA-23-2079-01.14	85	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000920134856144534220000
TCGA-24-1425-01.1	61	2_PATTERN_BINDING	33	6	0.0000920552083586047690000
TCGA-13-0886-01.1	45	2_DNA_METABOLIC_PROCESS	218	10	0.0000926294330568438270000
TCGA-24-1463-01.5	130	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000929225707116601160000
TCGA-36-1574-01.10	152	2_EXTRACELLULAR_REGION_PART	269	19	0.0000935142620722173480000
TCGA-61-2111-01.16	56	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	16	0.0000935580202109673270000
TCGA-24-1556-01.19	120	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0000935753753968841220000
TCGA-59-2348-01.14	123	0_HALLMARK_MITOTIC_SPINDLE	175	14	0.0000936530855087470750000
TCGA-09-1669-01.10	81	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000936640124313405060000
TCGA-25-2398-01.5	81	1_KEGG_BLADDER_CANCER	42	7	0.0000936640124313405060000
TCGA-04-1347-01.15	187	2_REGULATION_OF_CELL_PROLIFERATION	265	21	0.0000942182578177170570000
TCGA-13-1481-01.3	78	1_KEGG_FOCAL_ADHESION	195	12	0.0000949705877632535890000
TCGA-20-0987-01.19	194	2_ORGAN_DEVELOPMENT	460	29	0.0000954803101666267990000
TCGA-24-2030-01.8	161	2_ORGAN_DEVELOPMENT	460	26	0.0000961362957482731230000
TCGA-57-1993-01.8	52	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0000963587434028926180000
TCGA-25-1313-01.2	13	0_HALLMARK_MITOTIC_SPINDLE	175	6	0.0000965368221229303600000
TCGA-57-1582-01.26	174	1_KEGG_OOCYTE_MEIOSIS	105	13	0.0000968590883846790670000
TCGA-30-1891-01.4	84	1_KEGG_CELL_CYCLE	114	10	0.0000969618949680432870000
TCGA-23-1116-01.7	84	1_KEGG_CELL_CYCLE	114	10	0.0000969618949680432870000
TCGA-24-2030-01.8	161	2_MITOTIC_CELL_CYCLE	134	14	0.0000975352575644743670000
TCGA-04-1331-01.5	90	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0000977598816408316810000
TCGA-13-1482-01.7	62	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0000978992689586073990000
TCGA-13-0920-01.9	82	2_MICROTUBULE_CYTOSKELETON	117	10	0.0000983807015908774660000
TCGA-09-1665-01.16	131	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000986660642275477660000
TCGA-61-2012-01.6	78	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000987676969239956980000
TCGA-13-0795-01.9	67	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	18	0.0000991133652632861810000
TCGA-59-2351-01.5	31	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000999992563988622680000
TCGA-61-1919-01.9	87	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0001002731551698384800000
TCGA-61-2111-01.16	56	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0001003155148558806800000
TCGA-36-1575-01.9	193	2_CELL_PROLIFERATION_GO_0008283	436	28	0.0001005848048538274100000
TCGA-04-1356-01.1	71	2_CHROMOSOME	102	9	0.0001007653685259813700000
TCGA-30-1862-01.13	91	2_COLLAGEN	23	6	0.0001010757604025373800000
TCGA-25-2391-01.2	64	1_KEGG_DNA_REPLICATION	32	6	0.0001014860683939611200000
TCGA-24-1616-01.2	38	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0001016418002214013200000
TCGA-04-1356-01.1	71	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0001017391127169163500000
TCGA-13-1411-01.7	96	2_CELL_CYCLE_GO_0007049	265	15	0.0001018348002413287300000
TCGA-25-1318-01.11	46	2_EXTRACELLULAR_REGION	346	12	0.0001029115724903904900000
TCGA-23-1031-01.17	142	1_KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	107	12	0.0001029273253057272200000
TCGA-09-2050-01.18	196	2_M_PHASE	94	13	0.0001033575154769819700000
TCGA-57-1993-01.8	52	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001034089611327325600000
TCGA-24-1424-01.4	80	2_CONDENSED_CHROMOSOME	26	6	0.0001035995414849022000000
TCGA-36-1575-01.9	193	0_HALLMARK_APOPTOSIS	150	16	0.0001039635989675380800000
TCGA-24-1471-01.4	49	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0001039726969087038000000
TCGA-61-2109-01.13	122	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0001049346543584788800000
TCGA-24-1474-01.12	122	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0001049346543584788800000
TCGA-25-1318-01.11	46	1_KEGG_CELL_CYCLE	114	8	0.0001056064068412756900000
TCGA-13-1403-01.9	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0001061547046059134500000
TCGA-13-0893-01.4	112	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	12	0.0001063857335791892100000
TCGA-09-0369-01.9	109	2_DNA_REPAIR	113	11	0.0001064156428625822400000
TCGA-25-1319-01.10	69	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0001073305957940323600000
TCGA-24-2298-01.7	138	2_GLYCOSAMINOGLYCAN_BINDING	26	7	0.0001073660796142418600000
TCGA-13-1482-01.7	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001076530734267602700000
TCGA-10-0931-01.12	59	2_CELL_CYCLE_GO_0007049	265	12	0.0001082018468092147700000
TCGA-61-1919-01.9	87	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0001082635482126590700000
TCGA-04-1336-01.28	106	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0001086480693592141400000
TCGA-25-2399-01.16	103	2_M_PHASE	94	10	0.0001088383742185207300000
TCGA-24-2254-01.3	49	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0001091805947428042900000
TCGA-10-0934-01.11	145	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0001094271534654522000000
TCGA-25-1329-01.5	43	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0001102580641915401200000
TCGA-13-1509-01.9	117	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0001107042765505804300000
TCGA-13-1404-01.13	117	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0001107042765505804300000
TCGA-09-2044-01.4	83	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0001111115147929869000000
TCGA-23-2077-01.18	63	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0001113470980118594300000
TCGA-04-1338-01.7	85	2_CELL_CYCLE_PHASE	146	11	0.0001113687957835690700000
TCGA-25-2400-01.5	35	2_DNA_METABOLIC_PROCESS	218	9	0.0001113810570689814400000
TCGA-13-1494-01.4	65	0_HALLMARK_ANGIOGENESIS	32	6	0.0001115421401701010100000
TCGA-36-1580-01.1	65	0_HALLMARK_ANGIOGENESIS	32	6	0.0001115421401701010100000
TCGA-23-1026-01.5	65	0_HALLMARK_ANGIOGENESIS	32	6	0.0001115421401701010100000
TCGA-25-2042-01.3	63	2_PATTERN_BINDING	33	6	0.0001120937354764870200000
TCGA-61-2012-01.6	78	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0001124514805399297700000
TCGA-04-1331-01.5	90	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0001137265693206989800000
TCGA-24-0975-01.6	78	0_HALLMARK_COAGULATION	125	10	0.0001137713555763359500000
TCGA-24-1557-01.13	106	2_MICROTUBULE_CYTOSKELETON	117	11	0.0001142277037897333900000
TCGA-24-1558-01.12	174	2_CELL_CYCLE_PHASE	146	15	0.0001144738899985207800000
TCGA-61-2104-01.15	95	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	21	0.0001145557158369410400000
TCGA-13-0792-01.8	64	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0001147826428012019100000
TCGA-13-0905-01.7	160	2_CHROMOSOMAL_PART	78	11	0.0001151246888598386800000
TCGA-13-0804-01.5	78	2_REGULATION_OF_CELL_CYCLE	160	11	0.0001151246888598386800000
TCGA-13-1404-01.13	117	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0001155168237955481200000
TCGA-13-1404-01.13	117	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0001155168237955481200000
TCGA-25-1326-01.11	119	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0001157233516953765900000
TCGA-24-1557-01.13	106	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0001162844929985747300000
TCGA-25-1318-01.11	46	2_COLLAGEN	23	5	0.0001165272197257262800000
TCGA-09-1666-01.28	109	1_KEGG_CELL_CYCLE	114	11	0.0001166563774928218200000
TCGA-25-2400-01.5	35	2_DOUBLE_STRANDED_DNA_BINDING	30	5	0.0001167522251570940800000
TCGA-04-1365-01.6	150	2_REGULATION_OF_MITOSIS	36	8	0.0001175133011253005700000
TCGA-13-0887-01.6	47	2_DNA_REPAIR	113	8	0.0001175925143353426500000
TCGA-61-2102-01.7	172	0_HALLMARK_KRAS_SIGNALING_UP	148	15	0.0001177777201357026800000
TCGA-25-1322-01.15	93	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0001180944160350476200000
TCGA-13-0923-01.5	53	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001184934736261114500000
TCGA-24-2289-01.6	53	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001184934736261114500000
TCGA-31-1953-01.6	53	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001184934736261114500000
TCGA-24-2280-01.10	58	2_ORGAN_DEVELOPMENT	460	15	0.0001186661864721822600000
TCGA-61-2092-01.12	209	2_SIGNAL_TRANSDUCTION	1442	62	0.0001186805069884754800000
TCGA-13-1499-01.1	22	0_HALLMARK_E2F_TARGETS	169	7	0.0001189595804847757000000
TCGA-13-1498-01.13	104	2_MITOSIS	71	9	0.0001194440330359723300000
TCGA-13-1489-01.11	118	2_IMMUNE_SYSTEM_PROCESS	283	17	0.0001206269901009379800000
TCGA-23-1022-01.10	170	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0001206405282252266900000
TCGA-23-1026-01.5	65	1_KEGG_CELL_CYCLE	114	9	0.0001210561493795200700000
TCGA-09-2053-01.14	121	2_EXTRACELLULAR_REGION	346	19	0.0001213163860235157700000
TCGA-04-1347-01.15	187	2_EXTRACELLULAR_REGION_PART	269	21	0.0001219809924903739000000
TCGA-13-1483-01.3	66	0_HALLMARK_ANGIOGENESIS	32	6	0.0001224060307783025800000
TCGA-13-0883-01.3	23	2_M_PHASE	94	6	0.0001228917202579135600000
TCGA-25-1625-01.6	38	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0001229204276141794100000
TCGA-25-1626-01.2	86	2_LOCOMOTORY_BEHAVIOR	86	9	0.0001229957700521445400000
TCGA-24-1563-01.15	100	0_HALLMARK_COAGULATION	125	11	0.0001234456492658587600000
TCGA-24-1425-01.1	61	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0001236076320772513200000
TCGA-61-2016-01.10	50	1_KEGG_BLADDER_CANCER	42	6	0.0001236629891017127700000
TCGA-61-2016-01.10	50	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0001236629891017127700000
TCGA-57-1583-01.20	185	2_ORGAN_DEVELOPMENT	460	28	0.0001240378502913347300000
TCGA-13-1404-01.13	117	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0001243687367013500400000
TCGA-24-2262-01.25	141	2_CHROMOSOME_SEGREGATION	26	7	0.0001245610892558599500000
TCGA-24-1464-01.7	62	2_REGULATION_OF_CELL_CYCLE	160	10	0.0001247924814687937400000
TCGA-13-0893-01.4	112	2_REGULATION_OF_KINASE_ACTIVITY	138	12	0.0001252066949319715300000
TCGA-04-1356-01.1	71	2_RESPONSE_TO_STRESS	427	16	0.0001253307661154727300000
TCGA-24-2019-01.10	192	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0001255995616592506900000
TCGA-24-1549-01.21	158	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	23	0.0001260862270291046100000
TCGA-25-2396-01.6	42	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	10	0.0001270330375029076000000
TCGA-24-2035-01.8	102	2_ORGAN_DEVELOPMENT	460	20	0.0001273186903066131800000
TCGA-24-1416-01.4	38	2_M_PHASE	94	7	0.0001276912370925882700000
TCGA-24-1616-01.2	38	2_M_PHASE	94	7	0.0001276912370925882700000
TCGA-13-0897-01.2	61	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0001290004607651790400000
TCGA-04-1346-01.10	75	1_KEGG_MELANOMA	71	8	0.0001296549717337462200000
TCGA-13-0904-01.6	105	1_KEGG_MELANOMA	71	9	0.0001298671886210890000000
TCGA-13-1484-01.4	70	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0001300748537214067600000
TCGA-23-1123-01.7	70	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0001300748537214067600000
TCGA-61-2008-01.19	70	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0001300748537214067600000
TCGA-13-0884-01.11	68	2_CELL_CYCLE_PHASE	146	10	0.0001302479778351624800000
TCGA-61-2016-01.10	50	1_KEGG_MELANOMA	71	7	0.0001306540318577748400000
TCGA-24-1558-01.12	174	0_HALLMARK_E2F_TARGETS	169	16	0.0001306598645487461100000
TCGA-23-2081-01.7	56	2_EXTRACELLULAR_REGION	346	13	0.0001306903370348518300000
TCGA-31-1950-01.7	105	2_M_PHASE	94	10	0.0001309425021399783800000
TCGA-25-1635-01.6	129	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0001312084867639979900000
TCGA-13-0883-01.3	23	2_CELL_CYCLE_PROCESS	163	7	0.0001313496809005255600000
TCGA-10-0935-01.2	49	2_CELL_CYCLE_GO_0007049	265	11	0.0001314785363989411900000
TCGA-24-2254-01.3	49	2_CELL_CYCLE_GO_0007049	265	11	0.0001314785363989411900000
TCGA-04-1331-01.5	90	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0001319716103346323800000
TCGA-25-2391-01.2	64	2_MICROTUBULE_CYTOSKELETON	117	9	0.0001321226330036125900000
TCGA-04-1364-01.3	163	2_IMMUNE_SYSTEM_PROCESS	283	20	0.0001321331099461877200000
TCGA-23-1031-01.17	142	1_KEGG_PANCREATIC_CANCER	70	10	0.0001329888275933242600000
TCGA-10-0938-01.2	102	2_DNA_METABOLIC_PROCESS	218	14	0.0001335227652663739100000
TCGA-04-1331-01.5	90	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0001337289948967502200000
TCGA-04-1331-01.5	90	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0001337289948967502200000
TCGA-04-1361-01.4	27	2_DNA_RECOMBINATION	40	5	0.0001338249892220905000000
TCGA-13-0894-01.9	118	2_SKELETAL_DEVELOPMENT	84	10	0.0001349123649097059100000
TCGA-13-1498-01.13	104	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0001352710408879786200000
TCGA-61-2092-01.12	209	2_REGULATION_OF_CELL_CYCLE	160	17	0.0001359443279443997600000
TCGA-24-2271-01.3	44	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0001364348512173517300000
TCGA-13-0894-01.9	118	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	30	0.0001368170988722629900000
TCGA-04-1331-01.5	90	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0001371561470574095300000
TCGA-04-1530-01.2	90	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0001371561470574095300000
TCGA-13-0883-01.4	3	2_MITOCHONDRIAL_MEMBRANE_PART	42	3	0.0001380696111895146800000
TCGA-13-1509-01.9	117	2_EXTRACELLULAR_MATRIX	85	10	0.0001394980549979623700000
TCGA-13-1404-01.13	117	2_EXTRACELLULAR_MATRIX	85	10	0.0001394980549979623700000
TCGA-13-0923-01.5	53	2_CHROMOSOME	102	8	0.0001402550776774941500000
TCGA-36-1578-01.10	60	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0001403739872769409500000
TCGA-61-2000-01.11	69	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0001408396609567066300000
TCGA-04-1342-01.12	104	2_SPINDLE	35	7	0.0001409451872935007100000
TCGA-25-1315-01.7	93	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0001420032385002231500000
TCGA-24-2261-01.2	87	2_INTERPHASE	62	8	0.0001421000297061924600000
TCGA-61-1919-01.9	87	2_CELL_CYCLE_PHASE	146	11	0.0001423781534211169800000
TCGA-13-0911-01.3	47	2_CELL_CYCLE_PROCESS	163	9	0.0001425835910289003300000
TCGA-24-1474-01.12	122	2_INTERPHASE	62	9	0.0001430412348940294400000
TCGA-23-1026-01.5	65	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0001430713080124298900000
TCGA-13-0793-01.8	97	2_EXTRACELLULAR_REGION_PART	269	15	0.0001431355948696608200000
TCGA-29-2427-01.10	116	2_LOCOMOTORY_BEHAVIOR	86	10	0.0001439301478261183300000
TCGA-24-1470-01.7	76	2_MITOSIS	71	8	0.0001440478601976665800000
TCGA-61-2016-01.10	50	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0001441466390020251200000
TCGA-24-2280-01.10	58	1_KEGG_GLIOMA	62	7	0.0001447307351972260200000
TCGA-59-2350-01.1	62	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0001447307351972260200000
TCGA-23-1031-01.17	142	2_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING	9	5	0.0001450189008035603400000
TCGA-61-2102-01.7	172	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0001450742658334511500000
TCGA-25-1315-01.7	93	0_HALLMARK_E2F_TARGETS	169	12	0.0001455891975148371700000
TCGA-24-2293-01.3	33	2_COLLAGEN_BINDING	13	4	0.0001457614643173464600000
TCGA-24-0980-01.5	44	2_CELL_CYCLE_ARREST_GO_0007050	49	6	0.0001457749456736758900000
TCGA-09-0369-01.9	109	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	32	0.0001458254066868886500000
TCGA-25-1326-01.11	119	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0001462360372679815600000
TCGA-13-0755-01.6	16	2_CELL_CYCLE_PHASE	146	6	0.0001463806519212457900000
TCGA-24-1552-01.5	54	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0001464237110206856200000
TCGA-24-1474-01.12	122	2_DNA_REPLICATION	82	10	0.0001467951230531938800000
TCGA-24-1434-01.3	82	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001468776789268053300000
TCGA-13-0893-01.4	112	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	12	0.0001469539590277562600000
TCGA-13-1504-01.4	48	2_REGULATION_OF_CELL_CYCLE	160	9	0.0001473194866574125600000
TCGA-04-1331-01.5	90	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0001475605019490075600000
TCGA-09-1665-01.16	131	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0001479476880165991500000
TCGA-13-0762-01.2	68	0_HALLMARK_IL2_STAT5_SIGNALING	148	10	0.0001482015847625572100000
TCGA-13-0793-01.8	97	2_COLLAGEN	23	6	0.0001484541284831664500000
TCGA-20-0991-01.12	166	1_KEGG_CELL_CYCLE	114	13	0.0001495877861020368300000
TCGA-24-2293-01.1	22	2_CHROMOSOME	102	6	0.0001496669570564347100000
TCGA-13-1405-01.4	69	2_CELL_CYCLE_PHASE	146	10	0.0001503309094682294100000
TCGA-13-0761-01.6	75	2_MITOTIC_CELL_CYCLE	134	10	0.0001505205506849865300000
TCGA-13-0751-01.2	51	1_KEGG_MELANOMA	71	7	0.0001505417534171401400000
TCGA-13-1403-01.9	71	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0001505417534171422000000
TCGA-25-1320-01.4	71	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0001505417534171422000000
TCGA-24-1424-01.4	80	2_REGULATION_OF_CELL_CYCLE	160	11	0.0001506176502912738700000
TCGA-59-2354-01.2	44	0_HALLMARK_COAGULATION	125	8	0.0001506379179837612300000
TCGA-57-1993-01.8	52	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0001508605582314999300000
TCGA-61-1995-01.4	102	2_REGULATION_OF_MITOSIS	36	7	0.0001515514221582401500000
TCGA-10-0938-01.2	102	2_REGULATION_OF_MITOSIS	36	7	0.0001515514221582401500000
TCGA-09-1666-01.28	109	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0001521632009796789400000
TCGA-04-1347-01.15	187	1_KEGG_PATHWAYS_IN_CANCER	323	23	0.0001526815244615576500000
TCGA-24-2298-01.7	138	1_KEGG_CELL_CYCLE	114	12	0.0001527208694276719100000
TCGA-24-1544-01.7	84	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	24	0.0001528379096337308500000
TCGA-24-1470-01.7	76	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0001536815547361669900000
TCGA-24-1435-01.12	115	1_KEGG_FOCAL_ADHESION	195	14	0.0001544058011748508600000
TCGA-24-0980-01.5	44	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0001556112316738351200000
TCGA-59-2363-01.3	89	2_DNA_REPAIR	113	10	0.0001561006510919344100000
TCGA-13-1403-01.9	71	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0001570860693324693900000
TCGA-25-1320-01.4	71	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0001570860693324693900000
TCGA-36-1580-01.1	65	2_SKELETAL_DEVELOPMENT	84	8	0.0001572811292034301500000
TCGA-36-1575-01.9	193	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	26	0.0001577879304731949900000
TCGA-09-1666-01.28	109	1_KEGG_PANCREATIC_CANCER	70	9	0.0001586228556345858100000
TCGA-59-2354-01.2	44	2_ORGAN_DEVELOPMENT	460	13	0.0001601730669032575100000
TCGA-24-1470-01.7	76	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0001610154709440532600000
TCGA-13-0730-01.8	83	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001616553542414479700000
TCGA-24-1427-01.4	83	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001616553542414479700000
TCGA-25-1326-01.11	119	2_REGULATION_OF_CELL_CYCLE	160	13	0.0001619150900432012700000
TCGA-24-1552-01.5	54	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0001623914676642236600000
TCGA-24-1463-01.5	130	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0001627893230929426300000
TCGA-61-2109-01.13	122	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	6	0.0001637717547713163000000
TCGA-30-1862-01.13	91	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0001643020677125144000000
TCGA-31-1953-01.6	53	2_CELL_CYCLE_PHASE	146	9	0.0001648013193736692300000
TCGA-61-2109-01.13	122	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0001651034833602022300000
TCGA-23-2072-01.9	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0001651480561367767800000
TCGA-04-1542-01.4	141	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	26	0.0001652489787710882400000
TCGA-24-1544-01.7	84	2_SYSTEM_DEVELOPMENT	694	22	0.0001652709478310129200000
TCGA-24-1463-01.5	130	2_CHROMOSOMAL_PART	78	10	0.0001653340083120949100000
TCGA-61-2088-01.7	150	2_LOCOMOTORY_BEHAVIOR	86	11	0.0001664934308572414100000
TCGA-24-1614-01.5	86	2_REGULATION_OF_CELL_PROLIFERATION	265	14	0.0001668392640026768800000
TCGA-36-1571-01.6	109	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0001677311977643500200000
TCGA-36-1576-01.8	124	2_PROTEOLYSIS	154	13	0.0001684844325887109700000
TCGA-59-2363-01.3	89	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0001684882134898518000000
TCGA-13-1510-01.20	82	1_KEGG_FOCAL_ADHESION	195	12	0.0001685532317366525200000
TCGA-25-1635-01.6	129	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0001686259982233837500000
TCGA-59-2354-01.2	44	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0001691739004208967500000
TCGA-59-2354-01.2	44	2_SKELETAL_DEVELOPMENT	84	7	0.0001691739004208967500000
TCGA-13-1505-01.13	60	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	20	0.0001706375190471784300000
TCGA-13-0792-01.8	64	2_REGULATION_OF_CELL_CYCLE	160	10	0.0001707734119882279700000
TCGA-13-0795-01.9	67	1_KEGG_BASAL_CELL_CARCINOMA	55	7	0.0001715272035921512300000
TCGA-24-1563-01.15	100	2_EXTRACELLULAR_SPACE	192	13	0.0001717601986976482300000
TCGA-24-1549-01.21	158	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	11	0.0001718499057200676400000
TCGA-23-1110-01.7	299	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	43	0.0001719714792985529500000
TCGA-24-1567-01.3	141	2_REGULATION_OF_CELL_CYCLE	160	14	0.0001720982178950168400000
TCGA-13-0791-01.35	80	1_KEGG_RENAL_CELL_CARCINOMA	69	8	0.0001722699832645975500000
TCGA-25-1322-01.15	93	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0001723157863814514400000
TCGA-36-1577-01.14	168	1_KEGG_CELL_CYCLE	114	13	0.0001723204583459226600000
TCGA-23-1026-01.5	65	2_EXTRACELLULAR_MATRIX	85	8	0.0001726883917359037000000
TCGA-13-1504-01.4	48	2_CELL_CYCLE_PROCESS	163	9	0.0001729167441959335900000
TCGA-04-1525-01.7	52	2_MITOSIS	71	7	0.0001729276623265844400000
TCGA-10-0934-01.11	145	2_APOPTOSIS_GO	389	22	0.0001730123218009985000000
TCGA-04-1364-01.3	163	2_CELL_PROLIFERATION_GO_0008283	436	25	0.0001736920620341177800000
TCGA-24-1463-01.5	130	2_CELL_PROLIFERATION_GO_0008283	436	22	0.0001737238659604549600000
TCGA-25-1633-01.1	71	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	22	0.0001739817640308132000000
TCGA-13-0894-01.9	118	0_HALLMARK_ANGIOGENESIS	32	7	0.0001741081265290306500000
TCGA-24-2262-01.25	141	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0001751405358012799000000
TCGA-61-2111-01.16	56	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001753712355880748600000
TCGA-10-0931-01.12	59	2_M_PHASE	94	8	0.0001755252468335259200000
TCGA-23-1022-01.10	170	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	133	14	0.0001760050473556885900000
TCGA-24-1549-01.21	158	2_REGULATION_OF_MITOSIS	36	8	0.0001760364294148911700000
TCGA-25-1324-01.3	42	2_MITOTIC_CELL_CYCLE	134	8	0.0001764942620660632900000
TCGA-24-1417-01.14	94	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	9	0.0001765664924866654000000
TCGA-13-0923-01.5	53	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0001769096847902172800000
TCGA-13-0910-01.3	71	2_CHROMOSOMAL_PART	78	8	0.0001769989997367102300000
TCGA-61-2088-01.7	150	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0001773951202835582400000
TCGA-13-1483-01.3	66	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001776941793808656000000
TCGA-24-1418-01.16	84	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001776941793808656000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_CELL_CYCLE	160	9	0.0001778740335711881000000
TCGA-24-2262-01.25	141	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	13	0.0001780225578499366900000
TCGA-24-1567-01.3	141	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	13	0.0001780225578499366900000
TCGA-24-1614-01.5	86	0_HALLMARK_P53_PATHWAY	151	11	0.0001782591763486162400000
TCGA-20-0987-01.19	194	2_CELL_CYCLE_GO_0007049	265	21	0.0001785406721357135800000
TCGA-36-1574-01.10	152	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0001788373060609132400000
TCGA-23-1028-01.18	93	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0001788914941649814300000
TCGA-24-1567-01.3	141	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0001791979089617041600000
TCGA-24-0982-01.3	34	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0001796937151591878700000
TCGA-13-0804-01.5	78	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0001798020278053658800000
TCGA-36-1571-01.6	109	1_KEGG_MELANOMA	71	9	0.0001799174265915571400000
TCGA-09-1666-01.28	109	1_KEGG_MELANOMA	71	9	0.0001799174265915571400000
TCGA-13-1488-01.17	109	1_KEGG_MELANOMA	71	9	0.0001799174265915571400000
TCGA-10-0934-01.11	145	2_PROGRAMMED_CELL_DEATH	390	22	0.0001810055290257245200000
TCGA-04-1361-01.4	27	2_DNA_METABOLIC_PROCESS	218	8	0.0001817540463770472300000
TCGA-09-2051-01.26	142	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0001850332739474708300000
TCGA-23-2078-01.15	105	2_REGULATION_OF_MITOSIS	36	7	0.0001852795085757177300000
TCGA-36-1570-01.2	36	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0001852795085757177300000
TCGA-24-0970-01.6	94	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0001856086942564629500000
TCGA-24-2030-01.8	161	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	29	0.0001865076685070066200000
TCGA-25-1628-01.2	118	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001872695185247289300000
TCGA-13-1489-01.11	118	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001872695185247289300000
TCGA-13-1488-01.17	109	2_M_PHASE	94	10	0.0001873140256241098500000
TCGA-24-2030-01.8	161	2_REGULATION_OF_CELL_PROLIFERATION	265	19	0.0001873208227738716200000
TCGA-04-1331-01.5	90	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0001878912650210939700000
TCGA-04-1530-01.2	90	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0001878912650210939700000
TCGA-24-2298-01.7	138	2_POLYSACCHARIDE_BINDING	28	7	0.0001886042000396362400000
TCGA-20-0990-01.17	133	1_KEGG_MAPK_SIGNALING_PATHWAY	258	17	0.0001887152003002450600000
TCGA-57-1583-01.20	185	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	39	0.0001897811822358750500000
TCGA-04-1525-01.7	52	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0001907504458985431600000
TCGA-04-1365-01.6	150	2_CHROMOSOME_SEGREGATION	26	7	0.0001907816115724187100000
TCGA-10-0935-01.2	49	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	15	0.0001912425656798521600000
TCGA-13-1509-01.9	117	1_KEGG_FOCAL_ADHESION	195	14	0.0001923816759767643500000
TCGA-24-0975-01.6	78	2_SYSTEM_DEVELOPMENT	694	21	0.0001929881493389974700000
TCGA-24-1426-01.7	63	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0001935582665771375700000
TCGA-61-2094-01.6	63	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0001935582665771375700000
TCGA-13-1505-01.13	60	2_ORGAN_DEVELOPMENT	460	15	0.0001938909035193927100000
TCGA-36-1570-01.2	36	2_REGULATION_OF_CELL_CYCLE	160	8	0.0001940818280774439400000
TCGA-23-1122-01.11	77	2_MITOTIC_CELL_CYCLE	134	10	0.0001944696612988704100000
TCGA-61-1736-01.2	54	2_CELL_CYCLE_PHASE	146	9	0.0001951833220324401900000
TCGA-04-1530-01.2	90	1_KEGG_BLADDER_CANCER	42	7	0.0001954345391853064000000
TCGA-24-1466-01.15	82	2_REGULATION_OF_CELL_CYCLE	160	11	0.0001955092223969060800000
TCGA-24-1427-01.4	83	2_M_PHASE	94	9	0.0001964346886468302300000
TCGA-61-2104-01.15	95	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	22	0.0001970147357727810200000
TCGA-13-0717-01.6	103	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0001982241684854461800000
TCGA-25-2393-01.5	140	2_CELL_CYCLE_PROCESS	163	14	0.0001986251158243891000000
TCGA-23-1120-01.10	57	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001988297727384907100000
TCGA-13-0724-01.21	71	2_CELL_CYCLE_PHASE	146	10	0.0001988311951809813300000
TCGA-25-1320-01.4	71	2_CELL_CYCLE_PHASE	146	10	0.0001988311951809813300000
TCGA-13-1408-01.1	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0001989090549965582900000
TCGA-23-1026-01.5	65	2_REGULATION_OF_CELL_CYCLE	160	10	0.0001989123709089595900000
TCGA-23-1028-01.18	93	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0002008079371763274900000
TCGA-04-1361-01.4	27	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	7	0.0002013407461981618200000
TCGA-25-1326-01.11	119	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0002014859585357944700000
TCGA-13-0893-01.4	112	2_MICROTUBULE_CYTOSKELETON	117	11	0.0002026258817084173300000
TCGA-04-1530-01.2	90	2_CELL_CYCLE_PHASE	146	11	0.0002033068858555398200000
TCGA-13-1504-01.4	48	2_AGING	10	4	0.0002035180553371669200000
TCGA-23-1120-01.10	57	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0002038298684782985400000
TCGA-13-0886-01.1	45	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	9	0.0002041064654325667100000
TCGA-13-0751-01.2	51	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0002044794188579715600000
TCGA-09-2051-01.26	142	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0002048469479757671000000
TCGA-04-1346-01.10	75	2_DNA_METABOLIC_PROCESS	218	12	0.0002065644713986335400000
TCGA-13-1497-01.7	59	2_MITOTIC_CELL_CYCLE	134	9	0.0002066406049559461900000
TCGA-13-0897-01.2	61	2_INTERPHASE	62	7	0.0002068040115138066700000
TCGA-61-2088-01.7	150	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	9	0.0002080753571962480300000
TCGA-13-1497-01.7	59	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0002090832049304592800000
TCGA-25-1319-01.10	69	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0002093838675368467500000
TCGA-24-1434-01.3	82	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	8	0.0002093838675368467500000
TCGA-04-1347-01.15	187	1_KEGG_MELANOMA	71	11	0.0002094846763329652600000
TCGA-10-0928-01.6	70	1_KEGG_WNT_SIGNALING_PATHWAY	149	10	0.0002098107524537122700000
TCGA-04-1331-01.5	90	2_CHROMOSOME_SEGREGATION	26	6	0.0002107689268083485000000
TCGA-04-1530-01.2	90	2_GLYCOSAMINOGLYCAN_BINDING	26	6	0.0002107689268083485000000
TCGA-24-1423-01.5	27	2_CELL_CYCLE_PHASE	146	7	0.0002110847333794824100000
TCGA-61-2088-01.7	150	1_KEGG_MAPK_SIGNALING_PATHWAY	258	18	0.0002113786775539954600000
TCGA-24-2262-01.25	141	2_REGULATION_OF_KINASE_ACTIVITY	138	13	0.0002116880406711307400000
TCGA-24-1567-01.3	141	2_REGULATION_OF_KINASE_ACTIVITY	138	13	0.0002116880406711307400000
TCGA-04-1530-01.2	90	2_DNA_METABOLIC_PROCESS	218	13	0.0002128516415471315900000
TCGA-61-2016-01.10	50	2_REGULATION_OF_CELL_CYCLE	160	9	0.0002138037874969228800000
TCGA-24-1419-01.2	93	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0002138703059946350500000
TCGA-25-1626-01.2	86	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0002139143574803017300000
TCGA-25-1318-01.11	46	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0002143030518267708200000
TCGA-13-1492-01.2	162	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	29	0.0002143976257104092000000
TCGA-25-1630-01.10	35	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0002156912520427471100000
TCGA-25-1318-01.11	46	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0002157913207441102900000
TCGA-13-0800-01.9	124	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0002163716221767705600000
TCGA-10-0937-01.9	40	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0002176514327623196800000
TCGA-10-0934-01.11	145	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0002176514327623196800000
TCGA-24-2035-01.8	102	2_EXTRACELLULAR_SPACE	192	13	0.0002180410988808376600000
TCGA-24-1418-01.16	84	2_M_PHASE	94	9	0.0002182225931286280900000
TCGA-13-0916-01.11	92	1_KEGG_GLIOMA	62	8	0.0002206465137603794700000
TCGA-25-1634-01.4	75	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0002210309337326538800000
TCGA-24-1471-01.4	49	2_AGING	10	4	0.0002214955818343435300000
TCGA-13-0883-01.4	3	2_MITOCHONDRIAL_INNER_MEMBRANE	49	3	0.0002215848882016055600000
TCGA-24-1427-01.4	83	2_REGULATION_OF_CELL_CYCLE	160	11	0.0002221199223456369900000
TCGA-25-1623-01.7	111	2_M_PHASE	94	10	0.0002227876883819887100000
TCGA-23-1110-01.7	299	2_DNA_DEPENDENT_DNA_REPLICATION	46	11	0.0002228208988025373500000
TCGA-09-2053-01.14	121	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0002232227776953270500000
TCGA-23-1030-01.10	58	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0002248834179999945600000
TCGA-13-1411-01.7	96	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0002249871499697795700000
TCGA-13-0889-01.4	37	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0002264392295633655400000
TCGA-24-1558-01.12	174	2_M_PHASE	94	12	0.0002265485566084931000000
TCGA-25-2404-01.5	58	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0002266460249456800100000
TCGA-13-0900-01.8	90	2_EXTRACELLULAR_REGION	346	16	0.0002275820518143942100000
TCGA-13-0916-01.11	92	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0002276672417997061800000
TCGA-61-2113-01.15	99	2_MITOTIC_CELL_CYCLE	134	11	0.0002278983917982335400000
TCGA-13-1482-01.7	62	2_EXTRACELLULAR_REGION_PART	269	12	0.0002281514779470558300000
TCGA-24-1556-01.19	120	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	12	0.0002302724901741588100000
TCGA-24-1427-01.4	83	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	8	0.0002303852346195460900000
TCGA-13-0793-01.8	97	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0002308039862204585400000
TCGA-59-2350-01.1	62	2_INTERPHASE	62	7	0.0002319355287233610500000
TCGA-61-2094-01.6	63	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0002333870820318234900000
TCGA-61-1919-01.9	87	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0002342876330092707800000
TCGA-24-2030-01.8	161	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0002367303655629746300000
TCGA-24-2030-01.8	161	2_EXTRACELLULAR_REGION_PART	269	19	0.0002372397125860381500000
TCGA-25-1319-01.10	69	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	7	0.0002396520431531175800000
TCGA-24-2019-01.10	192	2_REGULATION_OF_CELL_CYCLE	160	16	0.0002397076879778286000000
TCGA-36-1571-01.6	109	2_REGULATION_OF_MITOSIS	36	7	0.0002399450622932181400000
TCGA-23-1028-01.18	93	1_KEGG_GLIOMA	62	8	0.0002401827806904111100000
TCGA-13-0760-01.12	93	1_KEGG_GLIOMA	62	8	0.0002401827806904111100000
TCGA-09-2049-01.8	96	2_IMMUNE_SYSTEM_PROCESS	283	15	0.0002416119169542475300000
TCGA-13-0893-01.4	112	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0002420664586492267100000
TCGA-13-0893-01.4	112	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0002420664586492267100000
TCGA-23-2079-01.14	85	2_M_PHASE	94	9	0.0002420853670186494800000
TCGA-36-1569-01.1	5	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	3	0.0002426147036405202200000
TCGA-04-1517-01.4	44	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	8	0.0002441664631685174600000
TCGA-10-0934-01.11	145	2_REGULATION_OF_CELL_CYCLE	160	14	0.0002447708794920035300000
TCGA-13-0751-01.2	51	1_KEGG_CELL_CYCLE	114	8	0.0002451252562228656900000
TCGA-23-1028-01.18	93	1_KEGG_BLADDER_CANCER	42	7	0.0002453968987182929800000
TCGA-09-1665-01.16	131	2_CHROMOSOME	102	11	0.0002462920652213366900000
TCGA-13-0762-01.2	68	1_KEGG_APOPTOSIS	85	8	0.0002474449674689177900000
TCGA-24-1549-01.21	158	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	5	0.0002477118563802852800000
TCGA-10-0934-01.11	145	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	13	0.0002478651814290297300000
TCGA-24-1463-01.5	130	2_INTERPHASE	62	9	0.0002479046070259446600000
TCGA-36-1575-01.9	193	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0002485383623501844400000
TCGA-61-2109-01.13	122	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0002499318160466614500000
TCGA-13-0911-01.3	47	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0002500921657919728600000
TCGA-13-1412-01.8	113	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0002506817735154081300000
TCGA-24-2262-01.25	141	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	13	0.0002509677116264726500000
TCGA-24-1567-01.3	141	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	13	0.0002509677116264726500000
TCGA-10-0931-01.12	59	2_DNA_RECOMBINATION	40	6	0.0002515242407808975400000
TCGA-13-1409-01.6	122	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0002518617792118518100000
TCGA-24-1474-01.12	122	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0002518617792118518100000
TCGA-24-1418-01.16	84	2_REGULATION_OF_CELL_CYCLE	160	11	0.0002518945414686943300000
TCGA-13-1405-01.4	69	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0002531715438125145000000
TCGA-13-1405-01.4	69	2_SKELETAL_DEVELOPMENT	84	8	0.0002531715438125145000000
TCGA-61-2104-01.15	95	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	21	0.0002538823469863135200000
TCGA-13-0795-01.9	67	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	18	0.0002550256874619860800000
TCGA-04-1343-01.7	50	2_MICROTUBULE_CYTOSKELETON	117	8	0.0002555977187048905600000
TCGA-04-1361-01.4	27	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	14	0.0002560439121614696900000
TCGA-25-1322-01.15	93	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	12	0.0002577372671476907600000
TCGA-13-1505-01.13	60	2_SYSTEM_DEVELOPMENT	694	18	0.0002590517782799314400000
TCGA-25-1315-01.7	93	1_KEGG_CELL_CYCLE	114	10	0.0002591417784811334600000
TCGA-23-2077-01.18	63	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0002592557093455475300000
TCGA-24-1426-01.7	63	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0002592557093455475300000
TCGA-13-1501-01.12	101	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0002608882916630527300000
TCGA-13-0751-01.2	51	2_AGING	10	4	0.0002609796406036150200000
TCGA-24-0982-01.3	34	2_REGULATION_OF_MITOSIS	36	5	0.0002612744778338835500000
TCGA-13-1498-01.13	104	2_CHROMOSOME	102	10	0.0002616227832565776900000
TCGA-04-1365-01.6	150	2_SPINDLE_POLE	17	6	0.0002623568097211575800000
TCGA-24-1435-01.12	115	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0002623808960955931200000
TCGA-13-0804-01.5	78	2_INTRACELLULAR_ORGANELLE_PART	912	24	0.0002625291761564095100000
TCGA-24-1424-01.4	80	2_BASE_EXCISION_REPAIR	16	5	0.0002632313764824768700000
TCGA-20-0990-01.17	133	2_CELL_PROLIFERATION_GO_0008283	436	22	0.0002639407667723562700000
TCGA-09-1665-01.16	131	1_KEGG_COLORECTAL_CANCER	62	9	0.0002648406213280918600000
TCGA-25-1320-01.4	71	1_KEGG_CELL_CYCLE	114	9	0.0002655160276672860300000
TCGA-25-1630-01.10	35	1_KEGG_CELL_CYCLE	114	7	0.0002659622201575538200000
TCGA-25-1318-01.11	46	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	14	0.0002666935349523878600000
TCGA-25-1322-01.15	93	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0002669027161083602300000
TCGA-23-1124-01.17	107	2_COLLAGEN	23	6	0.0002673195929371621700000
TCGA-13-0893-01.4	112	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0002676966947065895600000
TCGA-59-2348-01.14	123	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0002681914291387219300000
TCGA-24-1556-01.19	120	2_REGULATION_OF_KINASE_ACTIVITY	138	12	0.0002705846912571137100000
TCGA-24-1549-01.21	158	1_KEGG_OOCYTE_MEIOSIS	105	12	0.0002716191109578283900000
TCGA-24-0982-01.3	34	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	8	0.0002738987307176060600000
TCGA-61-1995-01.4	102	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0002740172495877706900000
TCGA-04-1362-01.4	35	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0002751830359448444000000
TCGA-24-1464-01.7	62	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0002753707756134560400000
TCGA-13-0791-01.35	80	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	4	0.0002765412828023442500000
TCGA-09-2051-01.26	142	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0002768766654723836400000
TCGA-23-2078-01.15	105	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	18	0.0002769793408854400000000
TCGA-24-1423-01.5	27	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0002778215578990108200000
TCGA-61-2095-01.1	32	2_ORGAN_DEVELOPMENT	460	11	0.0002783782412274765500000
TCGA-61-2002-01.1	118	0_HALLMARK_E2F_TARGETS	169	13	0.0002788637342842780400000
TCGA-09-2051-01.26	142	2_MICROTUBULE_CYTOSKELETON	117	12	0.0002799574690602275700000
TCGA-23-2079-01.14	85	2_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0002802462349196876500000
TCGA-23-2079-01.14	85	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0002802462349196876500000
TCGA-04-1342-01.12	104	2_REGULATION_OF_CELL_CYCLE	160	12	0.0002802490420581451500000
TCGA-04-1364-01.3	163	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0002817951794992632700000
TCGA-24-2030-01.8	161	2_SYSTEM_DEVELOPMENT	694	32	0.0002820586282493995100000
TCGA-13-0755-01.6	16	2_CELL_CYCLE_PROCESS	163	6	0.0002821503822919852300000
TCGA-24-1567-01.3	141	2_SIGNAL_TRANSDUCTION	1442	46	0.0002823800416580296600000
TCGA-61-2088-01.7	150	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	18	0.0002823909448602675900000
TCGA-04-1362-01.4	35	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0002827183461096762400000
TCGA-13-1489-01.11	118	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0002829614271882416300000
TCGA-24-1418-01.16	84	1_KEGG_PANCREATIC_CANCER	70	8	0.0002837931571137858600000
TCGA-20-0991-01.12	166	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	11	0.0002847865935615455400000
TCGA-13-0804-01.5	78	2_ORGANELLE_PART	916	24	0.0002850739985499052000000
TCGA-04-1338-01.7	85	2_REGULATION_OF_CELL_CYCLE	160	11	0.0002851549604372415400000
TCGA-24-1436-01.1	49	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0002855039312005270500000
TCGA-23-2078-01.15	105	2_CHROMOSOME	102	10	0.0002865954974367121600000
TCGA-25-2401-01.5	119	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	16	0.0002873547081545807900000
TCGA-13-0800-01.9	124	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0002876018980314960800000
TCGA-13-1403-01.9	71	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0002890161054670570800000
TCGA-09-2044-01.4	83	2_MITOSIS	71	8	0.0002890161054670573000000
TCGA-25-2401-01.5	119	1_KEGG_CELL_CYCLE	114	11	0.0002898026609528952500000
TCGA-25-2391-01.2	64	2_INTERPHASE	62	7	0.0002899903294923488800000
TCGA-23-1024-01.3	24	2_CELL_CYCLE_GO_0007049	265	8	0.0002902168420616788900000
TCGA-36-1574-01.10	152	2_MITOSIS	71	10	0.0002907110562353791200000
TCGA-13-0891-01.18	125	2_REGULATION_OF_CELL_CYCLE	160	13	0.0002908360468483648100000
TCGA-25-2400-01.5	35	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0002932197813178398500000
TCGA-13-0924-01.5	68	2_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0002933083904186529600000
TCGA-13-0924-01.5	68	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0002933083904186529600000
TCGA-13-1510-01.20	82	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	8	0.0002934996635943758100000
TCGA-24-1422-01.10	56	1_KEGG_FOCAL_ADHESION	195	10	0.0002936591478667471000000
TCGA-25-2399-01.16	103	1_KEGG_FOCAL_ADHESION	195	13	0.0002938301691028141300000
TCGA-10-0934-01.11	145	2_REGULATION_OF_KINASE_ACTIVITY	138	13	0.0002945052153558197900000
TCGA-20-0987-01.19	194	2_SYSTEM_DEVELOPMENT	694	36	0.0002948173427980842500000
TCGA-09-2044-01.4	83	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0002950874554545910600000
TCGA-24-1551-01.15	87	2_M_PHASE	94	9	0.0002967070491956088500000
TCGA-61-2095-01.1	32	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	14	0.0002967174730628611300000
TCGA-13-0905-01.7	160	2_CHROMOSOME_SEGREGATION	26	7	0.0002971110259041098800000
TCGA-09-0369-01.9	109	2_DNA_BINDING	496	21	0.0002983033218538945900000
TCGA-13-0883-01.4	3	2_ORGANELLE_INNER_MEMBRANE	54	3	0.0002983169543503493100000
TCGA-13-1404-01.13	117	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0003000445711297030100000
TCGA-13-0751-01.2	51	2_CELL_CYCLE_PROCESS	163	9	0.0003000927630734970400000
TCGA-24-1428-01.9	90	2_REGULATION_OF_CELL_PROLIFERATION	265	14	0.0003005487224689657100000
TCGA-04-1365-01.6	150	2_INTRACELLULAR_ORGANELLE_PART	912	36	0.0003009039313441690900000
TCGA-24-1424-01.4	80	2_STRUCTURE_SPECIFIC_DNA_BINDING	50	7	0.0003010556141763922000000
TCGA-10-0930-01.5	60	1_KEGG_MELANOGENESIS	99	8	0.0003014551045836357000000
TCGA-23-2079-01.14	85	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0003016948357463580500000
TCGA-20-0990-01.17	133	1_KEGG_GLIOMA	62	9	0.0003017589701352138100000
TCGA-13-0800-01.9	124	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0003033109420655778300000
TCGA-13-0887-01.6	47	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	9	0.0003038485574538968000000
TCGA-23-1110-01.7	299	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	133	18	0.0003041454871282498700000
TCGA-04-1525-01.7	52	2_REGULATION_OF_CELL_CYCLE	160	9	0.0003050042154075701400000
TCGA-13-1501-01.12	101	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0003052412885639516900000
TCGA-31-1953-01.6	53	2_AGING	10	4	0.0003054960049824473300000
TCGA-13-0900-01.8	90	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0003057223669564404100000
TCGA-04-1331-01.5	90	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0003057223669564404100000
TCGA-25-2396-01.6	42	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0003068329184260767200000
TCGA-13-0891-01.18	125	2_MITOTIC_CELL_CYCLE	134	12	0.0003074475734966335100000
TCGA-13-0891-01.18	125	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0003082241752549238600000
TCGA-24-1556-01.19	120	2_NUCLEUS	1110	35	0.0003084812904760997100000
TCGA-61-2113-01.15	99	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0003085391120264192600000
TCGA-24-2019-01.10	192	1_KEGG_OOCYTE_MEIOSIS	105	13	0.0003085871696381884600000
TCGA-13-0884-01.11	68	2_REGULATION_OF_CELL_CYCLE	160	10	0.0003092949377530050200000
TCGA-13-0886-01.1	45	2_MITOTIC_CELL_CYCLE	134	8	0.0003110104398080513300000
TCGA-61-1728-01.5	45	2_MITOTIC_CELL_CYCLE	134	8	0.0003110104398080513300000
TCGA-24-1558-01.12	174	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	14	0.0003116656634437141700000
TCGA-04-1342-01.12	104	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0003117857072758223500000
TCGA-04-1342-01.12	104	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0003117857072758223500000
TCGA-61-1998-01.14	105	2_REGULATION_OF_CELL_CYCLE	160	12	0.0003118285119511064500000
TCGA-13-1410-01.9	115	2_CELL_CYCLE_PHASE	146	12	0.0003138744075752645600000
TCGA-24-2298-01.7	138	2_ORGAN_DEVELOPMENT	460	23	0.0003144982365921776800000
TCGA-13-0760-01.12	93	2_DNA_METABOLIC_PROCESS	218	13	0.0003162730267215632200000
TCGA-24-1556-01.19	120	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	12	0.0003170838024644550300000
TCGA-25-1633-01.1	71	2_SKELETAL_DEVELOPMENT	84	8	0.0003175414387810875400000
TCGA-13-1487-01.3	79	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0003175624495267848500000
TCGA-13-1509-01.9	117	2_MICROTUBULE_CYTOSKELETON	117	11	0.0003180804860754075100000
TCGA-23-2081-01.7	56	2_COLLAGEN	23	5	0.0003195891642548654700000
TCGA-24-1424-01.4	80	2_SINGLE_STRANDED_DNA_BINDING	31	6	0.0003203460592352085900000
TCGA-13-0793-01.8	97	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0003223677594434091500000
TCGA-09-2044-01.4	83	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0003228465895186709700000
TCGA-23-1110-01.7	299	0_HALLMARK_KRAS_SIGNALING_UP	148	19	0.0003228893820817725000000
TCGA-13-0804-01.5	78	2_DNA_METABOLIC_PROCESS	218	12	0.0003231139570919248500000
TCGA-13-0761-01.6	75	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0003232800153145409800000
TCGA-13-0791-01.35	80	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0003237823359264434500000
TCGA-24-2030-01.8	161	1_KEGG_FOCAL_ADHESION	195	16	0.0003239183637742729400000
TCGA-09-1665-01.16	131	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0003241694351875449800000
TCGA-61-2092-01.12	209	1_KEGG_CELL_CYCLE	114	14	0.0003272722351388750400000
TCGA-24-1614-01.5	86	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	27	0.0003287291748220802500000
TCGA-13-0800-01.9	124	2_CELL_CYCLE_PROCESS	163	13	0.0003287745298106573600000
TCGA-24-0982-01.3	34	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0003290211928825112700000
TCGA-24-1563-01.15	100	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	12	0.0003294254072641529000000
TCGA-24-1552-01.5	54	2_AGING	10	4	0.0003297674407883177500000
TCGA-13-1495-01.22	101	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	9	0.0003300816383524801100000
TCGA-24-0966-01.2	18	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	8	0.0003303497409444540800000
TCGA-24-0966-01.2	18	2_CELL_CYCLE_PHASE	146	6	0.0003307824270028672600000
TCGA-61-2095-01.1	32	1_KEGG_FOCAL_ADHESION	195	8	0.0003316068236274769000000
TCGA-13-0910-01.3	71	2_MICROTUBULE_CYTOSKELETON	117	9	0.0003323282867008496500000
TCGA-24-1466-01.15	82	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	10	0.0003328093710792926600000
TCGA-36-1574-01.10	152	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0003329899196063520700000
TCGA-13-1487-01.3	79	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0003334427603073323200000
TCGA-36-1575-01.9	193	2_RESPONSE_TO_WOUNDING	163	16	0.0003335155790526943500000
TCGA-24-2030-01.8	161	1_KEGG_OOCYTE_MEIOSIS	105	12	0.0003338596733941108100000
TCGA-10-0933-01.2	97	2_INTERPHASE	62	8	0.0003339400079161761400000
TCGA-04-1365-01.6	150	2_ORGANELLE_PART	916	36	0.0003356007826562464800000
TCGA-24-1428-01.9	90	2_NUCLEUS	1110	29	0.0003362431623440930400000
TCGA-13-1481-01.3	78	0_HALLMARK_ANGIOGENESIS	32	6	0.0003363324719460837300000
TCGA-24-0975-01.6	78	0_HALLMARK_ANGIOGENESIS	32	6	0.0003363324719460837300000
TCGA-23-1032-01.16	250	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	13	0.0003391993574779043100000
TCGA-24-1463-01.5	130	0_HALLMARK_ANGIOGENESIS	32	7	0.0003392144681850870100000
TCGA-25-2404-01.5	58	1_KEGG_PANCREATIC_CANCER	70	7	0.0003396536130864825000000
TCGA-24-2280-01.10	58	1_KEGG_PANCREATIC_CANCER	70	7	0.0003396536130864825000000
TCGA-04-1530-01.2	90	2_POLYSACCHARIDE_BINDING	28	6	0.0003396622040960664000000
TCGA-24-1464-01.7	62	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0003399967263855296000000
TCGA-24-2293-01.1	22	2_MICROTUBULE_CYTOSKELETON	117	6	0.0003400829945159375500000
TCGA-13-1497-01.7	59	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0003404511247272889100000
TCGA-59-2350-01.1	62	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0003407576362168779200000
TCGA-04-1356-01.1	71	2_NUCLEUS	1110	25	0.0003416191352451441700000
TCGA-24-0966-01.2	18	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0003418566274844663200000
TCGA-25-1633-01.1	71	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	14	0.0003420086632694784400000
TCGA-13-1407-01.11	220	2_REGULATION_OF_APOPTOSIS	309	24	0.0003421910475350488600000
TCGA-23-1117-01.11	99	2_SKELETAL_DEVELOPMENT	84	9	0.0003425976267976255100000
TCGA-09-2053-01.14	121	1_KEGG_CELL_CYCLE	114	11	0.0003439507979656446100000
TCGA-24-1435-01.12	115	2_REGULATION_OF_MITOSIS	36	7	0.0003471391305147657100000
TCGA-13-1403-01.9	71	2_EXTRACELLULAR_MATRIX	85	8	0.0003484506219375225700000
TCGA-23-2079-01.14	85	2_MITOSIS	71	8	0.0003484506219375225700000
TCGA-10-0934-01.11	145	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	13	0.0003488757302399387900000
TCGA-30-1862-01.13	91	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	5	0.0003489887493007956200000
TCGA-24-1436-01.1	49	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0003491840590401285200000
TCGA-13-0717-01.6	103	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0003494734393764448900000
TCGA-57-1993-01.8	52	2_MICROTUBULE_CYTOSKELETON	117	8	0.0003509649340874128300000
TCGA-23-1023-01.1	93	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	17	0.0003512126842558581900000
TCGA-24-1418-01.16	84	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0003544966892976622900000
TCGA-04-1347-01.15	187	0_HALLMARK_KRAS_SIGNALING_UP	148	15	0.0003556336141320352100000
TCGA-23-1031-01.17	142	2_SIGNAL_TRANSDUCTION	1442	46	0.0003570519140159588900000
TCGA-13-1407-01.11	220	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0003579618339480769500000
TCGA-13-1496-01.13	120	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0003587055647709917600000
TCGA-13-0920-01.9	82	2_CHROMOSOME	102	9	0.0003595002871804976000000
TCGA-24-2271-01.3	44	1_KEGG_FOCAL_ADHESION	195	9	0.0003626324015192705700000
TCGA-13-1407-01.11	220	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	24	0.0003633737655698718300000
TCGA-25-2404-01.5	58	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0003636985448849251800000
TCGA-13-1496-01.13	120	1_KEGG_PANCREATIC_CANCER	70	9	0.0003647808637328104100000
TCGA-13-1495-01.22	101	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0003669787219460607800000
TCGA-13-0885-01.6	44	2_M_PHASE	94	7	0.0003693654733057847800000
TCGA-23-1110-01.7	299	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	44	0.0003693673651062616900000
TCGA-57-1583-01.20	185	2_REGULATION_OF_CELL_PROLIFERATION	265	20	0.0003708171242738363500000
TCGA-25-2404-01.5	58	2_CELL_CYCLE_PHASE	146	9	0.0003708594814474588500000
TCGA-13-0791-01.35	80	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0003714803410431413600000
TCGA-13-0893-01.4	112	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0003719782572538455800000
TCGA-13-0791-01.35	80	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0003722717699019623600000
TCGA-13-0804-01.5	78	2_CHROMOSOMAL_PART	78	8	0.0003724210377258123300000
TCGA-24-1563-01.15	100	2_SKELETAL_DEVELOPMENT	84	9	0.0003737840473268338000000
TCGA-24-1556-01.19	120	2_INTRACELLULAR_ORGANELLE_PART	912	31	0.0003740098808567051400000
TCGA-24-1558-01.12	174	2_REGULATION_OF_KINASE_ACTIVITY	138	14	0.0003741734539962702600000
TCGA-25-1631-01.6	30	1_KEGG_APOPTOSIS	85	6	0.0003744177815768404600000
TCGA-09-2053-01.14	121	0_HALLMARK_E2F_TARGETS	169	13	0.0003755037763398296200000
TCGA-13-1407-01.11	220	2_CELL_CYCLE_PROCESS	163	17	0.0003758345955384864900000
TCGA-04-1346-01.10	75	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0003766177332691110600000
TCGA-61-2113-01.15	99	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0003781500012072334300000
TCGA-24-1556-01.19	120	2_SPINDLE	35	7	0.0003785299475529775000000
TCGA-61-1998-01.14	105	2_EXTRACELLULAR_REGION	346	17	0.0003796592209411577500000
TCGA-23-1110-01.7	299	1_KEGG_ASTHMA	30	9	0.0003802476434428968400000
TCGA-25-1626-01.2	86	1_KEGG_MELANOMA	71	8	0.0003819070657208247900000
TCGA-23-1110-01.7	299	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	18	0.0003828174309416552200000
TCGA-24-2281-01.10	107	2_REGULATION_OF_CELL_CYCLE	160	12	0.0003846669239549319100000
TCGA-04-1350-01.2	130	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	25	0.0003862465251306187600000
TCGA-20-0991-01.12	166	2_EXTRACELLULAR_REGION_PART	269	19	0.0003863792162278480300000
TCGA-61-2101-01.2	38	2_CATION_BINDING	165	8	0.0003864139583966324000000
TCGA-57-1582-01.26	174	2_REGULATION_OF_CELL_CYCLE	160	15	0.0003865393842161311700000
TCGA-36-1580-01.1	65	2_BLOOD_COAGULATION	39	6	0.0003867849813034622500000
TCGA-36-1580-01.1	65	2_COAGULATION	39	6	0.0003867849813034622500000
TCGA-24-2262-01.25	141	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	6	0.0003881249585628703500000
TCGA-23-2079-01.14	85	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0003891647850579903500000
TCGA-25-1626-01.2	86	2_RESPONSE_TO_WOUNDING	163	11	0.0003892455998475161500000
TCGA-13-0883-01.3	23	1_KEGG_CELL_CYCLE	114	6	0.0003902114746727951600000
TCGA-24-2035-01.8	102	2_SYSTEM_DEVELOPMENT	694	24	0.0003937586429924787800000
TCGA-57-1583-01.20	185	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	39	0.0003948229479727372200000
TCGA-24-1423-01.5	27	2_REGULATION_OF_CELL_CYCLE	160	7	0.0003954273924923845200000
TCGA-24-1563-01.15	100	2_GLYCOSAMINOGLYCAN_BINDING	26	6	0.0003962347641536074400000
TCGA-13-0791-01.35	80	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0003977983786837144200000
TCGA-04-1364-01.3	163	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0003985093273872659100000
TCGA-24-2293-01.3	33	2_ORGAN_DEVELOPMENT	460	11	0.0003994485606885055500000
TCGA-04-1356-01.1	71	2_REGULATION_OF_MITOSIS	36	6	0.0004002604654964424900000
TCGA-24-1427-01.4	83	2_MITOTIC_CELL_CYCLE	134	10	0.0004012218269043007300000
TCGA-24-1563-01.15	100	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0004038388159324143000000
TCGA-59-2348-01.14	123	1_KEGG_CELL_CYCLE	114	11	0.0004068801939788362800000
TCGA-20-0991-01.12	166	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	30	0.0004088120144007716900000
TCGA-61-2008-01.19	70	2_REGULATION_OF_CELL_CYCLE	160	10	0.0004099216815860370600000
TCGA-13-1510-01.20	82	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0004105488419912666900000
TCGA-24-1431-01.3	57	2_AGING	10	4	0.0004112626947422273600000
TCGA-24-1556-01.19	120	2_ORGANELLE_PART	916	31	0.0004125086040832676400000
TCGA-13-0793-01.8	97	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0004132553360523811900000
TCGA-13-1497-01.7	59	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0004132654097654083000000
TCGA-13-1409-01.6	122	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	13	0.0004138297437882827500000
TCGA-04-1348-01.6	81	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0004149729959387441200000
TCGA-13-0897-01.2	61	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0004168047691045487100000
TCGA-13-0717-01.6	103	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0004176808425715008200000
TCGA-25-2398-01.5	81	2_BEHAVIOR	138	10	0.0004185818285437414400000
TCGA-25-1626-01.2	86	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	24	0.0004201385155953488800000
TCGA-13-0919-01.5	50	2_SKELETAL_DEVELOPMENT	84	7	0.0004224292778433151300000
TCGA-24-1549-01.21	158	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0004227046354674047000000
TCGA-61-2088-01.7	150	2_RESPONSE_TO_VIRUS	42	8	0.0004228795062051196200000
TCGA-61-2002-01.1	118	2_EXTRACELLULAR_REGION	346	18	0.0004230386644548596600000
TCGA-24-1474-01.12	122	2_SPINDLE	35	7	0.0004240065417184888500000
TCGA-61-2088-01.7	150	2_RECEPTOR_BINDING	331	20	0.0004246415512698059200000
TCGA-13-0791-01.35	80	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0004252476883531285300000
TCGA-04-1336-01.28	106	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0004258942326551097100000
TCGA-24-1557-01.13	106	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0004258942326551097100000
TCGA-24-1614-01.5	86	2_NUCLEUS	1110	28	0.0004268961420612934600000
TCGA-25-1635-01.6	129	2_DNA_METABOLIC_PROCESS	218	15	0.0004271697277085476400000
TCGA-20-0991-01.12	166	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	15	0.0004276950911806789600000
TCGA-24-1557-01.13	106	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	11	0.0004280688119333473100000
TCGA-09-1669-01.10	81	0_HALLMARK_MITOTIC_SPINDLE	175	11	0.0004281846842951173900000
TCGA-23-1030-01.10	58	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0004283005855343033900000
TCGA-30-1853-01.4	111	2_MULTI_ORGANISM_PROCESS	127	11	0.0004292022836032036400000
TCGA-10-0930-01.5	60	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0004311957192441004200000
TCGA-10-0935-01.2	49	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	15	0.0004313557164089467300000
TCGA-24-1463-01.5	130	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0004318331515298428800000
TCGA-10-0931-01.12	59	2_CELL_CYCLE_PHASE	146	9	0.0004319104287074803000000
TCGA-61-1728-01.5	45	2_M_PHASE	94	7	0.0004338846818144990100000
TCGA-13-1407-01.11	220	2_CELL_CYCLE_PHASE	146	16	0.0004366821430833531400000
TCGA-25-2398-01.5	81	2_ORGAN_DEVELOPMENT	460	17	0.0004366826550510728200000
TCGA-13-0919-01.5	50	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0004385292029705106800000
TCGA-04-1514-01.6	91	2_M_PHASE	94	9	0.0004388562204544668600000
TCGA-04-1364-01.3	163	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	11	0.0004390131848179424000000
TCGA-13-0893-01.4	112	2_DNA_METABOLIC_PROCESS	218	14	0.0004400653176822385400000
TCGA-23-2072-01.9	74	2_SKELETAL_DEVELOPMENT	84	8	0.0004402428939333502800000
TCGA-04-1350-01.2	130	2_ORGAN_DEVELOPMENT	460	22	0.0004421636331220116600000
TCGA-13-0887-01.6	47	2_MITOTIC_CELL_CYCLE	134	8	0.0004430365484117515600000
TCGA-13-1409-01.6	122	0_HALLMARK_INFLAMMATORY_RESPONSE	170	13	0.0004432618583729596500000
TCGA-13-0924-01.5	68	2_INTERPHASE	62	7	0.0004433844213709800600000
TCGA-10-0935-01.2	49	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	9	0.0004435090057874574000000
TCGA-61-2104-01.15	95	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0004449382183133459500000
TCGA-24-2281-01.10	107	2_CELL_CYCLE_GO_0007049	265	15	0.0004452520021300183100000
TCGA-13-1408-01.1	45	1_KEGG_FOCAL_ADHESION	195	9	0.0004452785096413914400000
TCGA-10-0938-01.2	102	2_CONDENSED_CHROMOSOME	26	6	0.0004459567795877174200000
TCGA-10-0938-01.2	102	2_CHROMOSOME_SEGREGATION	26	6	0.0004459567795877174200000
TCGA-24-1424-01.4	80	2_INTRACELLULAR_ORGANELLE_PART	912	24	0.0004461118032560217700000
TCGA-24-1558-01.12	174	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	14	0.0004477609854332978500000
TCGA-24-1423-01.5	27	2_CELL_CYCLE_PROCESS	163	7	0.0004489283710447550600000
TCGA-10-0934-01.11	145	2_DEFENSE_RESPONSE	222	16	0.0004492288689249592000000
TCGA-04-1367-01.3	74	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	15	0.0004510879180300721300000
TCGA-23-1110-01.7	299	2_REGULATION_OF_CELL_PROLIFERATION	265	26	0.0004537343819142995200000
TCGA-24-1424-01.4	80	2_CHROMOSOMAL_PART	78	8	0.0004543734739730183800000
TCGA-13-0791-01.35	80	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0004552344461351673300000
TCGA-04-1542-01.4	141	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	32	0.0004562071132096548400000
TCGA-13-0906-01.5	66	2_DNA_METABOLIC_PROCESS	218	11	0.0004569878127694668100000
TCGA-24-1470-01.7	76	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0004571453283172630800000
TCGA-04-1517-01.4	44	2_CELL_CYCLE_GO_0007049	265	10	0.0004598079517442414300000
TCGA-13-0913-01.5	44	2_CELL_CYCLE_GO_0007049	265	10	0.0004598079517442414300000
TCGA-24-0980-01.5	44	2_CELL_CYCLE_GO_0007049	265	10	0.0004598079517442414300000
TCGA-13-1482-01.7	62	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0004599524452426093500000
TCGA-25-2396-01.6	42	2_INTERPHASE	62	6	0.0004599524452426093500000
TCGA-04-1343-01.7	50	0_HALLMARK_MITOTIC_SPINDLE	175	9	0.0004604813814101280900000
TCGA-09-2044-01.4	83	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0004611286055357739100000
TCGA-23-1124-01.17	107	1_KEGG_FOCAL_ADHESION	195	13	0.0004625815144776225500000
TCGA-25-2409-01.5	29	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	11	0.0004629642822801249000000
TCGA-61-2102-01.7	172	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0004635878255686096800000
TCGA-25-2391-01.2	64	2_INTRACELLULAR_ORGANELLE_PART	912	21	0.0004653928840851903800000
TCGA-24-2267-01.8	26	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0004656440547620149900000
TCGA-13-0905-01.7	160	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0004656829176276596000000
TCGA-13-1496-01.13	120	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	9	0.0004673683608351103400000
TCGA-36-1574-01.10	152	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0004683086289130005800000
TCGA-20-0990-01.17	133	1_KEGG_APOPTOSIS	85	10	0.0004697208060892865400000
TCGA-04-1542-01.4	141	2_ORGAN_DEVELOPMENT	460	23	0.0004701574136832836700000
TCGA-13-1403-01.9	71	2_REGULATION_OF_CELL_CYCLE	160	10	0.0004702425551286813600000
TCGA-25-1320-01.4	71	2_REGULATION_OF_CELL_CYCLE	160	10	0.0004702425551286813600000
TCGA-23-1117-01.11	99	1_KEGG_CELL_CYCLE	114	10	0.0004703873375061325900000
TCGA-13-1510-01.20	82	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0004708469052380150000000
TCGA-04-1364-01.3	163	0_HALLMARK_APOPTOSIS	150	14	0.0004708735026280809900000
TCGA-61-2092-01.12	209	2_SKELETAL_DEVELOPMENT	84	12	0.0004720787697614212300000
TCGA-36-1571-01.6	109	2_REGULATION_OF_CELL_CYCLE	160	12	0.0004723057183187915000000
TCGA-24-1463-01.5	130	2_DNA_METABOLIC_PROCESS	218	15	0.0004731384180954703100000
TCGA-25-1318-01.11	46	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	14	0.0004745468922418138000000
TCGA-13-0795-01.9	67	2_CELL_CYCLE_GO_0007049	265	12	0.0004746506650406503900000
TCGA-13-0885-01.6	44	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0004762705262434357600000
TCGA-24-1435-01.4	3	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	63	3	0.0004776029904128550700000
TCGA-09-2044-01.3	3	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	63	3	0.0004776029904128550700000
TCGA-10-0934-01.11	145	2_RESPONSE_TO_CHEMICAL_STIMULUS	252	17	0.0004793869023212368200000
TCGA-13-0717-01.6	103	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0004826297136251576000000
TCGA-25-2399-01.16	103	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0004826297136251576000000
TCGA-13-1407-01.11	220	2_CELL_PROLIFERATION_GO_0008283	436	29	0.0004834549852011977200000
TCGA-13-0800-01.9	124	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0004835410052135175400000
TCGA-24-1424-01.4	80	2_ORGANELLE_PART	916	24	0.0004839967932106367600000
TCGA-13-1407-01.11	220	1_KEGG_ASTHMA	30	8	0.0004841461086826666800000
TCGA-25-1625-01.6	38	1_KEGG_CELL_CYCLE	114	7	0.0004844714989688054500000
TCGA-13-0920-01.9	82	0_HALLMARK_MITOTIC_SPINDLE	175	11	0.0004866596047541162700000
TCGA-24-1549-01.21	158	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	5	0.0004887425603917177500000
TCGA-24-0979-01.5	41	2_DNA_METABOLIC_PROCESS	218	9	0.0004899854744500711000000
TCGA-23-1032-01.16	250	2_MITOSIS	71	12	0.0004901036418275343500000
TCGA-23-1023-01.1	93	2_REGULATION_OF_APOPTOSIS	309	15	0.0004913824498485833600000
TCGA-13-1512-01.2	113	2_DNA_METABOLIC_PROCESS	218	14	0.0004921649693972325300000
TCGA-57-1582-01.26	174	2_CELL_CYCLE_PROCESS	163	15	0.0004931241465475737200000
TCGA-24-1558-01.12	174	2_CELL_CYCLE_PROCESS	163	15	0.0004931241465475737200000
TCGA-24-2262-01.25	141	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0004944381390824565300000
TCGA-09-1669-01.10	81	2_DNA_METABOLIC_PROCESS	218	12	0.0004950710022469008300000
TCGA-13-1483-01.3	66	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0004963272110929868100000
TCGA-13-0906-01.5	66	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0004963272110929868100000
TCGA-10-0937-01.9	40	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0004963272110929936400000
TCGA-36-1575-01.9	193	2_IMMUNE_SYSTEM_PROCESS	283	21	0.0004966032933599549000000
TCGA-13-0717-01.6	103	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0004967655496349730900000
TCGA-13-0890-01.2	48	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0005005438009454492800000
TCGA-09-1669-01.10	81	2_CHROMOSOMAL_PART	78	8	0.0005008427332462759100000
TCGA-23-1026-01.5	65	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0005010913422103116900000
TCGA-25-2391-01.2	64	2_ORGANELLE_PART	916	21	0.0005011134102148152100000
TCGA-13-0913-01.5	44	2_CELL_CYCLE_PHASE	146	8	0.0005021604469956931500000
TCGA-13-1407-01.11	220	2_IMMUNE_RESPONSE	206	19	0.0005027830224048800600000
TCGA-31-1959-01.7	101	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0005057226745577523300000
TCGA-36-1578-01.10	60	2_AGING	10	4	0.0005069222135085360800000
TCGA-24-1558-01.12	174	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0005070883629905662600000
TCGA-13-2060-01.10	86	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0005070961900680154300000
TCGA-24-1469-01.6	123	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0005071554065646211800000
TCGA-04-1542-01.4	141	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	21	0.0005096672214586915500000
TCGA-61-2113-01.15	99	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0005101538226704548200000
TCGA-24-1469-01.6	123	1_KEGG_MELANOMA	71	9	0.0005109506172249703900000
TCGA-09-2050-01.18	196	2_CELL_PROLIFERATION_GO_0008283	436	27	0.0005122534562107310300000
TCGA-23-1023-01.1	93	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	15	0.0005122887074986423100000
TCGA-61-1998-01.14	105	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0005133005537742799700000
TCGA-24-1105-01.8	52	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0005134261608152596400000
TCGA-24-1616-01.2	38	1_KEGG_PANCREATIC_CANCER	70	6	0.0005147568306855892200000
TCGA-09-0369-01.9	109	2_DNA_RECOMBINATION	40	7	0.0005159478730929278200000
TCGA-04-1530-01.2	90	2_REGULATION_OF_CELL_CYCLE	160	11	0.0005170156811339567500000
TCGA-23-1023-01.1	93	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0005170581240810613300000
TCGA-61-2016-01.10	50	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0005178782261222705800000
TCGA-10-0934-01.11	145	0_HALLMARK_INFLAMMATORY_RESPONSE	170	14	0.0005197673160890534500000
TCGA-23-2081-01.7	56	1_KEGG_CELL_CYCLE	114	8	0.0005201191529173610500000
TCGA-59-2355-01.2	14	2_AGING	10	3	0.0005221340863012896300000
TCGA-24-2262-01.25	141	2_CHROMOSOME	102	11	0.0005221727569252611900000
TCGA-20-0991-01.12	166	2_RECEPTOR_BINDING	331	21	0.0005235508527757265700000
TCGA-13-1509-01.9	117	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0005243980276108986200000
TCGA-13-1509-01.9	117	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0005243980276108986200000
TCGA-36-1575-01.9	193	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0005244850024169645100000
TCGA-13-0723-01.8	50	2_NUCLEUS	1110	20	0.0005246493218617555300000
TCGA-25-1630-01.10	35	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0005249831756695777600000
TCGA-13-1408-01.1	45	2_COLLAGEN_BINDING	13	4	0.0005258917133238642900000
TCGA-24-1463-01.5	130	0_HALLMARK_SPERMATOGENESIS	88	10	0.0005280066037217173900000
TCGA-13-1492-01.2	162	1_KEGG_MELANOMA	71	10	0.0005280679088847683500000
TCGA-09-2044-01.4	83	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0005287532816053753800000
TCGA-23-2078-01.15	105	2_CHROMOSOME_SEGREGATION	26	6	0.0005300777119102895100000
TCGA-13-0897-01.2	61	2_MITOSIS	71	7	0.0005345218110479127900000
TCGA-13-0894-01.9	118	2_ION_BINDING	210	14	0.0005357150978837025300000
TCGA-25-1313-01.2	13	2_MICROTUBULE_CYTOSKELETON	117	5	0.0005371102643433188700000
TCGA-04-1336-01.28	106	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0005372005237411609500000
TCGA-61-2016-01.10	50	1_KEGG_PROSTATE_CANCER	87	7	0.0005384739944478005100000
TCGA-13-1510-01.20	82	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0005387881899038458000000
TCGA-24-2024-01.3	55	2_EXTRACELLULAR_REGION_PART	269	11	0.0005406110801974531500000
TCGA-24-2290-01.3	70	1_KEGG_GLIOMA	62	7	0.0005426923861202968700000
TCGA-25-1318-01.11	46	1_KEGG_FOCAL_ADHESION	195	9	0.0005438057566536026900000
TCGA-23-1027-01.8	68	2_M_PHASE	94	8	0.0005438554061244961100000
TCGA-24-1428-01.9	90	2_MITOSIS	71	8	0.0005447863900251844700000
TCGA-23-1030-01.10	58	2_ZINC_ION_BINDING	75	7	0.0005491903904302820400000
TCGA-24-1466-01.15	82	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	19	0.0005493484793035822400000
TCGA-31-1959-01.7	101	2_ION_BINDING	210	13	0.0005497180897112135400000
TCGA-13-0883-01.4	3	2_MITOCHONDRIAL_MEMBRANE	66	3	0.0005503541296187100500000
TCGA-23-1122-01.11	77	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0005529785922883951700000
TCGA-04-1364-01.3	163	2_REGULATION_OF_APOPTOSIS	309	20	0.0005534171062923949700000
TCGA-13-1407-01.11	220	2_APOPTOSIS_GO	389	27	0.0005563689517909167100000
TCGA-04-1336-01.28	106	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0005569611004305986500000
TCGA-25-1633-01.1	71	2_RESPONSE_TO_WOUNDING	163	10	0.0005592545720407882400000
TCGA-04-1364-01.3	163	2_MITOSIS	71	10	0.0005592545720407888900000
TCGA-13-1483-01.3	66	2_MITOTIC_CELL_CYCLE	134	9	0.0005597708877893671000000
TCGA-61-2092-01.12	209	0_HALLMARK_ANGIOGENESIS	32	8	0.0005647653491697644500000
TCGA-20-0987-01.19	194	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0005648385868073405800000
TCGA-59-2351-01.5	31	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	7	0.0005663496487219487300000
TCGA-61-1998-01.14	105	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0005669478169812307600000
TCGA-13-0924-01.5	68	2_NUCLEUS	1110	24	0.0005685410671658851500000
TCGA-13-1409-01.6	122	2_RECEPTOR_ACTIVITY	499	22	0.0005693880950701891200000
TCGA-24-0966-01.2	18	2_REGULATION_OF_CELL_CYCLE	160	6	0.0005694435146120743000000
TCGA-09-1666-01.28	109	2_CELL_CYCLE_GO_0007049	265	15	0.0005701959249511853200000
TCGA-10-0933-01.2	97	2_NUCLEUS	1110	30	0.0005713618770390557900000
TCGA-09-2051-01.26	142	0_HALLMARK_MITOTIC_SPINDLE	175	14	0.0005731897024350456700000
TCGA-04-1342-01.12	104	1_KEGG_GLIOMA	62	8	0.0005742576287065449400000
TCGA-10-0938-01.2	102	2_DNA_REPAIR	113	10	0.0005743568290019641200000
TCGA-04-1361-01.4	27	0_HALLMARK_E2F_TARGETS	169	7	0.0005744165166277493800000
TCGA-23-1032-01.16	250	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	12	0.0005744787275912130900000
TCGA-13-1505-01.13	60	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	19	0.0005745204092853528100000
TCGA-24-2262-01.25	141	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0005758774066502333700000
TCGA-61-1728-01.5	45	2_CELL_CYCLE_GO_0007049	265	10	0.0005767237518162089100000
TCGA-10-0930-01.5	60	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	6	0.0005768633964925940200000
TCGA-24-0979-01.5	41	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0005782476431106865000000
TCGA-13-0913-01.5	44	2_IMMUNE_RESPONSE	206	9	0.0005783776680804916800000
TCGA-23-2079-01.14	85	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0005789374540172484600000
TCGA-25-2396-01.6	42	2_REGULATION_OF_MOLECULAR_FUNCTION	286	10	0.0005824028607063148000000
TCGA-04-1364-01.3	163	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	20	0.0005828893548852082000000
TCGA-13-1407-01.11	220	2_PROGRAMMED_CELL_DEATH	390	27	0.0005856495436089053300000
TCGA-13-0891-01.18	125	2_MITOSIS	71	9	0.0005866590050157525800000
TCGA-13-0795-01.9	67	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0005866602635116871000000
TCGA-13-0791-01.35	80	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0005871975457016390600000
TCGA-13-0791-01.35	80	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0005871975457016390600000
TCGA-13-0897-01.2	61	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0005891203094539071000000
TCGA-57-1582-01.26	174	2_SKELETAL_DEVELOPMENT	84	11	0.0005900970430225517100000
TCGA-25-1630-01.10	35	2_CELL_CYCLE_GO_0007049	265	9	0.0005908114424493050600000
TCGA-25-1630-01.10	35	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0005908114424493050600000
TCGA-13-0911-01.3	47	2_M_PHASE	94	7	0.0005916761722458655400000
TCGA-13-0887-01.6	47	2_M_PHASE	94	7	0.0005916761722458655400000
TCGA-24-2298-01.7	138	2_SKELETAL_DEVELOPMENT	84	10	0.0005928146075255425600000
TCGA-23-1027-01.8	68	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0005942112886087514600000
TCGA-13-0726-01.12	78	1_KEGG_WNT_SIGNALING_PATHWAY	149	10	0.0005975744444956434400000
TCGA-59-2350-01.1	62	2_MITOSIS	71	7	0.0005989785699522876300000
TCGA-24-1431-01.3	57	1_KEGG_CELL_CYCLE	114	8	0.0005990082820615780300000
TCGA-59-2351-01.5	31	2_DNA_INTEGRITY_CHECKPOINT	19	4	0.0006002192567075650700000
TCGA-61-1995-01.4	102	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0006002371092587689100000
TCGA-24-1470-01.7	76	2_REGULATION_OF_MITOSIS	36	6	0.0006026904833270799800000
TCGA-61-1728-01.5	45	2_CELL_CYCLE_PHASE	146	8	0.0006028215136803488200000
TCGA-24-2261-01.2	87	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0006039116854980842400000
TCGA-13-1487-01.3	79	2_RESPONSE_TO_STRESS	427	16	0.0006047826248567471800000
TCGA-09-2044-01.4	83	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0006049333875748835300000
TCGA-24-1557-01.13	106	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0006050580878979283100000
TCGA-24-1436-01.1	49	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	10	0.0006055989564695176800000
TCGA-13-0726-01.12	78	1_KEGG_CELL_CYCLE	114	9	0.0006059858809937530700000
TCGA-59-2363-01.3	89	1_KEGG_BASE_EXCISION_REPAIR	31	6	0.0006069030309659370600000
TCGA-36-1570-01.2	36	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0006077747685259547300000
TCGA-24-1428-01.9	90	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0006081545038522052600000
TCGA-61-2000-01.11	69	2_M_PHASE	94	8	0.0006102025838207315700000
TCGA-25-2396-01.6	42	2_DNA_METABOLIC_PROCESS	218	9	0.0006112384498411793400000
TCGA-36-1575-01.9	193	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	37	0.0006148296155894343600000
TCGA-23-1031-01.17	142	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0006151889441114808500000
TCGA-61-2094-01.6	63	2_AGING	10	4	0.0006182777651179925900000
TCGA-24-1464-01.7	62	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0006184497934159801300000
TCGA-59-2350-01.1	62	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0006184497934159801300000
TCGA-24-1549-01.21	158	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0006200391615428627100000
TCGA-24-1435-01.12	115	2_BLOOD_COAGULATION	39	7	0.0006206430253548684200000
TCGA-24-1435-01.12	115	2_COAGULATION	39	7	0.0006206430253548684200000
TCGA-04-1336-01.28	106	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0006229925860337805900000
TCGA-24-1544-01.7	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0006251805330738786900000
TCGA-24-1418-01.16	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0006251805330738786900000
TCGA-13-0717-01.6	103	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0006283491521987732800000
TCGA-24-1551-01.15	87	2_MITOTIC_CELL_CYCLE	134	10	0.0006289958274740403800000
TCGA-61-1919-01.9	87	2_MITOTIC_CELL_CYCLE	134	10	0.0006289958274740403800000
TCGA-61-1998-01.14	105	2_EXTRACELLULAR_MATRIX	85	9	0.0006312621863036796800000
TCGA-36-1570-01.2	36	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0006353638110780354700000
TCGA-24-0966-01.2	18	2_CELL_CYCLE_PROCESS	163	6	0.0006356055651050071900000
TCGA-24-2293-01.3	33	2_SKELETAL_DEVELOPMENT	84	6	0.0006368236640065967900000
TCGA-24-2288-01.12	112	2_REGULATION_OF_CELL_CYCLE	160	12	0.0006372248400988955400000
TCGA-24-1563-01.15	100	2_POLYSACCHARIDE_BINDING	28	6	0.0006373859651002502300000
TCGA-24-1425-01.1	61	2_CARBOHYDRATE_BINDING	45	6	0.0006375267638978928800000
TCGA-24-2289-01.6	53	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0006380563082074867900000
TCGA-24-1548-01.8	141	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	25	0.0006386117107178172600000
TCGA-04-1364-01.3	163	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0006399075119641366600000
TCGA-24-2298-01.7	138	2_PATTERN_BINDING	33	7	0.0006402667397760879500000
TCGA-13-1506-01.5	113	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0006426875404896392300000
TCGA-23-1124-01.17	107	1_KEGG_BLADDER_CANCER	42	7	0.0006453036272799692400000
TCGA-24-2281-01.10	107	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0006453036272799692400000
TCGA-23-1022-01.10	170	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0006474111851163128800000
TCGA-25-1628-01.2	118	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0006480446837439149700000
TCGA-24-2030-01.8	161	2_EXTRACELLULAR_REGION	346	21	0.0006494577799649373500000
TCGA-24-0980-01.5	44	0_HALLMARK_P53_PATHWAY	151	8	0.0006505246405180384400000
TCGA-09-2044-01.4	83	2_DNA_METABOLIC_PROCESS	218	12	0.0006509790291674718100000
TCGA-04-1337-01.2	31	0_HALLMARK_KRAS_SIGNALING_UP	148	7	0.0006512234012205723200000
TCGA-24-0982-01.3	34	2_MITOTIC_CELL_CYCLE	134	7	0.0006517935770105213000000
TCGA-13-1497-01.7	59	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	5	0.0006519586982778438700000
TCGA-24-1463-01.5	130	2_SPINDLE	35	7	0.0006548460835449186500000
TCGA-57-1993-01.8	52	0_HALLMARK_MITOTIC_SPINDLE	175	9	0.0006550190219500225900000
TCGA-36-1575-01.9	193	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	20	0.0006553051964084075700000
TCGA-25-1633-01.1	71	2_BLOOD_COAGULATION	39	6	0.0006586647758122973200000
TCGA-25-1633-01.1	71	2_COAGULATION	39	6	0.0006586647758122973200000
TCGA-59-2350-01.1	62	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0006600997850422393700000
TCGA-13-1407-01.11	220	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0006603927219152315800000
TCGA-13-1506-01.5	113	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0006605518136081780100000
TCGA-04-1542-01.4	141	2_IMMUNE_RESPONSE	206	15	0.0006618939453836707500000
TCGA-13-0891-01.18	125	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0006630628133891810600000
TCGA-23-2079-01.14	85	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0006635825330853794600000
TCGA-04-1348-01.6	81	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0006650751677208463200000
TCGA-24-0975-01.6	78	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0006654948756058503900000
TCGA-13-0884-01.11	68	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0006658079275220805500000
TCGA-13-0726-01.12	78	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0006666630082232883300000
TCGA-13-0804-01.5	78	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0006666630082232883300000
TCGA-61-2113-01.15	99	2_DNA_METABOLIC_PROCESS	218	13	0.0006671472349414731600000
TCGA-25-2399-01.16	103	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0006685649914046506100000
TCGA-61-2003-01.4	45	0_HALLMARK_KRAS_SIGNALING_UP	148	8	0.0006692258427942148100000
TCGA-24-0975-01.6	78	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	22	0.0006725976377941318900000
TCGA-36-1577-01.14	168	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0006772705598541816800000
TCGA-13-0883-01.3	23	2_CELL_PROLIFERATION_GO_0008283	436	9	0.0006775497579299866200000
TCGA-13-0804-01.5	78	2_NUCLEUS	1110	26	0.0006781324212110166100000
TCGA-23-1026-01.5	65	2_COLLAGEN	23	5	0.0006812314810823850000000
TCGA-24-1431-01.3	57	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0006823223054605228300000
TCGA-09-2053-01.14	121	1_KEGG_WNT_SIGNALING_PATHWAY	149	12	0.0006866971990065913700000
TCGA-13-1504-01.4	48	2_M_PHASE	94	7	0.0006871175316243589000000
TCGA-13-0883-01.4	3	2_MITOCHONDRIAL_ENVELOPE	71	3	0.0006874014483905075900000
TCGA-13-0791-01.35	80	2_SPINDLE	35	6	0.0006874543569986835400000
TCGA-23-1030-01.10	58	1_KEGG_CELL_CYCLE	114	8	0.0006879267724330269900000
TCGA-24-0979-01.5	41	2_REGULATION_OF_MITOSIS	36	5	0.0006902935574517659800000
TCGA-23-1110-01.7	299	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0006906898692269825700000
TCGA-24-1431-01.3	57	2_REGULATION_OF_CELL_CYCLE	160	9	0.0006937983206296420000000
TCGA-13-1407-01.11	220	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	21	0.0006940266057143190200000
TCGA-24-1563-01.15	100	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0006947448435143118500000
TCGA-23-1023-01.1	93	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	12	0.0006950165158937840900000
TCGA-24-1436-01.1	49	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0006952993763695329000000
TCGA-61-2000-01.11	69	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0006960573177081042200000
TCGA-24-2030-01.8	161	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	29	0.0006983980015459447200000
TCGA-24-1423-01.5	27	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0007004620450252337600000
TCGA-61-2008-01.19	70	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0007074210733570617100000
TCGA-13-1488-01.17	109	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0007147926680113575000000
TCGA-13-0795-01.9	67	2_APOPTOSIS_GO	389	14	0.0007182206571259598700000
TCGA-25-1318-01.11	46	2_CELL_CYCLE_GO_0007049	265	10	0.0007189052017601246000000
TCGA-04-1365-01.6	150	2_CHROMOSOME_ORGANIZATION_AND_BIOGENESIS	99	11	0.0007189556898676006200000
TCGA-61-2088-01.7	150	1_KEGG_MELANOGENESIS	99	11	0.0007189556898676006200000
TCGA-04-1336-01.28	106	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0007206871748311584700000
TCGA-23-1031-01.17	142	2_REGULATION_OF_CELL_PROLIFERATION	265	17	0.0007234586419450936100000
TCGA-23-1032-01.16	250	2_CHROMOSOME	102	14	0.0007235581675761323500000
TCGA-36-1568-01.20	6	1_KEGG_TIGHT_JUNCTION	125	4	0.0007253432253016472800000
TCGA-24-1555-01.1	14	1_KEGG_CELL_CYCLE	114	5	0.0007265690999468854500000
TCGA-23-1027-01.8	68	2_MITOTIC_CELL_CYCLE	134	9	0.0007276450892836725400000
TCGA-23-1022-01.10	170	1_KEGG_WNT_SIGNALING_PATHWAY	149	14	0.0007277382773379862500000
TCGA-25-2042-01.3	63	2_METALLOENDOPEPTIDASE_ACTIVITY	24	5	0.0007308368713107565200000
TCGA-13-1487-01.3	79	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0007351809559616784100000
TCGA-61-2012-01.6	78	2_EXTRACELLULAR_SPACE	192	11	0.0007355818845231487500000
TCGA-13-0883-01.3	23	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0007358961663151666000000
TCGA-13-1497-01.7	59	2_DNA_REPAIR	113	8	0.0007361634376691271400000
TCGA-10-0934-01.11	145	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	26	0.0007365519288815167400000
TCGA-13-0890-01.2	48	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0007372989551959258800000
TCGA-13-0890-01.2	48	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0007372989551959258800000
TCGA-36-1575-01.9	193	2_REGULATION_OF_CELL_PROLIFERATION	265	20	0.0007400013901813340800000
TCGA-04-1348-01.6	81	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0007406038395218894500000
TCGA-25-1623-01.7	111	2_MITOTIC_CELL_CYCLE	134	11	0.0007406397760991415200000
TCGA-13-0795-01.9	67	2_PROGRAMMED_CELL_DEATH	390	14	0.0007409486252511357600000
TCGA-25-1626-01.2	86	2_BEHAVIOR	138	10	0.0007416488472535791700000
TCGA-25-2409-01.5	29	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	11	0.0007418414518024840200000
TCGA-25-2391-01.2	64	2_MITOSIS	71	7	0.0007476574984902946000000
TCGA-13-1507-01.8	101	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0007503784807969939100000
TCGA-13-1501-01.12	101	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0007503784807969939100000
TCGA-13-0916-01.11	92	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0007507661895077544700000
TCGA-13-0910-01.3	71	2_INTRACELLULAR_ORGANELLE_PART	912	22	0.0007521110446273691500000
TCGA-23-2079-01.14	85	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0007588950691709988900000
TCGA-13-1404-01.13	117	2_DNA_METABOLIC_PROCESS	218	14	0.0007606792699106307400000
TCGA-13-1491-01.7	90	2_REGULATION_OF_MOLECULAR_FUNCTION	286	14	0.0007638073773084864600000
TCGA-13-0724-01.21	71	2_M_PHASE	94	8	0.0007639079886497993700000
TCGA-24-0970-01.6	94	2_MITOSIS	71	8	0.0007639079886497993700000
TCGA-04-1350-01.2	130	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0007640938747205544300000
TCGA-25-1635-01.6	129	2_MITOSIS	71	9	0.0007677585139429395300000
TCGA-04-1356-01.1	71	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0007703324250276528100000
TCGA-04-1356-01.1	71	2_DNA_RECOMBINATION	40	6	0.0007703324250276528100000
TCGA-13-1501-01.12	101	0_HALLMARK_KRAS_SIGNALING_UP	148	11	0.0007706655862975986000000
TCGA-25-2042-01.3	63	2_CARBOHYDRATE_BINDING	45	6	0.0007746121343840277100000
TCGA-09-2049-01.8	96	1_KEGG_ASTHMA	30	6	0.0007747581070744507200000
TCGA-13-0923-01.5	53	0_HALLMARK_MITOTIC_SPINDLE	175	9	0.0007765528961448844400000
TCGA-24-1436-01.1	49	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0007777847874073697800000
TCGA-13-0893-01.4	112	2_CHROMOSOME_SEGREGATION	26	6	0.0007779843275642967700000
TCGA-13-1405-01.4	69	2_EXTRACELLULAR_REGION_PART	269	12	0.0007795639036984560600000
TCGA-13-1484-01.4	70	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0007812944749104446100000
TCGA-61-2008-01.19	70	2_CELL_CYCLE_GO_0007049	265	12	0.0007812944749104446100000
TCGA-24-0966-01.2	18	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0007865931257884451300000
TCGA-04-1542-01.4	141	2_CELL_DEVELOPMENT	511	24	0.0007893229714449927700000
TCGA-29-2427-01.10	116	2_CHEMOKINE_ACTIVITY	40	7	0.0007901762106560646000000
TCGA-61-2110-01.3	37	1_KEGG_MAPK_SIGNALING_PATHWAY	258	9	0.0007907881113212246500000
TCGA-13-0900-01.8	90	0_HALLMARK_ANGIOGENESIS	32	6	0.0007924106660922527600000
TCGA-13-0795-01.9	67	2_AGING	10	4	0.0007939545134395744200000
TCGA-13-0792-01.8	64	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0007949057527473006300000
TCGA-13-1509-01.9	117	2_CHROMOSOME	102	10	0.0007962085571212890600000
TCGA-04-1346-01.10	75	2_REGULATION_OF_CELL_CYCLE	160	10	0.0007965584634346346900000
TCGA-25-1627-01.4	75	2_REGULATION_OF_CELL_CYCLE	160	10	0.0007965584634346346900000
TCGA-13-0761-01.6	75	2_REGULATION_OF_CELL_CYCLE	160	10	0.0007965584634346346900000
TCGA-13-1492-01.2	162	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	29	0.0007996561051252382000000
TCGA-36-1575-01.9	193	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	37	0.0007997282976512918400000
TCGA-04-1364-01.3	163	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0008006087652117655500000
TCGA-36-1575-01.9	193	2_CELL_DEVELOPMENT	511	29	0.0008013038137358278100000
TCGA-13-0894-01.9	118	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0008026538627000222700000
TCGA-25-1318-01.11	46	1_KEGG_COLORECTAL_CANCER	62	6	0.0008047225676920738100000
TCGA-04-1362-01.4	35	2_MITOTIC_CELL_CYCLE	134	7	0.0008051782858730688500000
TCGA-23-1032-01.16	250	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	18	0.0008093129206605968800000
TCGA-25-2404-01.5	58	2_REGULATION_OF_CELL_CYCLE	160	9	0.0008094412861909427300000
TCGA-23-1030-01.10	58	2_REGULATION_OF_CELL_CYCLE	160	9	0.0008094412861909427300000
TCGA-13-1488-01.17	109	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0008098975299802823900000
TCGA-61-2102-01.7	172	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0008108870486325565800000
TCGA-13-0910-01.3	71	2_ORGANELLE_PART	916	22	0.0008112908038112066100000
TCGA-04-1364-01.3	163	2_IMMUNE_RESPONSE	206	16	0.0008128749389792447200000
TCGA-36-1580-01.1	65	2_HEMOSTASIS	44	6	0.0008146976938220835200000
TCGA-13-0804-01.5	78	2_CYTOSKELETAL_PART	194	11	0.0008161074091315260200000
TCGA-04-1361-01.4	27	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	7	0.0008173907264295943000000
TCGA-25-2399-01.16	103	2_CELL_CYCLE_PHASE	146	11	0.0008210158894942666800000
TCGA-25-2391-01.2	64	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0008237975583098486800000
TCGA-10-0934-01.11	145	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	21	0.0008238231718844001600000
TCGA-24-2019-01.10	192	0_HALLMARK_MITOTIC_SPINDLE	175	16	0.0008246075514992410100000
TCGA-24-1614-01.5	86	2_BIOPOLYMER_METABOLIC_PROCESS	1367	31	0.0008251506083126333100000
TCGA-09-1666-01.28	109	1_KEGG_GLIOMA	62	8	0.0008256226572667837800000
TCGA-24-1604-01.9	19	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0008265692229528270800000
TCGA-61-2000-01.11	69	2_MITOTIC_CELL_CYCLE	134	9	0.0008268382624063837200000
TCGA-13-1488-01.17	109	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0008284624404243122200000
TCGA-13-0923-01.5	53	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0008300139349167594600000
TCGA-13-1407-01.11	220	2_HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY	32	8	0.0008357996737668210100000
TCGA-24-2293-01.1	22	2_MITOSIS	71	5	0.0008372450635554343800000
TCGA-13-1509-01.9	117	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0008378774195507636000000
TCGA-13-1404-01.13	117	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0008378774195507636000000
TCGA-13-1484-01.4	70	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0008394933714255231200000
TCGA-13-1483-01.3	66	1_KEGG_PANCREATIC_CANCER	70	7	0.0008394933714255231200000
TCGA-59-2351-01.5	31	2_M_PHASE	94	6	0.0008407192213096182800000
TCGA-23-2072-01.9	74	1_KEGG_AXON_GUIDANCE	125	9	0.0008421129717658313300000
TCGA-23-1027-01.8	68	2_AGING	10	4	0.0008431461004158617400000
TCGA-04-1365-01.6	150	2_INTERPHASE	62	9	0.0008435088210357272300000
TCGA-30-1862-01.13	91	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0008441905426828789700000
TCGA-13-0913-01.5	44	2_IMMUNE_SYSTEM_PROCESS	283	10	0.0008446525079228611000000
TCGA-10-0934-01.11	145	2_CYTOKINE_ACTIVITY	104	11	0.0008454895172314047800000
TCGA-24-1604-01.3	7	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	3	0.0008463220097907590700000
TCGA-23-1117-01.11	99	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0008484994171636851700000
TCGA-04-1542-01.4	141	2_SARCOMERE	12	5	0.0008485068889909453800000
TCGA-36-1576-01.8	124	2_METALLOENDOPEPTIDASE_ACTIVITY	24	6	0.0008485480898561595900000
TCGA-24-2290-01.3	70	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0008490187579111895300000
TCGA-10-0928-01.6	70	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0008490187579111895300000
TCGA-24-0970-01.6	94	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0008524425088456121500000
TCGA-24-2030-01.8	161	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	9	0.0008533354101962121600000
TCGA-13-0884-01.11	68	2_COLLAGEN	23	5	0.0008556248446164164400000
TCGA-04-1362-01.4	35	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0008566657206775059000000
TCGA-13-0911-01.3	47	2_CELL_CYCLE_PHASE	146	8	0.0008567785626898341700000
TCGA-13-0885-01.6	44	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	5	0.0008573135671293192600000
TCGA-23-1022-01.10	170	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	14	0.0008575111760124452200000
TCGA-24-0975-01.6	78	1_KEGG_FOCAL_ADHESION	195	11	0.0008592188495393834200000
TCGA-25-1635-01.6	129	2_MICROTUBULE_CYTOSKELETON	117	11	0.0008611581290201868900000
TCGA-04-1336-01.28	106	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	4	0.0008628464998230993700000
TCGA-24-1548-01.8	141	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0008638439442439242500000
TCGA-04-1542-01.4	141	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0008638439442439242500000
TCGA-23-2081-01.7	56	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0008652443644980630600000
TCGA-61-2111-01.16	56	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0008652443644980630600000
TCGA-23-1031-01.17	142	1_KEGG_APOPTOSIS	85	10	0.0008660055018478408300000
TCGA-25-2042-01.3	63	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0008664681503242195600000
TCGA-25-1635-01.6	129	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0008674165177937859100000
TCGA-24-1436-01.1	49	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0008685159273596591600000
TCGA-31-1959-01.7	101	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	12	0.0008725593659384240600000
TCGA-25-1631-01.6	30	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0008731295035850780900000
TCGA-13-1405-01.4	69	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0008765781984809239000000
TCGA-61-2000-01.11	69	1_KEGG_BLADDER_CANCER	42	6	0.0008765781984809239000000
TCGA-61-2000-01.11	69	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0008765781984809239000000
TCGA-23-1110-01.7	299	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0008780861646085437400000
TCGA-20-0990-01.17	133	1_KEGG_PANCREATIC_CANCER	70	9	0.0008797131155208268000000
TCGA-13-1412-01.8	113	1_KEGG_FOCAL_ADHESION	195	13	0.0008797453599180028700000
TCGA-10-0930-01.5	60	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	19	0.0008844948544332356400000
TCGA-24-1558-01.12	174	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0008857648078748770600000
TCGA-13-0791-01.35	80	1_KEGG_APOPTOSIS	85	8	0.0008892116816818968000000
TCGA-23-1021-01.7	44	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0008930726232723769200000
TCGA-13-0723-01.8	50	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0008949530659974609500000
TCGA-23-1124-01.17	107	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	4	0.0008961254946339444800000
TCGA-61-1995-01.4	102	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0008963161893030803500000
TCGA-24-2293-01.1	22	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	5	0.0008983720315826090700000
TCGA-61-2104-01.15	95	2_REGULATION_OF_CELL_CYCLE	160	11	0.0009021989546939741600000
TCGA-61-2113-01.15	99	2_M_PHASE	94	9	0.0009081270979993331500000
TCGA-13-0885-01.6	44	2_MITOCHONDRIAL_TRANSPORT	15	4	0.0009092423456698848500000
TCGA-24-1424-01.4	80	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	15	0.0009094555988523495300000
TCGA-13-1403-01.9	71	2_CELL_CYCLE_GO_0007049	265	12	0.0009170256872547500900000
TCGA-23-1031-01.17	142	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0009172623600216323700000
TCGA-61-2008-01.19	70	2_EXTRACELLULAR_REGION_PART	269	12	0.0009172960745413619700000
TCGA-24-1428-01.9	90	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	27	0.0009177117736050887200000
TCGA-23-1024-01.3	24	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0009245550378851480100000
TCGA-25-1320-01.4	71	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0009262193124537846800000
TCGA-13-0910-01.3	71	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0009262193124537846800000
TCGA-09-1665-01.16	131	2_CYTOSKELETON	293	17	0.0009296620347400321800000
TCGA-13-1407-01.11	220	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0009301121401413733100000
TCGA-24-1463-01.5	130	2_MICROTUBULE_CYTOSKELETON	117	11	0.0009310547431545867600000
TCGA-13-0720-01.5	32	2_CELL_CYCLE_ARREST_GO_0007050	49	5	0.0009322948301606161000000
TCGA-13-0885-01.6	44	2_DNA_METABOLIC_PROCESS	218	9	0.0009336252661050136700000
TCGA-29-2427-01.10	116	2_REGULATION_OF_CELL_CYCLE	160	12	0.0009360594231819811500000
TCGA-24-1422-01.10	56	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0009396102309835021900000
TCGA-24-1422-01.10	56	2_SKELETAL_DEVELOPMENT	84	7	0.0009396102309835021900000
TCGA-24-1424-01.4	80	2_MICROTUBULE_CYTOSKELETON	117	9	0.0009428617606070456900000
TCGA-13-0791-01.35	80	2_MICROTUBULE_CYTOSKELETON	117	9	0.0009428617606070456900000
TCGA-23-2081-01.7	56	0_HALLMARK_E2F_TARGETS	169	9	0.0009429417213879786300000
TCGA-13-1507-01.8	101	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	11	0.0009432165460948925900000
TCGA-29-2427-01.10	116	2_CHEMOKINE_RECEPTOR_BINDING	41	7	0.0009432569584382433300000
TCGA-36-1574-01.10	152	2_INTERPHASE	62	9	0.0009437553133669377700000
TCGA-13-0923-01.5	53	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0009447463862276823200000
TCGA-25-1627-01.4	75	2_CELL_CYCLE_PROCESS	163	10	0.0009462407188113160200000
TCGA-24-2290-01.3	70	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0009472076924337329000000
TCGA-25-2404-01.5	58	2_CELL_CYCLE_PROCESS	163	9	0.0009473582298582050900000
TCGA-13-0920-01.9	82	2_REGULATION_OF_MITOSIS	36	6	0.0009496234451774464700000
TCGA-24-2281-01.10	107	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0009555711917568384900000
TCGA-24-2290-01.3	70	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0009556196777216318500000
TCGA-23-1123-01.7	70	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0009556196777216318500000
TCGA-61-2008-01.19	70	1_KEGG_BLADDER_CANCER	42	6	0.0009556196777216318500000
TCGA-13-0883-01.3	23	2_DNA_METABOLIC_PROCESS	218	7	0.0009568846906400943400000
TCGA-13-1488-01.17	109	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0009578181525359104800000
TCGA-04-1530-01.2	90	2_PATTERN_BINDING	33	6	0.0009611302820149858400000
TCGA-10-0935-01.2	49	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	9	0.0009612663779413284200000
TCGA-61-2000-01.11	69	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0009616633357763978700000
TCGA-04-1514-01.6	91	2_MITOTIC_CELL_CYCLE	134	10	0.0009630614379034632500000
TCGA-23-1028-01.18	93	0_HALLMARK_ANGIOGENESIS	32	6	0.0009632433494136462600000
TCGA-13-1412-01.8	113	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0009634948900457863800000
TCGA-57-1583-01.20	185	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0009648368506490552700000
TCGA-13-1488-01.17	109	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	4	0.0009655480674418103800000
TCGA-09-2050-01.18	196	1_KEGG_PPAR_SIGNALING_PATHWAY	63	10	0.0009747028068882724900000
TCGA-10-0934-01.11	145	2_REGULATION_OF_CELL_PROLIFERATION	265	17	0.0009779268004688817700000
TCGA-25-2409-01.5	29	0_HALLMARK_E2F_TARGETS	169	7	0.0009795869329803682600000
TCGA-13-1487-01.3	79	1_KEGG_FOCAL_ADHESION	195	11	0.0009804195367440588700000
TCGA-24-1418-01.16	84	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0009829659898799188400000
TCGA-04-1364-01.3	163	1_KEGG_ASTHMA	30	7	0.0009852993925203511000000
TCGA-04-1514-01.6	91	2_IMMUNE_RESPONSE	206	12	0.0009856597673976431000000
TCGA-13-1411-01.7	96	1_KEGG_FOCAL_ADHESION	195	12	0.0009873143321140857900000
TCGA-13-0883-01.3	23	1_KEGG_PANCREATIC_CANCER	70	5	0.0009902672917781042500000
TCGA-61-2110-01.3	37	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0009909798486518214600000
TCGA-24-1563-01.15	100	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0009914648378537807700000
TCGA-13-1496-01.13	120	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0009957745036647057000000
TCGA-24-1428-01.9	90	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0009957757681503156700000
TCGA-31-1950-01.7	105	2_CELL_CYCLE_PHASE	146	11	0.0009988564995603136900000
TCGA-13-1491-01.7	90	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0010036231240727349000000
TCGA-25-1633-01.1	71	2_AGING	10	4	0.0010044098345244497000000
TCGA-04-1342-01.12	104	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0010057965018519133000000
TCGA-09-1665-01.16	131	2_MICROTUBULE_CYTOSKELETON	117	11	0.0010059146820029865000000
TCGA-13-1509-01.9	117	2_CHROMOSOME_SEGREGATION	26	6	0.0010078061830481792000000
TCGA-13-1407-01.11	220	2_CYTOKINE_BINDING	44	9	0.0010083173090742093000000
TCGA-36-1577-01.14	168	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0010084680223575830000000
TCGA-61-1998-01.14	105	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0010127726954849417000000
TCGA-13-0904-01.6	105	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0010127726954849417000000
TCGA-31-1950-01.7	105	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0010127726954849417000000
TCGA-13-1492-01.2	162	2_REGULATION_OF_CELL_PROLIFERATION	265	18	0.0010144062746350678000000
TCGA-13-1504-01.4	48	2_CELL_CYCLE_PHASE	146	8	0.0010148147105120166000000
TCGA-13-1483-01.3	66	2_EXTRACELLULAR_REGION	346	13	0.0010148787274458651000000
TCGA-24-1549-01.21	158	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	7	0.0010156867388144519000000
TCGA-13-0893-01.4	112	2_INTERPHASE	62	8	0.0010176159750958349000000
TCGA-24-2019-01.10	192	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0010186865371310196000000
TCGA-23-2081-01.7	56	2_EXTRACELLULAR_MATRIX	85	7	0.0010192774725335254000000
TCGA-61-2113-01.15	99	1_KEGG_PANCREATIC_CANCER	70	8	0.0010206327470772905000000
TCGA-09-2044-01.4	83	2_REGULATION_OF_MITOSIS	36	6	0.0010208251064964563000000
TCGA-04-1365-01.6	150	2_DNA_REPLICATION	82	10	0.0010242885634208756000000
TCGA-61-2088-01.7	150	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0010242885634208756000000
TCGA-13-0886-01.1	45	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0010248608762027248000000
TCGA-13-0724-01.21	71	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0010250767642674180000000
TCGA-24-1558-01.12	174	1_KEGG_MELANOMA	71	10	0.0010250767642674180000000
TCGA-04-1349-01.2	20	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	9	0.0010277359873373489000000
TCGA-13-0916-01.11	92	2_REPLICATION_FORK	18	5	0.0010279963312575891000000
TCGA-57-1582-01.26	174	1_KEGG_BASAL_CELL_CARCINOMA	55	9	0.0010283508374010280000000
TCGA-24-2019-01.10	192	2_CONDENSED_CHROMOSOME	26	7	0.0010284068441574990000000
TCGA-24-2019-01.10	192	2_CHROMOSOME_SEGREGATION	26	7	0.0010284068441574990000000
TCGA-24-1549-01.21	158	2_CHROMOSOMAL_PART	78	10	0.0010305561735108272000000
TCGA-13-1403-01.9	71	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0010316370693713162000000
TCGA-13-1407-01.11	220	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	18	0.0010327131797620889000000
TCGA-59-2350-01.1	62	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0010363210092786768000000
TCGA-13-0800-01.9	124	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	12	0.0010363267753474752000000
TCGA-24-1563-01.15	100	0_HALLMARK_HYPOXIA	154	11	0.0010383067389961461000000
TCGA-13-0724-01.21	71	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0010404145083967704000000
TCGA-13-1410-01.9	115	2_CELL_CYCLE_PROCESS	163	12	0.0010404769441120468000000
TCGA-09-1665-01.16	131	2_NUCLEUS	1110	36	0.0010419476924541668000000
TCGA-20-0991-01.12	166	2_IMMUNE_RESPONSE	206	16	0.0010420922419447356000000
TCGA-04-1361-01.4	27	2_DNA_REPAIR	113	6	0.0010442080293787586000000
TCGA-23-2078-01.15	105	2_MICROTUBULE_CYTOSKELETON	117	10	0.0010453243521118965000000
TCGA-09-1669-01.10	81	2_MICROTUBULE_CYTOSKELETON	117	9	0.0010498091144520918000000
TCGA-10-0937-01.9	40	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	8	0.0010534396395299823000000
TCGA-24-1435-01.12	115	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0010563272509620891000000
TCGA-25-1313-01.2	13	2_MITOTIC_CELL_CYCLE	134	5	0.0010573651100560433000000
TCGA-24-1548-01.8	141	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	12	0.0010574966778452558000000
TCGA-24-1614-01.5	86	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	6	0.0010586493864980810000000
TCGA-24-0968-01.9	71	2_MITOTIC_CELL_CYCLE	134	9	0.0010608704286625469000000
TCGA-10-0938-01.2	102	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0010616351938360822000000
TCGA-10-0938-01.2	102	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0010616351938360822000000
TCGA-23-1123-01.7	70	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0010631703037503784000000
TCGA-61-2008-01.19	70	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0010631703037503784000000
TCGA-13-0727-01.1	29	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0010645160759328377000000
TCGA-23-2078-01.15	105	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0010645160759328517000000
TCGA-13-1512-01.2	113	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0010684230341475385000000
TCGA-13-1412-01.8	113	2_SKELETAL_DEVELOPMENT	84	9	0.0010684230341475385000000
TCGA-36-1580-01.1	65	2_WOUND_HEALING	46	6	0.0010695020079182498000000
TCGA-04-1346-01.10	75	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0010697202574396151000000
TCGA-23-1023-01.1	93	2_CHROMOSOME	102	9	0.0010698063675589555000000
TCGA-25-2400-01.5	35	2_DNA_DEPENDENT_DNA_REPLICATION	46	5	0.0010763718636870730000000
TCGA-23-1031-01.17	142	1_KEGG_PROSTATE_CANCER	87	10	0.0010792845556737358000000
TCGA-04-1356-01.1	71	0_HALLMARK_MITOTIC_SPINDLE	175	10	0.0010807690103075041000000
TCGA-24-1544-01.7	84	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	23	0.0010831716571651935000000
TCGA-23-1116-01.7	84	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	23	0.0010831716571651935000000
TCGA-24-1563-01.15	100	2_SYSTEM_DEVELOPMENT	694	23	0.0010834135668573936000000
TCGA-24-1557-01.13	106	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0010894521580445346000000
TCGA-13-1506-01.5	113	2_INTERPHASE	62	8	0.0010895639907794214000000
TCGA-13-0730-01.8	83	2_REGULATION_OF_MITOTIC_CELL_CYCLE	20	5	0.0010945177976641523000000
TCGA-13-0906-01.5	66	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0010950826283687286000000
TCGA-24-2288-01.12	112	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	85	9	0.0010968405986686715000000
TCGA-04-1361-01.4	27	1_KEGG_CELL_CYCLE	114	6	0.0011001066612534454000000
TCGA-10-0931-01.12	59	2_CELL_CYCLE_PROCESS	163	9	0.0011015196966614959000000
TCGA-24-1431-01.3	57	0_HALLMARK_E2F_TARGETS	169	9	0.0011027172984627328000000
TCGA-24-2280-01.10	58	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0011060345030390302000000
TCGA-13-0730-01.8	83	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0011060345030390302000000
TCGA-09-2044-01.4	83	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0011060345030390302000000
TCGA-13-1409-01.6	122	2_PLASMA_MEMBRANE	1096	34	0.0011112662879073153000000
TCGA-13-1510-01.20	82	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	18	0.0011124906695025927000000
TCGA-24-1474-01.12	122	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0011143708218061498000000
TCGA-29-2427-01.10	116	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0011205022818539779000000
TCGA-25-1313-01.9	12	2_DNA_BINDING	496	7	0.0011207945844719065000000
TCGA-13-1512-01.2	113	2_EXTRACELLULAR_REGION	346	17	0.0011213829677298186000000
TCGA-20-0990-01.17	133	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	9	0.0011243200567892305000000
TCGA-25-1630-01.10	35	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0011243227365201570000000
TCGA-61-2109-01.13	122	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0011285291533938112000000
TCGA-20-0990-01.17	133	0_HALLMARK_E2F_TARGETS	169	13	0.0011345404161370860000000
TCGA-24-1105-01.8	52	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0011357823818544024000000
TCGA-24-1436-01.1	49	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0011359329688960100000000
TCGA-24-0968-01.9	71	1_KEGG_LONG_TERM_POTENTIATION	68	7	0.0011393322764001925000000
TCGA-24-1428-01.9	90	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0011402650536939429000000
TCGA-61-2110-01.3	37	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	7	0.0011442952919855040000000
TCGA-24-0966-01.2	18	2_M_PHASE	94	5	0.0011447946950949380000000
TCGA-13-0910-01.3	71	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	14	0.0011474446426128955000000
TCGA-13-0804-01.5	78	2_CYTOSKELETON	293	13	0.0011484569821515272000000
TCGA-13-1501-01.12	101	2_PROTEOLYSIS	154	11	0.0011490416708565120000000
TCGA-36-1574-01.10	152	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0011522442730373783000000
TCGA-61-2088-01.7	150	0_HALLMARK_APOPTOSIS	150	13	0.0011546877612807810000000
TCGA-13-1495-01.22	101	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0011560102089095421000000
TCGA-61-2012-01.6	78	2_REGULATION_OF_CELL_CYCLE	160	10	0.0011576351548468922000000
TCGA-24-1474-01.12	122	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0011588650965674945000000
TCGA-31-1953-01.6	53	2_MITOTIC_CELL_CYCLE	134	8	0.0011626512137363778000000
TCGA-13-0913-01.5	44	2_CELL_CYCLE_PROCESS	163	8	0.0011674660095212955000000
TCGA-24-1104-01.2	18	2_AGING	10	3	0.0011678965304047024000000
TCGA-24-0966-01.2	18	2_AGING	10	3	0.0011678965304047024000000
TCGA-04-1346-01.10	75	2_M_PHASE	94	8	0.0011726375758850784000000
TCGA-25-1627-01.4	75	2_M_PHASE	94	8	0.0011726375758850784000000
TCGA-13-0761-01.6	75	2_M_PHASE	94	8	0.0011726375758850784000000
TCGA-23-2079-01.14	85	2_REGULATION_OF_MITOSIS	36	6	0.0011763941029712948000000
TCGA-61-2109-01.13	122	2_CHROMOSOME	102	10	0.0011766194362360948000000
TCGA-04-1365-01.6	150	2_BIOPOLYMER_METABOLIC_PROCESS	1367	45	0.0011772997729028831000000
TCGA-13-1510-01.20	82	2_LOCOMOTORY_BEHAVIOR	86	8	0.0011797658746965766000000
TCGA-13-0791-01.35	80	2_REGULATION_OF_MOLECULAR_FUNCTION	286	13	0.0011804906440772785000000
TCGA-30-1862-01.13	91	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0011826303335377912000000
TCGA-04-1514-01.6	91	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0011826303335377912000000
TCGA-04-1367-01.3	74	2_AGING	10	4	0.0011876175082882520000000
TCGA-13-1509-01.9	117	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0011879239496397328000000
TCGA-25-1635-01.6	129	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0011885069203750780000000
TCGA-13-1495-01.22	101	1_KEGG_PANCREATIC_CANCER	70	8	0.0011907652073778110000000
TCGA-09-2044-01.4	83	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0011907767744320811000000
TCGA-13-0916-01.11	92	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0011925627031020064000000
TCGA-13-0765-01.4	54	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0011928101408938403000000
TCGA-24-1560-01.2	29	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0011934260213023724000000
TCGA-09-2051-01.26	142	2_SPINDLE	35	7	0.0011941193719485310000000
TCGA-13-0890-01.2	48	2_CHROMOSOME	102	7	0.0012023665382461829000000
TCGA-13-0724-01.21	71	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0012027909236451688000000
TCGA-23-1123-01.7	70	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0012031363160104863000000
TCGA-61-2008-01.19	70	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0012031363160104863000000
TCGA-25-2042-01.3	63	0_HALLMARK_HYPOXIA	154	9	0.0012129213133430332000000
TCGA-24-1471-01.4	49	2_SIGNAL_TRANSDUCTION	1442	22	0.0012211615210353296000000
TCGA-24-2260-01.11	63	2_REGULATION_OF_APOPTOSIS	309	12	0.0012222166356042397000000
TCGA-24-1435-01.12	115	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0012317594651113303000000
TCGA-13-1410-01.9	115	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0012317594651113303000000
TCGA-24-2019-01.10	192	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	11	0.0012336831363404643000000
TCGA-04-1343-01.7	50	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0012360947178860710000000
TCGA-04-1343-01.7	50	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0012360947178860710000000
TCGA-10-0933-01.2	97	1_KEGG_DNA_REPLICATION	32	6	0.0012369538662062487000000
TCGA-04-1331-01.5	90	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0012403465575520365000000
TCGA-24-1428-01.9	90	2_DNA_INTEGRITY_CHECKPOINT	19	5	0.0012403465575520365000000
TCGA-25-1313-01.2	13	2_MICROTUBULE_MOTOR_ACTIVITY	14	3	0.0012411608147733059000000
TCGA-36-1571-01.6	109	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0012442107641993058000000
TCGA-04-1350-01.2	130	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	25	0.0012457437605855183000000
TCGA-24-1545-01.2	28	2_EXTRACELLULAR_REGION_PART	269	8	0.0012464616273835953000000
TCGA-24-2035-01.8	102	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	16	0.0012470322734519448000000
TCGA-24-2288-01.12	112	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0012511371273755529000000
TCGA-25-1631-01.6	30	0_HALLMARK_E2F_TARGETS	169	7	0.0012586037834412659000000
TCGA-20-0991-01.12	166	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	28	0.0012586923510150803000000
TCGA-25-1628-01.2	118	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0012587234674507908000000
TCGA-13-1489-01.11	118	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0012587234674507908000000
TCGA-25-1319-01.10	69	2_MITOSIS	71	7	0.0012604476264270440000000
TCGA-24-1425-01.1	61	2_REGULATION_OF_CELL_CYCLE	160	9	0.0012622291898889320000000
TCGA-24-2260-01.11	63	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	12	0.0012649664129766884000000
TCGA-23-2081-01.7	56	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0012657058940119771000000
TCGA-23-1021-01.7	44	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	6	0.0012710590998195517000000
TCGA-24-0980-01.5	44	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	6	0.0012710590998195517000000
TCGA-13-0924-01.5	68	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0012797786577995866000000
TCGA-59-2354-01.2	44	2_CATION_BINDING	165	8	0.0012810768802712042000000
TCGA-13-0717-01.6	103	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0012851226290344470000000
TCGA-24-1422-01.10	56	2_COLLAGEN_BINDING	13	4	0.0012855257643381933000000
TCGA-23-1031-01.17	142	2_REGULATION_OF_CELL_CYCLE	160	13	0.0012895252318842476000000
TCGA-24-1474-01.12	122	2_CHROMOSOME_SEGREGATION	26	6	0.0012906399913480283000000
TCGA-24-0982-01.3	34	2_DNA_METABOLIC_PROCESS	218	8	0.0012931544591981783000000
TCGA-13-2060-01.10	86	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0012960201558802056000000
TCGA-29-2427-01.10	116	2_CELL_CYCLE_GO_0007049	265	15	0.0012965391140149498000000
TCGA-13-1504-01.4	48	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0012984105541454754000000
TCGA-36-1574-01.10	152	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0012985192042712776000000
TCGA-24-1463-01.5	130	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0012994990262614181000000
TCGA-24-1428-01.9	90	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0013027875990072602000000
TCGA-10-0934-01.11	145	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	10	0.0013097105876786412000000
TCGA-10-0934-01.11	145	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0013097105876786412000000
TCGA-13-0717-01.6	103	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	21	0.0013129856170547459000000
TCGA-24-1103-01.5	73	2_DNA_METABOLIC_PROCESS	218	11	0.0013140107150344891000000
TCGA-24-2271-01.3	44	2_ORGAN_DEVELOPMENT	460	12	0.0013190940443076552000000
TCGA-23-2077-01.18	63	1_KEGG_CELL_CYCLE	114	8	0.0013220917056120894000000
TCGA-24-1426-01.7	63	1_KEGG_CELL_CYCLE	114	8	0.0013220917056120894000000
TCGA-24-1416-01.4	38	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0013274615397343102000000
TCGA-36-1571-01.6	109	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0013282655876864270000000
TCGA-23-1031-01.17	142	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0013328333951460893000000
TCGA-23-1118-01.5	50	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0013349110005544489000000
TCGA-25-1320-01.4	71	2_METALLOENDOPEPTIDASE_ACTIVITY	24	5	0.0013356687747867804000000
TCGA-13-0910-01.3	71	2_KINETOCHORE	24	5	0.0013356687747867804000000
TCGA-13-0723-01.8	50	2_INTERPHASE	62	6	0.0013376714473805941000000
TCGA-23-1031-01.17	142	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	12	0.0013411610190135433000000
TCGA-25-2042-01.3	63	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	19	0.0013424527739961706000000
TCGA-24-2293-01.1	22	2_CHROMOSOMAL_PART	78	5	0.0013433098502705215000000
TCGA-59-2363-01.3	89	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	11	0.0013441509266444195000000
TCGA-31-1959-01.7	101	0_HALLMARK_COAGULATION	125	10	0.0013446119980023673000000
TCGA-24-1436-01.1	49	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0013455869001770292000000
TCGA-09-1662-01.6	49	2_CELL_CYCLE_GO_0007049	265	10	0.0013455869001770292000000
TCGA-25-2401-01.5	119	2_EXTRACELLULAR_SPACE	192	13	0.0013460742093032811000000
TCGA-61-1736-01.2	54	2_MITOTIC_CELL_CYCLE	134	8	0.0013487040340121074000000
TCGA-36-1571-01.6	109	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0013500023718010315000000
TCGA-13-1488-01.17	109	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0013500023718010315000000
TCGA-13-0804-01.5	78	2_DNA_RECOMBINATION	40	6	0.0013519020975261628000000
TCGA-61-2012-01.6	78	2_CHEMOKINE_ACTIVITY	40	6	0.0013519020975261628000000
TCGA-04-1346-01.10	75	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0013523649948850819000000
TCGA-24-1469-01.6	123	2_CONDENSED_CHROMOSOME	26	6	0.0013543478045008916000000
TCGA-23-1028-01.18	93	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0013558326240869210000000
TCGA-04-1337-01.2	31	2_COLLAGEN	23	4	0.0013587434865326776000000
TCGA-23-1123-01.7	70	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0013587975780850420000000
TCGA-61-2008-01.19	70	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0013587975780850420000000
TCGA-13-0724-01.21	71	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0013608781020062733000000
TCGA-20-0987-01.19	194	2_SIGNAL_TRANSDUCTION	1442	56	0.0013608977165872828000000
TCGA-04-1337-01.2	31	2_CATION_BINDING	165	7	0.0013621803196370117000000
TCGA-13-0791-01.35	80	1_KEGG_GLIOMA	62	7	0.0013664249691825007000000
TCGA-24-1567-01.3	141	2_DNA_METABOLIC_PROCESS	218	15	0.0013683206642743639000000
TCGA-61-2012-01.6	78	2_CELL_CYCLE_PROCESS	163	10	0.0013739731412145838000000
TCGA-23-2081-01.7	56	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	18	0.0013741678059951354000000
TCGA-13-1489-01.11	118	2_CELL_CYCLE_PROCESS	163	12	0.0013767169079990098000000
TCGA-10-0930-01.6	9	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	4	0.0013790324032930546000000
TCGA-25-1633-01.1	71	2_HEMOSTASIS	44	6	0.0013835925573855833000000
TCGA-61-2113-01.15	99	1_KEGG_FOCAL_ADHESION	195	12	0.0013840867912649881000000
TCGA-59-2354-01.2	44	1_KEGG_CELL_CYCLE	114	7	0.0013858739095271373000000
TCGA-24-1545-01.2	28	1_KEGG_CELL_CYCLE	114	6	0.0013864426576544416000000
TCGA-25-1319-01.10	69	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0013881661430914288000000
TCGA-24-2289-01.6	53	0_HALLMARK_ANGIOGENESIS	32	5	0.0013896807610518438000000
TCGA-04-1364-01.3	163	2_APOPTOSIS_GO	389	22	0.0013914059138299812000000
TCGA-24-2290-01.3	70	1_KEGG_MELANOMA	71	7	0.0013921925995763476000000
TCGA-23-1123-01.7	70	1_KEGG_MELANOMA	71	7	0.0013921925995763476000000
TCGA-13-0720-01.5	32	2_REGULATION_OF_CELL_CYCLE	160	7	0.0013957884444988653000000
TCGA-24-2019-01.10	192	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0013972304204230336000000
TCGA-61-1728-01.5	45	2_CELL_CYCLE_PROCESS	163	8	0.0013992417109628915000000
TCGA-24-1425-01.1	61	2_CELL_CYCLE_GO_0007049	265	11	0.0013997399234077243000000
TCGA-25-2392-01.4	60	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0014007489091982851000000
TCGA-25-1316-01.2	73	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0014085840939141849000000
TCGA-13-1407-01.11	220	2_INTERLEUKIN_BINDING	24	7	0.0014087657867670313000000
TCGA-13-1492-01.2	162	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	17	0.0014105196202874293000000
TCGA-24-2254-01.3	49	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0014125045618601825000000
TCGA-24-1551-01.15	87	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0014171822483631758000000
TCGA-24-2261-01.2	87	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0014171822483631758000000
TCGA-25-1626-01.2	86	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0014190667908882061000000
TCGA-24-1435-01.12	115	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0014259737128464890000000
TCGA-13-1410-01.9	115	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0014259737128464890000000
TCGA-24-1466-01.15	82	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	19	0.0014262837030835703000000
TCGA-09-2053-01.14	121	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0014291854256046671000000
TCGA-20-0987-01.19	194	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	39	0.0014299853431719600000000
TCGA-24-1603-01.3	69	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0014344173551004407000000
TCGA-61-2000-01.11	69	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0014344173551004407000000
TCGA-23-1122-01.11	77	2_M_PHASE	94	8	0.0014389766795905900000000
TCGA-13-0761-01.6	75	1_KEGG_BLADDER_CANCER	42	6	0.0014437200962588855000000
TCGA-04-1364-01.3	163	2_PROGRAMMED_CELL_DEATH	390	22	0.0014529703607727993000000
TCGA-13-1487-01.3	79	2_EXTRACELLULAR_REGION	346	14	0.0014548368834233533000000
TCGA-13-0727-01.1	29	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0014636999921798382000000
TCGA-24-1549-01.21	158	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0014684972779283746000000
TCGA-24-1567-01.3	141	2_CELL_CYCLE_PROCESS	163	13	0.0014705634116157146000000
TCGA-24-1435-01.12	115	2_HEMOSTASIS	44	7	0.0014706184977365550000000
TCGA-13-0720-01.5	32	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	11	0.0014738972923460153000000
TCGA-24-2035-01.8	102	0_HALLMARK_COAGULATION	125	10	0.0014742594517011551000000
TCGA-61-2088-01.7	150	2_IMMUNE_RESPONSE	206	15	0.0014779382900080781000000
TCGA-24-1563-01.15	100	0_HALLMARK_ANGIOGENESIS	32	6	0.0014815811119559881000000
TCGA-61-2104-01.15	95	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0014850382632651900000000
TCGA-20-0990-01.17	133	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0014919911776800352000000
TCGA-61-2092-01.12	209	0_HALLMARK_KRAS_SIGNALING_UP	148	15	0.0014946638228548071000000
TCGA-24-1474-01.12	122	2_NUCLEUS	1110	34	0.0014948387327778684000000
TCGA-25-1326-01.11	119	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0014959405755169952000000
TCGA-09-2051-01.26	142	2_DNA_METABOLIC_PROCESS	218	15	0.0014990491176795574000000
TCGA-04-1361-01.4	27	2_MEIOTIC_CELL_CYCLE	27	4	0.0014999843057733439000000
TCGA-61-2113-01.15	99	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0015026431193587572000000
TCGA-24-1435-01.4	3	1_KEGG_OXIDATIVE_PHOSPHORYLATION	92	3	0.0015103468443497753000000
TCGA-13-0883-01.4	3	1_KEGG_OXIDATIVE_PHOSPHORYLATION	92	3	0.0015103468443497753000000
TCGA-09-2044-01.3	3	1_KEGG_OXIDATIVE_PHOSPHORYLATION	92	3	0.0015103468443497753000000
TCGA-13-0894-01.9	118	2_ORGAN_DEVELOPMENT	460	20	0.0015142251745237736000000
TCGA-04-1364-01.3	163	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	22	0.0015170256023690223000000
TCGA-13-0890-01.2	48	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0015190070554940312000000
TCGA-04-1349-01.2	20	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	9	0.0015261518771030138000000
TCGA-24-2261-01.2	87	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0015273609086246637000000
TCGA-24-1548-01.8	141	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	25	0.0015277924720890959000000
TCGA-24-0979-01.5	41	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0015281665112790142000000
TCGA-13-0886-01.1	45	2_DNA_REPAIR	113	7	0.0015305682511584933000000
TCGA-24-2030-01.8	161	2_INTERPHASE	62	9	0.0015337139687484735000000
TCGA-13-0724-01.21	71	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0015366545561843773000000
TCGA-13-0913-01.5	44	0_HALLMARK_E2F_TARGETS	169	8	0.0015369142285489527000000
TCGA-59-2363-01.3	89	2_DNA_REPLICATION	82	8	0.0015377072530281634000000
TCGA-61-2002-01.1	118	2_SKELETAL_DEVELOPMENT	84	9	0.0015435772062786467000000
TCGA-04-1332-01.2	25	1_KEGG_PANCREATIC_CANCER	70	5	0.0015457186601497838000000
TCGA-13-0890-01.2	48	2_REGULATION_OF_MITOSIS	36	5	0.0015472853463339513000000
TCGA-13-1501-01.12	101	2_EXTRACELLULAR_REGION_PART	269	14	0.0015496874091441547000000
TCGA-13-1487-01.3	79	2_CELL_CYCLE_PROCESS	163	10	0.0015499773149145566000000
TCGA-23-1028-01.18	93	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0015516690132312226000000
TCGA-25-1623-01.7	111	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0015518337208775984000000
TCGA-13-0792-01.8	64	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0015668627017482539000000
TCGA-25-2391-01.2	64	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0015668627017482539000000
TCGA-29-2427-01.10	116	2_EXTRACELLULAR_REGION_PART	269	15	0.0015677477856923252000000
TCGA-24-1103-01.5	73	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0015694825187879320000000
TCGA-13-0795-01.9	67	1_KEGG_WNT_SIGNALING_PATHWAY	149	9	0.0015708488418354476000000
TCGA-61-2012-01.6	78	2_CHEMOKINE_RECEPTOR_BINDING	41	6	0.0015733226737810401000000
TCGA-57-1583-01.20	185	1_KEGG_PANCREATIC_CANCER	70	10	0.0015738902065834696000000
TCGA-59-2350-01.1	62	2_NUCLEUS	1110	22	0.0015752923576011766000000
TCGA-20-0987-01.19	194	2_REGULATION_OF_CELL_CYCLE	160	15	0.0015766478275065384000000
TCGA-13-1510-01.20	82	2_REGULATION_OF_MOLECULAR_FUNCTION	286	13	0.0015828753750353739000000
TCGA-25-1635-01.6	129	0_HALLMARK_P53_PATHWAY	151	12	0.0015896659679670749000000
TCGA-61-2012-01.6	78	2_M_PHASE	94	8	0.0015904581158739505000000
TCGA-13-1494-01.4	65	2_PROTEOLYSIS	154	9	0.0015933800927029171000000
TCGA-13-1492-01.2	162	2_RESPONSE_TO_STRESS	427	23	0.0016011126999858204000000
TCGA-61-2012-01.6	78	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	12	0.0016012253157394486000000
TCGA-24-2290-01.3	70	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0016047353799188734000000
TCGA-31-1950-01.7	105	1_KEGG_PANCREATIC_CANCER	70	8	0.0016047353799188734000000
TCGA-25-1326-01.11	119	1_KEGG_FOCAL_ADHESION	195	13	0.0016057781513539597000000
TCGA-24-1616-01.2	38	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0016124163780662337000000
TCGA-13-0904-01.6	105	2_SIGNAL_TRANSDUCTION	1442	36	0.0016174971194789947000000
TCGA-59-2350-01.1	62	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0016186381062324381000000
TCGA-13-0730-01.8	83	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0016197719196004397000000
TCGA-23-2078-01.15	105	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	6	0.0016205451096086825000000
TCGA-24-2019-01.10	192	2_CHROMOSOME	102	12	0.0016251512761008928000000
TCGA-36-1574-01.10	152	2_EXTRACELLULAR_MATRIX	85	10	0.0016252373551534861000000
TCGA-04-1337-01.2	31	2_METALLOENDOPEPTIDASE_ACTIVITY	24	4	0.0016267635429992931000000
TCGA-25-1635-01.6	129	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0016273510852711762000000
TCGA-24-2298-01.7	138	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	31	0.0016294078321767570000000
TCGA-23-1110-01.7	299	2_SPINDLE	35	9	0.0016321789152465246000000
TCGA-29-2427-01.10	116	2_EXTRACELLULAR_REGION	346	17	0.0016392571577340306000000
TCGA-10-0933-01.2	97	2_INTRACELLULAR_ORGANELLE_PART	912	26	0.0016417201798268823000000
TCGA-13-0893-01.4	112	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	14	0.0016448401412781674000000
TCGA-09-0369-01.9	109	2_DOUBLE_STRANDED_DNA_BINDING	30	6	0.0016448462102573590000000
TCGA-13-0924-01.5	68	2_CHROMOSOME_SEGREGATION	26	5	0.0016449440563891685000000
TCGA-25-2400-01.5	35	2_STRUCTURE_SPECIFIC_DNA_BINDING	50	5	0.0016461776241423498000000
TCGA-04-1343-01.7	50	2_SPINDLE	35	5	0.0016461776241423498000000
TCGA-24-1435-01.12	115	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0016467009205821575000000
TCGA-13-1410-01.9	115	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0016467009205821575000000
TCGA-13-0751-01.2	51	2_CELL_CYCLE_PHASE	146	8	0.0016467782918122005000000
TCGA-25-2399-01.16	103	2_CELL_CYCLE_GO_0007049	265	14	0.0016514656923385849000000
TCGA-04-1356-01.1	71	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	5	0.0016598762065424097000000
TCGA-24-1474-01.12	122	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	9	0.0016642827569951727000000
TCGA-13-0883-01.4	3	2_MITOCHONDRIAL_PART	95	3	0.0016647129993681681000000
TCGA-61-2102-01.7	172	2_M_PHASE	94	11	0.0016677745201793502000000
TCGA-24-2288-01.12	112	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0016712639585071030000000
TCGA-13-1410-01.9	115	1_KEGG_PROSTATE_CANCER	87	9	0.0016765726295505524000000
TCGA-13-0795-01.9	67	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	10	0.0016793658572101554000000
TCGA-13-0891-01.18	125	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0016822619573887252000000
TCGA-25-1322-01.15	93	2_SPINDLE	35	6	0.0016848761315461549000000
TCGA-13-0903-01.11	77	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0016888195954036912000000
TCGA-23-2078-01.15	105	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0016891764797046568000000
TCGA-23-2078-01.15	105	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0016891764797046568000000
TCGA-04-1348-01.6	81	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0016923733906507958000000
TCGA-24-1105-01.8	52	2_INTERPHASE	62	6	0.0016964031989141731000000
TCGA-61-2111-01.16	56	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	8	0.0016983754829841659000000
TCGA-04-1542-01.4	141	2_SYSTEM_DEVELOPMENT	694	28	0.0017014257110690111000000
TCGA-24-1436-01.1	49	2_REGULATION_OF_MITOSIS	36	5	0.0017183970550356401000000
TCGA-10-0935-01.2	49	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0017215431439845685000000
TCGA-13-1501-01.12	101	1_KEGG_FOCAL_ADHESION	195	12	0.0017216883360232445000000
TCGA-13-1501-01.12	101	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0017219022198109847000000
TCGA-09-0366-01.5	32	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0017249284461334682000000
TCGA-24-1556-01.19	120	2_INTERPHASE	62	8	0.0017262043735020870000000
TCGA-04-1361-01.4	27	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0017278842474497749000000
TCGA-24-2298-01.7	138	0_HALLMARK_E2F_TARGETS	169	13	0.0017353511307701367000000
TCGA-13-1405-01.4	69	2_EXTRACELLULAR_REGION	346	13	0.0017366776752861378000000
TCGA-30-1853-01.4	111	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0017397577261250910000000
TCGA-04-1364-01.3	163	2_DNA_METABOLIC_PROCESS	218	16	0.0017398201540202202000000
TCGA-23-2072-01.9	74	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	21	0.0017423397334717480000000
TCGA-04-1332-01.2	25	2_MITOTIC_CELL_CYCLE	134	6	0.0017449507026162708000000
TCGA-25-1321-01.3	33	2_REGULATION_OF_CELL_CYCLE	160	7	0.0017465458417899732000000
TCGA-13-1404-01.13	117	2_EXTRACELLULAR_REGION_PART	269	15	0.0017529939033733692000000
TCGA-59-2363-01.3	89	2_REGULATION_OF_CELL_PROLIFERATION	265	13	0.0017570822327119952000000
TCGA-13-2060-01.10	86	2_MICROTUBULE_CYTOSKELETON	117	9	0.0017572332900486951000000
TCGA-13-0730-01.8	83	2_INTERPHASE	62	7	0.0017587061570338599000000
TCGA-09-2044-01.4	83	2_INTERPHASE	62	7	0.0017587061570338599000000
TCGA-24-2030-01.8	161	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	27	0.0017605957563055078000000
TCGA-23-1023-01.1	93	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	19	0.0017638913880398731000000
TCGA-25-2399-01.16	103	0_HALLMARK_ANGIOGENESIS	32	6	0.0017645198366730856000000
TCGA-24-1603-01.3	69	2_CHROMOSOME_SEGREGATION	26	5	0.0017701610789450830000000
TCGA-61-2000-01.11	69	2_CONDENSED_CHROMOSOME	26	5	0.0017701610789450830000000
TCGA-13-0726-01.12	78	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0017706876154889965000000
TCGA-13-0804-01.5	78	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0017706876154889965000000
TCGA-23-1028-01.18	93	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0017718039833940651000000
TCGA-24-1616-01.2	38	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0017797049200294849000000
TCGA-10-0933-01.2	97	2_ORGANELLE_PART	916	26	0.0017851589199319989000000
TCGA-13-0893-01.4	112	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0017914051146247726000000
TCGA-61-1998-01.14	105	2_MITOSIS	71	8	0.0017920202296072825000000
TCGA-13-0910-01.3	71	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0017920202296072825000000
TCGA-13-0887-01.6	47	2_REGULATION_OF_MOLECULAR_FUNCTION	286	10	0.0017924017941599950000000
TCGA-04-1362-01.4	35	2_M_PHASE	94	6	0.0017950011450145122000000
TCGA-24-1563-01.15	100	2_PATTERN_BINDING	33	6	0.0017954057537857184000000
TCGA-24-1466-01.15	82	2_AGING	10	4	0.0017979270556488956000000
TCGA-13-1510-01.20	82	2_AGING	10	4	0.0017979270556488956000000
TCGA-57-1993-01.8	52	2_MITOCHONDRIAL_TRANSPORT	15	4	0.0017997786878356016000000
TCGA-57-1583-01.20	185	1_KEGG_MELANOMA	71	10	0.0018011338873609698000000
TCGA-10-0933-01.2	97	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0018030636382551947000000
TCGA-13-0903-01.11	77	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	24	0.0018096914196600435000000
TCGA-13-0807-01.8	46	2_MITOSIS	71	6	0.0018143470433939278000000
TCGA-61-1995-01.4	102	2_CYTOSKELETAL_PART	194	12	0.0018145461064764208000000
TCGA-13-1510-01.20	82	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0018150846145689541000000
TCGA-24-1425-01.1	61	2_COLLAGEN_BINDING	13	4	0.0018195347380295227000000
TCGA-09-1659-01.5	51	2_SPINDLE	35	5	0.0018202751144312502000000
TCGA-24-1435-01.12	115	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0018224821766599480000000
TCGA-04-1525-01.7	52	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0018233244260587446000000
TCGA-13-0804-01.5	78	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0018235660039633279000000
TCGA-13-1481-01.3	78	1_KEGG_BLADDER_CANCER	42	6	0.0018235660039633279000000
TCGA-24-2290-01.3	70	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0018264333200617969000000
TCGA-10-0934-01.11	145	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0018264333200617969000000
TCGA-10-0934-01.11	145	2_REGULATION_OF_APOPTOSIS	309	18	0.0018291264313380956000000
TCGA-04-1338-01.7	85	0_HALLMARK_HYPOXIA	154	10	0.0018327584391110406000000
TCGA-25-1326-01.11	119	2_EXTRACELLULAR_MATRIX	85	9	0.0018348156723239930000000
TCGA-13-1408-01.1	45	0_HALLMARK_E2F_TARGETS	169	8	0.0018409919420945846000000
TCGA-24-1548-01.8	141	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	9	0.0018413712291505998000000
TCGA-24-1544-01.7	84	1_KEGG_FOCAL_ADHESION	195	11	0.0018418488120600192000000
TCGA-13-0891-01.18	125	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0018468171215762789000000
TCGA-24-1463-01.5	130	2_EXTRACELLULAR_REGION	346	18	0.0018475521514053920000000
TCGA-13-1404-01.13	117	2_EXTRACELLULAR_REGION	346	17	0.0018549106133107845000000
TCGA-24-2293-01.1	22	2_SPINDLE	35	4	0.0018607018346234181000000
TCGA-24-2019-01.10	192	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0018717645381077805000000
TCGA-04-1337-01.2	31	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0018753726865199489000000
TCGA-24-1463-01.5	130	2_CHROMOSOME_SEGREGATION	26	6	0.0018764487364096559000000
TCGA-24-1463-01.5	130	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0018820477206120225000000
TCGA-36-1575-01.9	193	2_PLASMA_MEMBRANE	1096	46	0.0018917916874550294000000
TCGA-10-0938-01.2	102	2_NUCLEUS	1110	30	0.0018948310083107395000000
TCGA-24-2298-01.6	4	1_KEGG_CARDIAC_MUSCLE_CONTRACTION	63	3	0.0019013099459527262000000
TCGA-24-1413-01.6	34	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	5	0.0019040050504905961000000
TCGA-13-1492-01.2	162	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	39	0.0019045911037370595000000
TCGA-24-0970-01.6	94	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0019067715737908525000000
TCGA-24-1603-01.3	69	2_INTRACELLULAR_ORGANELLE_PART	912	21	0.0019101792048297369000000
TCGA-13-1481-01.3	78	0_HALLMARK_E2F_TARGETS	169	10	0.0019150198930975063000000
TCGA-24-0975-01.6	78	0_HALLMARK_E2F_TARGETS	169	10	0.0019150198930975063000000
TCGA-13-0886-01.1	45	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0019155979948841436000000
TCGA-13-0886-01.1	45	2_DNA_RECOMBINATION	40	5	0.0019155979948841436000000
TCGA-10-0934-01.11	145	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	18	0.0019166958568350291000000
TCGA-24-1428-01.9	90	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0019253037337352110000000
TCGA-24-1557-01.13	106	2_MITOSIS	71	8	0.0019267912594983355000000
TCGA-13-0800-01.9	124	2_REGULATION_OF_CELL_CYCLE	160	12	0.0019285887386098256000000
TCGA-24-1428-01.9	90	2_DNA_REPAIR	113	9	0.0019308596908850146000000
TCGA-24-1424-01.4	80	1_KEGG_MISMATCH_REPAIR	23	5	0.0019358338013393585000000
TCGA-20-0987-01.19	194	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	38	0.0019499740689263747000000
TCGA-24-2024-01.3	55	2_BEHAVIOR	138	8	0.0019507327756344615000000
TCGA-13-0723-01.8	50	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0019516177267437191000000
TCGA-10-0930-01.5	60	1_KEGG_BASAL_CELL_CARCINOMA	55	6	0.0019547535206808583000000
TCGA-61-2094-01.6	63	2_CELL_CYCLE_PROCESS	163	9	0.0019559216161552828000000
TCGA-61-2109-01.13	122	1_KEGG_COLORECTAL_CANCER	62	8	0.0019579995735935223000000
TCGA-13-1506-01.5	113	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0019587768205056692000000
TCGA-23-1031-01.17	142	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	16	0.0019603451175447505000000
TCGA-24-1616-01.2	38	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0019613307492537648000000
TCGA-24-1426-01.7	63	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0019616185905167315000000
TCGA-04-1350-01.2	130	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0019634069895004985000000
TCGA-61-2092-01.12	209	2_AGING	10	5	0.0019653261604655244000000
TCGA-13-0717-01.6	103	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0019674012689268987000000
TCGA-24-2288-01.12	112	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0019677209709366063000000
TCGA-13-0807-01.8	46	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	6	0.0019720938056705800000000
TCGA-25-1635-01.6	129	2_CHROMOSOME	102	10	0.0019723512423070631000000
TCGA-25-2399-01.16	103	2_EXTRACELLULAR_REGION_PART	269	14	0.0019755270601793558000000
TCGA-61-1998-01.14	105	0_HALLMARK_ANGIOGENESIS	32	6	0.0019766372784788344000000
TCGA-23-2078-01.15	105	0_HALLMARK_ANGIOGENESIS	32	6	0.0019766372784788344000000
TCGA-24-1555-01.3	10	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0019813831127545169000000
TCGA-24-1418-01.16	84	2_AGING	10	4	0.0019813831127545169000000
TCGA-20-0991-01.12	166	1_KEGG_GLIOMA	62	9	0.0019826393803309759000000
TCGA-13-0916-01.11	92	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0019845509297966141000000
TCGA-04-1347-01.15	187	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	15	0.0019883182363836815000000
TCGA-13-0714-01.9	51	2_CELL_CYCLE_GO_0007049	265	10	0.0019912205297752139000000
TCGA-25-1631-01.6	30	2_REGULATION_OF_CELL_PROLIFERATION	265	8	0.0019951137046964810000000
TCGA-61-1998-01.14	105	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0019976401003060002000000
TCGA-24-1425-01.1	61	0_HALLMARK_E2F_TARGETS	169	9	0.0019992820935506770000000
TCGA-04-1542-01.4	141	2_APOPTOSIS_GO	389	20	0.0020000213567784556000000
TCGA-20-0990-01.17	133	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0020006188915650462000000
TCGA-10-0934-01.11	145	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	19	0.0020060881205459847000000
TCGA-13-0916-01.11	92	2_INTRACELLULAR_ORGANELLE_PART	912	25	0.0020067960363552078000000
TCGA-57-1993-01.8	52	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	5	0.0020085863019499678000000
TCGA-23-2078-01.15	105	2_EXTRACELLULAR_REGION	346	16	0.0020119416738124674000000
TCGA-24-1435-01.12	115	2_WOUND_HEALING	46	7	0.0020132986019092513000000
TCGA-13-1509-01.9	117	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0020172814643938885000000
TCGA-04-1530-01.2	90	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0020184540266937946000000
TCGA-04-1530-01.2	90	2_SKELETAL_DEVELOPMENT	84	8	0.0020184540266937946000000
TCGA-13-0720-01.5	32	0_HALLMARK_E2F_TARGETS	169	7	0.0020191007674944762000000
TCGA-36-1577-01.14	168	2_SARCOMERE	12	5	0.0020268896814612447000000
TCGA-25-2401-01.5	119	2_LOCOMOTORY_BEHAVIOR	86	9	0.0020278121920204251000000
TCGA-13-0891-01.18	125	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	9	0.0020430650060432039000000
TCGA-04-1356-01.1	71	2_CHROMOSOME_SEGREGATION	26	5	0.0020431341088050707000000
TCGA-25-1633-01.1	71	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0020431341088050707000000
TCGA-24-2267-01.8	26	1_KEGG_MELANOMA	71	5	0.0020431341088050707000000
TCGA-24-1544-01.7	84	2_ORGAN_MORPHOGENESIS	122	9	0.0020459620620688944000000
TCGA-24-2035-01.8	102	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	25	0.0020470601924651283000000
TCGA-24-1603-01.3	69	2_ORGANELLE_PART	916	21	0.0020523197774968849000000
TCGA-24-1558-01.12	174	2_REGULATION_OF_MOLECULAR_FUNCTION	286	19	0.0020593971827794042000000
TCGA-61-2008-01.19	70	2_EXTRACELLULAR_REGION	346	13	0.0020632487966780882000000
TCGA-25-1626-01.2	86	2_BLOOD_COAGULATION	39	6	0.0020669042515702543000000
TCGA-25-1626-01.2	86	2_COAGULATION	39	6	0.0020669042515702543000000
TCGA-13-1409-01.6	122	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	11	0.0020721447071338200000000
TCGA-25-2042-01.3	63	2_COLLAGEN_BINDING	13	4	0.0020737098158019637000000
TCGA-13-0890-01.2	48	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0020757151876272602000000
TCGA-13-1504-01.4	48	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0020757151876272602000000
TCGA-13-1492-01.2	162	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0020810193767458051000000
TCGA-04-1542-01.4	141	2_PROGRAMMED_CELL_DEATH	390	20	0.0020817315545390356000000
TCGA-24-1464-01.5	2	2_AEROBIC_RESPIRATION	11	2	0.0020827905081597675000000
TCGA-10-0937-01.2	2	2_AEROBIC_RESPIRATION	11	2	0.0020827905081597675000000
TCGA-23-2078-01.8	2	2_AEROBIC_RESPIRATION	11	2	0.0020827905081597675000000
TCGA-24-1466-01.11	2	2_AEROBIC_RESPIRATION	11	2	0.0020827905081597675000000
TCGA-24-1469-01.6	123	1_KEGG_GLIOMA	62	8	0.0020835264780227378000000
TCGA-61-1998-01.14	105	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0020925936826508128000000
TCGA-23-2078-01.15	105	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0020925936826508128000000
TCGA-13-0904-01.6	105	2_REGULATION_OF_CELL_PROLIFERATION	265	14	0.0020942643464238776000000
TCGA-13-1497-01.7	59	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0020946908458023034000000
TCGA-30-1891-01.4	84	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0021000657845002620000000
TCGA-24-1418-01.16	84	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0021000657845002620000000
TCGA-25-2396-01.6	42	2_DNA_INTEGRITY_CHECKPOINT	19	4	0.0021054642128010702000000
TCGA-24-1424-01.4	80	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0021059113145991421000000
TCGA-23-1110-01.7	299	2_REGULATION_OF_MITOSIS	36	9	0.0021163894552549364000000
TCGA-25-2400-01.5	35	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	15	0.0021178093388439590000000
TCGA-13-1407-01.11	220	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	26	0.0021191539236637908000000
TCGA-13-0791-01.35	80	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0021195132856908255000000
TCGA-25-1628-01.2	118	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0021208889522043263000000
TCGA-24-1435-01.4	3	1_KEGG_PARKINSONS_DISEASE	103	3	0.0021269816035198322000000
TCGA-13-0883-01.4	3	1_KEGG_PARKINSONS_DISEASE	103	3	0.0021269816035198322000000
TCGA-09-2044-01.3	3	1_KEGG_PARKINSONS_DISEASE	103	3	0.0021269816035198322000000
TCGA-09-1669-01.10	81	2_M_PHASE	94	8	0.0021292506767558680000000
TCGA-04-1364-01.3	163	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	15	0.0021339411599443710000000
TCGA-24-1557-01.13	106	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0021476729396633630000000
TCGA-57-1583-01.20	185	1_KEGG_FOCAL_ADHESION	195	16	0.0021481826342979083000000
TCGA-23-1022-01.10	170	2_SARCOMERE	12	5	0.0021492886973700446000000
TCGA-13-0893-01.4	112	2_REGULATION_OF_MOLECULAR_FUNCTION	286	15	0.0021515058363039004000000
TCGA-24-1551-01.15	87	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0021520023754994155000000
TCGA-24-2261-01.2	87	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0021520023754994155000000
TCGA-25-2391-01.2	64	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0021543625418797949000000
TCGA-25-1322-01.15	93	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0021561997396784163000000
TCGA-13-0760-01.12	93	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0021561997396784163000000
TCGA-13-1499-01.1	22	2_REGULATION_OF_CELL_CYCLE	160	6	0.0021637432041575360000000
TCGA-30-1853-01.4	111	2_PROTEIN_KINASE_CASCADE	251	14	0.0021702136074588569000000
TCGA-13-1510-01.20	82	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	14	0.0021719163111244464000000
TCGA-04-1530-01.2	90	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0021733766118335446000000
TCGA-61-2095-01.1	32	2_SYSTEM_DEVELOPMENT	694	12	0.0021761227795473589000000
TCGA-13-0916-01.11	92	2_ORGANELLE_PART	916	25	0.0021763352335784870000000
TCGA-13-2060-01.10	86	2_AGING	10	4	0.0021784269070293321000000
TCGA-25-1326-01.11	119	2_EXTRACELLULAR_REGION_PART	269	15	0.0021836208450730977000000
TCGA-24-0968-01.9	71	2_CELL_CYCLE_PHASE	146	9	0.0021870783536476037000000
TCGA-24-1558-01.12	174	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	15	0.0021897679331820104000000
TCGA-23-1031-01.17	142	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	25	0.0021922477896841683000000
TCGA-24-2280-01.10	58	0_HALLMARK_ANGIOGENESIS	32	5	0.0021926090232070061000000
TCGA-13-0714-01.9	51	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0021930780803088791000000
TCGA-13-1510-01.20	82	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	18	0.0021958287398443901000000
TCGA-30-1862-01.13	91	2_SKELETAL_DEVELOPMENT	84	8	0.0021971674685231568000000
TCGA-13-1407-01.11	220	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0021999385702592082000000
TCGA-25-2398-01.5	81	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	22	0.0022007742220320810000000
TCGA-24-2030-01.8	161	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0022031889261984678000000
TCGA-61-2008-01.19	70	2_EXTRACELLULAR_SPACE	192	10	0.0022105289634961047000000
TCGA-13-0916-01.11	92	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0022112553023163899000000
TCGA-20-0991-01.12	166	2_EXTRACELLULAR_SPACE	192	15	0.0022118039064509504000000
TCGA-59-2348-01.14	123	2_CYTOSKELETAL_PART	194	13	0.0022167379310121683000000
TCGA-23-1024-01.3	24	2_CELL_CYCLE_PHASE	146	6	0.0022215783550476186000000
TCGA-13-1405-01.4	69	1_KEGG_FOCAL_ADHESION	195	10	0.0022216060060357692000000
TCGA-24-1435-01.12	115	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0022235536913171733000000
TCGA-24-2261-01.2	87	0_HALLMARK_SPERMATOGENESIS	88	8	0.0022248457709410814000000
TCGA-25-1318-01.11	46	2_ORGAN_DEVELOPMENT	460	12	0.0022263325498566634000000
TCGA-24-2035-01.8	102	2_RESPONSE_TO_WOUNDING	163	11	0.0022349905247075596000000
TCGA-04-1364-01.3	163	2_CHROMOSOME	102	11	0.0022349905247075596000000
TCGA-13-0916-01.11	92	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0022361952097744746000000
TCGA-23-1030-01.10	58	2_TRANSITION_METAL_ION_BINDING	92	7	0.0022361952097744746000000
TCGA-61-1998-01.14	105	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0022416072138234278000000
TCGA-36-1580-01.1	65	2_REGULATION_OF_BODY_FLUID_LEVELS	52	6	0.0022508950124599230000000
TCGA-13-1495-01.22	101	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0022528615197934488000000
TCGA-13-1498-01.13	104	2_REGULATION_OF_CELL_CYCLE	160	11	0.0022606421070245756000000
TCGA-59-2351-01.5	31	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	7	0.0022711090712792753000000
TCGA-23-1122-01.11	77	2_DNA_METABOLIC_PROCESS	218	11	0.0022754671657178836000000
TCGA-13-0885-01.6	44	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	8	0.0022765639053892364000000
TCGA-04-1348-01.6	81	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0022815812275513809000000
TCGA-24-1551-01.15	87	2_AGING	10	4	0.0022822443750468726000000
TCGA-04-1514-01.6	91	1_KEGG_CELL_CYCLE	114	9	0.0022853760640989102000000
TCGA-25-1322-01.15	93	2_DNA_METABOLIC_PROCESS	218	12	0.0022856488620731866000000
TCGA-24-2267-01.8	26	2_CELL_PROLIFERATION_GO_0008283	436	9	0.0022884601114084194000000
TCGA-24-1464-01.7	62	0_HALLMARK_E2F_TARGETS	169	9	0.0023032357702941777000000
TCGA-04-1542-01.4	141	1_KEGG_MAPK_SIGNALING_PATHWAY	258	16	0.0023088183206281926000000
TCGA-10-0938-01.2	102	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0023158911122159137000000
TCGA-24-2019-01.10	192	2_CHROMOSOMEPERICENTRIC_REGION	29	7	0.0023172198381833718000000
TCGA-25-1317-01.1	13	2_PROTEIN_DIMERIZATION_ACTIVITY	157	5	0.0023223280460224521000000
TCGA-10-0937-01.9	40	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0023255492838908532000000
TCGA-13-0916-01.11	92	2_DNA_REPAIR	113	9	0.0023283107479815960000000
TCGA-61-2113-01.15	99	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0023334994061004516000000
TCGA-13-0792-01.8	64	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0023335443412617197000000
TCGA-24-0970-01.6	94	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0023403516696495689000000
TCGA-13-0910-01.3	71	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0023407657100924560000000
TCGA-13-0720-01.5	32	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	11	0.0023432042836524984000000
TCGA-36-1576-01.8	124	2_SKELETAL_DEVELOPMENT	84	9	0.0023462562255761299000000
TCGA-13-1494-01.4	65	2_COLLAGEN_BINDING	13	4	0.0023533989335642810000000
TCGA-13-0891-01.18	125	1_KEGG_GLIOMA	62	8	0.0023552935235438446000000
TCGA-23-1032-01.16	250	2_ORGAN_DEVELOPMENT	460	31	0.0023644958709344052000000
TCGA-25-1315-01.7	93	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0023671126191996362000000
TCGA-23-1030-01.10	58	2_MITOTIC_CELL_CYCLE	134	8	0.0023691573333371198000000
TCGA-25-1321-01.3	33	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0023739808193408434000000
TCGA-24-1564-01.4	47	2_CHEMOKINE_ACTIVITY	40	5	0.0023902310431139517000000
TCGA-13-1512-01.2	113	0_HALLMARK_KRAS_SIGNALING_UP	148	11	0.0024005793401599938000000
TCGA-23-1031-01.17	142	0_HALLMARK_E2F_TARGETS	169	13	0.0024052615063583620000000
TCGA-25-1322-01.15	93	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0024067661832691328000000
TCGA-25-1626-01.2	86	2_CHEMOKINE_ACTIVITY	40	6	0.0024140298544733847000000
TCGA-13-2060-01.10	86	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0024140298544733847000000
TCGA-23-2079-01.14	85	2_REGULATION_OF_MOLECULAR_FUNCTION	286	13	0.0024166103449351425000000
TCGA-13-0885-01.6	44	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	17	0.0024170503787882447000000
TCGA-24-1469-01.6	123	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0024194360540448850000000
TCGA-23-1122-01.11	77	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0024222016686672307000000
TCGA-25-2042-01.3	63	2_ORGAN_DEVELOPMENT	460	14	0.0024239899594839143000000
TCGA-24-1464-01.7	62	1_KEGG_PROSTATE_CANCER	87	7	0.0024250615937662016000000
TCGA-24-1463-01.5	130	1_KEGG_BLADDER_CANCER	42	7	0.0024251694136619237000000
TCGA-24-2030-01.8	161	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	26	0.0024256976182751968000000
TCGA-61-2101-01.2	38	2_ION_BINDING	210	8	0.0024283200204659777000000
TCGA-24-1424-01.4	80	2_KINETOCHORE	24	5	0.0024291092454853795000000
TCGA-25-1630-01.10	35	2_APOPTOTIC_PROGRAM	54	5	0.0024311890173040330000000
TCGA-24-2261-01.2	87	2_INTRACELLULAR_ORGANELLE_PART	912	24	0.0024362496404227150000000
TCGA-23-1117-01.11	99	2_SPINDLE	35	6	0.0024378397404703216000000
TCGA-13-0795-01.9	67	2_REGULATION_OF_APOPTOSIS	309	12	0.0024427499152898610000000
TCGA-23-1028-01.18	93	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0024455146500520588000000
TCGA-13-0760-01.12	93	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0024455146500520588000000
TCGA-24-1471-01.4	49	1_KEGG_PANCREATIC_CANCER	70	6	0.0024457315414545266000000
TCGA-24-1103-01.5	73	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	23	0.0024508194339263305000000
TCGA-13-0920-01.9	82	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0024536476831451800000000
TCGA-24-1434-01.3	82	1_KEGG_BLADDER_CANCER	42	6	0.0024536476831451800000000
TCGA-24-2280-01.10	58	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	18	0.0024549176221373733000000
TCGA-57-1582-01.26	174	1_KEGG_DNA_REPLICATION	32	7	0.0024564246935876526000000
TCGA-24-1552-01.5	54	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0024565434657268688000000
TCGA-13-1408-01.1	45	1_KEGG_BLADDER_CANCER	42	5	0.0024590261002024596000000
TCGA-13-0905-01.7	160	0_HALLMARK_MITOTIC_SPINDLE	175	14	0.0024630679056915693000000
TCGA-24-2030-01.8	161	2_SKELETAL_DEVELOPMENT	84	10	0.0024646418515195476000000
TCGA-25-2399-01.16	103	2_CELL_CYCLE_PROCESS	163	11	0.0024653374259843964000000
TCGA-04-1525-01.7	52	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0024656436175924698000000
TCGA-04-1347-01.15	187	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	16	0.0024789195333276277000000
TCGA-31-1950-01.7	105	2_REGULATION_OF_CELL_CYCLE	160	11	0.0024886947617669694000000
TCGA-23-1123-01.7	70	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0024892508067638599000000
TCGA-13-0920-01.9	82	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0024927710178559879000000
TCGA-24-1413-01.6	34	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0024942203228746039000000
TCGA-13-1409-01.6	122	2_REGULATION_OF_CELL_PROLIFERATION	265	15	0.0024942505771634585000000
TCGA-13-1507-01.6	2	2_CORNIFIED_ENVELOPE	12	2	0.0024993486097923874000000
TCGA-13-0760-01.1	2	2_CORNIFIED_ENVELOPE	12	2	0.0024993486097923874000000
TCGA-25-1630-01.9	2	2_CORNIFIED_ENVELOPE	12	2	0.0024993486097923874000000
TCGA-25-1630-01.5	2	2_HOMOPHILIC_CELL_ADHESION	12	2	0.0024993486097923874000000
TCGA-25-2042-01.3	63	2_LOCOMOTORY_BEHAVIOR	86	7	0.0025031134256034591000000
TCGA-09-2056-01.6	63	1_KEGG_ERBB_SIGNALING_PATHWAY	86	7	0.0025031134256034591000000
TCGA-61-2000-01.11	69	2_DNA_REPAIR	113	8	0.0025138168506078835000000
TCGA-25-1627-01.4	75	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0025140067195918731000000
TCGA-61-2009-01.1	46	2_CALCIUM_ION_BINDING	75	6	0.0025140067195918731000000
TCGA-13-0727-01.1	29	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0025144917862392835000000
TCGA-25-2409-01.5	29	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0025144917862392835000000
TCGA-24-2035-01.8	102	2_CATION_BINDING	165	11	0.0025214268563755957000000
TCGA-24-1551-01.1	3	2_CATION_TRANSPORT	109	3	0.0025248698393182441000000
TCGA-13-0924-01.4	3	2_CATION_TRANSPORT	109	3	0.0025248698393182441000000
TCGA-13-0795-01.9	67	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	12	0.0025271895139480673000000
TCGA-13-0923-01.5	53	2_REGULATION_OF_MITOSIS	36	5	0.0025578329295503810000000
TCGA-13-1504-01.4	48	1_KEGG_CELL_CYCLE	114	7	0.0025590315634948383000000
TCGA-25-1322-01.15	93	2_NUCLEUS	1110	28	0.0025639715659727057000000
TCGA-23-1023-01.1	93	2_NUCLEUS	1110	28	0.0025639715659727057000000
TCGA-10-0937-01.9	40	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0025658721881886806000000
TCGA-24-1105-01.8	52	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0025668344713595877000000
TCGA-24-0970-01.6	94	2_DNA_METABOLIC_PROCESS	218	12	0.0025675039209452199000000
TCGA-23-1110-01.7	299	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	19	0.0025718123727408631000000
TCGA-24-1560-01.2	29	2_ATP_BINDING	122	6	0.0025798923198566467000000
TCGA-25-1628-01.2	118	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0025819029019465353000000
TCGA-25-1628-01.2	118	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0025819029019465353000000
TCGA-24-1551-01.15	87	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0025848273586406550000000
TCGA-24-2261-01.2	87	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0025848273586406550000000
TCGA-25-2404-01.5	58	2_M_PHASE	94	7	0.0025881066519811789000000
TCGA-24-0970-01.6	94	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0025881066519811789000000
TCGA-13-1505-01.13	60	0_HALLMARK_ANGIOGENESIS	32	5	0.0026009594701174765000000
TCGA-23-1110-01.7	299	2_DNA_REPLICATION	82	13	0.0026098056772078031000000
TCGA-04-1350-01.2	130	2_IMMUNE_SYSTEM_PROCESS	283	16	0.0026132080910390440000000
TCGA-23-1027-01.8	68	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0026203529942375853000000
TCGA-61-2101-01.2	38	2_TRANSITION_METAL_ION_BINDING	92	6	0.0026255438991885762000000
TCGA-23-1118-01.5	50	2_NUCLEUS	1110	19	0.0026273856366389242000000
TCGA-24-2261-01.2	87	2_ORGANELLE_PART	916	24	0.0026350548015611494000000
TCGA-24-1427-01.4	83	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0026361829689906416000000
TCGA-25-2042-01.3	63	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	9	0.0026462706104843996000000
TCGA-24-1426-01.7	63	0_HALLMARK_E2F_TARGETS	169	9	0.0026462706104843996000000
TCGA-24-2030-01.8	161	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0026545862133951531000000
TCGA-13-0726-01.12	78	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0026546147482438762000000
TCGA-20-0991-01.12	166	2_CELL_SURFACE_RECEPTOR_LINKED_SIGNAL_TRANSDUCTION_GO_0007166	563	27	0.0026550852249269037000000
TCGA-13-1488-01.17	109	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	8	0.0026567995112359750000000
TCGA-25-2393-01.5	140	2_CELL_CYCLE_PHASE	146	12	0.0026662745718122123000000
TCGA-09-2056-01.6	63	0_HALLMARK_COAGULATION	125	8	0.0026682432889286395000000
TCGA-24-0982-01.3	34	2_RESPONSE_TO_STRESS	427	10	0.0026697429267606206000000
TCGA-25-1630-01.10	35	2_REGULATION_OF_CELL_CYCLE	160	7	0.0026720685511982330000000
TCGA-24-1548-01.8	141	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	12	0.0026734589021728443000000
TCGA-24-1567-01.3	141	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	12	0.0026734589021728443000000
TCGA-13-1404-01.13	117	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0026762284597701088000000
TCGA-25-2393-01.5	140	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0026837044607385110000000
TCGA-23-2079-01.14	85	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0026921587011882833000000
TCGA-24-0970-01.6	94	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0027011304657724301000000
TCGA-59-2348-01.14	123	1_KEGG_THYROID_CANCER	29	6	0.0027065002104636007000000
TCGA-59-2348-01.14	123	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0027065002104636007000000
TCGA-24-1564-01.4	47	2_CHEMOKINE_RECEPTOR_BINDING	41	5	0.0027121240419615018000000
TCGA-23-1026-01.5	65	2_CELL_CYCLE_GO_0007049	265	11	0.0027130132139419508000000
TCGA-13-0793-01.8	97	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0027184172711224586000000
TCGA-09-0369-01.9	109	2_RESPONSE_TO_STRESS	427	18	0.0027255678693795253000000
TCGA-24-1470-01.7	76	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	14	0.0027271166893480616000000
TCGA-30-1862-01.13	91	2_AGING	10	4	0.0027347311127656365000000
TCGA-23-1122-01.11	77	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0027374252351506125000000
TCGA-30-1853-01.4	111	1_KEGG_MELANOMA	71	8	0.0027381032687024791000000
TCGA-25-1623-01.7	111	0_HALLMARK_ANGIOGENESIS	32	6	0.0027416836636937275000000
TCGA-61-2088-01.7	150	1_KEGG_MELANOMA	71	9	0.0027424272335960721000000
TCGA-04-1342-01.12	104	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0027470088476128298000000
TCGA-13-1411-01.7	96	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0027491569208802479000000
TCGA-25-1318-01.11	46	1_KEGG_BLADDER_CANCER	42	5	0.0027499006054307819000000
TCGA-24-2030-01.8	161	2_EXTRACELLULAR_MATRIX	85	10	0.0027527471160539740000000
TCGA-23-1116-01.7	84	2_CELL_CYCLE_PROCESS	163	10	0.0027585356421003446000000
TCGA-13-1409-01.6	122	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	9	0.0027595959847311253000000
TCGA-61-2016-01.10	50	1_KEGG_PANCREATIC_CANCER	70	6	0.0027631161053039434000000
TCGA-09-2050-01.18	196	1_KEGG_OOCYTE_MEIOSIS	105	12	0.0027681610713217713000000
TCGA-04-1342-01.12	104	2_CHROMOSOME	102	9	0.0027707092488388979000000
TCGA-24-1563-01.15	100	2_HEPARIN_BINDING	20	5	0.0027746572363843095000000
TCGA-24-1103-01.5	73	2_CELL_CYCLE_PHASE	146	9	0.0027772341953202100000000
TCGA-13-1484-01.4	70	2_SIGNAL_TRANSDUCTION	1442	27	0.0027814256072723298000000
TCGA-36-1575-01.9	193	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	29	0.0027843974277747059000000
TCGA-25-1313-01.2	13	2_CELL_CYCLE_PROCESS	163	5	0.0027960221361194538000000
TCGA-24-1469-01.6	123	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0027965607288535340000000
TCGA-25-1635-01.6	129	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0028050951311543284000000
TCGA-25-1626-01.2	86	2_CHEMOKINE_RECEPTOR_BINDING	41	6	0.0028073714025637570000000
TCGA-24-1614-01.5	86	2_KINASE_REGULATOR_ACTIVITY	41	6	0.0028073714025637570000000
TCGA-23-1110-01.7	299	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0028129915748724213000000
TCGA-24-1556-01.19	120	2_SPINDLE_POLE	17	5	0.0028141777787900027000000
TCGA-04-1343-01.7	50	2_REGULATION_OF_CELL_CYCLE	160	8	0.0028159531809104472000000
TCGA-24-1435-01.12	115	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0028222802075419749000000
TCGA-13-1410-01.9	115	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0028222802075419749000000
TCGA-24-2298-01.7	138	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	30	0.0028238501702199503000000
TCGA-23-1026-01.5	65	2_APOPTOTIC_PROGRAM	54	6	0.0028250498734688806000000
TCGA-10-0934-01.11	145	2_REGULATION_OF_MOLECULAR_FUNCTION	286	17	0.0028259250702932378000000
TCGA-10-0937-01.9	40	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0028266792562279793000000
TCGA-30-1891-01.4	84	1_KEGG_BLADDER_CANCER	42	6	0.0028296725709964152000000
TCGA-23-1116-01.7	84	1_KEGG_BLADDER_CANCER	42	6	0.0028296725709964152000000
TCGA-13-1494-01.4	65	2_CATION_BINDING	165	9	0.0028397863419560108000000
TCGA-24-1423-01.5	27	2_MITOTIC_CELL_CYCLE	134	6	0.0028493814106528275000000
TCGA-13-1404-01.13	117	2_MICROTUBULE_CYTOSKELETON	117	10	0.0028541187464194710000000
TCGA-04-1364-01.3	163	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	27	0.0028586761359737181000000
TCGA-25-2404-01.5	58	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0028685401855826436000000
TCGA-24-2289-01.6	53	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	17	0.0028696573347320054000000
TCGA-24-1470-01.7	76	2_CHROMOSOME_SEGREGATION	26	5	0.0028723117938257896000000
TCGA-29-2427-01.10	116	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	7	0.0028778188938075977000000
TCGA-04-1331-01.5	90	0_HALLMARK_SPERMATOGENESIS	88	8	0.0028852205204898070000000
TCGA-25-1635-01.6	129	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0028912392475582355000000
TCGA-61-2092-01.12	209	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	14	0.0028988121563934010000000
TCGA-25-1320-01.4	71	1_KEGG_FOCAL_ADHESION	195	10	0.0029106411948105933000000
TCGA-13-0924-01.5	68	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0029204973774630120000000
TCGA-13-0924-01.5	68	2_MICROTUBULE_CYTOSKELETON	117	8	0.0029239071550206741000000
TCGA-13-0923-01.5	53	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0029306481157172410000000
TCGA-24-2288-01.12	112	2_MITOSIS	71	8	0.0029312057870152551000000
TCGA-61-2002-01.1	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0029317489139052706000000
TCGA-23-1028-01.18	93	2_REGULATION_OF_CELL_PROLIFERATION	265	13	0.0029348718003666219000000
TCGA-23-1116-01.7	84	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0029374594813336881000000
TCGA-23-2078-01.15	105	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0029389039687170784000000
TCGA-24-2293-01.3	33	2_GLYCOSAMINOGLYCAN_BINDING	26	4	0.0029518513599886900000000
TCGA-25-1635-01.6	129	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0029522808483540496000000
TCGA-04-1347-01.7	2	2_GLAND_DEVELOPMENT	13	2	0.0029537756297555143000000
TCGA-24-1556-01.17	2	2_GLAND_DEVELOPMENT	13	2	0.0029537756297555143000000
TCGA-25-1316-01.2	73	2_ORGAN_DEVELOPMENT	460	15	0.0029539791681472516000000
TCGA-13-0897-01.2	61	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0029651682647642849000000
TCGA-24-1567-01.3	141	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0029651924729666348000000
TCGA-24-2030-01.8	161	1_KEGG_MAPK_SIGNALING_PATHWAY	258	17	0.0029687868582275205000000
TCGA-61-1995-01.4	102	2_CHROMOSOMAL_PART	78	8	0.0029717077574460916000000
TCGA-10-0938-01.2	102	2_CHROMOSOMAL_PART	78	8	0.0029717077574460916000000
TCGA-36-1570-01.2	36	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0029741642933152237000000
TCGA-04-1364-01.3	163	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	28	0.0029745176366953322000000
TCGA-25-1623-01.7	111	2_PROTEOLYSIS	154	11	0.0029751152214549368000000
TCGA-25-2393-01.5	140	2_CELL_CYCLE_GO_0007049	265	16	0.0029851934523484900000000
TCGA-09-2050-01.18	196	0_HALLMARK_COAGULATION	125	13	0.0029921998839272531000000
TCGA-24-2030-01.8	161	2_COLLAGEN	23	6	0.0029936996985782884000000
TCGA-36-1574-01.10	152	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	12	0.0030032899936874220000000
TCGA-13-1487-01.3	79	2_CELL_CYCLE_GO_0007049	265	12	0.0030043413840660257000000
TCGA-09-2051-01.26	142	2_NUCLEUS	1110	37	0.0030111167845851728000000
TCGA-13-0899-01.1	28	2_MITOSIS	71	5	0.0030171925153982043000000
TCGA-25-1633-01.1	71	2_POLYSACCHARIDE_BINDING	28	5	0.0030171925153982043000000
TCGA-23-1117-01.11	99	2_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0030296018792148817000000
TCGA-23-1117-01.11	99	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0030296018792148817000000
TCGA-13-1512-01.2	113	0_HALLMARK_ANGIOGENESIS	32	6	0.0030448266613434839000000
TCGA-25-1634-01.4	75	2_APOPTOSIS_GO	389	14	0.0030459980812383913000000
TCGA-61-2088-01.7	150	2_BEHAVIOR	138	12	0.0030482291303775104000000
TCGA-36-1571-01.6	109	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0030482694724354412000000
TCGA-36-1571-01.6	109	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0030482694724354412000000
TCGA-09-2050-01.18	196	2_MITOSIS	71	10	0.0030489628894994447000000
TCGA-10-0934-01.11	145	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	13	0.0030497533467706869000000
TCGA-24-1428-01.9	90	2_INTERPHASE	62	7	0.0030534996213341680000000
TCGA-25-2042-01.3	63	0_HALLMARK_MYOGENESIS	172	9	0.0030641532226114701000000
TCGA-13-0911-01.3	47	1_KEGG_BLADDER_CANCER	42	5	0.0030672237385717836000000
TCGA-24-1614-01.5	86	2_DNA_BINDING	496	17	0.0030683912219631347000000
TCGA-13-1492-01.2	162	2_REGULATION_OF_MOLECULAR_FUNCTION	286	18	0.0030687872891548367000000
TCGA-13-0717-01.6	103	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	6	0.0030780424431913291000000
TCGA-04-1364-01.3	163	1_KEGG_APOPTOSIS	85	10	0.0030804018483275167000000
TCGA-13-1482-01.7	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0030809989294250115000000
TCGA-04-1338-01.7	85	2_M_PHASE	94	8	0.0030839608386107483000000
TCGA-25-1628-01.2	118	2_MICROTUBULE_CYTOSKELETON	117	10	0.0030862444059434010000000
TCGA-23-1122-01.11	77	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0030874663660195364000000
TCGA-25-2400-01.5	35	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0031051756078943372000000
TCGA-23-1028-01.18	93	1_KEGG_ERBB_SIGNALING_PATHWAY	86	8	0.0031085393227473319000000
TCGA-23-1031-01.17	142	1_KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	76	9	0.0031085663272349667000000
TCGA-36-1575-01.9	193	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0031089349116960414000000
TCGA-13-1506-01.5	113	2_DNA_METABOLIC_PROCESS	218	13	0.0031144370151801326000000
TCGA-13-0916-01.11	92	1_KEGG_PROSTATE_CANCER	87	8	0.0031270822534629856000000
TCGA-61-1919-01.9	87	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0031296662774471717000000
TCGA-13-1506-01.5	113	1_KEGG_MELANOMA	71	8	0.0031357918655430740000000
TCGA-13-1506-01.5	113	2_MITOSIS	71	8	0.0031357918655430740000000
TCGA-13-1412-01.8	113	1_KEGG_MELANOMA	71	8	0.0031357918655430740000000
TCGA-24-1560-01.2	29	2_DOUBLE_STRANDED_DNA_BINDING	30	4	0.0031375304271639088000000
TCGA-25-1634-01.4	75	2_PROGRAMMED_CELL_DEATH	390	14	0.0031398548105612393000000
TCGA-25-2396-01.6	42	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0031410930293817091000000
TCGA-09-2050-01.18	196	2_REGULATION_OF_MOLECULAR_FUNCTION	286	20	0.0031487846848959927000000
TCGA-61-2000-01.11	69	2_NUCLEUS	1110	23	0.0031493996495609187000000
TCGA-61-2101-01.2	38	2_COLLAGEN	23	4	0.0031517696426228191000000
TCGA-20-0991-01.12	166	2_GROWTH_FACTOR_ACTIVITY	49	8	0.0031676119721554662000000
TCGA-29-2427-01.10	116	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0031738703827663473000000
TCGA-13-1483-01.3	66	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0031757179562361044000000
TCGA-04-1346-01.10	75	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	17	0.0031830249935513749000000
TCGA-23-2079-01.14	85	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0031835702176814555000000
TCGA-24-1474-01.12	122	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0031859516728824601000000
TCGA-25-1630-01.10	35	2_CASPASE_ACTIVATION	25	4	0.0031924827540191505000000
TCGA-10-0933-01.2	97	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0032022292285387687000000
TCGA-13-0720-01.5	32	1_KEGG_CELL_CYCLE	114	6	0.0032063639048372588000000
TCGA-25-1326-01.11	119	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0032086148256568305000000
TCGA-13-0793-01.8	97	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	11	0.0032131175293758766000000
TCGA-24-2281-01.10	107	1_KEGG_FOCAL_ADHESION	195	12	0.0032131659755664172000000
TCGA-24-1416-01.4	38	2_DNA_METABOLIC_PROCESS	218	8	0.0032168707664071410000000
TCGA-13-1499-01.1	22	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0032229951732329716000000
TCGA-25-2393-01.5	140	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	11	0.0032244237034438918000000
TCGA-24-1469-01.6	123	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0032244237034438918000000
TCGA-23-1032-01.16	250	2_REGULATION_OF_CELL_PROLIFERATION	265	22	0.0032276913726152819000000
TCGA-13-0905-01.7	160	1_KEGG_PROSTATE_CANCER	87	10	0.0032298940971843752000000
TCGA-13-1489-01.11	118	2_CELL_CYCLE_PHASE	146	11	0.0032314845203875267000000
TCGA-57-1584-01.8	54	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	10	0.0032334717858072369000000
TCGA-13-0889-01.4	37	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0032355603641810436000000
TCGA-13-0899-01.1	28	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	5	0.0032357613783450812000000
TCGA-25-1634-01.4	75	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	14	0.0032362941166862672000000
TCGA-09-2050-01.18	196	1_KEGG_BLADDER_CANCER	42	8	0.0032398072988207897000000
TCGA-09-2050-01.18	196	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0032398072988207897000000
TCGA-09-2045-01.1	9	2_REGULATION_OF_CELL_PROLIFERATION	265	5	0.0032469618753651836000000
TCGA-25-1626-01.2	86	1_KEGG_BLADDER_CANCER	42	6	0.0032515340278562099000000
TCGA-13-2060-01.10	86	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0032515340278562099000000
TCGA-24-1431-01.3	57	1_KEGG_MELANOGENESIS	99	7	0.0032599850205274400000000
TCGA-13-1507-01.8	101	2_REGULATION_OF_MITOSIS	36	6	0.0032629287895261198000000
TCGA-24-2288-01.12	112	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0032653872300726821000000
TCGA-10-0934-01.11	145	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	25	0.0032666373887097269000000
TCGA-13-0905-01.7	160	2_REGULATION_OF_MITOSIS	36	7	0.0032702032774685826000000
TCGA-23-1118-01.5	50	2_DNA_RECOMBINATION	40	5	0.0032710186458519762000000
TCGA-04-1343-01.7	50	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0032710186458519762000000
TCGA-24-1603-01.3	69	2_MICROTUBULE_CYTOSKELETON	117	8	0.0032735113061337293000000
TCGA-13-1491-01.7	90	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0032778964998320509000000
TCGA-24-1548-01.8	141	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0032837041351896036000000
TCGA-04-1542-01.4	141	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0032837041351896036000000
TCGA-09-1659-01.5	51	2_REGULATION_OF_CELL_CYCLE	160	8	0.0032922439957097723000000
TCGA-59-2363-01.3	89	1_KEGG_MISMATCH_REPAIR	23	5	0.0032947750310162961000000
TCGA-24-2262-01.25	141	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0033055090636921265000000
TCGA-24-2262-01.25	141	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0033055090636921265000000
TCGA-09-2049-01.8	96	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0033072219870618575000000
TCGA-13-0912-01.2	55	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0033092421904977161000000
TCGA-04-1542-01.4	141	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0033224290437009669000000
TCGA-13-0884-01.11	68	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0033230487939242175000000
TCGA-23-1027-01.8	68	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0033230487939242175000000
TCGA-61-2016-01.10	50	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0033251473444828252000000
TCGA-04-1343-01.7	50	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0033251473444828252000000
TCGA-24-1558-01.12	174	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	28	0.0033293420194487481000000
TCGA-23-1023-01.1	93	0_HALLMARK_APOPTOSIS	150	10	0.0033328285341950653000000
TCGA-25-1326-01.11	119	2_MICROTUBULE_CYTOSKELETON	117	10	0.0033346544918054564000000
TCGA-61-1736-01.2	54	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0033366266215643699000000
TCGA-31-1959-01.7	101	2_BEHAVIOR	138	10	0.0033416812694031903000000
TCGA-25-1313-01.2	13	0_HALLMARK_E2F_TARGETS	169	5	0.0033430143697780056000000
TCGA-13-0894-01.9	118	2_TRANSITION_METAL_ION_BINDING	92	9	0.0033509701471746566000000
TCGA-13-0910-01.3	71	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0033619395404748341000000
TCGA-25-1313-01.2	13	2_MITOSIS	71	4	0.0033619395404748341000000
TCGA-13-1482-01.7	62	2_EXTRACELLULAR_REGION	346	12	0.0033670588563999805000000
TCGA-24-1435-01.12	115	0_HALLMARK_ANGIOGENESIS	32	6	0.0033748405085906323000000
TCGA-13-1410-01.9	115	0_HALLMARK_ANGIOGENESIS	32	6	0.0033748405085906323000000
TCGA-61-2008-01.19	70	2_NEGATIVE_REGULATION_OF_GROWTH	29	5	0.0033764913502361978000000
TCGA-24-1603-01.3	69	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0033819452239303173000000
TCGA-13-0795-01.9	67	2_APOPTOTIC_PROGRAM	54	6	0.0033835379474262172000000
TCGA-13-0760-01.12	93	1_KEGG_PROSTATE_CANCER	87	8	0.0033959547488390238000000
TCGA-13-1494-01.4	65	0_HALLMARK_COAGULATION	125	8	0.0034014322293893762000000
TCGA-13-0884-01.11	68	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0034058723503916717000000
TCGA-13-0890-01.2	48	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0034127002204910402000000
TCGA-13-0720-01.5	32	2_CELL_CYCLE_GO_0007049	265	8	0.0034148664774190972000000
TCGA-25-1320-01.4	71	2_PROTEOLYSIS	154	9	0.0034156006671808084000000
TCGA-24-1560-01.2	29	2_ADENYL_RIBONUCLEOTIDE_BINDING	128	6	0.0034182524214384914000000
TCGA-61-2111-01.16	56	2_CELL_CYCLE_PHASE	146	8	0.0034418846234154847000000
TCGA-61-2012-01.6	78	2_CYTOKINE_ACTIVITY	104	8	0.0034445621273655690000000
TCGA-04-1336-01.28	106	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	20	0.0034493591740089305000000
TCGA-24-1557-01.13	106	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	20	0.0034493591740089305000000
TCGA-61-2092-01.12	209	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	23	0.0034497393508134120000000
TCGA-61-2092-01.12	209	2_REGULATION_OF_KINASE_ACTIVITY	138	14	0.0034560542698831458000000
TCGA-24-2262-01.25	141	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	11	0.0034591564570174873000000
TCGA-24-1567-01.3	141	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	11	0.0034591564570174873000000
TCGA-13-0765-01.4	54	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0034625901223021812000000
TCGA-13-0795-01.9	67	2_CELL_DEVELOPMENT	511	15	0.0034655201222246234000000
TCGA-13-0755-01.6	16	2_MITOTIC_CELL_CYCLE	134	5	0.0034677240097087496000000
TCGA-13-1510-01.20	82	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	8	0.0034757374851788906000000
TCGA-13-0791-01.35	80	1_KEGG_MELANOMA	71	7	0.0034762562213337227000000
TCGA-09-2050-01.18	196	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0034775642380173639000000
TCGA-24-1551-01.15	87	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0034809549691265746000000
TCGA-61-1919-01.9	87	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0034809549691265746000000
TCGA-13-0751-01.2	51	2_DNA_METABOLIC_PROCESS	218	9	0.0034823131331328150000000
TCGA-24-2030-01.8	161	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	33	0.0034825213205203097000000
TCGA-25-1626-01.2	86	2_METALLOENDOPEPTIDASE_ACTIVITY	24	5	0.0034836348096928872000000
TCGA-04-1362-01.4	35	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0034853353057491205000000
TCGA-13-1506-01.5	113	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0034929693336371477000000
TCGA-23-1021-01.7	44	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0034980952531487195000000
TCGA-57-1993-01.8	52	1_KEGG_PANCREATIC_CANCER	70	6	0.0034990377973588291000000
TCGA-25-1627-01.4	75	2_CELL_CYCLE_PHASE	146	9	0.0034999584084002655000000
TCGA-13-0717-01.6	103	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0035044275506233677000000
TCGA-36-1574-01.10	152	2_REGULATION_OF_KINASE_ACTIVITY	138	12	0.0035069715907206788000000
TCGA-24-2293-01.3	33	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	13	0.0035077109443455131000000
TCGA-24-1464-01.7	62	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0035089768245370190000000
TCGA-23-1110-01.7	299	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	16	0.0035280129324078780000000
TCGA-13-1499-01.1	22	0_HALLMARK_G2M_CHECKPOINT	174	6	0.0035335046001135502000000
TCGA-13-1498-01.13	104	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0035373409482072431000000
TCGA-13-0916-01.11	92	2_INTERPHASE	62	7	0.0035439431209827120000000
TCGA-23-1023-01.1	93	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	19	0.0035535219948666838000000
TCGA-25-1313-01.2	13	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	4	0.0035569765737649950000000
TCGA-25-1633-01.1	71	2_TISSUE_DEVELOPMENT	115	8	0.0035816549871542946000000
TCGA-13-0899-01.1	28	2_MITOTIC_CELL_CYCLE	134	6	0.0035844869543534964000000
TCGA-24-2298-01.7	138	2_SYSTEM_DEVELOPMENT	694	27	0.0035846277845766874000000
TCGA-04-1332-01.2	25	2_REGULATION_OF_MITOSIS	36	4	0.0035851514500713924000000
TCGA-61-2102-01.7	172	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0035918793813032412000000
TCGA-13-0717-01.6	103	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	21	0.0035936126455028278000000
TCGA-13-0916-01.11	92	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0035938522588163740000000
TCGA-24-1560-01.2	29	2_SINGLE_STRANDED_DNA_BINDING	31	4	0.0035947210906210419000000
TCGA-13-1411-01.7	96	1_KEGG_CELL_CYCLE	114	9	0.0035952897969326364000000
TCGA-13-0793-01.8	97	2_EXTRACELLULAR_REGION	346	15	0.0035967308561297745000000
TCGA-13-0793-01.8	97	2_DNA_METABOLIC_PROCESS	218	12	0.0036063452620699018000000
TCGA-13-0717-01.6	103	2_IMMUNE_SYSTEM_PROCESS	283	14	0.0036070550175048184000000
TCGA-23-1031-01.17	142	2_CELL_CYCLE_GO_0007049	265	16	0.0036088146740139446000000
TCGA-23-1031-01.17	142	2_RECEPTOR_BINDING	331	18	0.0036101755686917857000000
TCGA-10-0933-01.2	97	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0036129079254465248000000
TCGA-13-0751-01.2	51	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0036153625492205922000000
TCGA-13-0751-01.2	51	2_DNA_RECOMBINATION	40	5	0.0036153625492205922000000
TCGA-10-0931-01.12	59	1_KEGG_COLORECTAL_CANCER	62	6	0.0036230032792979087000000
TCGA-24-1557-01.13	106	2_SPINDLE	35	6	0.0036433027332078032000000
TCGA-36-1575-01.9	193	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	14	0.0036516342247807933000000
TCGA-31-1950-01.7	105	2_MITOTIC_CELL_CYCLE	134	10	0.0036542850056803778000000
TCGA-25-2042-01.3	63	2_ENDOPEPTIDASE_ACTIVITY	91	7	0.0036737023875835144000000
TCGA-13-1405-01.4	69	2_REGULATION_OF_CELL_CYCLE	160	9	0.0036745421429927377000000
TCGA-61-1919-01.9	87	2_M_PHASE	94	8	0.0036842568604335177000000
TCGA-61-2002-01.1	118	0_HALLMARK_KRAS_SIGNALING_UP	148	11	0.0036951148118071859000000
TCGA-24-1470-01.7	76	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0037005843981590060000000
TCGA-24-1553-01.7	26	2_AGING	10	3	0.0037047090012235092000000
TCGA-24-1424-01.4	80	2_CHROMOSOME_SEGREGATION	26	5	0.0037098359595742572000000
TCGA-25-1630-01.10	35	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	8	0.0037218993161346197000000
TCGA-23-1110-01.7	299	2_CHROMOSOMEPERICENTRIC_REGION	29	8	0.0037220614172839952000000
TCGA-30-1853-01.4	111	2_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION	99	9	0.0037260418030566999000000
TCGA-13-0755-01.6	16	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	5	0.0037312307064723401000000
TCGA-24-2290-01.3	70	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0037316331894781296000000
TCGA-24-1466-01.15	82	1_KEGG_PANCREATIC_CANCER	70	7	0.0037316331894781296000000
TCGA-23-1123-01.7	70	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0037316331894781296000000
TCGA-09-2051-01.26	142	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0037316958286831656000000
TCGA-09-2051-01.26	142	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0037316958286831656000000
TCGA-13-1404-01.13	117	0_HALLMARK_ANGIOGENESIS	32	6	0.0037335288969983882000000
TCGA-24-1560-01.2	29	2_ADENYL_NUCLEOTIDE_BINDING	130	6	0.0037426939925259183000000
TCGA-24-2271-01.3	44	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0037541661264352288000000
TCGA-20-0991-01.12	166	2_IMMUNE_SYSTEM_PROCESS	283	18	0.0037636826982751651000000
TCGA-04-1350-01.2	130	2_TRANSCRIPTION_FACTOR_ACTIVITY	291	16	0.0037654883929956248000000
TCGA-24-1567-01.3	141	2_IMMUNE_RESPONSE	206	14	0.0037694778415649165000000
TCGA-09-1666-01.28	109	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0037714473747947680000000
TCGA-13-0804-01.5	78	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	14	0.0037750936066055030000000
TCGA-04-1348-01.6	81	2_MITOSIS	71	7	0.0037825299777190535000000
TCGA-04-1364-01.3	163	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0037857968391425672000000
TCGA-24-1436-01.1	49	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0037881001779620084000000
TCGA-23-1024-01.3	24	2_REGULATION_OF_CELL_CYCLE	160	6	0.0037952240043330034000000
TCGA-25-1633-01.1	71	2_REGULATION_OF_BODY_FLUID_LEVELS	52	6	0.0038060633482844995000000
TCGA-20-0990-01.17	133	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0038106387743304265000000
TCGA-10-0937-01.9	40	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0038115322724778635000000
TCGA-25-1322-01.15	93	2_INTERPHASE	62	7	0.0038128538463550032000000
TCGA-23-1028-01.18	93	1_KEGG_COLORECTAL_CANCER	62	7	0.0038128538463550032000000
TCGA-10-0927-01.5	3	1_KEGG_TIGHT_JUNCTION	125	3	0.0038215695954115052000000
TCGA-10-0937-01.5	3	1_KEGG_TIGHT_JUNCTION	125	3	0.0038215695954115052000000
TCGA-59-2351-01.6	3	1_KEGG_TIGHT_JUNCTION	125	3	0.0038215695954115052000000
TCGA-13-1505-01.12	3	1_KEGG_TIGHT_JUNCTION	125	3	0.0038215695954115052000000
TCGA-31-1953-01.5	3	1_KEGG_TIGHT_JUNCTION	125	3	0.0038215695954115052000000
TCGA-25-1318-01.12	3	1_KEGG_TIGHT_JUNCTION	125	3	0.0038215695954115052000000
TCGA-24-1422-01.11	3	1_KEGG_TIGHT_JUNCTION	125	3	0.0038215695954115052000000
TCGA-23-1028-01.18	93	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0038298202913978458000000
TCGA-13-0760-01.12	93	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0038298202913978458000000
TCGA-61-1998-01.14	105	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0038335691127231574000000
TCGA-23-2081-01.7	56	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0038474142508611842000000
TCGA-24-2024-01.3	55	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	10	0.0038562625300426986000000
TCGA-24-1556-01.19	120	2_REPLICATION_FORK	18	5	0.0038571071555382843000000
TCGA-13-1409-01.6	122	2_APOPTOSIS_GO	389	18	0.0038578394562288655000000
TCGA-25-1329-01.5	43	2_CELL_CYCLE_GO_0007049	265	9	0.0038761490770703676000000
TCGA-04-1365-01.6	150	2_CYTOSKELETAL_PART	194	14	0.0038824372903761722000000
TCGA-13-0883-01.3	23	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0038896312105820628000000
TCGA-13-0883-01.3	23	2_DNA_RECOMBINATION	40	4	0.0038896312105820628000000
TCGA-24-1466-01.15	82	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	9	0.0038938581460934776000000
TCGA-13-1510-01.20	82	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	9	0.0038938581460934776000000
TCGA-09-2049-01.8	96	2_DEFENSE_RESPONSE	222	12	0.0039019212922248125000000
TCGA-36-1575-01.9	193	2_GROWTH_FACTOR_BINDING	31	7	0.0039050096374991664000000
TCGA-13-0884-01.11	68	2_EXTRACELLULAR_MATRIX	85	7	0.0039059380113403114000000
TCGA-23-1027-01.8	68	2_EXTRACELLULAR_MATRIX	85	7	0.0039059380113403114000000
TCGA-09-1665-01.16	131	1_KEGG_THYROID_CANCER	29	6	0.0039141052682624515000000
TCGA-24-1474-01.12	122	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	6	0.0039153223335109868000000
TCGA-09-1666-01.28	109	1_KEGG_FOCAL_ADHESION	195	12	0.0039182131905391524000000
TCGA-31-1953-01.6	53	1_KEGG_PANCREATIC_CANCER	70	6	0.0039228341730862945000000
TCGA-25-1628-01.2	118	0_HALLMARK_ANGIOGENESIS	32	6	0.0039242121525590182000000
TCGA-13-0897-01.2	61	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0039271368019890094000000
TCGA-25-1626-01.2	86	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	14	0.0039284938767934399000000
TCGA-13-1499-01.1	22	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0039353277203997413000000
TCGA-10-0934-01.11	145	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	24	0.0039367207341244161000000
TCGA-61-2113-01.15	99	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	11	0.0039411161934490490000000
TCGA-13-0894-01.9	118	1_KEGG_WNT_SIGNALING_PATHWAY	149	11	0.0039481007466469330000000
TCGA-25-2391-01.2	64	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0039519732289221392000000
TCGA-36-1575-01.9	193	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	14	0.0039534767267984617000000
TCGA-13-1411-01.7	96	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0039555147052670056000000
TCGA-24-1614-01.5	86	2_ENZYME_INHIBITOR_ACTIVITY	96	8	0.0039589227603982462000000
TCGA-24-1464-01.5	2	2_CELLULAR_RESPIRATION	15	2	0.0039762364246729324000000
TCGA-13-1507-01.6	2	2_KERATINOCYTE_DIFFERENTIATION	15	2	0.0039762364246729324000000
TCGA-10-0937-01.2	2	2_CELLULAR_RESPIRATION	15	2	0.0039762364246729324000000
TCGA-23-2078-01.8	2	2_CELLULAR_RESPIRATION	15	2	0.0039762364246729324000000
TCGA-13-0760-01.1	2	2_KERATINOCYTE_DIFFERENTIATION	15	2	0.0039762364246729324000000
TCGA-24-1466-01.11	2	2_CELLULAR_RESPIRATION	15	2	0.0039762364246729324000000
TCGA-25-1630-01.9	2	2_KERATINOCYTE_DIFFERENTIATION	15	2	0.0039762364246729324000000
TCGA-13-0889-01.4	37	2_REGULATION_OF_CELL_CYCLE	160	7	0.0039762971275157594000000
TCGA-24-1557-01.13	106	2_CHROMOSOMAL_PART	78	8	0.0039800045377716047000000
TCGA-24-1567-01.3	141	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	13	0.0039814020247261528000000
TCGA-04-1525-01.7	52	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0039876206234139800000000
TCGA-57-1993-01.8	52	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0039876206234139800000000
TCGA-24-1558-01.12	174	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0039884905477094636000000
TCGA-24-1422-01.10	56	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0039941522198295391000000
TCGA-13-1489-01.11	118	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0039976066030251306000000
TCGA-13-1409-01.6	122	2_PROGRAMMED_CELL_DEATH	390	18	0.0040012341954624260000000
TCGA-13-0717-01.6	103	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0040028888405472633000000
TCGA-10-0933-01.2	97	2_DNA_BINDING	496	18	0.0040056160105100252000000
TCGA-13-1408-01.1	45	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0040081130601092073000000
TCGA-24-1565-01.1	16	2_BEHAVIOR	138	5	0.0040102885922684217000000
TCGA-13-0755-01.6	16	2_REGULATION_OF_KINASE_ACTIVITY	138	5	0.0040102885922684217000000
TCGA-13-1492-01.2	162	0_HALLMARK_SPERMATOGENESIS	88	10	0.0040199152893909094000000
TCGA-24-2293-01.3	33	2_POLYSACCHARIDE_BINDING	28	4	0.0040229214400438725000000
TCGA-23-1022-01.10	170	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0040417807143530984000000
TCGA-61-2008-01.19	70	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0040515477461111659000000
TCGA-25-1630-01.10	35	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	11	0.0040693948764131578000000
TCGA-24-2019-01.10	192	2_CELL_PROLIFERATION_GO_0008283	436	25	0.0040729169616891322000000
TCGA-29-2427-01.10	116	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	14	0.0040769028906569643000000
TCGA-04-1356-01.1	71	2_MICROTUBULE_CYTOSKELETON	117	8	0.0040803809655683811000000
TCGA-36-1574-01.10	152	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	12	0.0040839225589747920000000
TCGA-24-0970-01.6	94	2_INTERPHASE	62	7	0.0040986201233776855000000
TCGA-61-2012-01.6	78	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	6	0.0041016021570648075000000
TCGA-61-2092-01.12	209	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	14	0.0041070614751804735000000
TCGA-13-0920-01.9	82	1_KEGG_MELANOMA	71	7	0.0041110456109104904000000
TCGA-25-2401-01.5	119	0_HALLMARK_ANGIOGENESIS	32	6	0.0041227778291270910000000
TCGA-23-1031-01.17	142	0_HALLMARK_APOPTOSIS	150	12	0.0041259469159524616000000
TCGA-13-0885-01.6	44	2_MITOTIC_CELL_CYCLE	134	7	0.0041260628700162255000000
TCGA-13-0912-01.2	55	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0041287092285634966000000
TCGA-13-0924-01.5	68	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	5	0.0041323054838595160000000
TCGA-23-1122-01.11	77	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0041362017193621132000000
TCGA-59-2351-01.5	31	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	4	0.0041382704468604838000000
TCGA-13-1409-01.6	122	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	18	0.0041494429191916114000000
TCGA-13-1484-01.4	70	2_REGULATION_OF_CELL_CYCLE	160	9	0.0041562074569701192000000
TCGA-04-1348-01.6	81	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0041611822368602209000000
TCGA-13-0924-01.5	68	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	13	0.0041645203875147890000000
TCGA-61-2092-01.12	209	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0041664505290325612000000
TCGA-09-1659-01.5	51	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0041692110920033779000000
TCGA-61-2113-01.15	99	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0041789376995267739000000
TCGA-61-2113-01.15	99	2_SKELETAL_DEVELOPMENT	84	8	0.0041789376995267739000000
TCGA-23-1117-01.11	99	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0041789376995267739000000
TCGA-13-0717-01.6	103	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	5	0.0041811990622774679000000
TCGA-13-0904-01.6	105	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0041821338239841545000000
TCGA-13-0723-01.8	50	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0041952598656128008000000
TCGA-23-1118-01.5	50	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0041952598656128008000000
TCGA-13-0720-01.5	32	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0041955141030254432000000
TCGA-24-1553-01.7	26	2_PROTEIN_N_TERMINUS_BINDING	36	4	0.0042255181644295656000000
TCGA-23-1024-01.3	24	2_CELL_CYCLE_PROCESS	163	6	0.0042292189975417565000000
TCGA-57-1582-01.26	174	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	13	0.0042310378544504843000000
TCGA-61-2016-01.10	50	0_HALLMARK_E2F_TARGETS	169	8	0.0042495489566645242000000
TCGA-24-0979-01.5	41	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	7	0.0042591208374882809000000
TCGA-23-1023-01.1	93	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	19	0.0042600585458005486000000
TCGA-13-0807-01.8	46	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0042617955365664316000000
TCGA-09-2056-01.6	63	1_KEGG_INSULIN_SIGNALING_PATHWAY	133	8	0.0042633506279179494000000
TCGA-61-2094-01.6	63	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	8	0.0042633506279179494000000
TCGA-09-2045-01.1	9	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	6	0.0042907044623324156000000
TCGA-23-2072-01.9	74	1_KEGG_FOCAL_ADHESION	195	10	0.0042917852644149806000000
TCGA-13-1408-01.1	45	2_SKELETAL_DEVELOPMENT	84	6	0.0043011287528099251000000
TCGA-13-0755-01.6	16	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	5	0.0043055559061273840000000
TCGA-25-1626-01.2	86	2_HEMOSTASIS	44	6	0.0043122910103498930000000
TCGA-13-2060-01.10	86	2_CASPASE_ACTIVATION	25	5	0.0043234866449853660000000
TCGA-25-1623-01.7	111	2_REGULATION_OF_CELL_CYCLE	160	11	0.0043318526115774334000000
TCGA-09-1666-01.28	109	2_CELL_CYCLE_PROCESS	163	11	0.0043385804842682122000000
TCGA-59-2363-01.3	89	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0043477225417713960000000
TCGA-13-1489-01.11	118	1_KEGG_MELANOMA	71	8	0.0043511262017037339000000
TCGA-61-1995-01.4	102	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0043597175556350700000000
TCGA-23-1110-01.7	299	0_HALLMARK_MITOTIC_SPINDLE	175	19	0.0043620149301215622000000
TCGA-04-1331-01.5	90	2_KINETOCHORE	24	5	0.0043666825329531905000000
TCGA-04-1348-01.6	81	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0043707530130972973000000
TCGA-20-0991-01.12	166	2_EXTRACELLULAR_REGION	346	20	0.0043826889443764408000000
TCGA-13-0897-01.2	61	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0043830983524814470000000
TCGA-29-2427-01.10	116	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0043897766285082651000000
TCGA-13-0916-01.11	92	2_CYTOSKELETAL_PART	194	11	0.0043906789350355874000000
TCGA-09-2044-01.4	83	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0043909875219722023000000
TCGA-25-1321-01.3	33	2_CELL_CYCLE_GO_0007049	265	8	0.0043991462187645729000000
TCGA-25-1635-01.6	129	1_KEGG_PROSTATE_CANCER	87	9	0.0044001588499526833000000
TCGA-04-1347-01.15	187	2_CELL_DEVELOPMENT	511	27	0.0044002313484382445000000
TCGA-24-0966-01.2	18	2_MITOCHONDRIAL_TRANSPORT	15	3	0.0044019631818398150000000
TCGA-13-0883-01.4	3	2_ENVELOPE	131	3	0.0044036147899663772000000
TCGA-13-0883-01.4	3	2_ORGANELLE_ENVELOPE	131	3	0.0044036147899663772000000
TCGA-24-2280-01.10	58	2_SYSTEM_DEVELOPMENT	694	16	0.0044061678500879053000000
TCGA-13-1496-01.13	120	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	8	0.0044287921505211016000000
TCGA-04-1347-01.15	187	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	23	0.0044326475736224226000000
TCGA-24-1603-01.3	69	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	5	0.0044449044597918014000000
TCGA-13-1409-01.6	122	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	26	0.0044504891560985440000000
TCGA-24-1464-01.7	62	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0044547828845204500000000
TCGA-59-2350-01.1	62	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0044547828845204500000000
TCGA-13-0724-01.21	71	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0044630746443062221000000
TCGA-13-0730-01.8	83	2_MITOSIS	71	7	0.0044630746443062230000000
TCGA-13-0727-01.1	29	2_MITOTIC_CELL_CYCLE	134	6	0.0044672379002495995000000
TCGA-61-2088-01.7	150	1_KEGG_GNRH_SIGNALING_PATHWAY	96	10	0.0044677877692918299000000
TCGA-04-1365-01.6	150	2_DNA_RECOMBINATION	40	7	0.0044886370556805897000000
TCGA-23-1116-01.7	84	2_MITOTIC_CELL_CYCLE	134	9	0.0044888501143650807000000
TCGA-13-0897-01.2	61	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	5	0.0044892810562194036000000
TCGA-10-0938-01.2	102	0_HALLMARK_MITOTIC_SPINDLE	175	11	0.0044940931247208927000000
TCGA-13-0717-01.6	103	2_AGING	10	4	0.0044962541964054274000000
TCGA-36-1574-01.10	152	2_EXTRACELLULAR_REGION	346	19	0.0044997636494666154000000
TCGA-04-1530-01.2	90	0_HALLMARK_COAGULATION	125	9	0.0045053897762893829000000
TCGA-13-1510-01.20	82	2_CELL_CYCLE_GO_0007049	265	12	0.0045101755656773313000000
TCGA-09-1662-01.6	49	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0045102192599478681000000
TCGA-23-1021-01.7	44	1_KEGG_FOCAL_ADHESION	195	8	0.0045188035286844157000000
TCGA-59-2354-01.2	44	1_KEGG_FOCAL_ADHESION	195	8	0.0045188035286844157000000
TCGA-23-1030-01.10	58	2_CELL_CYCLE_PHASE	146	8	0.0045249782841387098000000
TCGA-13-1509-01.9	117	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0045346880304010326000000
TCGA-09-1665-01.16	131	2_CYTOSKELETAL_PART	194	13	0.0045404638768988788000000
TCGA-24-1469-01.6	123	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0045550458053560299000000
TCGA-13-0913-01.5	44	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0045562881905629364000000
TCGA-13-0904-01.6	105	2_IMMUNE_SYSTEM_PROCESS	283	14	0.0045578042509870536000000
TCGA-24-1469-01.6	123	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0045613733298347139000000
TCGA-20-0987-01.19	194	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0045618352855388150000000
TCGA-13-0717-01.6	103	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0045619834881459303000000
TCGA-04-1338-01.7	85	2_ORGAN_DEVELOPMENT	460	16	0.0045631117858359596000000
TCGA-57-1582-01.26	174	2_CELL_CYCLE_PHASE	146	13	0.0045709763900873028000000
TCGA-13-1404-01.13	117	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0045725749769081657000000
TCGA-61-2094-01.6	63	2_M_PHASE	94	7	0.0045738530259968472000000
TCGA-25-1318-01.11	46	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0045771845613510774000000
TCGA-23-1022-01.10	170	2_REGULATION_OF_APOPTOSIS	309	19	0.0045870182352245360000000
TCGA-25-1627-01.4	75	2_BIOPOLYMER_METABOLIC_PROCESS	1367	27	0.0046005509679115496000000
TCGA-24-1551-01.1	3	2_ION_TRANSPORT	133	3	0.0046100096155424798000000
TCGA-13-0924-01.4	3	2_ION_TRANSPORT	133	3	0.0046100096155424798000000
TCGA-61-1995-01.4	102	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	16	0.0046183202206338718000000
TCGA-36-1576-01.8	124	2_ENDOPEPTIDASE_ACTIVITY	91	9	0.0046248825560119382000000
TCGA-23-1026-01.5	65	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0046289606207017258000000
TCGA-09-1659-01.5	51	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0046360823620848852000000
TCGA-13-1492-01.2	162	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	12	0.0046423970165990949000000
TCGA-13-1509-01.9	117	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0046500323048868104000000
TCGA-36-1575-01.9	193	2_DEFENSE_RESPONSE	222	17	0.0046519166840505574000000
TCGA-23-1024-01.3	24	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0046533344061121650000000
TCGA-24-1470-01.7	76	2_CHROMOSOMAL_PART	78	7	0.0046533594292968872000000
TCGA-13-0899-01.1	28	2_CELL_PROLIFERATION_GO_0008283	436	9	0.0046576402059843878000000
TCGA-24-2035-01.8	102	2_RESPONSE_TO_STRESS	427	17	0.0046586561644583755000000
TCGA-13-0904-01.6	105	2_IMMUNE_RESPONSE	206	12	0.0046660117240899116000000
TCGA-25-1626-01.2	86	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	7	0.0046709599320834145000000
TCGA-13-1498-01.13	104	2_AGING	10	4	0.0046737118686757794000000
TCGA-13-1510-01.20	82	2_BEHAVIOR	138	9	0.0046751191614916518000000
TCGA-36-1576-01.8	124	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0046803636718995775000000
TCGA-04-1336-01.28	106	0_HALLMARK_E2F_TARGETS	169	11	0.0046838169948448883000000
TCGA-25-1630-01.10	35	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0046841854393012538000000
TCGA-24-1428-01.9	90	2_REGULATION_OF_MOLECULAR_FUNCTION	286	13	0.0046941916681963545000000
TCGA-30-1853-01.4	111	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	21	0.0047190423879055251000000
TCGA-30-1891-01.4	84	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0047288282956881780000000
TCGA-24-1564-01.4	47	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	8	0.0047367814415559184000000
TCGA-24-1435-01.12	115	2_REGULATION_OF_BODY_FLUID_LEVELS	52	7	0.0047383449137851329000000
TCGA-13-0906-01.5	66	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0047441721065320892000000
TCGA-13-0883-01.3	23	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0047484962841786924000000
TCGA-24-2271-01.3	44	2_CELL_CYCLE_GO_0007049	265	9	0.0047546367950107244000000
TCGA-24-0980-01.5	44	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0047546367950107244000000
TCGA-24-1549-01.21	158	2_MICROTUBULE_BASED_PROCESS	72	9	0.0047622978825433444000000
TCGA-61-2095-01.1	32	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0047682855881817391000000
TCGA-04-1530-01.2	90	2_M_PHASE	94	8	0.0047697360197196149000000
TCGA-13-0765-01.4	54	1_KEGG_MELANOMA	71	6	0.0047717155517232723000000
TCGA-23-1022-01.10	170	0_HALLMARK_APOPTOSIS	150	13	0.0047746067987974872000000
TCGA-13-0904-01.6	105	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0047751523922954656000000
TCGA-61-2008-01.19	70	2_REGULATION_OF_CELL_GROWTH	31	5	0.0047758203968864847000000
TCGA-24-1431-01.3	57	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0048002569799272810000000
TCGA-25-1625-01.6	38	2_REGULATION_OF_CELL_CYCLE	160	7	0.0048053531188170439000000
TCGA-30-1853-01.4	111	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0048109200896250546000000
TCGA-23-1022-01.10	170	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	19	0.0048110556053069997000000
TCGA-13-1403-01.9	71	2_SKELETAL_DEVELOPMENT	84	7	0.0048399412993535822000000
TCGA-25-1320-01.4	71	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0048399412993535822000000
TCGA-23-1032-01.16	250	2_SIGNAL_TRANSDUCTION	1442	66	0.0048448598932194966000000
TCGA-23-1120-01.10	57	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0048469832900686453000000
TCGA-13-0911-01.3	47	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0048518435483341582000000
TCGA-13-0904-01.6	105	2_AGING	10	4	0.0048563232265659397000000
TCGA-23-2078-01.15	105	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	4	0.0048563232265659397000000
TCGA-31-1950-01.7	105	2_AGING	10	4	0.0048563232265659397000000
TCGA-13-1501-01.12	101	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0048627161324567023000000
TCGA-13-1482-01.7	62	2_INTERPHASE	62	6	0.0048681394825146928000000
TCGA-04-1362-01.4	35	1_KEGG_COLORECTAL_CANCER	62	5	0.0048701403006692389000000
TCGA-04-1362-01.4	35	2_INTERPHASE	62	5	0.0048701403006692389000000
TCGA-23-1027-01.8	68	0_HALLMARK_ANGIOGENESIS	32	5	0.0048703694943050988000000
TCGA-20-0990-01.17	133	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	11	0.0048760493960952811000000
TCGA-13-0897-01.2	61	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0048833428462862309000000
TCGA-61-2012-01.6	78	2_CELL_CYCLE_PHASE	146	9	0.0048860017474070408000000
TCGA-10-0928-01.6	70	1_KEGG_BASAL_CELL_CARCINOMA	55	6	0.0048962769669595322000000
TCGA-13-1494-01.4	65	2_TRANSITION_METAL_ION_BINDING	92	7	0.0048994494425383794000000
TCGA-24-1419-01.2	93	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0049028666395659467000000
TCGA-23-2081-01.7	56	2_CELL_CYCLE_GO_0007049	265	10	0.0049035341481747201000000
TCGA-61-2111-01.16	56	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0049035341481747201000000
TCGA-61-2008-01.19	70	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0049072996225448346000000
TCGA-13-0730-01.8	83	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0049089453578982055000000
TCGA-13-0804-01.5	78	2_KINESIN_COMPLEX	13	4	0.0049091686793657288000000
TCGA-25-1318-01.11	46	2_SKELETAL_DEVELOPMENT	84	6	0.0049113573822165794000000
TCGA-13-0755-01.6	16	2_REGULATION_OF_CELL_PROLIFERATION	265	6	0.0049163948851602621000000
TCGA-24-1614-01.5	86	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0049396738388511911000000
TCGA-24-2271-01.3	44	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	15	0.0049465747988140562000000
TCGA-59-2354-01.2	44	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	15	0.0049465747988140562000000
TCGA-24-1603-01.3	69	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	13	0.0049471805113019511000000
TCGA-13-0714-01.9	51	0_HALLMARK_E2F_TARGETS	169	8	0.0049641035465647033000000
TCGA-24-1464-01.7	62	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0049710714496201862000000
TCGA-59-2350-01.1	62	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0049710714496201862000000
TCGA-04-1347-01.15	187	2_REGULATION_OF_APOPTOSIS	309	20	0.0049759906612326810000000
TCGA-13-0884-01.11	68	2_EXTRACELLULAR_REGION_PART	269	11	0.0049882944822589054000000
TCGA-04-1331-01.5	90	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0050017933417606875000000
TCGA-24-1428-01.9	90	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0050017933417606875000000
TCGA-13-1491-01.7	90	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0050017933417606875000000
TCGA-61-2000-01.11	69	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0050051612495226961000000
TCGA-23-1110-01.7	299	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	29	0.0050062995734413652000000
TCGA-04-1338-01.7	85	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0050150418597218619000000
TCGA-61-2109-01.13	122	1_KEGG_PANCREATIC_CANCER	70	8	0.0050159355925230636000000
TCGA-13-0913-01.5	44	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0050234066761893096000000
TCGA-13-0913-01.5	44	2_BEHAVIOR	138	7	0.0050234066761893096000000
TCGA-13-0893-01.4	112	2_SPINDLE	35	6	0.0050289984661883065000000
TCGA-24-2288-01.12	112	2_SPINDLE	35	6	0.0050289984661883065000000
TCGA-57-1582-01.26	174	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0050315948520159894000000
TCGA-23-1122-01.11	77	2_REGULATION_OF_MOLECULAR_FUNCTION	286	12	0.0050338116574197176000000
TCGA-57-1584-01.8	54	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	11	0.0050424653189842100000000
TCGA-04-1336-01.28	106	2_AGING	10	4	0.0050441847860274967000000
TCGA-24-1557-01.13	106	2_AGING	10	4	0.0050441847860274967000000
TCGA-25-2396-01.6	42	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	7	0.0050458449234388504000000
TCGA-24-1614-01.5	86	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0050638698522120608000000
TCGA-25-1635-01.6	129	2_DNA_REPAIR	113	10	0.0050649439872894816000000
TCGA-24-2035-01.8	102	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	13	0.0050704634724811253000000
TCGA-24-1424-01.4	80	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0051061738202298557000000
TCGA-36-1568-01.22	80	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0051061738202298557000000
TCGA-09-1666-01.25	3	2_AGING	10	2	0.0051094175018648030000000
TCGA-24-1105-01.8	52	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0051125382407514047000000
TCGA-24-1555-01.1	14	0_HALLMARK_E2F_TARGETS	169	5	0.0051251835905637838000000
TCGA-25-1633-01.1	71	2_REGULATION_OF_CELL_GROWTH	31	5	0.0051258187958790865000000
TCGA-25-1630-01.10	35	2_POSITIVE_REGULATION_OF_CASPASE_ACTIVITY	28	4	0.0051266983535471471000000
TCGA-29-2427-01.10	116	2_DEFENSE_RESPONSE	222	13	0.0051394428283424781000000
TCGA-24-1614-01.5	86	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	9	0.0051448596063868139000000
TCGA-09-0369-01.9	109	2_MITOTIC_CELL_CYCLE	134	10	0.0051474643411293869000000
TCGA-13-1488-01.17	109	2_MITOTIC_CELL_CYCLE	134	10	0.0051474643411293869000000
TCGA-13-0760-01.12	93	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0051519605739195149000000
TCGA-25-2393-01.5	140	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	25	0.0051725830919953824000000
TCGA-24-1556-01.19	120	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0051816638030120054000000
TCGA-24-1556-01.19	120	2_DNA_INTEGRITY_CHECKPOINT	19	5	0.0051816638030120054000000
TCGA-61-2092-01.12	209	1_KEGG_PROSTATE_CANCER	87	11	0.0051820658322413501000000
TCGA-13-0791-01.35	80	1_KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	107	8	0.0051852177590280164000000
TCGA-23-1022-01.10	170	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0051880134611656838000000
TCGA-25-2409-01.5	29	2_AGING	10	3	0.0051978537996790284000000
TCGA-25-1326-01.11	119	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0052093623070896882000000
TCGA-04-1347-01.15	187	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	20	0.0052281103842251224000000
TCGA-36-1576-01.8	124	0_HALLMARK_ANGIOGENESIS	32	6	0.0052427444465160409000000
TCGA-13-1403-01.9	71	1_KEGG_APOPTOSIS	85	7	0.0052430237960443852000000
TCGA-24-1424-01.4	80	2_DNA_BINDING	496	16	0.0052506481920258502000000
TCGA-25-1318-01.11	46	2_EXTRACELLULAR_MATRIX	85	6	0.0052651625559049968000000
TCGA-59-2363-01.3	89	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	6	0.0052749004958299881000000
TCGA-13-0800-01.9	124	2_CELL_CYCLE_PHASE	146	11	0.0052767831973926909000000
TCGA-25-1631-01.6	30	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	6	0.0052838412402349631000000
TCGA-61-2016-01.10	50	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0052857792707998955000000
TCGA-24-2024-01.3	55	2_CHEMOKINE_ACTIVITY	40	5	0.0052882054847892762000000
TCGA-13-1492-01.2	162	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	6	0.0052930390306930525000000
TCGA-13-1407-01.11	220	2_INTERLEUKIN_RECEPTOR_ACTIVITY	19	6	0.0052985020134453022000000
TCGA-13-1496-01.13	120	0_HALLMARK_P53_PATHWAY	151	11	0.0053115187205949078000000
TCGA-24-1616-01.2	38	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0053138271160754775000000
TCGA-04-1365-01.6	150	2_DNA_BINDING	496	23	0.0053143990325392526000000
TCGA-25-1633-01.1	71	2_GROWTH	55	6	0.0053244568318342681000000
TCGA-10-0926-01.2	45	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0053313507762408046000000
TCGA-24-1469-01.6	123	1_KEGG_PANCREATIC_CANCER	70	8	0.0053334908437729749000000
TCGA-09-1669-01.10	81	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0053371570399104876000000
TCGA-13-0723-01.8	50	2_REGULATION_OF_MITOTIC_CELL_CYCLE	20	4	0.0053393425887197617000000
TCGA-24-1567-01.3	141	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	15	0.0053442842957342387000000
TCGA-24-1436-01.1	49	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	8	0.0053457861485984035000000
TCGA-13-1409-01.6	122	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	17	0.0053576846527188578000000
TCGA-25-1626-01.2	86	2_ORGAN_DEVELOPMENT	460	16	0.0053593273707651526000000
TCGA-24-1474-01.12	122	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0053610129044292737000000
TCGA-13-0717-01.6	103	2_KINASE_INHIBITOR_ACTIVITY	22	5	0.0053642892284900493000000
TCGA-13-1507-01.8	101	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0053721650967977893000000
TCGA-10-0926-01.2	45	2_CELL_CYCLE_ARREST_GO_0007050	49	5	0.0053775253500973723000000
TCGA-24-2262-01.25	141	2_SIGNAL_TRANSDUCTION	1442	43	0.0054001110056058205000000
TCGA-04-1337-01.2	31	0_HALLMARK_ANGIOGENESIS	32	4	0.0054053061870755802000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_APOPTOSIS	309	10	0.0054149966110326828000000
TCGA-13-1409-01.6	122	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	26	0.0054152742105375217000000
TCGA-23-1024-01.3	24	2_M_PHASE	94	5	0.0054172077973997394000000
TCGA-61-1998-01.14	105	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0054280052213623526000000
TCGA-04-1336-01.28	106	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	12	0.0054290630774425051000000
TCGA-13-0903-01.11	77	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0054306622557838994000000
TCGA-13-0904-01.6	105	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0054400177688890038000000
TCGA-24-1549-01.21	158	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	5	0.0054422587683336972000000
TCGA-09-1665-01.16	131	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0054475591606597496000000
TCGA-13-0894-01.9	118	2_PROTEOLYSIS	154	11	0.0054549537128418951000000
TCGA-13-1481-01.3	78	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0054687365802261381000000
TCGA-24-0970-01.6	94	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0054852116323409559000000
TCGA-24-1418-01.16	84	2_DNA_METABOLIC_PROCESS	218	11	0.0054905056022568248000000
TCGA-04-1542-01.4	141	2_REGULATION_OF_APOPTOSIS	309	17	0.0054939217787439137000000
TCGA-61-2113-01.15	99	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0055262809227693069000000
TCGA-23-1117-01.11	99	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0055262809227693069000000
TCGA-13-0913-01.5	44	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0055299034509128410000000
TCGA-24-1464-01.7	62	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0055373795515457295000000
TCGA-59-2350-01.1	62	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0055373795515457295000000
TCGA-04-1365-01.6	150	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0055409990790330627000000
TCGA-13-1495-01.22	101	2_DNA_METABOLIC_PROCESS	218	12	0.0055605985524379920000000
TCGA-61-1919-01.9	87	1_KEGG_PANCREATIC_CANCER	70	7	0.0055701226745743489000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	10	0.0055740803648484990000000
TCGA-25-1633-01.1	71	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0055923857636646585000000
TCGA-24-0982-01.3	34	2_REGULATION_OF_CELL_PROLIFERATION	265	8	0.0056143229733336217000000
TCGA-24-1474-01.12	122	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0056219888531257693000000
TCGA-25-2042-01.3	63	2_BEHAVIOR	138	8	0.0056246973473811175000000
TCGA-59-2350-01.1	62	2_REGULATION_OF_MITOSIS	36	5	0.0056272462373685422000000
TCGA-13-0720-01.5	32	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	5	0.0056278288176696235000000
TCGA-24-2261-01.2	87	2_CHROMOSOME_SEGREGATION	26	5	0.0056283029607611338000000
TCGA-61-2092-01.12	209	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	31	0.0056293764930762076000000
TCGA-20-0991-01.12	166	1_KEGG_PANCREATIC_CANCER	70	9	0.0056360555433560625000000
TCGA-25-2399-01.16	103	2_SKELETAL_DEVELOPMENT	84	8	0.0056393283186805523000000
TCGA-25-1626-01.2	86	2_WOUND_HEALING	46	6	0.0056394745805168145000000
TCGA-09-2045-01.1	9	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	6	0.0056457998453289205000000
TCGA-13-0924-01.5	68	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0056612867030621204000000
TCGA-13-0800-01.9	124	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0056679701429837850000000
TCGA-24-1463-01.5	130	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	6	0.0056717665520191292000000
TCGA-24-1614-01.5	86	2_MITOSIS	71	7	0.0056737556582245555000000
TCGA-04-1347-01.15	187	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	36	0.0056738183599712704000000
TCGA-30-1853-01.4	111	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	133	10	0.0056771699540583455000000
TCGA-23-1123-01.7	70	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	16	0.0056777422500786500000000
TCGA-61-2008-01.19	70	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	16	0.0056777422500786500000000
TCGA-13-0761-01.6	75	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0056817302745355734000000
TCGA-10-0930-01.5	60	1_KEGG_FOCAL_ADHESION	195	9	0.0056861115587095775000000
TCGA-25-2391-01.2	64	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0056924962059441550000000
TCGA-24-1416-01.4	38	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0057051518468786136000000
TCGA-61-1736-01.2	54	2_DNA_METABOLIC_PROCESS	218	9	0.0057322291120176054000000
TCGA-24-1552-01.5	54	2_DNA_METABOLIC_PROCESS	218	9	0.0057322291120176054000000
TCGA-04-1542-01.4	141	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	17	0.0057394005483747202000000
TCGA-57-1582-01.26	174	1_KEGG_WNT_SIGNALING_PATHWAY	149	13	0.0057408992717634380000000
TCGA-25-2404-01.5	58	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0057453937488680246000000
TCGA-04-1367-01.3	74	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	16	0.0057485346186637414000000
TCGA-13-1512-01.2	113	1_KEGG_FOCAL_ADHESION	195	12	0.0057493243913737859000000
TCGA-24-1562-01.4	36	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0057543641081879053000000
TCGA-24-1563-01.15	100	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0057545406507148915000000
TCGA-13-0899-01.1	28	2_REGULATION_OF_MITOSIS	36	4	0.0057558091555917510000000
TCGA-24-1474-01.12	122	2_INTRACELLULAR_ORGANELLE_PART	912	29	0.0057642241573042851000000
TCGA-10-0934-01.11	145	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0057737258868417046000000
TCGA-04-1336-01.28	106	2_REGULATION_OF_MOLECULAR_FUNCTION	286	14	0.0057830492684989307000000
TCGA-10-0928-01.6	70	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0057926618346189254000000
TCGA-23-1123-01.7	70	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0057926618346189254000000
TCGA-61-2008-01.19	70	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0057926618346189254000000
TCGA-13-1408-01.1	45	2_CELL_CYCLE_GO_0007049	265	9	0.0057991150558084443000000
TCGA-24-2262-01.25	141	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0058016266429779702000000
TCGA-23-1120-01.10	57	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0058016643274745932000000
TCGA-13-0913-01.5	44	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0058016984133710181000000
TCGA-13-0885-01.6	44	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0058016984133710181000000
TCGA-24-0980-01.5	44	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0058016984133710181000000
TCGA-25-2393-01.5	140	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	24	0.0058108852034475687000000
TCGA-31-1959-01.7	101	2_LOCOMOTORY_BEHAVIOR	86	8	0.0058154675896154228000000
TCGA-61-2102-01.7	172	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0058286466773882469000000
TCGA-61-2104-01.15	95	1_KEGG_BLADDER_CANCER	42	6	0.0058358300495812481000000
TCGA-24-1567-01.3	141	1_KEGG_GLIOMA	62	8	0.0058405000393543420000000
TCGA-25-1315-01.7	93	1_KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	66	7	0.0058481000854217549000000
TCGA-23-1116-01.7	84	2_CELL_CYCLE_GO_0007049	265	12	0.0058520245838511262000000
TCGA-61-2102-01.7	172	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	13	0.0058590866516470344000000
TCGA-24-1549-01.21	158	2_CHROMOSOME_SEGREGATION	26	6	0.0058677689900608326000000
TCGA-24-2298-01.7	138	2_CARBOHYDRATE_BINDING	45	7	0.0058768404700242976000000
TCGA-10-0926-01.2	45	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0058768404700242976000000
TCGA-13-1499-01.1	22	2_CELL_PROLIFERATION_GO_0008283	436	8	0.0058851911151192498000000
TCGA-13-0886-01.1	45	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0058939238598195954000000
TCGA-61-2003-01.4	45	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0058939238598195954000000
TCGA-24-1464-01.7	62	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	10	0.0059075263317209465000000
TCGA-13-0883-01.3	23	2_REGULATION_OF_MOLECULAR_FUNCTION	286	7	0.0059124837370742363000000
TCGA-61-2088-01.7	150	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	10	0.0059250138445494493000000
TCGA-23-1124-01.17	107	2_ORGAN_DEVELOPMENT	460	18	0.0059563112180225355000000
TCGA-25-1315-01.7	93	2_REGULATION_OF_CELL_CYCLE	160	10	0.0059788519700906591000000
TCGA-20-0987-01.19	194	1_KEGG_CELL_CYCLE	114	12	0.0059826296832349267000000
TCGA-31-1950-01.7	105	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0059901600641903262000000
TCGA-61-2008-01.19	70	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0059938034552194991000000
TCGA-24-2024-01.3	55	2_CHEMOKINE_RECEPTOR_BINDING	41	5	0.0059961396813586719000000
TCGA-13-1407-01.11	220	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	11	0.0059983979601928548000000
TCGA-24-2298-01.6	4	1_KEGG_OXIDATIVE_PHOSPHORYLATION	92	3	0.0059986914951924725000000
TCGA-24-1434-01.3	82	2_COLLAGEN_BINDING	13	4	0.0060011319603726016000000
TCGA-09-1669-01.10	81	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0060062208597297141000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0060072953926912876000000
TCGA-24-2254-01.3	49	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0060072953926912876000000
TCGA-24-2262-01.25	141	2_CHROMOSOMEPERICENTRIC_REGION	29	6	0.0060091230893656294000000
TCGA-13-0891-01.18	125	1_KEGG_PANCREATIC_CANCER	70	8	0.0060201038347266556000000
TCGA-61-2113-01.15	99	2_REGULATION_OF_CELL_PROLIFERATION	265	13	0.0060202226483326085000000
TCGA-13-0893-01.4	112	2_CHROMOSOMAL_PART	78	8	0.0060308778927939443000000
TCGA-24-1564-01.4	47	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	5	0.0060380535321203372000000
TCGA-13-1403-01.9	71	0_HALLMARK_ANGIOGENESIS	32	5	0.0060397344765737802000000
TCGA-25-1320-01.4	71	0_HALLMARK_ANGIOGENESIS	32	5	0.0060397344765737802000000
TCGA-09-0366-01.5	32	1_KEGG_MELANOMA	71	5	0.0060397344765737828000000
TCGA-13-1501-01.12	101	2_EXTRACELLULAR_REGION	346	15	0.0060533887198085433000000
TCGA-13-0923-01.5	53	2_MICROTUBULE_CYTOSKELETON	117	7	0.0060658971469223881000000
TCGA-13-0906-01.5	66	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	9	0.0060688307520450034000000
TCGA-04-1331-01.5	90	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0060765724058251813000000
TCGA-24-1603-01.3	69	2_DNA_METABOLIC_PROCESS	218	10	0.0060865297904747406000000
TCGA-36-1574-01.10	152	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0061177594286540684000000
TCGA-24-1544-01.7	84	2_ANATOMICAL_STRUCTURE_MORPHOGENESIS	315	13	0.0061604605532773462000000
TCGA-61-2095-01.1	32	0_HALLMARK_ANGIOGENESIS	32	4	0.0061628452470069055000000
TCGA-23-1026-01.5	65	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	5	0.0061671931139057881000000
TCGA-25-1319-01.10	69	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0061712052959607584000000
TCGA-61-2000-01.11	69	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0061712052959607584000000
TCGA-10-0938-01.2	102	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0061775963761175534000000
TCGA-23-1032-01.16	250	1_KEGG_OOCYTE_MEIOSIS	105	13	0.0061799815807379874000000
TCGA-13-1411-01.7	96	1_KEGG_BLADDER_CANCER	42	6	0.0062045027515965304000000
TCGA-31-1959-01.7	101	2_CHEMOKINE_ACTIVITY	40	6	0.0062117127475845996000000
TCGA-13-1495-01.22	101	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0062117127475845996000000
TCGA-13-0807-01.8	46	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0062133847939735446000000
TCGA-24-1466-01.15	82	2_CELL_CYCLE_ARREST_GO_0007050	49	6	0.0062319975833539376000000
TCGA-24-1614-01.5	86	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0062388457846243176000000
TCGA-10-0934-01.11	145	2_MULTI_ORGANISM_PROCESS	127	11	0.0062390177199418036000000
TCGA-04-1542-01.4	141	2_MYOFIBRIL	17	5	0.0062419897935176386000000
TCGA-24-1558-01.12	174	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0062431356849755107000000
TCGA-13-1409-01.6	122	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0062437670960112639000000
TCGA-24-1435-01.4	3	2_AEROBIC_RESPIRATION	11	2	0.0062444026245060662000000
TCGA-09-2044-01.3	3	2_AEROBIC_RESPIRATION	11	2	0.0062444026245060662000000
TCGA-04-1367-01.3	74	2_RESPONSE_TO_CHEMICAL_STIMULUS	252	11	0.0062471108965390307000000
TCGA-13-1409-01.6	122	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	11	0.0062484148980135948000000
TCGA-23-1118-01.5	50	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	8	0.0062626641498236373000000
TCGA-13-2060-01.10	86	2_CHROMOSOME	102	8	0.0062640706418811316000000
TCGA-13-0755-01.6	16	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0062723337805505935000000
TCGA-24-1474-01.12	122	2_ORGANELLE_PART	916	29	0.0062903565847883085000000
TCGA-13-1409-01.6	122	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	22	0.0062969928059097542000000
TCGA-09-2044-01.4	83	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0063001587846461277000000
TCGA-13-1507-01.8	101	0_HALLMARK_IL2_STAT5_SIGNALING	148	10	0.0063022192292216941000000
TCGA-61-2009-01.1	46	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0063031198120667440000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	11	0.0063086220332598392000000
TCGA-10-0933-01.2	97	2_KINETOCHORE	24	5	0.0063281345422276578000000
TCGA-61-2088-01.7	150	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	11	0.0063449283401211063000000
TCGA-25-2391-01.2	64	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0063498407831029269000000
TCGA-24-1435-01.4	3	1_KEGG_ALZHEIMERS_DISEASE	148	3	0.0063670296067092312000000
TCGA-13-0883-01.4	3	1_KEGG_ALZHEIMERS_DISEASE	148	3	0.0063670296067092312000000
TCGA-09-2044-01.3	3	1_KEGG_ALZHEIMERS_DISEASE	148	3	0.0063670296067092312000000
TCGA-24-2288-01.12	112	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	26	0.0063768190959049816000000
TCGA-13-1482-01.7	62	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0063792261784731026000000
TCGA-04-1337-01.2	31	2_AGING	10	3	0.0063870698422590693000000
TCGA-25-1630-01.10	35	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	11	0.0064189178172621951000000
TCGA-29-2427-01.10	116	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	14	0.0064215663074209386000000
TCGA-24-1435-01.12	115	2_CHROMOSOME	102	9	0.0064298585163930838000000
TCGA-04-1530-01.2	90	2_CARBOHYDRATE_BINDING	45	6	0.0064492214522309105000000
TCGA-24-2024-01.3	55	2_EXTRACELLULAR_REGION	346	11	0.0064517425783294667000000
TCGA-13-1506-01.5	113	2_NUCLEUS	1110	31	0.0064664998828734051000000
TCGA-10-0926-01.2	45	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0064681876274625934000000
TCGA-13-0760-01.12	93	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	26	0.0064730096777366559000000
TCGA-23-1122-01.11	77	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0064754825381153165000000
TCGA-24-1464-01.5	2	2_MITOCHONDRIAL_RESPIRATORY_CHAIN	19	2	0.0064755850344723719000000
TCGA-10-0937-01.2	2	2_MITOCHONDRIAL_RESPIRATORY_CHAIN	19	2	0.0064755850344723719000000
TCGA-23-2078-01.8	2	2_MITOCHONDRIAL_RESPIRATORY_CHAIN	19	2	0.0064755850344723719000000
TCGA-24-1466-01.11	2	2_MITOCHONDRIAL_RESPIRATORY_CHAIN	19	2	0.0064755850344723719000000
TCGA-24-2035-01.8	102	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0064757186382027416000000
TCGA-24-1560-01.2	29	2_CELL_PROLIFERATION_GO_0008283	436	9	0.0064804937589055811000000
TCGA-13-1509-01.9	117	2_SPINDLE	35	6	0.0064879959389545928000000
TCGA-25-2392-01.4	60	0_HALLMARK_KRAS_SIGNALING_UP	148	8	0.0065145924364433108000000
TCGA-23-2078-01.15	105	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0065188303694844246000000
TCGA-24-1418-01.16	84	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0065188303694844246000000
TCGA-23-1032-01.16	250	1_KEGG_FOCAL_ADHESION	195	18	0.0065425420529621504000000
TCGA-61-2003-01.4	45	2_EXTRACELLULAR_REGION	346	10	0.0065426834190735472000000
TCGA-61-2102-01.7	172	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0065523190783848490000000
TCGA-10-0938-01.2	102	2_DNA_RECOMBINATION	40	6	0.0065795244030477590000000
TCGA-13-0793-01.8	97	1_KEGG_BLADDER_CANCER	42	6	0.0065919350333787088000000
TCGA-13-0793-01.8	97	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0065919350333787088000000
TCGA-24-1417-01.14	94	2_REGULATION_OF_CELL_CYCLE	160	10	0.0065942588757554399000000
TCGA-23-1116-01.7	84	2_COLLAGEN_BINDING	13	4	0.0066101009660876368000000
TCGA-04-1542-01.4	141	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	24	0.0066103097849483572000000
TCGA-13-0894-01.9	118	2_ZINC_ION_BINDING	75	8	0.0066191616022488482000000
TCGA-24-1562-01.4	36	1_KEGG_CELL_CYCLE	114	6	0.0066263781542162722000000
TCGA-24-2293-01.1	22	2_MICROTUBULE_MOTOR_ACTIVITY	14	3	0.0066307991805050316000000
TCGA-24-2293-01.3	33	0_HALLMARK_COAGULATION	125	6	0.0066426444279225807000000
TCGA-10-0931-01.12	59	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	8	0.0066464561517774485000000
TCGA-24-0966-01.2	18	2_MITOTIC_CELL_CYCLE	134	5	0.0066485128454544231000000
TCGA-25-2400-01.5	35	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0066550211353694688000000
TCGA-04-1362-01.4	35	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0066550211353694688000000
TCGA-13-0900-01.8	90	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0066572098135440332000000
TCGA-04-1347-01.15	187	2_ANATOMICAL_STRUCTURE_MORPHOGENESIS	315	20	0.0066716762969779662000000
TCGA-04-1356-01.1	71	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0066865284616344361000000
TCGA-24-1564-01.4	47	2_RECEPTOR_BINDING	331	10	0.0067051725248595826000000
TCGA-25-1320-01.4	71	0_HALLMARK_COAGULATION	125	8	0.0067100650829431596000000
TCGA-13-0911-01.3	47	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0067307335782963848000000
TCGA-13-0887-01.6	47	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0067307335782963848000000
TCGA-04-1332-01.2	25	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0067400046127251562000000
TCGA-23-1031-01.17	142	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	25	0.0067452338620015827000000
TCGA-59-2351-01.5	31	2_MITOTIC_CELL_CYCLE	134	6	0.0067648343755728991000000
TCGA-13-0912-01.2	55	1_KEGG_BLADDER_CANCER	42	5	0.0067764377094779631000000
TCGA-13-1409-01.6	122	2_PROTEIN_KINASE_CASCADE	251	14	0.0068047164197547055000000
TCGA-13-0804-01.5	78	2_MICROTUBULE_MOTOR_ACTIVITY	14	4	0.0068298220314881829000000
TCGA-24-1544-01.7	84	2_EXTRACELLULAR_REGION_PART	269	12	0.0068328740041025300000000
TCGA-23-2081-01.7	56	2_REGULATION_OF_CELL_CYCLE	160	8	0.0068357825530543474000000
TCGA-25-1313-01.2	13	2_MOTOR_ACTIVITY	24	3	0.0068467664631209945000000
TCGA-04-1337-01.2	31	2_ION_BINDING	210	7	0.0068476618731708443000000
TCGA-13-0807-01.8	46	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0068478527659901166000000
TCGA-24-2298-01.7	138	2_WOUND_HEALING	46	7	0.0068478527659901166000000
TCGA-23-1124-01.17	107	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0068604579864862897000000
TCGA-24-2281-01.10	107	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0068604579864862897000000
TCGA-24-0980-01.5	44	2_METALLOENDOPEPTIDASE_ACTIVITY	24	4	0.0068653258686616004000000
TCGA-24-1552-01.5	54	2_REGULATION_OF_MOLECULAR_FUNCTION	286	10	0.0068676864963256026000000
TCGA-13-0800-01.9	124	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0068686797179487585000000
TCGA-09-0369-01.9	109	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0068737523340466934000000
TCGA-24-2262-01.25	141	2_NUCLEUS	1110	36	0.0069002801436615574000000
TCGA-23-1030-01.10	58	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0069011159304388156000000
TCGA-24-1463-01.5	130	1_KEGG_DNA_REPLICATION	32	6	0.0069023554944424598000000
TCGA-36-1574-01.10	152	1_KEGG_BLADDER_CANCER	42	7	0.0069073937452836312000000
TCGA-24-1463-01.5	130	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0069093251420573026000000
TCGA-25-1625-01.6	38	0_HALLMARK_E2F_TARGETS	169	7	0.0069164436231591176000000
TCGA-24-1103-01.5	73	2_CELL_CYCLE_PROCESS	163	9	0.0069237630198640873000000
TCGA-04-1367-01.3	74	1_KEGG_APOPTOSIS	85	7	0.0069422618489320426000000
TCGA-31-1959-01.7	101	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	13	0.0069516395242552615000000
TCGA-24-2290-01.3	70	2_DNA_METABOLIC_PROCESS	218	10	0.0069594454638172805000000
TCGA-30-1891-01.4	84	2_POLYSACCHARIDE_BINDING	28	5	0.0069672760430887866000000
TCGA-13-1410-01.9	115	2_REGULATION_OF_MITOSIS	36	6	0.0069720243390070900000000
TCGA-24-2030-01.8	161	2_M_PHASE	94	10	0.0069738951257738652000000
TCGA-09-1669-01.10	81	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0069827917229239927000000
TCGA-24-2293-01.3	33	0_HALLMARK_ANGIOGENESIS	32	4	0.0069962647172715810000000
TCGA-36-1577-01.14	168	2_MITOSIS	71	9	0.0070164348889224550000000
TCGA-13-0887-01.6	47	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	17	0.0070308864783099273000000
TCGA-13-0807-01.8	46	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0070348417770623433000000
TCGA-09-0366-01.5	32	2_AGING	10	3	0.0070438784722486074000000
TCGA-13-0720-01.5	32	2_AGING	10	3	0.0070438784722486074000000
TCGA-13-0906-01.5	66	2_INTERPHASE	62	6	0.0070500150028320087000000
TCGA-04-1336-01.28	106	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	20	0.0070541685429015297000000
TCGA-24-1557-01.13	106	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	20	0.0070541685429015297000000
TCGA-24-1567-01.3	141	2_ORGAN_DEVELOPMENT	460	21	0.0070615647840576116000000
TCGA-13-0727-01.1	29	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	6	0.0070690021766951919000000
TCGA-25-2391-01.2	64	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0070705592823363753000000
TCGA-36-1575-01.9	193	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	29	0.0070727809048443356000000
TCGA-13-1512-01.2	113	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0070761779986942977000000
TCGA-25-1633-01.1	71	2_PATTERN_BINDING	33	5	0.0070768884533302743000000
TCGA-13-0717-01.6	103	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0070900482559289489000000
TCGA-04-1362-01.4	35	2_REGULATION_OF_CELL_PROLIFERATION	265	8	0.0071027708343362481000000
TCGA-23-1028-01.18	93	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0071055191581821326000000
TCGA-13-0905-01.7	160	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	25	0.0071372291483248725000000
TCGA-23-1032-01.16	250	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	25	0.0071496834239850020000000
TCGA-04-1347-01.15	187	2_COLLAGEN	23	6	0.0071521471934852740000000
TCGA-25-1326-01.11	119	2_SPINDLE	35	6	0.0071605159109568760000000
TCGA-25-1324-01.3	42	2_DNA_METABOLIC_PROCESS	218	8	0.0071710244184928097000000
TCGA-13-0795-01.9	67	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	5	0.0071726614097179188000000
TCGA-13-0890-01.2	48	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0071771623704562481000000
TCGA-24-1471-01.4	49	2_SKELETAL_DEVELOPMENT	84	6	0.0071779446403170298000000
TCGA-24-1549-01.21	158	2_CYTOSKELETAL_PART	194	14	0.0071902555144458275000000
TCGA-20-0987-01.19	194	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	18	0.0071955864983417606000000
TCGA-13-0920-01.9	82	2_NUCLEUS	1110	25	0.0071988424263883227000000
TCGA-31-1959-01.7	101	2_CHEMOKINE_RECEPTOR_BINDING	41	6	0.0072140263171513149000000
TCGA-24-1616-01.2	38	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	8	0.0072341814960361610000000
TCGA-13-1411-01.7	96	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0072376974260379267000000
TCGA-24-2298-01.7	138	2_EXTRACELLULAR_SPACE	192	13	0.0072578068495628241000000
TCGA-25-1626-01.2	86	2_COLLAGEN_BINDING	13	4	0.0072637542208171335000000
TCGA-24-1614-01.5	86	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0072637542208171335000000
TCGA-25-1635-01.6	129	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0072690394705072934000000
TCGA-25-1626-01.2	86	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	6	0.0072816587648558886000000
TCGA-36-1575-01.9	193	2_PLASMA_MEMBRANE_PART	901	39	0.0072970986900809795000000
TCGA-04-1356-01.1	71	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0073034110714873379000000
TCGA-13-0910-01.3	71	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0073034110714873379000000
TCGA-24-2271-01.3	44	2_CELL_CYCLE_PHASE	146	7	0.0073123523254243839000000
TCGA-61-2092-01.12	209	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	32	0.0073153648356581273000000
TCGA-13-0724-01.21	71	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0073375545082903894000000
TCGA-25-1318-01.11	46	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0073500780898983556000000
TCGA-24-1563-01.15	100	2_METALLOENDOPEPTIDASE_ACTIVITY	24	5	0.0073554232103543874000000
TCGA-25-2399-01.16	103	1_KEGG_PROSTATE_CANCER	87	8	0.0073581330528113970000000
TCGA-13-0886-01.1	45	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0073641819048683183000000
TCGA-13-1408-01.1	45	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0073641819048683183000000
TCGA-04-1338-01.7	85	2_POLYSACCHARIDE_BINDING	28	5	0.0073876682161813844000000
TCGA-61-2111-01.16	56	1_KEGG_BLADDER_CANCER	42	5	0.0074165048240072062000000
TCGA-24-1616-01.2	38	2_INTERPHASE	62	5	0.0074172855039017997000000
TCGA-13-0883-01.3	23	2_RESPONSE_TO_STRESS	427	8	0.0074181052603429177000000
TCGA-61-1995-01.4	102	2_MICROTUBULE_CYTOSKELETON	117	9	0.0074182826990942113000000
TCGA-10-0938-01.2	102	2_MICROTUBULE_CYTOSKELETON	117	9	0.0074182826990942113000000
TCGA-13-0727-01.1	29	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	5	0.0074204357749423147000000
TCGA-13-0920-01.9	82	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0074204357749423147000000
TCGA-13-0923-01.5	53	2_CHROMOSOMAL_PART	78	6	0.0074262745482780350000000
TCGA-04-1346-01.10	75	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	17	0.0074267371420980765000000
TCGA-10-0933-01.2	97	2_CYTOSKELETAL_PART	194	11	0.0074305161543745521000000
TCGA-13-1497-01.7	59	1_KEGG_PANCREATIC_CANCER	70	6	0.0074350589594619747000000
TCGA-61-2111-01.16	56	1_KEGG_CELL_CYCLE	114	7	0.0074446677596647090000000
TCGA-24-2024-01.3	55	2_CATION_BINDING	165	8	0.0074761323665790925000000
TCGA-13-1509-01.9	117	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	4	0.0074855829128113076000000
TCGA-25-2393-01.5	140	2_MITOTIC_CELL_CYCLE	134	11	0.0074867716183355075000000
TCGA-04-1525-01.5	3	2_CORNIFIED_ENVELOPE	12	2	0.0074927539627462954000000
TCGA-13-1497-01.7	59	2_DNA_RECOMBINATION	40	5	0.0075168188646656808000000
TCGA-13-1482-01.7	62	1_KEGG_FOCAL_ADHESION	195	9	0.0075300349659340408000000
TCGA-24-0980-01.5	44	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	12	0.0075340188245801203000000
TCGA-13-1491-01.7	90	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	9	0.0075354213517876854000000
TCGA-13-0807-01.8	46	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0075355099611630208000000
TCGA-31-1959-01.7	101	2_CELL_CYCLE_GO_0007049	265	13	0.0075547329714175564000000
TCGA-24-1464-01.7	62	2_CELL_CYCLE_PHASE	146	8	0.0075765458216811490000000
TCGA-13-1482-01.7	62	2_CELL_CYCLE_PHASE	146	8	0.0075765458216811490000000
TCGA-13-0717-01.6	103	2_INTERPHASE	62	7	0.0075767688076089548000000
TCGA-10-0934-01.11	145	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	15	0.0075845868516009928000000
TCGA-25-1634-01.4	75	1_KEGG_APOPTOSIS	85	7	0.0076016572739490730000000
TCGA-23-1032-01.16	250	1_KEGG_GLIOMA	62	10	0.0076138843879431858000000
TCGA-23-1032-01.16	250	2_INTERPHASE	62	10	0.0076138843879431858000000
TCGA-24-1423-01.5	27	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0076154519060974571000000
TCGA-09-2053-01.14	121	1_KEGG_MELANOGENESIS	99	9	0.0076422290998247114000000
TCGA-09-1662-01.6	49	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0076428028808501313000000
TCGA-23-1032-01.16	250	1_KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	107	13	0.0076498014812061829000000
TCGA-13-0755-01.6	16	2_REGULATION_OF_MOLECULAR_FUNCTION	286	6	0.0076515313940470446000000
TCGA-13-0760-01.12	93	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	18	0.0076575280513615134000000
TCGA-24-1463-01.5	130	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0076864939596315001000000
TCGA-13-0900-01.8	90	2_MITOSIS	71	7	0.0077038563099717872000000
TCGA-04-1542-01.4	141	2_IMMUNE_SYSTEM_PROCESS	283	16	0.0077039237136559613000000
TCGA-13-0897-01.2	61	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0077123613945487670000000
TCGA-23-1122-01.11	77	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0077358766648714756000000
TCGA-09-2050-01.18	196	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	13	0.0077424991218349249000000
TCGA-25-1321-01.3	33	2_AGING	10	3	0.0077439535104327564000000
TCGA-61-2002-01.1	118	2_AGING	10	4	0.0077442668956343667000000
TCGA-23-2077-01.18	63	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0077497413098884874000000
TCGA-13-0795-01.9	67	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0077550125248268473000000
TCGA-61-2097-01.6	13	2_CASPASE_ACTIVATION	25	3	0.0077742341409975700000000
TCGA-13-0920-01.9	82	2_CHROMOSOMAL_PART	78	7	0.0077782221200029533000000
TCGA-61-2012-01.6	78	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0077782221200029533000000
TCGA-10-0937-01.9	40	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0077908308126275879000000
TCGA-24-2261-01.2	87	2_DNA_METABOLIC_PROCESS	218	11	0.0077911942516764813000000
TCGA-13-0730-01.8	83	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0077947554098141839000000
TCGA-23-1023-01.1	93	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0077947608473836558000000
TCGA-04-1364-01.3	163	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0078049885691307925000000
TCGA-30-1853-01.4	111	0_HALLMARK_INFLAMMATORY_RESPONSE	170	11	0.0078152424573217742000000
TCGA-25-2400-01.5	35	2_SINGLE_STRANDED_DNA_BINDING	31	4	0.0078165958044913129000000
TCGA-04-1337-01.2	31	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0078165958044913147000000
TCGA-24-0979-01.5	41	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0078229033271852277000000
TCGA-13-2060-01.10	86	2_POSITIVE_REGULATION_OF_CASPASE_ACTIVITY	28	5	0.0078277368158811127000000
TCGA-25-1322-01.15	93	2_CHROMOSOME_SEGREGATION	26	5	0.0078285201778550920000000
TCGA-10-0933-01.2	97	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	5	0.0078461264766714871000000
TCGA-59-2354-01.2	44	2_ION_BINDING	210	8	0.0078475410393040110000000
TCGA-25-2393-01.5	140	1_KEGG_ERBB_SIGNALING_PATHWAY	86	9	0.0078623321295182257000000
TCGA-24-1563-01.15	100	1_KEGG_BLADDER_CANCER	42	6	0.0078741228126796396000000
TCGA-36-1577-01.14	168	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0078977637171789242000000
TCGA-61-2002-01.1	118	2_REGULATION_OF_CELL_CYCLE	160	11	0.0079102505480028330000000
TCGA-04-1342-01.12	104	1_KEGG_PROSTATE_CANCER	87	8	0.0079120449694017152000000
TCGA-13-0714-01.9	51	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0079159663397148569000000
TCGA-24-2280-01.10	58	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	6	0.0079297719277020111000000
TCGA-24-2267-01.8	26	1_KEGG_BLADDER_CANCER	42	4	0.0079398451020587010000000
TCGA-61-1736-01.2	54	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0079409299144766396000000
TCGA-24-2293-01.3	33	2_PATTERN_BINDING	33	4	0.0079417177345984923000000
TCGA-24-1564-01.4	47	2_BEHAVIOR	138	7	0.0079489581951839219000000
TCGA-25-1634-01.4	75	2_IMMUNE_RESPONSE	206	10	0.0079549927374258089000000
TCGA-25-1313-01.2	13	0_HALLMARK_SPERMATOGENESIS	88	4	0.0079641632690156030000000
TCGA-04-1542-01.4	141	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	30	0.0079693494019430888000000
TCGA-36-1568-01.22	80	0_HALLMARK_P53_PATHWAY	151	9	0.0079880980988360963000000
TCGA-13-0791-01.35	80	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	9	0.0079880980988360963000000
TCGA-04-1361-01.4	27	2_REGULATION_OF_CELL_CYCLE	160	6	0.0080028158617321318000000
TCGA-04-1530-01.2	90	2_MITOTIC_CELL_CYCLE	134	9	0.0080155057374484695000000
TCGA-13-1491-01.7	90	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	10	0.0080430351960627325000000
TCGA-24-1435-01.4	3	1_KEGG_HUNTINGTONS_DISEASE	160	3	0.0080571074849944257000000
TCGA-13-0883-01.4	3	1_KEGG_HUNTINGTONS_DISEASE	160	3	0.0080571074849944257000000
TCGA-09-2044-01.3	3	1_KEGG_HUNTINGTONS_DISEASE	160	3	0.0080571074849944257000000
TCGA-10-0931-01.12	59	1_KEGG_MELANOMA	71	6	0.0080823277420037105000000
TCGA-13-1488-01.17	109	2_REGULATION_OF_MOLECULAR_FUNCTION	286	14	0.0080848536110983572000000
TCGA-13-0717-01.6	103	2_KINASE_REGULATOR_ACTIVITY	41	6	0.0080872668151999571000000
TCGA-13-0795-01.9	67	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0080898916645678748000000
TCGA-25-1628-01.2	118	2_REGULATION_OF_MITOSIS	36	6	0.0080981319926611544000000
TCGA-13-0919-01.5	50	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0080991512806535583000000
TCGA-23-1120-01.10	57	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0081030923452190106000000
TCGA-10-0938-01.2	102	2_KINETOCHORE	24	5	0.0081100368721258448000000
TCGA-25-2396-01.6	42	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	12	0.0081115759826176411000000
TCGA-29-2427-01.10	116	2_CYTOKINE_ACTIVITY	104	9	0.0081196092799002556000000
TCGA-24-1469-01.6	123	2_DNA_METABOLIC_PROCESS	218	13	0.0081297716646023827000000
TCGA-57-1582-01.26	174	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	14	0.0081507011265374973000000
TCGA-24-1428-01.9	90	2_BIOPOLYMER_METABOLIC_PROCESS	1367	30	0.0081523025932902417000000
TCGA-13-1512-01.2	113	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0081645382063258807000000
TCGA-04-1350-01.2	130	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0081681526497642820000000
TCGA-13-0905-01.7	160	2_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0081728802657388272000000
TCGA-13-0905-01.7	160	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0081728802657388272000000
TCGA-29-2427-01.10	116	2_SIGNAL_TRANSDUCTION	1442	37	0.0081746905281713227000000
TCGA-24-2298-01.7	138	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0081796550827116475000000
TCGA-23-1124-01.17	107	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	20	0.0081975522747526931000000
TCGA-10-0933-01.2	97	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0082006217794408677000000
TCGA-13-0913-01.5	44	2_RESPONSE_TO_BIOTIC_STIMULUS	96	6	0.0082137091950739236000000
TCGA-23-1124-01.17	107	2_EXTRACELLULAR_MATRIX	85	8	0.0082154459806149625000000
TCGA-24-1614-01.5	86	2_CELL_CYCLE_ARREST_GO_0007050	49	6	0.0082376085688935854000000
TCGA-24-1545-01.2	28	2_EXTRACELLULAR_REGION	346	8	0.0082435690994347409000000
TCGA-24-0982-01.3	34	2_MITOSIS	71	5	0.0082488247744866069000000
TCGA-24-1474-01.12	122	2_DNA_BINDING	496	20	0.0082666834080257819000000
TCGA-13-1496-01.13	120	2_AGING	10	4	0.0082814752211237529000000
TCGA-24-1436-01.1	49	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	7	0.0082964647657048710000000
TCGA-13-1404-01.13	117	1_KEGG_FOCAL_ADHESION	195	12	0.0082967523573289174000000
TCGA-24-1603-01.3	69	2_SPINDLE	35	5	0.0083025849427868070000000
TCGA-09-1669-01.10	81	2_DOUBLE_STRANDED_DNA_BINDING	30	5	0.0083232937350913288000000
TCGA-13-2060-01.10	86	2_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0083233861582371858000000
TCGA-13-2060-01.10	86	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0083233861582371858000000
TCGA-57-1583-01.20	185	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0083297452653033829000000
TCGA-13-1495-01.22	101	1_KEGG_BLADDER_CANCER	42	6	0.0083440220128860407000000
TCGA-13-1501-01.12	101	1_KEGG_BLADDER_CANCER	42	6	0.0083440220128860407000000
TCGA-36-1568-01.22	80	1_KEGG_CELL_CYCLE	114	8	0.0083475428784187209000000
TCGA-24-1548-01.8	141	2_RESPONSE_TO_STRESS	427	20	0.0083545746054485715000000
TCGA-13-0916-01.11	92	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0083683280062797367000000
TCGA-13-1410-01.9	115	2_MITOTIC_CELL_CYCLE	134	10	0.0083745959083217861000000
TCGA-23-1027-01.8	68	1_KEGG_COLORECTAL_CANCER	62	6	0.0084067897979026949000000
TCGA-13-0893-01.4	112	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0084102864300021809000000
TCGA-25-1634-01.4	75	2_REGULATION_OF_APOPTOSIS	309	12	0.0084173079918951049000000
TCGA-24-1423-01.5	27	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	41	4	0.0084222990817596852000000
TCGA-61-2012-01.6	78	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0084388112200572910000000
TCGA-24-2298-01.6	4	1_KEGG_PARKINSONS_DISEASE	103	3	0.0084403674430836191000000
TCGA-09-1665-01.16	131	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0084448693474525518000000
TCGA-13-0900-01.8	90	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0084680088121684236000000
TCGA-24-1413-01.6	34	2_AGING	10	3	0.0084886405974585466000000
TCGA-61-1919-01.9	87	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0085009088374441537000000
TCGA-04-1525-01.7	52	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	8	0.0085009611648993854000000
TCGA-13-0792-01.8	64	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0085049297291153788000000
TCGA-13-1407-01.11	220	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	11	0.0085069406523214999000000
TCGA-24-1551-01.15	87	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0085242115042690365000000
TCGA-61-1919-01.9	87	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0085242115042690365000000
TCGA-09-1665-01.16	131	1_KEGG_PANCREATIC_CANCER	70	8	0.0085476189916983431000000
TCGA-13-1409-01.6	122	2_RECEPTOR_BINDING	331	16	0.0085487999456866585000000
TCGA-61-2094-01.6	63	2_CELL_CYCLE_PHASE	146	8	0.0085663085736739381000000
TCGA-61-2104-01.15	95	2_CELL_CYCLE_PROCESS	163	10	0.0085791292670580697000000
TCGA-13-1510-01.20	82	2_CELL_SURFACE_RECEPTOR_LINKED_SIGNAL_TRANSDUCTION_GO_0007166	563	17	0.0085864356393024963000000
TCGA-13-0720-01.5	32	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	6	0.0085919278300536014000000
TCGA-24-1103-01.5	73	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0085991430449416512000000
TCGA-13-1492-01.2	162	2_MEIOTIC_CELL_CYCLE	27	6	0.0085991747769276483000000
TCGA-61-2088-01.7	150	1_KEGG_THYROID_CANCER	29	6	0.0086032880717186126000000
TCGA-24-2298-01.7	138	1_KEGG_FOCAL_ADHESION	195	13	0.0086095358986369112000000
TCGA-04-1336-01.28	106	2_CELL_CYCLE_PHASE	146	10	0.0086533590408670695000000
TCGA-24-2288-01.12	112	2_SYSTEM_DEVELOPMENT	694	23	0.0086737104413314066000000
TCGA-59-2348-01.14	123	2_SPINDLE	35	6	0.0086762360116545874000000
TCGA-24-1435-01.4	3	0_HALLMARK_OXIDATIVE_PHOSPHORYLATION	164	3	0.0086806336977540265000000
TCGA-13-0883-01.4	3	0_HALLMARK_OXIDATIVE_PHOSPHORYLATION	164	3	0.0086806336977540265000000
TCGA-09-2044-01.3	3	0_HALLMARK_OXIDATIVE_PHOSPHORYLATION	164	3	0.0086806336977540265000000
TCGA-57-1583-01.20	185	2_EXTRACELLULAR_REGION_PART	269	18	0.0086814107217129330000000
TCGA-25-1634-01.4	75	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	12	0.0087013951186092064000000
TCGA-04-1331-01.5	90	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0087134408416410306000000
TCGA-25-1322-01.15	93	1_KEGG_PANCREATIC_CANCER	70	7	0.0087189595222544707000000
TCGA-24-1436-01.1	49	2_MITOTIC_CELL_CYCLE	134	7	0.0087195533929763473000000
TCGA-24-1548-01.8	141	2_BIOPOLYMER_METABOLIC_PROCESS	1367	41	0.0087196302904612930000000
TCGA-24-1558-01.12	174	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	5	0.0087420814262025495000000
TCGA-59-2351-01.5	31	2_DNA_METABOLIC_PROCESS	218	7	0.0087700333888558451000000
TCGA-59-2351-01.5	31	2_REGULATION_OF_MITOSIS	36	4	0.0087735629563295489000000
TCGA-09-1669-01.10	81	2_INTRACELLULAR_ORGANELLE_PART	912	22	0.0087892115414899153000000
TCGA-29-2427-01.10	116	2_ION_HOMEOSTASIS	105	9	0.0087903706352914588000000
TCGA-23-1023-01.1	93	2_INTRACELLULAR_ORGANELLE_PART	912	24	0.0088069409737038234000000
TCGA-04-1347-01.15	187	2_SYSTEM_DEVELOPMENT	694	32	0.0088101786063579327000000
TCGA-24-1471-01.4	49	1_KEGG_PROSTATE_CANCER	87	6	0.0088132430816301541000000
TCGA-09-2051-01.26	142	1_KEGG_ERBB_SIGNALING_PATHWAY	86	9	0.0088352868091665943000000
TCGA-23-1023-01.1	93	2_APOPTOSIS_GO	389	15	0.0088374447679820008000000
TCGA-25-2404-01.5	58	1_KEGG_BLADDER_CANCER	42	5	0.0088385885175572502000000
TCGA-25-2404-01.5	58	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0088385885175572502000000
TCGA-25-1324-01.3	42	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0088385885175572537000000
TCGA-61-2110-01.3	37	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0088402234943895860000000
TCGA-24-0982-01.3	34	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	5	0.0088416994723826102000000
TCGA-61-2109-01.13	122	2_AGING	10	4	0.0088458586626967046000000
TCGA-24-1474-01.12	122	2_AGING	10	4	0.0088458586626967046000000
TCGA-24-1474-01.12	122	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	4	0.0088458586626967046000000
TCGA-13-1499-01.1	22	1_KEGG_CELL_CYCLE	114	5	0.0088476545737935092000000
TCGA-09-1666-01.25	3	2_GLAND_DEVELOPMENT	13	2	0.0088544474626462560000000
TCGA-13-0899-01.1	28	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0088576248639384344000000
TCGA-24-1425-01.1	61	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0088772302231692902000000
TCGA-24-2267-01.8	26	2_CELL_CYCLE_GO_0007049	265	7	0.0088804796660945720000000
TCGA-13-0913-01.5	44	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0088848109353524916000000
TCGA-25-1634-01.4	75	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	7	0.0088863381355020737000000
TCGA-04-1525-01.7	52	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0088869057107715879000000
TCGA-57-1993-01.8	52	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0088869057107715879000000
TCGA-57-1993-01.8	52	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	11	0.0088997199144199238000000
TCGA-36-1568-01.22	80	2_TISSUE_DEVELOPMENT	115	8	0.0089108122047805924000000
TCGA-25-1628-01.2	118	2_CHROMOSOMAL_PART	78	8	0.0089170713593707349000000
TCGA-04-1362-01.4	35	1_KEGG_PANCREATIC_CANCER	70	5	0.0089175540536110751000000
TCGA-13-0905-01.7	160	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	19	0.0089176690153840825000000
TCGA-20-0990-01.17	133	2_EXTRACELLULAR_REGION_PART	269	15	0.0089620782949489351000000
TCGA-13-0904-01.6	105	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0089710890867745700000000
TCGA-24-1563-01.15	100	2_TRANSITION_METAL_ION_BINDING	92	8	0.0089826685551759738000000
TCGA-24-1431-01.3	57	2_CELL_CYCLE_PROCESS	163	8	0.0089983936763698771000000
TCGA-24-1417-01.14	94	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0090025535188880488000000
TCGA-13-0795-01.9	67	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0090189898837269543000000
TCGA-24-0979-01.5	41	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0090446683211303208000000
TCGA-13-0800-01.9	124	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	14	0.0090515392020247120000000
TCGA-13-1491-01.7	90	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0090549598492706170000000
TCGA-13-1409-01.6	122	2_DEFENSE_RESPONSE	222	13	0.0090592512139540862000000
TCGA-13-1405-01.4	69	2_MITOTIC_CELL_CYCLE	134	8	0.0090674601803529559000000
TCGA-25-1628-01.2	118	1_KEGG_FOCAL_ADHESION	195	12	0.0090711293610277136000000
TCGA-09-2050-01.18	196	2_REGULATION_OF_KINASE_ACTIVITY	138	13	0.0091072165383789087000000
TCGA-23-1116-01.7	84	2_CELL_CYCLE_PHASE	146	9	0.0091176095416351383000000
TCGA-23-1023-01.1	93	2_PROGRAMMED_CELL_DEATH	390	15	0.0091180051720766118000000
TCGA-24-1603-01.3	69	2_INTERPHASE	62	6	0.0091606814796033192000000
TCGA-25-1319-01.10	69	1_KEGG_COLORECTAL_CANCER	62	6	0.0091606814796033192000000
TCGA-25-1319-01.10	69	2_INTERPHASE	62	6	0.0091606814796033192000000
TCGA-61-2000-01.11	69	2_INTERPHASE	62	6	0.0091606814796033192000000
TCGA-24-1464-01.7	62	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	6	0.0091606814796034424000000
TCGA-25-2042-01.3	63	2_METALLOPEPTIDASE_ACTIVITY	39	5	0.0091675237589827450000000
TCGA-23-2077-01.18	63	2_BLOOD_COAGULATION	39	5	0.0091675237589827450000000
TCGA-23-2077-01.18	63	2_COAGULATION	39	5	0.0091675237589827450000000
TCGA-09-2044-01.4	83	2_NUCLEUS	1110	25	0.0091704703759105301000000
TCGA-24-1557-01.13	106	2_INTERPHASE	62	7	0.0091773227291195771000000
TCGA-24-1548-01.8	141	1_KEGG_PROSTATE_CANCER	87	9	0.0091819120453051385000000
TCGA-24-1557-01.13	106	2_DNA_METABOLIC_PROCESS	218	12	0.0092761914282343347000000
TCGA-25-2400-01.5	35	2_AGING	10	3	0.0092792822898188909000000
TCGA-25-1630-01.10	35	2_AGING	10	3	0.0092792822898188909000000
TCGA-24-1423-01.5	27	1_KEGG_BLADDER_CANCER	42	4	0.0092907162452183240000000
TCGA-24-1423-01.5	27	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0092907162452183240000000
TCGA-25-1324-01.3	42	2_MEIOTIC_CELL_CYCLE	27	4	0.0092907162452183240000000
TCGA-13-1497-01.7	59	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0092948492853432048000000
TCGA-13-1497-01.7	59	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0092948492853432048000000
TCGA-13-1512-01.2	113	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0093079280437013828000000
TCGA-23-1027-01.8	68	2_EXTRACELLULAR_REGION	346	12	0.0093122179516773318000000
TCGA-23-1022-01.10	170	1_KEGG_BASAL_CELL_CARCINOMA	55	8	0.0093313727323798001000000
TCGA-13-0730-01.8	83	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0093903030470208239000000
TCGA-13-2060-01.10	86	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0093910898595994628000000
TCGA-24-1614-01.5	86	2_NEGATIVE_REGULATION_OF_GROWTH	29	5	0.0093910898595994628000000
TCGA-36-1578-01.10	60	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0094055878111126614000000
TCGA-24-2289-01.6	53	0_HALLMARK_COAGULATION	125	7	0.0094244899945580066000000
TCGA-13-0717-01.6	103	2_REGULATION_OF_CELL_PROLIFERATION	265	13	0.0094257201325382758000000
TCGA-09-1666-01.28	109	1_KEGG_APOPTOSIS	85	8	0.0094371612663230256000000
TCGA-09-1669-01.10	81	2_ORGANELLE_PART	916	22	0.0094396361330681359000000
TCGA-25-1322-01.15	93	2_DNA_BINDING	496	17	0.0094468978891141565000000
TCGA-24-1564-01.4	47	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	10	0.0094493742554475815000000
TCGA-04-1357-01.6	22	1_KEGG_PATHWAYS_IN_CANCER	323	7	0.0094669006163845149000000
TCGA-25-1318-01.11	46	2_M_PHASE	94	6	0.0094860216751851151000000
TCGA-24-1556-01.19	120	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	17	0.0094860948256983105000000
TCGA-23-1023-01.1	93	2_ORGANELLE_PART	916	24	0.0095007272717117473000000
TCGA-25-2401-01.5	119	2_CELL_CYCLE_GO_0007049	265	14	0.0095034842571921820000000
TCGA-13-0807-01.8	46	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	7	0.0095106700911272990000000
TCGA-13-1407-01.11	220	2_SIGNAL_TRANSDUCTION	1442	59	0.0095353455835421267000000
TCGA-23-1117-01.11	99	1_KEGG_FOCAL_ADHESION	195	11	0.0095461845178762949000000
TCGA-13-0910-01.3	71	2_SPINDLE	35	5	0.0095677075194255373000000
TCGA-59-2348-01.14	123	2_CYTOSKELETON	293	15	0.0095711415555126030000000
TCGA-25-1319-01.10	69	2_REGULATION_OF_MITOSIS	36	5	0.0095873787724513708000000
TCGA-13-0760-01.12	93	2_MITOSIS	71	7	0.0095956973064757426000000
TCGA-25-1315-01.7	93	1_KEGG_MELANOMA	71	7	0.0095956973064757426000000
TCGA-13-0791-01.35	80	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0096082108708783615000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0096198277431038363000000
TCGA-24-2254-01.3	49	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0096198277431038363000000
TCGA-10-0931-01.12	59	2_RESPONSE_TO_VIRUS	42	5	0.0096254530909664800000000
TCGA-59-2350-01.1	62	2_DNA_RECOMBINATION	40	5	0.0096261103544653115000000
TCGA-13-1482-01.7	62	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0096261103544653115000000
TCGA-10-0933-01.2	97	2_CONDENSED_CHROMOSOME	26	5	0.0096356160665171369000000
TCGA-04-1367-01.3	74	2_SIGNAL_TRANSDUCTION	1442	27	0.0096490129462537544000000
TCGA-23-2072-01.9	74	2_SIGNAL_TRANSDUCTION	1442	27	0.0096490129462537544000000
TCGA-24-1466-01.15	82	2_EXTRACELLULAR_SPACE	192	10	0.0096500779864402697000000
TCGA-13-1510-01.20	82	2_EXTRACELLULAR_SPACE	192	10	0.0096500779864402697000000
TCGA-13-0893-01.4	112	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0096595309034312651000000
TCGA-31-1959-01.7	101	2_TRANSITION_METAL_ION_BINDING	92	8	0.0096782962832511286000000
TCGA-13-0905-01.7	160	1_KEGG_BLADDER_CANCER	42	7	0.0097046573185006584000000
TCGA-13-0723-01.8	50	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0097549572755102672000000
TCGA-61-2016-01.10	50	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0097549572755102672000000
TCGA-24-2267-01.8	26	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	12	0.0097570991953477848000000
TCGA-24-2298-01.7	138	0_HALLMARK_ANGIOGENESIS	32	6	0.0097576494113625813000000
TCGA-20-0990-01.17	133	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0097663375326949610000000
TCGA-25-1633-01.1	71	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	19	0.0097688846037404450000000
TCGA-09-2053-01.14	121	1_KEGG_BASAL_CELL_CARCINOMA	55	7	0.0097848381381118541000000
TCGA-13-0900-01.8	90	2_POLYSACCHARIDE_BINDING	28	5	0.0097980993328418125000000
TCGA-13-0916-01.11	92	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0098099615025851114000000
TCGA-13-1492-01.2	162	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0098281936487697470000000
TCGA-09-1669-01.10	81	2_SINGLE_STRANDED_DNA_BINDING	31	5	0.0098575452254042618000000
TCGA-04-1361-01.4	27	2_MEIOTIC_RECOMBINATION	13	3	0.0098710912343101843000000
TCGA-24-1413-01.6	34	2_REGULATION_OF_MOLECULAR_FUNCTION	286	8	0.0098845713515020635000000
TCGA-25-1623-01.7	111	2_SKELETAL_DEVELOPMENT	84	8	0.0098876653126842799000000
TCGA-04-1342-01.12	104	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0098924403715446516000000
TCGA-36-1580-01.1	65	2_EXTRACELLULAR_SPACE	192	9	0.0099136541939657714000000
TCGA-09-2051-01.26	142	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0099213134647208011000000
TCGA-10-0934-01.11	145	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	25	0.0099336163987993106000000
TCGA-04-1530-01.2	90	2_ORGAN_DEVELOPMENT	460	16	0.0099407943577643227000000
TCGA-13-0897-01.2	61	2_PROTEOLYSIS	154	8	0.0099425554851235373000000
TCGA-24-2261-01.2	87	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0099425656373211130000000
TCGA-13-1510-01.20	82	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0099524475366024358000000
TCGA-25-1318-01.11	46	2_CELL_CYCLE_PHASE	146	7	0.0099533518103560835000000
TCGA-59-2350-01.1	62	1_KEGG_PANCREATIC_CANCER	70	6	0.0099686179571164754000000
TCGA-24-2290-01.3	70	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	9	0.0099952398540329290000000
TCGA-24-1562-01.4	36	0_HALLMARK_ANGIOGENESIS	32	4	0.0099997683065329440000000
TCGA-25-1634-01.1	4	2_CATION_TRANSPORT	109	3	0.0100144705050862410000000
TCGA-10-0938-01.2	102	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0100237136786029220000000
TCGA-13-0795-01.9	67	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0100370012130275040000000
TCGA-24-1423-01.5	27	2_M_PHASE	94	5	0.0100493058831287040000000
TCGA-04-1361-01.4	27	2_M_PHASE	94	5	0.0100493058831287040000000
TCGA-24-1417-01.14	94	2_MEIOTIC_CELL_CYCLE	27	5	0.0100493058831287090000000
TCGA-10-0938-01.2	102	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	5	0.0100510325641211440000000
TCGA-23-2077-01.18	63	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	6	0.0100671616763992180000000
TCGA-25-1634-01.4	75	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	58	6	0.0100758821940966150000000
TCGA-24-1548-01.8	141	0_HALLMARK_SPERMATOGENESIS	88	9	0.0100996712731455940000000
TCGA-24-2030-01.8	161	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0101126683848290450000000
TCGA-04-1365-01.6	150	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0101153998470501010000000
TCGA-10-0928-01.6	70	2_MITOTIC_CELL_CYCLE	134	8	0.0101164814957373660000000
TCGA-36-1570-01.2	36	2_AGING	10	3	0.0101172180638189090000000
TCGA-36-1575-01.9	193	2_RESPONSE_TO_STRESS	427	24	0.0101899006585955830000000
TCGA-23-1116-01.7	84	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0101933855084036800000000
TCGA-25-1316-01.2	73	2_EXTRACELLULAR_REGION_PART	269	11	0.0102067849668682490000000
TCGA-13-1491-01.7	90	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0102080707870243590000000
TCGA-59-2350-01.1	62	2_DNA_INTEGRITY_CHECKPOINT	19	4	0.0102294663847523940000000
TCGA-13-0791-01.35	80	2_MITOCHONDRIAL_TRANSPORT	15	4	0.0102426274467238040000000
TCGA-13-0727-01.1	29	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0102435417599830990000000
TCGA-13-0727-01.1	29	2_DNA_RECOMBINATION	40	4	0.0102435417599830990000000
TCGA-24-1560-01.2	29	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0102435417599830990000000
TCGA-25-2409-01.5	29	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0102435417599830990000000
TCGA-57-1583-01.20	185	1_KEGG_OOCYTE_MEIOSIS	105	11	0.0102467436527637610000000
TCGA-24-2267-01.8	26	0_HALLMARK_G2M_CHECKPOINT	174	6	0.0102557604148200130000000
TCGA-13-0765-01.4	54	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0102730291040753640000000
TCGA-24-2290-01.3	70	2_REGULATION_OF_MITOSIS	36	5	0.0102966049453401990000000
TCGA-10-0928-01.6	70	2_REGULATION_OF_MITOSIS	36	5	0.0102966049453401990000000
TCGA-23-1123-01.7	70	2_REGULATION_OF_MITOSIS	36	5	0.0102966049453401990000000
TCGA-24-1417-01.14	94	2_MITOSIS	71	7	0.0103063010446910060000000
TCGA-13-1512-01.2	113	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0103220860282602080000000
TCGA-13-0883-01.4	3	2_NADH_DEHYDROGENASE_COMPLEX	14	2	0.0103294590702666960000000
TCGA-13-0883-01.4	3	2_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I	14	2	0.0103294590702666960000000
TCGA-13-0883-01.4	3	2_RESPIRATORY_CHAIN_COMPLEX_I	14	2	0.0103294590702666960000000
TCGA-20-0990-01.17	133	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0103609069149085950000000
TCGA-25-1313-01.2	13	2_M_PHASE	94	4	0.0103672562011235500000000
TCGA-36-1571-01.6	109	1_KEGG_CELL_CYCLE	114	9	0.0103747427384257310000000
TCGA-13-1509-01.9	117	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0103941600298224720000000
TCGA-13-1404-01.13	117	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0103941600298224720000000
TCGA-61-2000-01.11	69	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0104298655228528430000000
TCGA-24-1104-01.2	18	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0104354938722547760000000
TCGA-24-0966-01.2	18	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0104354938722547760000000
TCGA-23-1022-01.10	170	2_APOPTOSIS_GO	389	21	0.0104487597636766120000000
TCGA-24-1464-01.5	2	2_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS	24	2	0.0104518214591537840000000
TCGA-04-1347-01.7	2	2_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION	24	2	0.0104518214591537840000000
TCGA-10-0937-01.2	2	2_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS	24	2	0.0104518214591537840000000
TCGA-23-2078-01.8	2	2_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS	24	2	0.0104518214591537840000000
TCGA-24-1466-01.11	2	2_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS	24	2	0.0104518214591537840000000
TCGA-24-1556-01.17	2	2_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION	24	2	0.0104518214591537840000000
TCGA-20-0990-01.17	133	2_CELL_CYCLE_PHASE	146	11	0.0104554688943915030000000
TCGA-61-1998-01.14	105	1_KEGG_BLADDER_CANCER	42	6	0.0104576217384876710000000
TCGA-23-2078-01.15	105	1_KEGG_BLADDER_CANCER	42	6	0.0104576217384876710000000
TCGA-23-2078-01.15	105	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0104576217384876710000000
TCGA-31-1950-01.7	105	1_KEGG_BLADDER_CANCER	42	6	0.0104576217384876710000000
TCGA-13-1496-01.13	120	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	7	0.0104725288058882520000000
TCGA-61-2088-01.7	150	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	31	0.0104818501338947940000000
TCGA-04-1367-01.3	74	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	16	0.0104888277560877730000000
TCGA-23-1028-01.18	93	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0105445816035318640000000
TCGA-13-0760-01.12	93	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0105445816035318640000000
TCGA-24-1558-01.12	174	2_MITOTIC_CELL_CYCLE	134	12	0.0105572247333635210000000
TCGA-23-1117-01.11	99	2_REGULATION_OF_CELL_CYCLE	160	10	0.0105678769396133280000000
TCGA-13-1512-01.2	113	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0105876200427626000000000
TCGA-24-1417-01.14	94	2_NUCLEUS	1110	27	0.0105932259035110900000000
TCGA-25-2404-01.5	58	2_DNA_METABOLIC_PROCESS	218	9	0.0105955547496608790000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0105962499210172640000000
TCGA-24-2254-01.3	49	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0105962499210172640000000
TCGA-23-1023-01.1	93	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	19	0.0105999500751491410000000
TCGA-24-1434-01.3	82	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	21	0.0106173565694439010000000
TCGA-23-1022-01.10	170	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	20	0.0106279212521524800000000
TCGA-04-1364-01.3	163	2_SIGNAL_TRANSDUCTION	1442	47	0.0106420305413860940000000
TCGA-13-0887-01.6	47	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0106452293021270950000000
TCGA-23-1117-01.11	99	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0106540160437459760000000
TCGA-04-1356-01.1	71	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	8	0.0106571149922783170000000
TCGA-25-1635-01.6	129	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0106786254324482310000000
TCGA-25-1635-01.6	129	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0106786254324482310000000
TCGA-09-2050-01.18	196	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	13	0.0106805042222352640000000
TCGA-61-2003-01.4	45	0_HALLMARK_P53_PATHWAY	151	7	0.0106827120647145760000000
TCGA-04-1347-01.15	187	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	36	0.0107011348417755570000000
TCGA-13-0883-01.3	23	2_DNA_REPAIR	113	5	0.0107229648126374170000000
TCGA-04-1347-01.15	187	0_HALLMARK_COAGULATION	125	12	0.0107564679367392020000000
TCGA-09-2049-01.8	96	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0107787614586991620000000
TCGA-25-1634-01.4	75	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0108024639083845950000000
TCGA-13-0899-01.1	28	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0108043163862118020000000
TCGA-10-0926-01.2	45	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0108147388471850760000000
TCGA-04-1337-01.2	31	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	12	0.0108181334234109040000000
TCGA-13-1512-01.2	113	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0108259386659961020000000
TCGA-13-0923-01.5	53	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	11	0.0108312365493965760000000
TCGA-04-1356-01.1	71	2_INTERPHASE	62	6	0.0108335077467000530000000
TCGA-13-0910-01.3	71	2_INTERPHASE	62	6	0.0108335077467000530000000
TCGA-24-1464-01.7	62	1_KEGG_MELANOMA	71	6	0.0108335077467000530000000
TCGA-25-1326-01.11	119	2_EXTRACELLULAR_REGION	346	16	0.0108403157385127090000000
TCGA-59-2363-01.3	89	2_CELL_CYCLE_GO_0007049	265	12	0.0108537437280510390000000
TCGA-23-1022-01.10	170	2_PROGRAMMED_CELL_DEATH	390	21	0.0108731274211185960000000
TCGA-09-1669-01.10	81	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0108743503891396870000000
TCGA-10-0937-01.9	40	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	8	0.0108815166436847210000000
TCGA-24-2298-01.7	138	2_TISSUE_DEVELOPMENT	115	10	0.0109013174375274180000000
TCGA-13-0887-01.6	47	2_APOPTOTIC_PROGRAM	54	5	0.0109063620750473830000000
TCGA-24-0979-01.5	41	2_INTERPHASE	62	5	0.0109080342569375120000000
TCGA-13-0912-01.2	55	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	7	0.0109089185304484390000000
TCGA-61-2094-01.6	63	2_MESODERM_DEVELOPMENT	19	4	0.0109090824358746910000000
TCGA-24-1549-01.21	158	2_SPINDLE_POLE	17	5	0.0109145233726123930000000
TCGA-13-1499-01.1	22	2_APOPTOTIC_PROGRAM	54	4	0.0109170564238166450000000
TCGA-20-0990-01.17	133	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0109233116687263120000000
TCGA-61-2094-01.6	63	1_KEGG_PANCREATIC_CANCER	70	6	0.0109540551499428260000000
TCGA-13-1409-01.6	122	2_EXTRACELLULAR_SPACE	192	12	0.0109542377614198720000000
TCGA-13-0897-01.2	61	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0109753619067389840000000
TCGA-24-1423-01.5	27	0_HALLMARK_E2F_TARGETS	169	6	0.0109784700603929790000000
TCGA-24-2019-01.10	192	2_REGULATION_OF_MITOSIS	36	7	0.0109868392654402910000000
TCGA-20-0990-01.17	133	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	13	0.0110008914386583010000000
TCGA-04-1356-01.1	71	2_PROTEIN_N_TERMINUS_BINDING	36	5	0.0110463280119942020000000
TCGA-13-0724-01.21	71	2_REGULATION_OF_MITOSIS	36	5	0.0110463280119942020000000
TCGA-61-2097-01.6	13	2_POSITIVE_REGULATION_OF_CASPASE_ACTIVITY	28	3	0.0110468365946745740000000
TCGA-24-1545-01.2	28	2_COLLAGEN_BINDING	13	3	0.0110468365946745740000000
TCGA-24-1558-01.12	174	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	28	0.0110647201548037360000000
TCGA-24-1105-01.8	52	2_CELL_CYCLE_ARREST_GO_0007050	49	5	0.0111322003488258480000000
TCGA-09-1666-01.28	109	2_CELL_CYCLE_PHASE	146	10	0.0111339615706752200000000
TCGA-24-2289-01.6	53	2_ORGAN_DEVELOPMENT	460	12	0.0111817429854593230000000
TCGA-24-1614-01.5	86	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0111889840349683400000000
TCGA-24-1560-01.2	29	2_PROTEIN_DIMERIZATION_ACTIVITY	157	6	0.0111969641002821530000000
TCGA-59-2348-01.14	123	2_CHROMOSOME	102	9	0.0112051715538428990000000
TCGA-13-1488-01.17	109	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	5	0.0112420710182300420000000
TCGA-04-1364-01.3	163	2_CELL_DEVELOPMENT	511	24	0.0112509089096751360000000
TCGA-23-2078-01.15	105	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0112523561560619270000000
TCGA-36-1575-01.9	193	2_INTERLEUKIN_BINDING	24	6	0.0112539459982069850000000
TCGA-23-1030-01.10	58	2_CATION_BINDING	165	8	0.0112578268738813220000000
TCGA-25-1320-01.4	71	2_MITOTIC_CELL_CYCLE	134	8	0.0112664003613963530000000
TCGA-23-1110-01.7	299	2_NON_MEMBRANE_BOUND_ORGANELLE	476	34	0.0112699133946626270000000
TCGA-23-1110-01.7	299	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	34	0.0112699133946626270000000
TCGA-25-2391-01.2	64	2_DNA_RECOMBINATION	40	5	0.0112720888366805280000000
TCGA-13-1411-01.7	96	2_COLLAGEN_BINDING	13	4	0.0112762220651054030000000
TCGA-09-2044-01.4	83	2_REGULATION_OF_MOLECULAR_FUNCTION	286	12	0.0112819535685000330000000
TCGA-09-1665-01.16	131	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0112865936907272400000000
TCGA-57-1583-01.20	185	1_KEGG_WNT_SIGNALING_PATHWAY	149	13	0.0112890992916621510000000
TCGA-10-0928-01.6	70	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0112925622832307430000000
TCGA-13-1510-01.20	82	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0113060824208150810000000
TCGA-24-1417-01.14	94	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0113244088870116440000000
TCGA-57-1583-01.20	185	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	28	0.0113274477440490000000000
TCGA-13-0893-01.4	112	2_DNA_RECOMBINATION	40	6	0.0113330805908662040000000
TCGA-09-1661-01.1	20	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	5	0.0113355078858192030000000
TCGA-59-2350-01.1	62	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0113498820842695590000000
TCGA-29-2427-01.10	116	0_HALLMARK_E2F_TARGETS	169	11	0.0113507259063556740000000
TCGA-13-1497-01.1	2	2_CHROMATIN	25	2	0.0113606754990808290000000
TCGA-24-1558-01.5	2	2_CHROMATIN	25	2	0.0113606754990808290000000
TCGA-24-1425-01.1	61	1_KEGG_BLADDER_CANCER	42	5	0.0113634868206558040000000
TCGA-24-1552-01.5	54	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	8	0.0113822388835678740000000
TCGA-36-1574-01.10	152	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0113841161655419810000000
TCGA-24-1463-01.5	130	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	4	0.0113928550948632830000000
TCGA-09-2051-01.26	142	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0114255771069848060000000
TCGA-25-1329-01.5	43	2_REGULATION_OF_CELL_CYCLE	160	7	0.0114281418695687880000000
TCGA-24-1413-01.6	34	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0114303497243823610000000
TCGA-61-2109-01.13	122	2_CHROMOSOMAL_PART	78	8	0.0114307786163460060000000
TCGA-25-1635-01.6	129	2_SPINDLE	35	6	0.0114308461173093960000000
TCGA-24-2289-01.6	53	2_SKELETAL_DEVELOPMENT	84	6	0.0114548178149316580000000
TCGA-13-1491-01.7	90	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0114849475683427100000000
TCGA-30-1862-01.13	91	2_ORGAN_DEVELOPMENT	460	16	0.0115309071470557170000000
TCGA-24-1434-01.3	82	2_PROTEOLYSIS	154	9	0.0115387356221133100000000
TCGA-24-2024-01.3	55	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0115631519801385370000000
TCGA-36-1575-01.9	193	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	21	0.0115649504332079360000000
TCGA-24-2261-01.2	87	2_CHROMOSOMAL_PART	78	7	0.0115675446369526720000000
TCGA-04-1346-01.10	75	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0115819680990513780000000
TCGA-09-2050-01.18	196	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	10	0.0115895474306119440000000
TCGA-09-1669-01.10	81	1_KEGG_DNA_REPLICATION	32	5	0.0116048766406199270000000
TCGA-25-2398-01.5	81	0_HALLMARK_ANGIOGENESIS	32	5	0.0116048766406199270000000
TCGA-25-2391-01.2	64	2_NUCLEUS	1110	21	0.0116460864330954280000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0116538435693398260000000
TCGA-24-2254-01.3	49	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0116538435693398260000000
TCGA-25-2393-01.5	140	2_GROWTH_FACTOR_ACTIVITY	49	7	0.0116538435693398280000000
TCGA-13-0761-01.6	75	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	9	0.0116865716018872740000000
TCGA-04-1350-01.2	130	2_SYSTEM_DEVELOPMENT	694	25	0.0117329883911452220000000
TCGA-25-1626-01.2	86	2_REGULATION_OF_BODY_FLUID_LEVELS	52	6	0.0117341768593153660000000
TCGA-13-1407-01.11	220	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0117472078737870470000000
TCGA-24-0979-01.5	41	2_NUCLEUS	1110	16	0.0117483531191846100000000
TCGA-10-0933-01.2	97	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0117522078236000830000000
TCGA-61-2002-01.1	118	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0117527561454107530000000
TCGA-29-2427-01.10	116	2_BEHAVIOR	138	10	0.0117829581462481280000000
TCGA-10-0937-01.9	40	2_DOUBLE_STRANDED_DNA_BINDING	30	4	0.0117834638847883690000000
TCGA-04-1337-01.2	31	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0117958531659095260000000
TCGA-04-1337-01.2	31	2_SKELETAL_DEVELOPMENT	84	5	0.0117958531659095260000000
TCGA-23-1031-01.17	142	2_CELL_DEVELOPMENT	511	22	0.0118056131251009660000000
TCGA-24-1466-01.15	82	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0118057011798936780000000
TCGA-23-2077-01.18	63	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	41	5	0.0118107461609703730000000
TCGA-09-2051-01.26	142	1_KEGG_FOCAL_ADHESION	195	13	0.0118114467892544640000000
TCGA-61-2104-01.15	95	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	9	0.0118149936708533030000000
TCGA-25-1316-01.2	73	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0118168098565498880000000
TCGA-13-0889-01.4	37	1_KEGG_PANCREATIC_CANCER	70	5	0.0118373228873946450000000
TCGA-25-1631-01.6	30	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	5	0.0118449937179392670000000
TCGA-59-2348-01.14	123	2_REGULATION_OF_CELL_CYCLE	160	11	0.0118465836063181860000000
TCGA-13-1411-01.7	96	2_MITOSIS	71	7	0.0118593379854811070000000
TCGA-24-0968-01.9	71	1_KEGG_GNRH_SIGNALING_PATHWAY	96	7	0.0118593379854811070000000
TCGA-13-0726-01.12	78	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	16	0.0118633468419370720000000
TCGA-24-1471-01.4	49	2_SYSTEM_DEVELOPMENT	694	14	0.0118750607395020790000000
TCGA-13-0760-01.12	93	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0118906552442998600000000
TCGA-04-1365-01.6	150	2_DNA_DEPENDENT_DNA_REPLICATION	46	7	0.0118996632120018530000000
TCGA-24-1426-01.7	63	1_KEGG_MELANOMA	71	6	0.0119033659504789760000000
TCGA-24-1563-01.15	100	2_CARBOHYDRATE_BINDING	45	6	0.0119167828499586680000000
TCGA-04-1525-01.5	3	2_KERATINOCYTE_DIFFERENTIATION	15	2	0.0119177647316685340000000
TCGA-24-1435-01.4	3	2_CELLULAR_RESPIRATION	15	2	0.0119177647316685340000000
TCGA-09-2044-01.3	3	2_CELLULAR_RESPIRATION	15	2	0.0119177647316685340000000
TCGA-24-1425-01.1	61	2_HEPARIN_BINDING	20	4	0.0119193942670340730000000
TCGA-57-1584-01.8	54	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0119336998520999590000000
TCGA-13-0791-01.35	80	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	6	0.0119398174374719700000000
TCGA-25-1625-01.6	38	2_AGING	10	3	0.0119403143848004710000000
TCGA-24-1416-01.4	38	2_AGING	10	3	0.0119403143848004710000000
TCGA-61-2095-01.1	32	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	12	0.0119442909231211730000000
TCGA-09-2049-01.8	96	2_IMMUNE_RESPONSE	206	11	0.0119452316452694200000000
TCGA-61-2008-01.19	70	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	12	0.0120059655581843780000000
TCGA-30-1891-01.4	84	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	9	0.0120106271771514630000000
TCGA-23-1123-01.7	70	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0120461382635622460000000
TCGA-13-1489-01.11	118	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0120574982675389460000000
TCGA-23-1124-01.17	107	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0120756504515889730000000
TCGA-23-1120-01.10	57	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0121069806793896090000000
TCGA-13-0924-01.5	68	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0121482538665194270000000
TCGA-04-1337-01.2	31	2_METALLOPEPTIDASE_ACTIVITY	39	4	0.0121669728403773860000000
TCGA-29-2427-01.10	116	2_COLLAGEN	23	5	0.0121941677167503770000000
TCGA-24-0980-01.5	44	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	12	0.0121978975122598330000000
TCGA-13-0883-01.3	23	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	4	0.0122043863550215790000000
TCGA-04-1530-01.2	90	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0122153980727206180000000
TCGA-13-1491-01.7	90	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0122153980727206180000000
TCGA-04-1365-01.6	150	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0122188506942084800000000
TCGA-25-1623-01.7	111	2_METALLOENDOPEPTIDASE_ACTIVITY	24	5	0.0122914431798213650000000
TCGA-04-1347-01.7	2	2_PATTERN_SPECIFICATION_PROCESS	26	2	0.0123073984573378050000000
TCGA-24-1556-01.17	2	2_PATTERN_SPECIFICATION_PROCESS	26	2	0.0123073984573378050000000
TCGA-13-0919-01.5	50	1_KEGG_FOCAL_ADHESION	195	8	0.0123118094268927760000000
TCGA-13-1408-01.1	45	2_ORGAN_DEVELOPMENT	460	11	0.0123148208458459060000000
TCGA-61-2016-01.10	50	1_KEGG_ENDOMETRIAL_CANCER	52	5	0.0123178789595782130000000
TCGA-25-1324-01.3	42	2_INTERPHASE	62	5	0.0123199372044629890000000
TCGA-24-1434-01.3	82	0_HALLMARK_ANGIOGENESIS	32	5	0.0123289472080292760000000
TCGA-61-1995-01.4	102	2_CHROMOSOME_SEGREGATION	26	5	0.0123379553699647820000000
TCGA-13-1408-01.1	45	2_DNA_METABOLIC_PROCESS	218	8	0.0123390224227716680000000
TCGA-13-1498-01.13	104	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0123459106183262890000000
TCGA-57-1582-01.26	174	2_REGULATION_OF_CELL_PROLIFERATION	265	17	0.0123743405957254420000000
TCGA-25-1318-01.11	46	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	7	0.0124328037146230940000000
TCGA-04-1347-01.15	187	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	5	0.0124394004529011160000000
TCGA-61-2101-01.2	38	0_HALLMARK_ANGIOGENESIS	32	4	0.0124715543219240340000000
TCGA-04-1525-01.7	52	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	7	0.0124757635687566850000000
TCGA-24-2298-01.6	4	2_AEROBIC_RESPIRATION	11	2	0.0124808724916065940000000
TCGA-13-0804-01.5	78	0_HALLMARK_SPERMATOGENESIS	88	7	0.0124846281263204790000000
TCGA-13-0727-01.1	29	2_REGULATION_OF_CELL_CYCLE	160	6	0.0124875124154690210000000
TCGA-24-1560-01.2	29	2_REGULATION_OF_CELL_CYCLE	160	6	0.0124875124154690210000000
TCGA-25-2409-01.5	29	2_REGULATION_OF_CELL_CYCLE	160	6	0.0124875124154690210000000
TCGA-09-1665-01.16	131	2_SPINDLE	35	6	0.0124928539024533380000000
TCGA-59-2351-01.5	31	1_KEGG_APOPTOSIS	85	5	0.0125042844075492230000000
TCGA-30-1853-01.4	111	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	21	0.0125210487362891680000000
TCGA-04-1361-01.4	27	2_MEIOSIS_I	14	3	0.0125392747483082190000000
TCGA-29-2427-01.10	116	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0125453214883116460000000
TCGA-29-2427-01.10	116	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0125453214883116460000000
TCGA-24-1564-01.4	47	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	15	0.0125454567412444950000000
TCGA-24-2288-01.12	112	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	25	0.0125458588973376640000000
TCGA-10-0930-01.6	9	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	4	0.0125459651748003000000000
TCGA-24-1435-01.12	115	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	13	0.0125744766720025150000000
TCGA-25-2401-01.5	119	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	58	7	0.0125795639025441420000000
TCGA-10-0928-01.6	70	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0125823860780770280000000
TCGA-09-1662-01.6	49	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0126002673418094970000000
TCGA-10-0935-01.2	49	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0126002673418094970000000
TCGA-13-0723-01.8	50	2_DNA_BINDING	496	12	0.0126326511418232750000000
TCGA-23-1123-01.7	70	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	16	0.0126329523515266600000000
TCGA-61-2008-01.19	70	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	16	0.0126329523515266600000000
TCGA-09-2049-01.8	96	2_SIGNAL_TRANSDUCTION	1442	32	0.0126488091271506410000000
TCGA-13-0751-01.2	51	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0126586521179065290000000
TCGA-36-1574-01.10	152	2_SKELETAL_DEVELOPMENT	84	9	0.0126750380798038070000000
TCGA-61-2110-01.3	37	1_KEGG_MELANOMA	71	5	0.0126981114282700890000000
TCGA-13-0889-01.4	37	2_MITOSIS	71	5	0.0126981114282700890000000
TCGA-25-2042-01.3	63	2_PROTEOLYSIS	154	8	0.0127206510088664370000000
TCGA-25-2400-01.5	35	2_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS	11	3	0.0127266115908144240000000
TCGA-23-2081-01.7	56	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0127301958698978250000000
TCGA-24-1103-01.5	73	2_INTERPHASE	62	6	0.0127463012257098360000000
TCGA-23-1117-01.11	99	2_COLLAGEN_BINDING	13	4	0.0127486245965757820000000
TCGA-23-1110-01.7	299	2_CYTOKINE_BINDING	44	9	0.0127533958897073920000000
TCGA-13-0904-01.6	105	0_HALLMARK_HYPOXIA	154	10	0.0127883974325796460000000
TCGA-24-1434-01.3	82	2_SKELETAL_DEVELOPMENT	84	7	0.0127895861971668420000000
TCGA-23-1031-01.17	142	1_KEGG_MTOR_SIGNALING_PATHWAY	49	7	0.0127978683539013310000000
TCGA-23-1031-01.17	142	2_GROWTH_FACTOR_ACTIVITY	49	7	0.0127978683539013310000000
TCGA-04-1362-01.4	35	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	14	0.0128080468461100150000000
TCGA-57-1993-01.8	52	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0128374490052949010000000
TCGA-57-1993-01.8	52	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0128374490052949010000000
TCGA-13-0893-01.4	112	2_KINETOCHORE	24	5	0.0128441422163049160000000
TCGA-36-1571-01.6	109	2_MICROTUBULE_CYTOSKELETON	117	9	0.0128450996735693430000000
TCGA-04-1356-01.1	71	2_INTRACELLULAR_ORGANELLE_PART	912	20	0.0128482014692186970000000
TCGA-04-1350-01.2	130	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	28	0.0128600018339327090000000
TCGA-09-2049-01.8	96	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	133	9	0.0128835759658465710000000
TCGA-13-1409-01.6	122	2_CELL_DEVELOPMENT	511	20	0.0129212855922061670000000
TCGA-61-1998-01.14	105	2_TRANSITION_METAL_ION_BINDING	92	8	0.0129355735627005830000000
TCGA-36-1576-01.8	124	2_EXTRACELLULAR_SPACE	192	12	0.0129712186747972580000000
TCGA-24-2288-01.12	112	1_KEGG_CELL_CYCLE	114	9	0.0129737035261904830000000
TCGA-36-1571-01.6	109	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0129871940244149120000000
TCGA-13-1488-01.17	109	1_KEGG_BLADDER_CANCER	42	6	0.0129871940244149120000000
TCGA-13-1488-01.17	109	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0129871940244149120000000
TCGA-04-1365-01.6	150	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	6	0.0129902921720055150000000
TCGA-23-1028-01.18	93	2_CELL_CYCLE_ARREST_GO_0007050	49	6	0.0129944315768535540000000
TCGA-13-1411-01.7	96	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0130284572370594370000000
TCGA-13-0792-01.8	64	2_MITOSIS	71	6	0.0130574047558559330000000
TCGA-24-1427-01.4	83	0_HALLMARK_ANGIOGENESIS	32	5	0.0130879552299267340000000
TCGA-13-0807-01.8	46	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0130928027645437030000000
TCGA-13-0916-01.11	92	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0130928395911059820000000
TCGA-13-0885-01.6	44	2_REGULATION_OF_MEMBRANE_POTENTIAL	9	3	0.0131207934905731660000000
TCGA-09-2051-01.26	142	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0131251817039916820000000
TCGA-13-1483-01.3	66	2_DNA_RECOMBINATION	40	5	0.0131308751524198510000000
TCGA-13-0906-01.5	66	2_DNA_RECOMBINATION	40	5	0.0131308751524198510000000
TCGA-23-1028-01.18	93	1_KEGG_MAPK_SIGNALING_PATHWAY	258	12	0.0131362518887768350000000
TCGA-30-1853-01.4	111	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	13	0.0131420068832065870000000
TCGA-61-2092-01.12	209	2_EXTRACELLULAR_REGION	346	22	0.0131427206874639370000000
TCGA-13-0906-01.5	66	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0131554204699574320000000
TCGA-23-2078-01.15	105	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0131554204699574320000000
TCGA-13-0894-01.9	118	2_METALLOPEPTIDASE_ACTIVITY	39	6	0.0131567328757690830000000
TCGA-13-1494-01.4	65	1_KEGG_PANCREATIC_CANCER	70	6	0.0131624611738870340000000
TCGA-13-1412-01.8	113	2_ORGAN_DEVELOPMENT	460	18	0.0132055379852947430000000
TCGA-10-0928-01.6	70	1_KEGG_MELANOGENESIS	99	7	0.0132282935391717250000000
TCGA-24-1614-01.5	86	2_REGULATION_OF_CELL_GROWTH	31	5	0.0132456355266392600000000
TCGA-61-2092-01.12	209	1_KEGG_COLORECTAL_CANCER	62	9	0.0132521832010615010000000
TCGA-61-2002-01.1	118	2_COLLAGEN	23	5	0.0132597680620913230000000
TCGA-36-1571-01.6	109	1_KEGG_MAPK_SIGNALING_PATHWAY	258	13	0.0132728445201839520000000
TCGA-13-0893-01.4	112	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	11	0.0132740188566637940000000
TCGA-24-2024-01.3	55	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	5	0.0132836302514152270000000
TCGA-13-0727-01.1	29	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0132873165266691670000000
TCGA-13-0727-01.1	29	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0132873165266691670000000
TCGA-24-1556-01.19	120	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0132955870403061780000000
TCGA-24-1474-01.12	122	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0133088715192732720000000
TCGA-23-1023-01.1	93	0_HALLMARK_MITOTIC_SPINDLE	175	10	0.0133110270446058480000000
TCGA-23-1028-01.18	93	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0133110270446058480000000
TCGA-13-0760-01.12	93	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0133110270446058480000000
TCGA-59-2348-01.14	123	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	17	0.0133228313192897860000000
TCGA-24-1425-01.1	61	1_KEGG_CELL_CYCLE	114	7	0.0133262573800350760000000
TCGA-23-2077-01.18	63	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0133383192914470950000000
TCGA-61-2094-01.6	63	1_KEGG_BLADDER_CANCER	42	5	0.0133383192914470950000000
TCGA-24-0975-01.6	78	2_CATION_BINDING	165	9	0.0133439905281201450000000
TCGA-10-0934-01.11	145	2_INFLAMMATORY_RESPONSE	112	10	0.0133660884191035830000000
TCGA-13-1404-01.13	117	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0133709898468283900000000
TCGA-13-0760-01.12	93	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0133972403827981240000000
TCGA-24-1470-01.7	76	2_SPINDLE	35	5	0.0133973553307489490000000
TCGA-23-1021-01.7	44	2_REGULATION_OF_CELL_CYCLE	160	7	0.0133985262248101590000000
TCGA-13-0913-01.5	44	2_REGULATION_OF_CELL_CYCLE	160	7	0.0133985262248101590000000
TCGA-25-2404-01.5	58	2_REGULATION_OF_MOLECULAR_FUNCTION	286	10	0.0134548463726719660000000
TCGA-24-2260-01.11	63	2_APOPTOSIS_GO	389	12	0.0134574256874261460000000
TCGA-23-2081-01.7	56	2_SYSTEM_DEVELOPMENT	694	15	0.0134681546571794740000000
TCGA-59-2351-01.5	31	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0134879481318470470000000
TCGA-09-0366-01.5	32	2_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY	146	6	0.0135078779774455530000000
TCGA-13-1510-01.20	82	2_ORGAN_DEVELOPMENT	460	15	0.0135153814620710320000000
TCGA-24-1416-01.4	38	1_KEGG_PANCREATIC_CANCER	70	5	0.0135528631990162320000000
TCGA-25-1635-01.6	129	2_REGULATION_OF_MITOSIS	36	6	0.0135645238887875870000000
TCGA-25-2042-01.3	63	2_HEPARIN_BINDING	20	4	0.0135683261993905040000000
TCGA-04-1342-01.12	104	2_CONDENSED_CHROMOSOME	26	5	0.0135717421056793500000000
TCGA-13-1498-01.13	104	2_CONDENSED_CHROMOSOME	26	5	0.0135717421056793500000000
TCGA-24-2298-01.7	138	2_HEPARIN_BINDING	20	5	0.0135797673618954400000000
TCGA-36-1574-01.10	152	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	15	0.0135828166073714750000000
TCGA-20-0991-01.12	166	1_KEGG_FOCAL_ADHESION	195	14	0.0135873140512000000000000
TCGA-13-0889-01.4	37	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	5	0.0136071774232312350000000
TCGA-25-1630-01.10	35	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	6	0.0136336816897126570000000
TCGA-57-1583-01.20	185	0_HALLMARK_MITOTIC_SPINDLE	175	14	0.0136377506038799660000000
TCGA-04-1347-01.15	187	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	13	0.0136633478573197010000000
TCGA-23-1118-01.5	50	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0136715647747152160000000
TCGA-13-1411-01.7	96	2_MITOTIC_CELL_CYCLE	134	9	0.0136965822843840050000000
TCGA-20-0987-01.19	194	2_EXTRACELLULAR_REGION	346	21	0.0137180681390519640000000
TCGA-25-1625-01.6	38	2_CELL_CYCLE_GO_0007049	265	8	0.0137193368260639190000000
TCGA-30-1862-01.13	91	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0137247106932623900000000
TCGA-04-1356-01.1	71	2_ORGANELLE_PART	916	20	0.0137259853063788210000000
TCGA-13-1489-01.11	118	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0137328811941369590000000
TCGA-13-0893-01.4	112	1_KEGG_PROSTATE_CANCER	87	8	0.0137594205147831380000000
TCGA-13-1409-01.6	122	2_PLASMA_MEMBRANE_PART	901	28	0.0137872126590538410000000
TCGA-24-1418-01.16	84	1_KEGG_FOCAL_ADHESION	195	10	0.0137921025512241500000000
TCGA-23-1032-01.16	250	0_HALLMARK_IL2_STAT5_SIGNALING	148	15	0.0138050306612728000000000
TCGA-31-1959-01.7	101	2_COLLAGEN_BINDING	13	4	0.0138062496936144950000000
TCGA-24-2260-01.11	63	2_PROGRAMMED_CELL_DEATH	390	12	0.0138136852414848590000000
TCGA-09-1659-01.5	51	2_CYTOSKELETAL_PART	194	8	0.0138145858606759580000000
TCGA-09-2044-01.4	83	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0138296602833798250000000
TCGA-30-1891-01.4	84	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0138680978711637620000000
TCGA-24-1427-01.4	83	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0138680978711637620000000
TCGA-13-0724-01.21	71	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0138764950438052380000000
TCGA-61-2095-01.1	32	2_SKELETAL_DEVELOPMENT	84	5	0.0138830949616285250000000
TCGA-24-1560-01.2	29	2_PURINE_RIBONUCLEOTIDE_BINDING	163	6	0.0138964957761629290000000
TCGA-24-1103-01.5	73	2_MITOTIC_CELL_CYCLE	134	8	0.0139003011756902530000000
TCGA-24-1552-01.5	54	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0139010380079899450000000
TCGA-23-1031-01.17	142	1_KEGG_RENAL_CELL_CARCINOMA	69	8	0.0139380328389892800000000
TCGA-13-0751-01.2	51	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0139383595738482090000000
TCGA-13-1497-01.7	59	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	19	0.0139588091515955740000000
TCGA-57-1584-01.8	54	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	8	0.0139608230669230550000000
TCGA-13-0807-01.8	46	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0139782533797694250000000
TCGA-24-1558-01.12	174	2_SIGNAL_TRANSDUCTION	1442	49	0.0139833310895137400000000
TCGA-10-0928-01.6	70	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0139947274312320020000000
TCGA-04-1347-01.15	187	2_APOPTOSIS_GO	389	22	0.0139999266255312890000000
TCGA-24-2267-01.8	26	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	9	0.0140019507796837910000000
TCGA-13-1496-01.13	120	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0140145971809721470000000
TCGA-13-0916-01.11	92	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0140325231631211140000000
TCGA-23-1023-01.1	93	2_CELL_DEVELOPMENT	511	17	0.0140379784493268960000000
TCGA-04-1525-01.7	52	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0141378019653981450000000
TCGA-13-0795-01.9	67	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0141459891972229470000000
TCGA-13-0792-01.8	64	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	6	0.0141695508647223990000000
TCGA-24-2260-01.11	63	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	12	0.0141782206871493950000000
TCGA-23-2078-01.15	105	2_CONDENSED_CHROMOSOME	26	5	0.0142238253253675550000000
TCGA-59-2348-01.14	123	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0142282314492811720000000
TCGA-09-1669-01.10	81	2_BASE_EXCISION_REPAIR	16	4	0.0142594209696074920000000
TCGA-24-1558-01.12	174	2_BEHAVIOR	138	12	0.0143122905806260400000000
TCGA-13-0893-01.2	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-61-2097-01.3	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-23-1110-01.3	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-04-1331-01.1	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-0755-01.3	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-25-2042-01.2	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-23-1117-01.4	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-0807-01.3	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-1497-01.5	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-1484-01.3	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-1509-01.7	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-0883-01.2	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-1505-01.7	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-0885-01.4	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-04-1342-01.8	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-25-1326-01.7	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-61-2094-01.5	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-13-1495-01.15	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-24-0980-01.4	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-24-1614-01.3	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-04-1343-01.8	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-25-2399-01.12	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-04-1338-01.6	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428170000000
TCGA-10-0933-01.2	97	2_CYTOSKELETON	293	13	0.0143153355383483310000000
TCGA-24-1469-01.6	123	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	10	0.0143254037258062210000000
TCGA-24-2261-01.2	87	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	14	0.0143435431209840250000000
TCGA-13-0714-01.9	51	1_KEGG_FOCAL_ADHESION	195	8	0.0143468191809747820000000
TCGA-10-0938-01.2	102	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0143587549542325750000000
TCGA-25-2396-01.6	42	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	4	0.0143683207079214580000000
TCGA-24-1555-01.1	14	2_M_PHASE	94	4	0.0144037380477646400000000
TCGA-25-1623-01.7	111	1_KEGG_BLADDER_CANCER	42	6	0.0144264288031888300000000
TCGA-23-1124-01.17	107	2_REGULATION_OF_CELL_PROLIFERATION	265	13	0.0144337236187580210000000
TCGA-04-1362-01.4	35	2_REGULATION_OF_MITOSIS	36	4	0.0144422903345281780000000
TCGA-36-1570-01.2	36	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0144422903345281780000000
TCGA-24-1105-01.8	52	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0144537253597302670000000
TCGA-13-1506-01.5	113	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	11	0.0144677983623319270000000
TCGA-13-1512-01.2	113	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0144735943995490690000000
TCGA-13-0723-01.8	50	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0145022401651825010000000
TCGA-23-1118-01.5	50	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0145022401651825010000000
TCGA-61-2016-01.10	50	2_CELL_CYCLE_GO_0007049	265	9	0.0145022401651825010000000
TCGA-61-2016-01.10	50	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0145022401651825010000000
TCGA-24-1416-01.4	38	2_MITOSIS	71	5	0.0145371228138137050000000
TCGA-13-0893-01.4	112	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0145502309947192770000000
TCGA-13-0910-01.3	71	2_CHROMOSOME_ORGANIZATION_AND_BIOGENESIS	99	7	0.0145504077406384250000000
TCGA-10-0934-01.11	145	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0145749136625449180000000
TCGA-04-1347-01.15	187	2_PROGRAMMED_CELL_DEATH	390	22	0.0145831424712459380000000
TCGA-61-2012-01.6	78	2_RESPONSE_TO_STRESS	427	14	0.0146096018327977920000000
TCGA-24-2019-01.10	192	2_EXTRACELLULAR_REGION_PART	269	18	0.0146261304641761880000000
TCGA-13-1404-01.13	117	2_SKELETAL_DEVELOPMENT	84	8	0.0146272901814903200000000
TCGA-24-2035-01.8	102	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	7	0.0146397917361455170000000
TCGA-13-0807-01.8	46	2_DNA_METABOLIC_PROCESS	218	8	0.0146432589741038040000000
TCGA-09-2050-01.18	196	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	30	0.0146568366458005060000000
TCGA-24-0966-01.2	18	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0146676410898780460000000
TCGA-13-2060-01.10	86	2_APOPTOTIC_PROGRAM	54	6	0.0146714023357721250000000
TCGA-10-0935-01.2	49	2_RESPONSE_TO_STRESS	427	11	0.0146728577970951980000000
TCGA-13-0760-01.12	93	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	18	0.0146728990499210980000000
TCGA-61-2104-01.15	95	2_CELL_CYCLE_ARREST_GO_0007050	49	6	0.0147006554248281340000000
TCGA-04-1342-01.12	104	2_CYTOSKELETAL_PART	194	11	0.0147036324251384500000000
TCGA-13-0912-01.2	55	2_GROWTH_FACTOR_ACTIVITY	49	5	0.0147279700735385520000000
TCGA-13-1496-01.13	120	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0147291738259582840000000
TCGA-24-1556-01.19	120	2_DNA_REPLICATION	82	8	0.0147291738259582840000000
TCGA-36-1577-01.14	168	2_MYOFIBRIL	17	5	0.0147328750472839210000000
TCGA-13-0717-01.6	103	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0147920837817166660000000
TCGA-13-0924-01.5	68	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0148200325480004080000000
TCGA-13-1409-01.6	122	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	58	7	0.0148295588398989430000000
TCGA-24-1470-01.7	76	2_DNA_METABOLIC_PROCESS	218	10	0.0148410591423827480000000
TCGA-10-0934-01.11	145	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	13	0.0148617138799227790000000
TCGA-13-0897-01.2	61	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0148726911732015890000000
TCGA-24-1560-01.2	29	2_PURINE_NUCLEOTIDE_BINDING	165	6	0.0149056146047603050000000
TCGA-04-1347-01.15	187	2_PEPTIDASE_ACTIVITY	129	12	0.0149099634766976640000000
TCGA-61-2088-01.7	150	2_RESPONSE_TO_OTHER_ORGANISM	66	8	0.0149156519733957640000000
TCGA-13-0905-01.7	160	2_INTERPHASE	62	8	0.0149290244696354930000000
TCGA-36-1580-01.1	65	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	18	0.0149574654859282090000000
TCGA-29-2427-01.10	116	2_INFLAMMATORY_RESPONSE	112	9	0.0149613430344706830000000
TCGA-13-2060-01.10	86	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0149625202742547280000000
TCGA-23-1024-01.5	4	2_STEROID_HORMONE_RECEPTOR_ACTIVITY	12	2	0.0149749317560417970000000
TCGA-29-2427-01.10	116	2_EXTRACELLULAR_MATRIX	85	8	0.0149977671130435350000000
TCGA-13-1409-01.6	122	2_EXTRACELLULAR_REGION	346	16	0.0150115504267190200000000
TCGA-10-0938-01.2	102	2_MEIOTIC_CELL_CYCLE	27	5	0.0150128576020553540000000
TCGA-24-1544-01.7	84	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0150210907966471730000000
TCGA-30-1891-01.4	84	2_SKELETAL_DEVELOPMENT	84	7	0.0150210907966471730000000
TCGA-23-1116-01.7	84	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0150210907966471730000000
TCGA-23-1116-01.7	84	2_SKELETAL_DEVELOPMENT	84	7	0.0150210907966471730000000
TCGA-23-1122-01.11	77	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0150340302351451070000000
TCGA-24-0979-01.5	41	2_AGING	10	3	0.0150629747150833670000000
TCGA-13-1487-01.3	79	0_HALLMARK_COAGULATION	125	8	0.0150634882609811460000000
TCGA-13-0760-01.12	93	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0150644462001795260000000
TCGA-04-1542-01.4	141	2_CONTRACTILE_FIBER_PART	20	5	0.0150847785212486350000000
TCGA-31-1959-01.7	101	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0151053338893358430000000
TCGA-61-1919-01.8	4	1_KEGG_TIGHT_JUNCTION	125	3	0.0151381900309931220000000
TCGA-24-2271-01.3	44	2_CELL_CYCLE_PROCESS	163	7	0.0151393807297436920000000
TCGA-25-2401-01.5	119	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0151607870627464070000000
TCGA-36-1570-01.2	36	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	9	0.0151773829591792620000000
TCGA-61-1995-01.4	102	2_INTRACELLULAR_ORGANELLE_PART	912	25	0.0151910597500634420000000
TCGA-24-1563-01.15	100	2_CATION_BINDING	165	10	0.0152050841844457930000000
TCGA-24-1470-01.7	76	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0152513909609012460000000
TCGA-13-1410-01.9	115	2_REGULATION_OF_MOLECULAR_FUNCTION	286	14	0.0152516461018295140000000
TCGA-04-1530-01.2	90	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0152912437355815660000000
TCGA-61-2102-01.7	172	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0152926757290812420000000
TCGA-04-1346-01.10	75	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	22	0.0152967293824937990000000
TCGA-25-1627-01.4	75	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	22	0.0152967293824937990000000
TCGA-36-1576-01.8	124	2_CELL_CYCLE_PROCESS	163	11	0.0153051137843477280000000
TCGA-25-1628-01.2	118	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0153218070444514180000000
TCGA-13-1489-01.11	118	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0153218070444514180000000
TCGA-13-0751-01.2	51	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0153238529560514870000000
TCGA-25-2398-01.5	81	2_RESPONSE_TO_CHEMICAL_STIMULUS	252	11	0.0153673615037285480000000
TCGA-24-1417-01.11	2	2_EXCRETION	29	2	0.0153747808420905490000000
TCGA-24-2019-01.4	2	2_EXCRETION	29	2	0.0153747808420905490000000
TCGA-25-2396-01.6	42	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	12	0.0153864835112650780000000
TCGA-24-2262-01.25	141	2_REGULATION_OF_CELL_PROLIFERATION	265	15	0.0153869192745621250000000
TCGA-25-1631-01.6	30	2_REGULATION_OF_CELL_CYCLE	160	6	0.0153922392314859020000000
TCGA-24-2262-01.25	141	2_MICROTUBULE_CYTOSKELETON	117	10	0.0154077990738672420000000
TCGA-23-1028-01.18	93	2_ORGAN_DEVELOPMENT	460	16	0.0154085865165283080000000
TCGA-36-1576-01.8	124	2_CELL_CYCLE_GO_0007049	265	14	0.0154247323727296230000000
TCGA-09-2044-01.3	3	2_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	17	2	0.0154341620000586180000000
TCGA-23-1028-01.18	93	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0154699288317278000000000
TCGA-13-0760-01.12	93	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0154699288317278000000000
TCGA-24-1413-01.6	34	2_MAP_KINASE_ACTIVITY	12	3	0.0154860301628335050000000
TCGA-04-1365-01.6	150	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0154954196799274080000000
TCGA-24-1552-01.1	4	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0155061707333225990000000
TCGA-24-1103-01.5	73	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0155075324217460800000000
TCGA-24-1435-01.4	3	2_MITOCHONDRION	199	3	0.0155592785649434890000000
TCGA-13-0883-01.4	3	2_MITOCHONDRION	199	3	0.0155592785649434890000000
TCGA-13-0887-01.6	47	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0155693103421233070000000
TCGA-23-1021-01.7	44	1_KEGG_COLORECTAL_CANCER	62	5	0.0155707916915599820000000
TCGA-13-1494-01.4	65	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0155722487014754770000000
TCGA-36-1580-01.1	65	1_KEGG_BLADDER_CANCER	42	5	0.0155722487014754770000000
TCGA-23-1026-01.5	65	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0155722487014754770000000
TCGA-24-1416-01.4	38	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	5	0.0155764735444634420000000
TCGA-25-1628-01.2	118	2_SKELETAL_DEVELOPMENT	84	8	0.0155788329433229730000000
TCGA-25-1626-01.2	86	0_HALLMARK_ANGIOGENESIS	32	5	0.0155866651386228900000000
TCGA-24-1614-01.5	86	1_KEGG_DNA_REPLICATION	32	5	0.0155866651386228900000000
TCGA-13-1489-01.11	118	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0156059487560270530000000
TCGA-23-1022-01.10	170	2_MYOFIBRIL	17	5	0.0156086729222580360000000
TCGA-09-2056-01.1	12	1_KEGG_CELL_CYCLE	114	4	0.0156113818456833500000000
TCGA-59-2363-01.3	89	2_RESPONSE_TO_STRESS	427	15	0.0156142847895774750000000
TCGA-59-2363-01.3	89	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0156266642508805130000000
TCGA-36-1570-01.2	36	2_REGULATION_OF_MOLECULAR_FUNCTION	286	8	0.0156289141740013240000000
TCGA-24-2030-01.8	161	1_KEGG_GLIOMA	62	8	0.0156294328618385960000000
TCGA-24-1469-01.6	123	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0156500031587893070000000
TCGA-23-1117-01.11	99	2_POLYSACCHARIDE_BINDING	28	5	0.0156557282263056210000000
TCGA-09-2053-01.14	121	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0156620472332515900000000
TCGA-23-1124-01.17	107	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	19	0.0156817471459015540000000
TCGA-61-2101-01.2	38	0_HALLMARK_COAGULATION	125	6	0.0156855426933599110000000
TCGA-23-1022-01.10	170	2_RECEPTOR_ACTIVITY	499	24	0.0156952014659608660000000
TCGA-24-1603-01.3	69	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0157120005509368100000000
TCGA-13-0795-01.9	67	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	6	0.0157189674314518570000000
TCGA-24-1567-01.3	141	2_AGING	10	4	0.0157353621138483570000000
TCGA-13-0762-01.2	68	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	15	0.0157553175885977240000000
TCGA-13-0795-01.9	67	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0157773405082266630000000
TCGA-04-1348-01.6	81	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0157855197741761620000000
TCGA-24-1471-01.4	49	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	15	0.0158535241504080060000000
TCGA-13-0903-01.11	77	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0158615632478320940000000
TCGA-20-0987-01.19	194	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0158728376493791800000000
TCGA-25-1324-01.3	42	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0158747464407261900000000
TCGA-24-1105-01.8	52	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0159119605155542310000000
TCGA-13-0804-01.5	78	2_SPINDLE_POLE	17	4	0.0159358562028857480000000
TCGA-61-2000-01.11	69	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	10	0.0159542093722149540000000
TCGA-13-1496-01.13	120	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0159557936956791660000000
TCGA-24-1469-01.6	123	2_RESPONSE_TO_STRESS	427	18	0.0159767521559379360000000
TCGA-13-1512-01.2	113	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0159924882536999040000000
TCGA-13-1506-01.5	113	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0159924882536999040000000
TCGA-13-0893-01.4	112	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	16	0.0160380773666246830000000
TCGA-61-2101-01.2	38	2_EXTRACELLULAR_SPACE	192	7	0.0160487511106045500000000
TCGA-24-2288-01.12	112	2_MICROTUBULE_CYTOSKELETON	117	9	0.0160491880219215470000000
TCGA-13-1407-01.11	220	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	23	0.0160517047658773650000000
TCGA-09-2050-01.18	196	1_KEGG_APOPTOSIS	85	10	0.0160619708431322810000000
TCGA-25-1326-01.11	119	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0160854121046176450000000
TCGA-23-2078-01.15	105	2_KINESIN_COMPLEX	13	4	0.0161146493558957870000000
TCGA-23-2078-01.15	105	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0161146493558957870000000
TCGA-25-1634-01.4	75	1_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	133	8	0.0161210952274965240000000
TCGA-24-1470-01.7	76	2_INTERPHASE	62	6	0.0161214013269846590000000
TCGA-36-1575-01.9	193	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	126	12	0.0161392417095176930000000
TCGA-13-0889-01.4	37	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0161503797178360820000000
TCGA-24-1466-01.15	82	1_KEGG_PROSTATE_CANCER	87	7	0.0161588499590978980000000
TCGA-24-2030-01.8	161	2_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING	9	4	0.0161855814007334200000000
TCGA-13-0905-01.7	160	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	25	0.0162073921689388990000000
TCGA-30-1853-01.4	111	1_KEGG_MAPK_SIGNALING_PATHWAY	258	13	0.0162400049016982950000000
TCGA-61-2109-01.13	122	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0162405183305037550000000
TCGA-30-1891-01.4	84	2_PATTERN_BINDING	33	5	0.0162485005504895940000000
TCGA-24-2030-01.8	161	0_HALLMARK_P53_PATHWAY	151	12	0.0163098546096537570000000
TCGA-09-1665-01.16	131	2_DNA_METABOLIC_PROCESS	218	13	0.0163397106020314290000000
TCGA-24-2024-01.3	55	2_LOCOMOTORY_BEHAVIOR	86	6	0.0163486845633712410000000
TCGA-09-1661-01.1	20	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0163501002303827090000000
TCGA-13-1492-01.2	162	2_INTERPHASE	62	8	0.0163574203015630910000000
TCGA-24-1603-01.3	69	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0163600221500036220000000
TCGA-25-1319-01.10	69	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0163600221500036220000000
TCGA-24-2260-01.11	63	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0163999142432300630000000
TCGA-24-1426-01.7	63	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0163999142432300630000000
TCGA-24-0980-01.5	44	2_CATION_BINDING	165	7	0.0164013145566364420000000
TCGA-61-1995-01.4	102	2_ORGANELLE_PART	916	25	0.0164026868391700840000000
TCGA-13-2060-01.10	86	2_REGULATION_OF_MOLECULAR_FUNCTION	286	12	0.0164258785517574610000000
TCGA-23-1027-01.8	68	1_KEGG_FOCAL_ADHESION	195	9	0.0164399153145501250000000
TCGA-25-1322-01.15	93	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0164406017328474210000000
TCGA-23-1028-01.18	93	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0164406017328474210000000
TCGA-13-0760-01.12	93	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0164406017328474210000000
TCGA-13-1409-01.6	122	2_REGULATION_OF_APOPTOSIS	309	15	0.0164427574910405200000000
TCGA-04-1337-01.2	31	1_KEGG_BLADDER_CANCER	42	4	0.0164439239473184100000000
TCGA-13-0800-01.9	124	2_MITOTIC_CELL_CYCLE	134	10	0.0164569263523539480000000
TCGA-61-1919-01.9	87	0_HALLMARK_ANGIOGENESIS	32	5	0.0164976029277277940000000
TCGA-13-1492-01.2	162	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	6	0.0165302214188399810000000
TCGA-24-0979-01.5	41	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	7	0.0165634833392322640000000
TCGA-24-2030-01.8	161	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	9	0.0165650700118692910000000
TCGA-61-2094-01.6	63	1_KEGG_CELL_CYCLE	114	7	0.0165679316792043570000000
TCGA-25-1320-01.4	71	2_METALLOPEPTIDASE_ACTIVITY	39	5	0.0165780725252832330000000
TCGA-13-0894-01.9	118	2_METALLOENDOPEPTIDASE_ACTIVITY	24	5	0.0165827669011955410000000
TCGA-13-1495-01.22	101	2_MITOSIS	71	7	0.0166119850767925990000000
TCGA-61-2109-01.13	122	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0166443464947428930000000
TCGA-24-1434-01.3	82	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0166443464947431050000000
TCGA-24-1417-01.14	94	2_DNA_METABOLIC_PROCESS	218	11	0.0166743980123802460000000
TCGA-10-0934-01.11	145	2_CELL_DEVELOPMENT	511	22	0.0166744010703194150000000
TCGA-09-2056-01.6	63	2_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY	21	4	0.0166772701236690970000000
TCGA-36-1568-01.22	80	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	16	0.0167065678725584890000000
TCGA-24-1435-01.12	115	1_KEGG_PROSTATE_CANCER	87	8	0.0167371194733456320000000
TCGA-04-1350-01.2	130	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0167372219042152650000000
TCGA-24-0975-01.6	78	2_TRANSITION_METAL_ION_BINDING	92	7	0.0167801172081623840000000
TCGA-24-1558-01.12	174	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	16	0.0167806489261110930000000
TCGA-61-2094-01.6	63	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	14	0.0167825937088443150000000
TCGA-13-1483-01.3	66	1_KEGG_BLADDER_CANCER	42	5	0.0167936665593672150000000
TCGA-13-0906-01.5	66	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0167936665593672150000000
TCGA-13-1407-01.11	220	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	14	0.0167972755664642680000000
TCGA-24-0982-01.3	34	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	5	0.0168057679458865630000000
TCGA-13-0724-01.21	71	2_BIOPOLYMER_METABOLIC_PROCESS	1367	25	0.0168154998239265640000000
TCGA-24-1545-01.2	28	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	6	0.0168205855995135420000000
TCGA-25-2042-01.3	63	2_RECEPTOR_BINDING	331	11	0.0168212280807118720000000
TCGA-13-0793-01.8	97	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0168302003268659540000000
TCGA-10-0933-01.2	97	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0168302003268659540000000
TCGA-24-2271-01.3	44	2_SYSTEM_DEVELOPMENT	694	13	0.0168395568615999250000000
TCGA-59-2354-01.2	44	2_SYSTEM_DEVELOPMENT	694	13	0.0168395568615999250000000
TCGA-09-1666-01.28	109	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0168485111137991510000000
TCGA-09-0369-01.9	109	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0168485111137991510000000
TCGA-24-0966-01.2	18	2_REGULATION_OF_MOLECULAR_FUNCTION	286	6	0.0168516684986409790000000
TCGA-23-2077-01.18	63	2_HEMOSTASIS	44	5	0.0168549271912989750000000
TCGA-23-2077-01.18	63	2_REGULATION_OF_CELL_CYCLE	160	8	0.0168570897728082920000000
TCGA-61-2094-01.6	63	2_REGULATION_OF_CELL_CYCLE	160	8	0.0168570897728082920000000
TCGA-24-1558-01.12	174	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0168583560063650900000000
TCGA-13-0723-01.8	50	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	7	0.0168618367773293860000000
TCGA-25-2396-01.6	42	2_NUCLEUS	1110	16	0.0169270208059560290000000
TCGA-61-1998-01.14	105	1_KEGG_FOCAL_ADHESION	195	11	0.0169412992166324690000000
TCGA-25-2404-01.5	58	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0169514105557666720000000
TCGA-13-1484-01.4	70	0_HALLMARK_ALLOGRAFT_REJECTION	190	9	0.0169806734704387450000000
TCGA-61-2111-01.16	56	1_KEGG_APOPTOSIS	85	6	0.0169868112605474670000000
TCGA-61-2109-01.13	122	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0170013549807733230000000
TCGA-61-2109-01.13	122	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0170013549807733230000000
TCGA-24-0970-01.6	94	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0170327631533362490000000
TCGA-04-1346-01.10	75	2_MITOTIC_CELL_CYCLE	134	8	0.0170363716902974940000000
TCGA-23-1032-01.16	250	1_KEGG_ASTHMA	30	7	0.0170675424858290100000000
TCGA-13-0726-01.12	78	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0170734132882803600000000
TCGA-61-2012-01.6	78	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0170734132882803600000000
TCGA-36-1571-01.6	109	2_CONDENSED_CHROMOSOME	26	5	0.0170816558754624190000000
TCGA-36-1571-01.6	109	2_CHROMOSOME_SEGREGATION	26	5	0.0170816558754624190000000
TCGA-13-1409-01.6	122	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	15	0.0170924922785362990000000
TCGA-13-0755-01.6	16	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0171001201303383370000000
TCGA-24-1544-01.7	84	2_EXTRACELLULAR_REGION	346	13	0.0171134989728175430000000
TCGA-24-1464-01.7	62	2_CELL_CYCLE_PROCESS	163	8	0.0171138600110475290000000
TCGA-13-1482-01.7	62	2_CELL_CYCLE_PROCESS	163	8	0.0171138600110475290000000
TCGA-13-1409-01.6	122	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	22	0.0171197060962871640000000
TCGA-24-1614-01.5	86	2_ENZYME_BINDING	154	9	0.0171300296537333400000000
TCGA-13-0884-01.11	68	1_KEGG_PANCREATIC_CANCER	70	6	0.0171402052799386820000000
TCGA-61-2088-01.7	150	2_IMMUNE_SYSTEM_PROCESS	283	16	0.0171889739683657760000000
TCGA-13-0717-01.6	103	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0171984354023027340000000
TCGA-13-0717-01.6	103	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0171984354023027340000000
TCGA-13-1509-01.9	117	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0172144074691426910000000
TCGA-04-1338-01.7	85	2_PATTERN_BINDING	33	5	0.0172213127528874700000000
TCGA-13-0791-01.35	80	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	5	0.0172489904490644510000000
TCGA-24-1103-01.5	73	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0172690617314116490000000
TCGA-04-1332-01.2	25	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	4	0.0172906476128327770000000
TCGA-13-0890-01.2	48	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0172985682952656280000000
TCGA-24-2293-01.3	33	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	12	0.0173071463038082450000000
TCGA-13-1510-01.20	82	2_RESPONSE_TO_CHEMICAL_STIMULUS	252	11	0.0173354362616718220000000
TCGA-24-1423-01.5	27	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0173481930722697260000000
TCGA-24-2030-01.8	161	2_SIGNAL_TRANSDUCTION	1442	46	0.0173553863569080830000000
TCGA-13-0916-01.11	92	1_KEGG_ENDOMETRIAL_CANCER	52	6	0.0173555095389728780000000
TCGA-24-1555-01.1	14	2_DOUBLE_STRANDED_DNA_BINDING	30	3	0.0173593436046835660000000
TCGA-13-1505-01.13	60	0_HALLMARK_E2F_TARGETS	169	8	0.0173969297537019150000000
TCGA-25-1627-01.4	75	2_REPLICATION_FORK	18	4	0.0174113997858267210000000
TCGA-61-2003-01.4	45	1_KEGG_COLORECTAL_CANCER	62	5	0.0174292241576172770000000
TCGA-13-0912-01.2	55	1_KEGG_PROSTATE_CANCER	87	6	0.0174816190110196270000000
TCGA-24-1105-01.8	52	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0174903987157507090000000
TCGA-36-1576-01.8	124	2_METALLOPEPTIDASE_ACTIVITY	39	6	0.0175105191523024090000000
TCGA-23-1122-01.11	77	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0175214771358337960000000
TCGA-13-0714-01.9	51	2_M_PHASE	94	6	0.0175241138332306520000000
TCGA-13-0751-01.2	51	2_M_PHASE	94	6	0.0175241138332306520000000
TCGA-23-1124-01.17	107	2_EXTRACELLULAR_SPACE	192	11	0.0175489118065080930000000
TCGA-13-0795-01.9	67	0_HALLMARK_P53_PATHWAY	151	8	0.0175494490763439640000000
TCGA-24-2290-01.3	70	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0175640683866673290000000
TCGA-24-2290-01.3	70	2_DNA_RECOMBINATION	40	5	0.0175640683866673290000000
TCGA-10-0928-01.6	70	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0175640683866673290000000
TCGA-10-0928-01.6	70	2_DNA_RECOMBINATION	40	5	0.0175640683866673290000000
TCGA-25-1626-01.2	86	2_SKELETAL_DEVELOPMENT	84	7	0.0175666725229151160000000
TCGA-23-1116-01.7	84	1_KEGG_ERBB_SIGNALING_PATHWAY	86	7	0.0175666725229151160000000
TCGA-13-0804-01.5	78	2_REGULATION_OF_MITOSIS	36	5	0.0175706035709088380000000
TCGA-04-1356-01.1	71	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0176141734466605080000000
TCGA-04-1356-01.1	71	2_DNA_INTEGRITY_CHECKPOINT	19	4	0.0176141734466605080000000
TCGA-13-0910-01.3	71	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0176141734466605080000000
TCGA-13-0791-01.35	80	2_SPINDLE_POLE	17	4	0.0176302149901817990000000
TCGA-36-1574-01.10	152	2_DNA_METABOLIC_PROCESS	218	14	0.0176344198519177080000000
TCGA-25-1633-01.1	71	2_SYSTEM_DEVELOPMENT	694	17	0.0176466159251904740000000
TCGA-13-1509-01.9	117	1_KEGG_GLIOMA	62	7	0.0176547412037725560000000
TCGA-13-1509-01.9	117	2_INTERPHASE	62	7	0.0176547412037725560000000
TCGA-10-0926-01.2	45	2_CELL_CYCLE_PROCESS	163	7	0.0176704589700430180000000
TCGA-13-0804-01.5	78	2_DNA_BINDING	496	15	0.0176706666290370740000000
TCGA-59-2348-01.14	123	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0176781690922606750000000
TCGA-13-1510-01.20	82	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	8	0.0176781690922609010000000
TCGA-24-1435-01.12	115	1_KEGG_BLADDER_CANCER	42	6	0.0176937040096641660000000
TCGA-25-1319-01.10	69	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0177345475058323480000000
TCGA-23-1022-01.10	170	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	13	0.0178038232023031430000000
TCGA-23-1022-01.10	170	0_HALLMARK_E2F_TARGETS	169	13	0.0178038232023031430000000
TCGA-36-1575-01.9	193	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	8	0.0178759727532000690000000
TCGA-24-2254-01.3	49	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0178836383030171120000000
TCGA-13-0904-01.6	105	2_REGULATION_OF_CELL_CYCLE	160	10	0.0179381818711547400000000
TCGA-24-1556-01.19	120	2_KINETOCHORE	24	5	0.0180018872641793770000000
TCGA-23-1117-01.11	99	2_CHROMOSOME	102	8	0.0180095947411113050000000
TCGA-25-1322-01.15	93	2_CHROMOSOMAL_PART	78	7	0.0180267159893259460000000
TCGA-23-1026-01.5	65	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0180275366898026980000000
TCGA-23-2072-01.9	74	2_ORGAN_DEVELOPMENT	460	14	0.0180664364900214660000000
TCGA-23-1022-01.10	170	1_KEGG_MELANOGENESIS	99	10	0.0180828644660588340000000
TCGA-57-1993-01.8	52	2_APOPTOTIC_PROGRAM	54	5	0.0180832469769560830000000
TCGA-13-1496-01.13	120	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0181250960158103780000000
TCGA-20-0991-01.12	166	0_HALLMARK_IL2_STAT5_SIGNALING	148	12	0.0181484711954568580000000
TCGA-23-1022-01.10	170	2_CELL_PROLIFERATION_GO_0008283	436	22	0.0181750433858974820000000
TCGA-25-1318-01.11	46	2_REGULATION_OF_CELL_CYCLE	160	7	0.0181904346049308950000000
TCGA-61-2009-01.1	46	2_REGULATION_OF_CELL_CYCLE	160	7	0.0181904346049308950000000
TCGA-61-2008-01.19	70	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	10	0.0181983691331206730000000
TCGA-61-2111-01.16	56	2_METALLOENDOPEPTIDASE_ACTIVITY	24	4	0.0182005162775987670000000
TCGA-13-1407-01.11	220	2_COLLAGEN	23	6	0.0182326742303742930000000
TCGA-23-1026-01.5	65	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0182377259256038190000000
TCGA-13-1495-01.22	101	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0182412141251095220000000
TCGA-25-1634-01.1	4	2_ION_TRANSPORT	133	3	0.0182496833801096720000000
TCGA-24-1560-01.2	29	2_NUCLEOTIDE_BINDING	171	6	0.0182957925911785970000000
TCGA-57-1583-01.20	185	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	12	0.0182981613056119670000000
TCGA-13-1498-01.13	104	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0183319479549387300000000
TCGA-09-1669-01.10	81	2_SPINDLE	35	5	0.0183350759474825740000000
TCGA-24-1567-01.3	141	2_CELL_CYCLE_PHASE	146	11	0.0183365212842808360000000
TCGA-24-1562-01.4	36	2_APOPTOSIS_GO	389	9	0.0183366974059729140000000
TCGA-10-0935-01.2	49	0_HALLMARK_APOPTOSIS	150	7	0.0183520824174947940000000
TCGA-23-1116-01.7	84	2_ORGAN_DEVELOPMENT	460	15	0.0183594807618953360000000
TCGA-23-1110-01.7	299	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0183654345752791330000000
TCGA-13-1409-01.6	122	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	21	0.0183698695218385310000000
TCGA-13-2060-01.10	86	2_NUCLEUS	1110	25	0.0183977206886497620000000
TCGA-13-0723-01.8	50	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	17	0.0184032712803949250000000
TCGA-04-1337-01.2	31	2_TRANSITION_METAL_ION_BINDING	92	5	0.0184472361267953470000000
TCGA-25-1631-01.6	30	1_KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	253	7	0.0184524780960143370000000
TCGA-61-2109-01.13	122	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0184829412309869820000000
TCGA-31-1959-01.7	101	2_G_PROTEIN_COUPLED_RECEPTOR_BINDING	48	6	0.0185343200285816680000000
TCGA-24-2261-01.2	87	2_REGULATION_OF_MOLECULAR_FUNCTION	286	12	0.0185467444456984060000000
TCGA-61-2109-01.13	122	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0185634561714747500000000
TCGA-04-1336-01.28	106	1_KEGG_FOCAL_ADHESION	195	11	0.0185665909011950950000000
TCGA-29-2427-01.10	116	2_CELLULAR_HOMEOSTASIS	115	9	0.0185690107993610430000000
TCGA-29-2427-01.10	116	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0185976968311803020000000
TCGA-24-1603-01.3	69	1_KEGG_PANCREATIC_CANCER	70	6	0.0186637730231307320000000
TCGA-61-2000-01.11	69	1_KEGG_PANCREATIC_CANCER	70	6	0.0186637730231307320000000
TCGA-61-1736-01.2	54	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0186809365512605250000000
TCGA-24-1552-01.5	54	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0186809365512605250000000
TCGA-04-1517-01.4	44	2_AGING	10	3	0.0186830150254176900000000
TCGA-13-0885-01.6	44	2_AGING	10	3	0.0186830150254176900000000
TCGA-13-0885-01.6	44	2_APOPTOTIC_MITOCHONDRIAL_CHANGES	10	3	0.0186830150254176900000000
TCGA-24-0980-01.5	44	2_AGING	10	3	0.0186830150254176900000000
TCGA-59-2354-01.2	44	2_AGING	10	3	0.0186830150254176900000000
TCGA-13-0762-01.2	68	0_HALLMARK_APOPTOSIS	150	8	0.0186891975875481640000000
TCGA-13-0924-01.5	68	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0187015057091650500000000
TCGA-36-1577-01.14	168	2_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0187167905742084900000000
TCGA-36-1577-01.14	168	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0187167905742084900000000
TCGA-04-1342-01.12	104	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0187169877064890940000000
TCGA-24-1562-01.4	36	2_PROGRAMMED_CELL_DEATH	390	9	0.0187202623329610800000000
TCGA-09-0366-01.5	32	1_KEGG_BLADDER_CANCER	42	4	0.0187326402743685850000000
TCGA-13-0720-01.5	32	1_KEGG_BLADDER_CANCER	42	4	0.0187326402743685850000000
TCGA-13-0804-01.5	78	2_INTERPHASE	62	6	0.0187489199431840230000000
TCGA-09-2053-01.14	121	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0187531583310433580000000
TCGA-24-1560-01.2	29	2_PROTEIN_HOMODIMERIZATION_ACTIVITY	99	5	0.0187609671196199560000000
TCGA-23-1117-01.11	99	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0187609671196199630000000
TCGA-13-0905-01.7	160	2_REGULATION_OF_CELL_GROWTH	31	6	0.0188209148598881480000000
TCGA-23-2072-01.9	74	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	19	0.0188227322202107890000000
TCGA-61-2002-01.1	118	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	10	0.0188284858554063560000000
TCGA-13-1403-01.9	71	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0188363211110329500000000
TCGA-25-1320-01.4	71	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0188363211110329500000000
TCGA-13-0910-01.3	71	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0188363211110329500000000
TCGA-25-1329-01.5	43	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0189013187080854480000000
TCGA-13-0793-01.8	97	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0189482459097450870000000
TCGA-10-0933-01.2	97	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0189482459097450870000000
TCGA-04-1350-01.2	130	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0189825176739012900000000
TCGA-30-1853-01.4	111	2_RESPONSE_TO_OTHER_ORGANISM	66	7	0.0189951846652442090000000
TCGA-04-1346-01.10	75	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0189990856699091270000000
TCGA-13-1509-01.9	117	1_KEGG_PROSTATE_CANCER	87	8	0.0190104973258262140000000
TCGA-61-2101-01.2	38	2_ZINC_ION_BINDING	75	5	0.0190470573613246080000000
TCGA-04-1542-01.4	141	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	24	0.0190890769256634420000000
TCGA-09-2056-01.6	63	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY	77	6	0.0191024794617476730000000
TCGA-24-1556-01.19	120	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0191396831354558770000000
TCGA-24-2254-01.3	49	0_HALLMARK_P53_PATHWAY	151	7	0.0191689889085972130000000
TCGA-23-1031-01.17	142	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0191915741771142430000000
TCGA-24-1103-01.5	73	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0191966637849240210000000
TCGA-23-1031-01.17	142	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0191967283794261400000000
TCGA-24-1555-01.1	14	2_SINGLE_STRANDED_DNA_BINDING	31	3	0.0192024738212465410000000
TCGA-23-1031-01.17	142	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	8	0.0192093982079456110000000
TCGA-30-1891-01.4	84	2_REGULATION_OF_CELL_CYCLE	160	9	0.0192212735105347570000000
TCGA-09-2050-01.18	196	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	17	0.0192664354888056370000000
TCGA-24-0970-01.6	94	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0192780714669913630000000
TCGA-59-2363-01.3	89	2_BIOPOLYMER_METABOLIC_PROCESS	1367	29	0.0192985646756515740000000
TCGA-24-1564-01.4	47	2_ORGAN_DEVELOPMENT	460	11	0.0193434191335211630000000
TCGA-13-0889-01.4	37	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	9	0.0193521959546417570000000
TCGA-59-2348-01.14	123	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0193528204133589200000000
TCGA-25-1329-01.5	43	1_KEGG_CELL_CYCLE	114	6	0.0193632826901083760000000
TCGA-24-1564-01.4	47	2_CYTOKINE_ACTIVITY	104	6	0.0193673241427590350000000
TCGA-24-1435-01.4	3	2_MITOCHONDRIAL_RESPIRATORY_CHAIN	19	2	0.0194034468363017550000000
TCGA-09-2044-01.3	3	2_MITOCHONDRIAL_RESPIRATORY_CHAIN	19	2	0.0194034468363017550000000
TCGA-29-2427-01.10	116	2_CELL_CYCLE_PHASE	146	10	0.0194294069597661620000000
TCGA-61-2111-01.16	56	1_KEGG_PROSTATE_CANCER	87	6	0.0194359255055490050000000
TCGA-13-0920-01.9	82	2_SPINDLE_POLE	17	4	0.0194540960822533920000000
TCGA-13-0807-01.8	46	2_INTERPHASE	62	5	0.0194566024002891800000000
TCGA-24-1464-01.7	62	2_WOUND_HEALING	46	5	0.0194566024002891910000000
TCGA-24-1552-01.5	54	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0194599088993093190000000
TCGA-24-1552-01.5	54	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0194599088993093190000000
TCGA-13-0762-01.2	68	2_RESPONSE_TO_VIRUS	42	5	0.0194606448506672060000000
TCGA-23-1027-01.8	68	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0194606448506672060000000
TCGA-13-0920-01.9	82	2_SPINDLE	35	5	0.0194739223316483070000000
TCGA-25-2400-01.5	35	2_DNA_REPLICATION	82	5	0.0194739223316483180000000
TCGA-04-1331-01.5	90	1_KEGG_DNA_REPLICATION	32	5	0.0194825742369699180000000
TCGA-04-1530-01.2	90	0_HALLMARK_ANGIOGENESIS	32	5	0.0194825742369699180000000
TCGA-24-1417-01.14	94	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0194920685472198750000000
TCGA-24-1418-01.16	84	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0194926722605409520000000
TCGA-13-0893-01.4	112	2_CONDENSED_CHROMOSOME	26	5	0.0195055745860195600000000
TCGA-24-1474-01.12	122	2_KINETOCHORE	24	5	0.0195143817477960580000000
TCGA-61-1998-01.14	105	1_KEGG_PANCREATIC_CANCER	70	7	0.0195267488531538290000000
TCGA-13-1509-01.9	117	1_KEGG_BLADDER_CANCER	42	6	0.0195387656355874190000000
TCGA-25-2396-01.6	42	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	7	0.0195630549894161950000000
TCGA-13-2060-01.10	86	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0195831732976899480000000
TCGA-24-1560-01.2	29	2_CELL_CYCLE_GO_0007049	265	7	0.0196042953623856810000000
TCGA-25-2409-01.5	29	2_CELL_CYCLE_GO_0007049	265	7	0.0196042953623856810000000
TCGA-25-2042-01.4	9	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	4	0.0196182429722727010000000
TCGA-23-1110-01.7	299	2_CHROMOSOME_SEGREGATION	26	7	0.0196289285128149440000000
TCGA-23-2081-01.7	56	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0196667338628591610000000
TCGA-61-2012-01.6	78	2_EXTRACELLULAR_REGION_PART	269	11	0.0196694990241718350000000
TCGA-13-1494-01.4	65	2_ZINC_ION_BINDING	75	6	0.0196793620236769590000000
TCGA-24-1413-01.6	34	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0196986618821778720000000
TCGA-24-0982-01.3	34	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0196986618821778720000000
TCGA-13-1404-01.13	117	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0197349679279572690000000
TCGA-13-1494-01.4	65	2_CELL_CYCLE_GO_0007049	265	10	0.0197387332019743100000000
TCGA-13-0795-01.9	67	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0197586638449591780000000
TCGA-13-0751-01.2	51	2_RESPONSE_TO_BIOTIC_STIMULUS	96	6	0.0197898218661109110000000
TCGA-09-2050-01.18	196	1_KEGG_PROSTATE_CANCER	87	10	0.0198105781699883420000000
TCGA-61-2088-01.7	150	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	24	0.0198164126202464290000000
TCGA-24-1470-01.7	76	2_NUCLEUS	1110	23	0.0198243686910817390000000
TCGA-13-0904-01.6	105	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	24	0.0198264264897140520000000
TCGA-36-1580-01.1	65	2_ORGAN_DEVELOPMENT	460	13	0.0198277294968985320000000
TCGA-13-1492-01.2	162	2_DNA_BINDING	496	23	0.0198634103196385740000000
TCGA-24-1470-01.7	76	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	9	0.0198732257406790990000000
TCGA-31-1953-01.6	53	2_APOPTOTIC_PROGRAM	54	5	0.0198807275297080800000000
TCGA-61-2008-01.19	70	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	41	5	0.0198890940127325820000000
TCGA-61-2008-01.19	70	2_REGULATION_OF_GROWTH	41	5	0.0198890940127325820000000
TCGA-24-1424-01.4	80	2_REGULATION_OF_MITOSIS	36	5	0.0198989224927319900000000
TCGA-13-0791-01.35	80	2_REGULATION_OF_MITOSIS	36	5	0.0198989224927319900000000
TCGA-13-0883-01.4	3	2_ORGANELLE_MEMBRANE	216	3	0.0199209913927641570000000
TCGA-25-1316-01.2	73	2_EXTRACELLULAR_REGION	346	12	0.0199390995223126080000000
TCGA-24-1549-01.21	158	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	5	0.0199617026041010690000000
TCGA-57-1583-01.20	185	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	8	0.0199675149191225550000000
TCGA-25-1623-01.7	111	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0200010506774925680000000
TCGA-13-0886-01.1	45	2_AGING	10	3	0.0200063676960854540000000
TCGA-61-1728-01.5	45	2_AGING	10	3	0.0200063676960854540000000
TCGA-61-2003-01.4	45	2_AGING	10	3	0.0200063676960854540000000
TCGA-13-1408-01.1	45	2_AGING	10	3	0.0200063676960854540000000
TCGA-13-1492-01.2	162	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0200125304714326370000000
TCGA-09-1666-01.28	109	2_M_PHASE	94	8	0.0200347159229225630000000
TCGA-04-1542-01.4	141	2_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	176	12	0.0200522422577997760000000
TCGA-20-0991-01.12	166	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0200698506656426940000000
TCGA-25-1623-01.7	111	2_COLLAGEN_BINDING	13	4	0.0200968413416061470000000
TCGA-04-1365-01.6	150	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	4	0.0201134375988931450000000
TCGA-24-1556-01.19	120	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	13	0.0201137706269444790000000
TCGA-29-2427-01.10	116	2_RECEPTOR_BINDING	331	15	0.0201167632306952710000000
TCGA-13-0891-01.18	125	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0201502047054821710000000
TCGA-57-1583-01.20	185	2_DNA_BINDING	496	25	0.0201502667392035180000000
TCGA-13-0724-01.21	71	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0201630115671604870000000
TCGA-25-1320-01.4	71	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0201630115671604870000000
TCGA-13-0714-01.9	51	2_CELL_CYCLE_PHASE	146	7	0.0201845547676317220000000
TCGA-13-0924-01.5	68	2_MICROTUBULE_BASED_PROCESS	72	6	0.0201956011503787790000000
TCGA-24-1434-01.3	82	2_CATION_BINDING	165	9	0.0202017188002620690000000
TCGA-13-0887-01.6	47	2_NUCLEUS	1110	17	0.0202117867448727080000000
TCGA-25-1326-01.11	119	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0202587842422606230000000
TCGA-04-1525-01.7	52	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0202762598848087690000000
TCGA-23-1123-01.7	70	1_KEGG_PANCREATIC_CANCER	70	6	0.0202951608200387410000000
TCGA-23-1031-01.17	142	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0203420685065404080000000
TCGA-13-0923-01.5	53	2_CHROMOSOME_SEGREGATION	26	4	0.0203497391688481740000000
TCGA-10-0938-01.2	102	2_RESPONSE_TO_STRESS	427	16	0.0204175257990653890000000
TCGA-61-2109-01.13	122	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0204370938925935480000000
TCGA-24-1474-01.12	122	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0204370938925935480000000
TCGA-13-0911-01.3	47	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0204645655278888930000000
TCGA-24-2267-01.8	26	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	9	0.0204737382910344730000000
TCGA-23-2081-01.7	56	2_ORGAN_DEVELOPMENT	460	12	0.0204845986351594250000000
TCGA-29-2427-01.10	116	2_RESPONSE_TO_CHEMICAL_STIMULUS	252	13	0.0204891468380196640000000
TCGA-13-1494-01.4	65	2_ION_BINDING	210	9	0.0204896589519218340000000
TCGA-13-1481-01.3	78	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0205141277922299690000000
TCGA-61-2002-01.1	118	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0205180536088799790000000
TCGA-36-1576-01.8	124	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0205414249726393020000000
TCGA-25-1318-01.11	46	2_CELL_CYCLE_PROCESS	163	7	0.0205424818704322660000000
TCGA-61-1736-01.2	54	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0205580547613099970000000
TCGA-61-1736-01.2	54	2_BEHAVIOR	138	7	0.0205580547613099970000000
TCGA-24-1552-01.5	54	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0205580547613099970000000
TCGA-09-1659-01.5	51	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	3	0.0205624001750103200000000
TCGA-25-2401-01.5	119	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0205648451088628720000000
TCGA-30-1862-01.13	91	0_HALLMARK_ANGIOGENESIS	32	5	0.0205660764529557550000000
TCGA-24-0979-01.5	41	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	3	0.0206491451609283550000000
TCGA-25-1630-01.10	35	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0206673362169661060000000
TCGA-24-1104-01.2	18	0_HALLMARK_E2F_TARGETS	169	5	0.0206961349431625390000000
TCGA-13-0724-01.21	71	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	10	0.0207096509803169870000000
TCGA-04-1362-01.4	35	2_DNA_METABOLIC_PROCESS	218	7	0.0207338144031251480000000
TCGA-25-1630-01.10	35	2_DNA_METABOLIC_PROCESS	218	7	0.0207338144031251480000000
TCGA-04-1336-01.28	106	1_KEGG_PANCREATIC_CANCER	70	7	0.0207854170887802540000000
TCGA-09-1666-01.28	109	2_EXTRACELLULAR_REGION_PART	269	13	0.0208170651849321100000000
TCGA-13-0893-01.4	112	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0208251841144279390000000
TCGA-13-1496-01.13	120	1_KEGG_COLORECTAL_CANCER	62	7	0.0208539533094387920000000
TCGA-61-1998-01.14	105	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0209404613369585760000000
TCGA-23-2078-01.15	105	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0209404613369585760000000
TCGA-23-1030-01.10	58	2_METALLOENDOPEPTIDASE_ACTIVITY	24	4	0.0209528376705047990000000
TCGA-61-2109-01.13	122	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0209877771202269320000000
TCGA-13-0793-01.8	97	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0210084484304876620000000
TCGA-04-1349-01.2	20	2_REGULATION_OF_TRANSCRIPTIONDNA_DEPENDENT	407	7	0.0210345123479235080000000
TCGA-09-2056-01.6	63	2_WOUND_HEALING	46	5	0.0210574993436038300000000
TCGA-23-2077-01.18	63	2_WOUND_HEALING	46	5	0.0210574993436038300000000
TCGA-13-1487-01.3	79	2_M_PHASE	94	7	0.0210596844372451140000000
TCGA-13-0911-01.3	47	2_REGULATION_OF_CELL_CYCLE	160	7	0.0210724192809264780000000
TCGA-13-0885-01.6	44	2_DNA_REPAIR	113	6	0.0211062447602459840000000
TCGA-59-2348-01.14	123	2_SARCOMERE	12	4	0.0211096384995801130000000
TCGA-04-1356-01.1	71	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	21	0.0211313608287627890000000
TCGA-04-1346-01.10	75	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0211492945784095730000000
TCGA-23-1118-01.5	50	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0212054441874500250000000
TCGA-04-1517-01.4	44	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0212100682061363460000000
TCGA-24-2271-01.3	44	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0212100682061363460000000
TCGA-59-2354-01.2	44	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0212100682061363460000000
TCGA-24-1604-01.9	19	2_REGULATION_OF_CELL_CYCLE	160	5	0.0212216651564749860000000
TCGA-13-1491-01.7	90	0_HALLMARK_P53_PATHWAY	151	9	0.0212398120321221070000000
TCGA-36-1577-01.14	168	2_CHROMOSOME	102	10	0.0212765360143065790000000
TCGA-13-0793-01.8	97	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0212900697187628980000000
TCGA-10-0933-01.2	97	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0212900697187628980000000
TCGA-25-1633-01.1	71	2_REGULATION_OF_GROWTH	41	5	0.0213278836450542380000000
TCGA-13-0891-01.18	125	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0213423103822848560000000
TCGA-24-1616-01.2	38	2_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0213757026744806240000000
TCGA-24-1616-01.2	38	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0213757026744806240000000
TCGA-13-0807-01.8	46	2_AGING	10	3	0.0213902406713405160000000
TCGA-25-1318-01.11	46	2_AGING	10	3	0.0213902406713405160000000
TCGA-13-0726-01.12	78	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	16	0.0214160884781616520000000
TCGA-31-1950-01.7	105	1_KEGG_MELANOMA	71	7	0.0214664847963519440000000
TCGA-04-1356-01.1	71	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0214664847963522210000000
TCGA-13-0761-01.6	75	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0215120617265539510000000
TCGA-25-2401-01.5	119	1_KEGG_BLADDER_CANCER	42	6	0.0215367271104839300000000
TCGA-13-1505-01.13	60	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0215374886434094960000000
TCGA-23-1032-01.16	250	2_SYSTEM_DEVELOPMENT	694	38	0.0215458311706264070000000
TCGA-24-1431-01.3	57	1_KEGG_PROSTATE_CANCER	87	6	0.0215633236148100000000000
TCGA-13-1512-01.2	113	2_G1_PHASE_OF_MITOTIC_CELL_CYCLE	13	4	0.0215728515640125630000000
TCGA-13-0894-01.9	118	2_SYSTEM_DEVELOPMENT	694	23	0.0215811675495787110000000
TCGA-13-1405-01.4	69	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0215963928224640400000000
TCGA-24-1563-01.15	100	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0216003580211093890000000
TCGA-04-1349-01.2	20	2_REGULATION_OF_CELL_PROLIFERATION	265	6	0.0216459878750901790000000
TCGA-09-1661-01.1	20	2_REGULATION_OF_CELL_PROLIFERATION	265	6	0.0216459878750901790000000
TCGA-24-1466-01.15	82	1_KEGG_MAPK_SIGNALING_PATHWAY	258	11	0.0216468420211549350000000
TCGA-13-1510-01.20	82	1_KEGG_MAPK_SIGNALING_PATHWAY	258	11	0.0216468420211549350000000
TCGA-13-0887-01.6	47	2_INTERPHASE	62	5	0.0216636026463798910000000
TCGA-13-0727-01.1	29	2_CHROMOSOME	102	5	0.0217090278217842260000000
TCGA-36-1568-01.22	80	1_KEGG_COLORECTAL_CANCER	62	6	0.0217129058288024580000000
TCGA-61-2003-01.4	45	2_REGULATION_OF_CELL_GROWTH	31	4	0.0217394396079982450000000
TCGA-24-1463-01.5	130	2_INTRACELLULAR_ORGANELLE_PART	912	29	0.0217581114871303710000000
TCGA-61-2109-01.13	122	1_KEGG_APOPTOSIS	85	8	0.0217606019236112990000000
TCGA-24-1549-01.21	158	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	15	0.0217633650611029970000000
TCGA-24-1616-01.2	38	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0217691593672661690000000
TCGA-23-1022-01.10	170	1_KEGG_ASTHMA	30	6	0.0217863661890174040000000
TCGA-57-1993-01.8	52	2_REGULATION_OF_MEMBRANE_POTENTIAL	9	3	0.0218108996424307630000000
TCGA-36-1568-01.22	80	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0218843666554294870000000
TCGA-24-1551-01.15	87	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0219156585028039110000000
TCGA-24-2261-01.2	87	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0219156585028039110000000
TCGA-24-1428-01.9	90	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0219279824628637220000000
TCGA-25-1313-01.2	13	2_SPINDLE	35	3	0.0219475766835551430000000
TCGA-61-2016-01.10	50	0_HALLMARK_P53_PATHWAY	151	7	0.0219937102566065930000000
TCGA-36-1580-01.1	65	2_CARBOHYDRATE_BINDING	45	5	0.0220128889522128860000000
TCGA-13-1403-01.9	71	1_KEGG_PANCREATIC_CANCER	70	6	0.0220400501942334720000000
TCGA-13-0724-01.21	71	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	6	0.0220400501942334720000000
TCGA-10-0928-01.6	70	2_MITOSIS	71	6	0.0220400501942334720000000
TCGA-25-1320-01.4	71	1_KEGG_PANCREATIC_CANCER	70	6	0.0220400501942334720000000
TCGA-61-2008-01.19	70	1_KEGG_MELANOMA	71	6	0.0220400501942334720000000
TCGA-24-0968-01.9	71	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	6	0.0220400501942334720000000
TCGA-24-1603-01.3	69	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0220921523051256990000000
TCGA-25-1319-01.10	69	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0220921523051256990000000
TCGA-23-1124-01.17	107	1_KEGG_PANCREATIC_CANCER	70	7	0.0221106080020623260000000
TCGA-24-2281-01.10	107	1_KEGG_PANCREATIC_CANCER	70	7	0.0221106080020623260000000
TCGA-10-0928-01.6	70	1_KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	107	7	0.0221106080020623260000000
TCGA-04-1342-01.12	104	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0221254303091401980000000
TCGA-23-1122-01.11	77	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	9	0.0221429732936465650000000
TCGA-59-2363-01.3	89	2_DNA_BINDING	496	16	0.0221784885021347850000000
TCGA-10-0930-01.5	60	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0221819760540368090000000
TCGA-57-1582-01.26	174	1_KEGG_MELANOGENESIS	99	10	0.0221830297484305330000000
TCGA-24-1435-01.12	115	2_CHROMOSOME_SEGREGATION	26	5	0.0221906860483443370000000
TCGA-24-2271-01.3	44	1_KEGG_CELL_CYCLE	114	6	0.0222018209186186120000000
TCGA-24-0980-01.5	44	1_KEGG_CELL_CYCLE	114	6	0.0222018209186186120000000
TCGA-24-1471-01.4	49	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	15	0.0222075985023530920000000
TCGA-36-1569-01.2	8	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	2	0.0222198156816002490000000
TCGA-13-0765-01.4	54	1_KEGG_FOCAL_ADHESION	195	8	0.0222335719217344390000000
TCGA-24-2262-01.25	141	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	18	0.0223247474752728370000000
TCGA-09-0369-01.9	109	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0223380979178563930000000
TCGA-23-2078-01.15	105	2_MICROTUBULE_MOTOR_ACTIVITY	14	4	0.0223679655345352040000000
TCGA-25-2400-01.5	35	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	6	0.0223909871410955670000000
TCGA-30-1853-01.4	111	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	9	0.0224102858223843990000000
TCGA-09-0366-01.5	32	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	7	0.0224192889261463010000000
TCGA-24-1563-01.15	100	2_ZINC_ION_BINDING	75	7	0.0224249421304483080000000
TCGA-25-2396-01.6	42	1_KEGG_PANCREATIC_CANCER	70	5	0.0224476716255697230000000
TCGA-10-0928-01.6	70	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0224476716255697230000000
TCGA-61-2008-01.19	70	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0224476716255697230000000
TCGA-24-1548-01.8	141	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	12	0.0224862591385486530000000
TCGA-09-2053-01.14	121	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0225082224326679550000000
TCGA-13-1492-01.2	162	2_DNA_INTEGRITY_CHECKPOINT	19	5	0.0225430757585718120000000
TCGA-10-0935-01.2	49	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0225453567830885340000000
TCGA-24-2254-01.3	49	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0225453567830885340000000
TCGA-13-1484-01.4	70	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0225561985980800500000000
TCGA-10-0933-01.2	97	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0225664347668196460000000
TCGA-61-1736-01.2	54	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0225890277035725660000000
TCGA-24-1552-01.5	54	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0225890277035725660000000
TCGA-13-1496-01.13	120	1_KEGG_BLADDER_CANCER	42	6	0.0225959758680819400000000
TCGA-24-2271-01.3	44	0_HALLMARK_ANGIOGENESIS	32	4	0.0226117345322546340000000
TCGA-23-1024-01.3	24	2_DNA_METABOLIC_PROCESS	218	6	0.0226298860459691990000000
TCGA-24-1471-01.4	49	2_PROTEIN_TYROSINE_KINASE_ACTIVITY	60	5	0.0226774164548434780000000
TCGA-04-1350-01.2	130	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	27	0.0226801943418318070000000
TCGA-24-2293-01.3	33	2_SYSTEM_DEVELOPMENT	694	11	0.0226991325599160200000000
TCGA-25-1318-01.11	46	2_APOPTOSIS_GO	389	10	0.0227366330331216120000000
TCGA-61-2092-01.12	209	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0227637979522078250000000
TCGA-13-1487-01.3	79	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0227894772589676380000000
TCGA-13-0900-01.8	90	2_PATTERN_BINDING	33	5	0.0227899749432122140000000
TCGA-36-1577-01.14	168	1_KEGG_MAPK_SIGNALING_PATHWAY	258	16	0.0228120260149465810000000
TCGA-13-0800-01.9	124	0_HALLMARK_INFLAMMATORY_RESPONSE	170	11	0.0228252229309490810000000
TCGA-24-2024-01.3	55	2_EXTRACELLULAR_SPACE	192	8	0.0228328338745123380000000
TCGA-13-0911-01.3	47	2_AGING	10	3	0.0228359398062337840000000
TCGA-13-0887-01.6	47	2_AGING	10	3	0.0228359398062337840000000
TCGA-36-1577-01.14	168	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0228432880034365360000000
TCGA-04-1347-01.15	187	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0228667762242763810000000
TCGA-13-0883-01.3	23	1_KEGG_GLIOMA	62	4	0.0229149362894579200000000
TCGA-13-0891-01.18	125	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0229192756894379260000000
TCGA-13-0913-01.5	44	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	8	0.0229446395318976810000000
TCGA-36-1574-01.10	152	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	8	0.0229827263848410570000000
TCGA-04-1336-01.28	106	2_CELL_CYCLE_PROCESS	163	10	0.0229833491140999930000000
TCGA-24-2261-01.2	87	2_NUCLEUS	1110	25	0.0229836640282101680000000
TCGA-13-0727-01.1	29	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	6	0.0230155039860498700000000
TCGA-13-1407-01.11	220	2_MITOTIC_CELL_CYCLE	134	13	0.0230866698635770820000000
TCGA-24-1470-01.7	76	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0231105253147700430000000
TCGA-24-1435-01.12	115	2_COLLAGEN_BINDING	13	4	0.0231274657972220100000000
TCGA-04-1349-01.2	20	2_REGULATION_OF_RNA_METABOLIC_PROCESS	413	7	0.0231480128659147660000000
TCGA-24-1549-01.21	158	1_KEGG_PROSTATE_CANCER	87	9	0.0231775867970062560000000
TCGA-23-2079-01.14	85	2_SPINDLE	35	5	0.0232252697096917880000000
TCGA-36-1574-01.10	152	2_REGULATION_OF_MOLECULAR_FUNCTION	286	16	0.0232320051101676150000000
TCGA-61-2109-01.13	122	2_INTERPHASE	62	7	0.0232427979500614170000000
TCGA-25-1318-01.11	46	2_PROGRAMMED_CELL_DEATH	390	10	0.0232520423858988790000000
TCGA-31-1959-01.7	101	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0232968464487418490000000
TCGA-13-1501-01.12	101	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0232968464487418490000000
TCGA-25-2409-01.5	29	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0232995438712628770000000
TCGA-23-1032-01.16	250	1_KEGG_PANCREATIC_CANCER	70	10	0.0233283545938378220000000
TCGA-04-1348-01.6	81	2_INTERPHASE	62	6	0.0233308941273896380000000
TCGA-09-1669-01.10	81	1_KEGG_COLORECTAL_CANCER	62	6	0.0233308941273896380000000
TCGA-09-1669-01.10	81	2_INTERPHASE	62	6	0.0233308941273896380000000
TCGA-13-0916-01.11	92	2_DNA_REPLICATION	82	7	0.0233971677998385980000000
TCGA-24-1434-01.3	82	2_TRANSITION_METAL_ION_BINDING	92	7	0.0233971677998385980000000
TCGA-25-1633-01.1	71	0_HALLMARK_KRAS_SIGNALING_UP	148	8	0.0234260179596223370000000
TCGA-13-0724-01.21	71	0_HALLMARK_IL2_STAT5_SIGNALING	148	8	0.0234260179596223370000000
TCGA-25-1320-01.4	71	0_HALLMARK_KRAS_SIGNALING_UP	148	8	0.0234260179596223370000000
TCGA-04-1346-01.10	75	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0235012021838880180000000
TCGA-24-1562-01.4	36	2_CELL_DEVELOPMENT	511	10	0.0235213945577751470000000
TCGA-23-2078-01.15	105	2_MICROTUBULE_BASED_PROCESS	72	7	0.0235631296097699480000000
TCGA-24-1419-01.2	93	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0236309197815196100000000
TCGA-36-1575-01.9	193	0_HALLMARK_COMPLEMENT	176	14	0.0236471475764565770000000
TCGA-13-0717-01.6	103	2_IMMUNE_RESPONSE	206	11	0.0236472219321554040000000
TCGA-24-1463-01.5	130	2_ORGANELLE_PART	916	29	0.0236609729914073090000000
TCGA-24-2261-01.2	87	2_CYTOSKELETON	293	12	0.0236629038555501850000000
TCGA-24-1413-01.6	34	0_HALLMARK_P53_PATHWAY	151	6	0.0236977581860780030000000
TCGA-13-1408-01.1	45	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0237332191223759360000000
TCGA-13-0900-01.8	90	2_SKELETAL_DEVELOPMENT	84	7	0.0237379395934230950000000
TCGA-10-0934-01.11	145	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0237523230213203680000000
TCGA-23-1021-01.7	44	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0237627440399072050000000
TCGA-23-1024-01.3	24	2_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0237813184705657210000000
TCGA-23-1024-01.3	24	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0237813184705657210000000
TCGA-61-2111-01.16	56	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0238101426220167260000000
TCGA-24-2298-01.6	4	2_CELLULAR_RESPIRATION	15	2	0.0238136612364194500000000
TCGA-09-2044-01.3	3	2_MONOVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	21	2	0.0238254268088847370000000
TCGA-31-1953-01.6	53	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0238321307610382250000000
TCGA-24-1427-01.4	83	2_REGULATION_OF_MITOSIS	36	5	0.0238361283315568390000000
TCGA-04-1346-01.10	75	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0238398246972855060000000
TCGA-24-1436-01.1	49	2_DNA_METABOLIC_PROCESS	218	8	0.0238464066883897170000000
TCGA-10-0935-01.2	49	2_DNA_METABOLIC_PROCESS	218	8	0.0238464066883897170000000
TCGA-24-2254-01.3	49	2_DNA_METABOLIC_PROCESS	218	8	0.0238464066883897170000000
TCGA-13-1498-01.13	104	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0238672840106583380000000
TCGA-25-2404-01.5	58	1_KEGG_PROSTATE_CANCER	87	6	0.0238751654655213890000000
TCGA-10-0928-01.6	70	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	6	0.0239043167049302380000000
TCGA-24-2261-01.2	87	1_KEGG_PROSTATE_CANCER	87	7	0.0239314187206043640000000
TCGA-31-1959-01.7	101	2_ZINC_ION_BINDING	75	7	0.0239432224003287220000000
TCGA-04-1337-01.2	31	2_MITOCHONDRIAL_TRANSPORT	15	3	0.0239497617101565060000000
TCGA-25-1625-01.6	38	2_REGULATION_OF_MOLECULAR_FUNCTION	286	8	0.0239624095168893650000000
TCGA-24-1616-01.2	38	2_REGULATION_OF_MOLECULAR_FUNCTION	286	8	0.0239624095168893650000000
TCGA-24-0982-01.3	34	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0240035779858048390000000
TCGA-13-0890-01.2	48	2_INTERPHASE	62	5	0.0240612790045978510000000
TCGA-25-1320-01.4	71	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0240694335283841430000000
TCGA-24-0968-01.9	71	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0240694335283841430000000
TCGA-25-1324-01.3	42	2_MITOSIS	71	5	0.0240694335283841610000000
TCGA-24-0982-01.3	34	1_KEGG_PATHWAYS_IN_CANCER	323	8	0.0241256673728973520000000
TCGA-13-1404-01.13	117	2_CHROMOSOME_SEGREGATION	26	5	0.0241354812393182110000000
TCGA-24-1425-01.1	61	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	17	0.0241413008973572480000000
TCGA-09-2056-01.6	63	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	11	0.0241852623600310700000000
TCGA-29-2427-01.10	116	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	11	0.0242109652676840110000000
TCGA-13-1499-01.1	22	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	6	0.0242814551794701720000000
TCGA-23-1124-01.17	107	1_KEGG_MELANOMA	71	7	0.0243025365489216850000000
TCGA-24-1563-01.15	100	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0243048815101076230000000
TCGA-13-0903-01.11	77	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0243458043626556230000000
TCGA-23-1122-01.11	77	2_DNA_INTEGRITY_CHECKPOINT	19	4	0.0243458043626556230000000
TCGA-25-2401-01.5	119	2_CELL_CYCLE_PHASE	146	10	0.0243619250450288310000000
TCGA-13-0717-01.6	103	2_MITOTIC_CELL_CYCLE	134	9	0.0243850863868444730000000
TCGA-23-1123-01.7	70	0_HALLMARK_P53_PATHWAY	151	8	0.0243937857651872620000000
TCGA-25-1318-01.11	46	2_REGULATION_OF_APOPTOSIS	309	9	0.0244133725346600240000000
TCGA-24-1425-01.1	61	0_HALLMARK_COAGULATION	125	7	0.0244375867691092770000000
TCGA-13-0755-01.6	16	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	7	0.0244395197980131550000000
TCGA-04-1331-01.5	90	2_MICROTUBULE_CYTOSKELETON	117	8	0.0244527386184144840000000
TCGA-13-1510-01.20	82	0_HALLMARK_E2F_TARGETS	169	9	0.0245000896270573220000000
TCGA-24-1434-01.3	82	0_HALLMARK_E2F_TARGETS	169	9	0.0245000896270573220000000
TCGA-13-1404-01.13	117	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	29	0.0245045905838827510000000
TCGA-04-1362-01.4	35	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	41	4	0.0245052656022106100000000
TCGA-24-1469-01.6	123	2_INTERPHASE	62	7	0.0245196505388903880000000
TCGA-23-1120-01.10	57	2_NUCLEUS	1110	19	0.0245593830693204220000000
TCGA-13-0924-01.5	68	2_INTRACELLULAR_ORGANELLE_PART	912	19	0.0245817006880972090000000
TCGA-13-1403-01.9	71	1_KEGG_WNT_SIGNALING_PATHWAY	149	8	0.0246080173276300060000000
TCGA-29-2427-01.10	116	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0246459997343331450000000
TCGA-25-1632-01.11	116	0_HALLMARK_APOPTOSIS	150	10	0.0246459997343331450000000
TCGA-04-1542-01.4	141	2_EXTRACELLULAR_REGION	346	17	0.0246618578183663740000000
TCGA-04-1346-01.10	75	2_DNA_RECOMBINATION	40	5	0.0246626554004810320000000
TCGA-25-1627-01.4	75	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0246626554004810320000000
TCGA-13-0761-01.6	75	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0246626554004810320000000
TCGA-24-1463-01.5	130	1_KEGG_FOCAL_ADHESION	195	12	0.0246870055597603330000000
TCGA-24-1556-01.19	120	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0246945184905401900000000
TCGA-61-2003-01.4	45	0_HALLMARK_ANGIOGENESIS	32	4	0.0247589220381118950000000
TCGA-13-1408-01.1	45	0_HALLMARK_ANGIOGENESIS	32	4	0.0247589220381118950000000
TCGA-61-2111-01.16	56	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	11	0.0248334717918212990000000
TCGA-59-2350-01.1	62	2_REGULATION_OF_MOLECULAR_FUNCTION	286	10	0.0249127997663991730000000
TCGA-29-2427-01.10	116	2_CELLULAR_CATION_HOMEOSTASIS	91	8	0.0249155737813202580000000
TCGA-24-0979-01.5	41	2_REGULATION_OF_CELL_PROLIFERATION	265	8	0.0249192905719871000000000
TCGA-09-2056-01.2	5	2_STEROID_HORMONE_RECEPTOR_ACTIVITY	12	2	0.0249406052421289500000000
TCGA-25-1631-01.6	30	2_CELL_CYCLE_GO_0007049	265	7	0.0249636115190772400000000
TCGA-25-1623-01.7	111	2_EXTRACELLULAR_SPACE	192	11	0.0249751504996680970000000
TCGA-30-1853-01.4	111	2_EXTRACELLULAR_SPACE	192	11	0.0249751504996680970000000
TCGA-24-2281-01.10	107	2_CELL_CYCLE_PROCESS	163	10	0.0249807017848267150000000
TCGA-61-1995-01.4	102	2_CYTOSKELETON	293	13	0.0250023476252856750000000
TCGA-61-1998-01.14	105	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0250074224073940710000000
TCGA-04-1542-01.4	141	2_CONTRACTILE_FIBER	22	5	0.0250130945411399800000000
TCGA-09-0369-01.9	109	2_REGULATION_OF_CELL_CYCLE	160	10	0.0250167903652523840000000
TCGA-13-1496-01.13	120	2_REGULATION_OF_MOLECULAR_FUNCTION	286	14	0.0250424328912309260000000
TCGA-24-1466-01.15	82	1_KEGG_GLIOMA	62	6	0.0250450196027422540000000
TCGA-13-1510-01.20	82	1_KEGG_COLORECTAL_CANCER	62	6	0.0250450196027422540000000
TCGA-25-1318-01.11	46	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	9	0.0250531169727652580000000
TCGA-04-1336-01.28	106	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0250773538187662770000000
TCGA-23-1023-01.1	93	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0251260838047342550000000
TCGA-25-1628-01.2	118	2_CHROMOSOME_SEGREGATION	26	5	0.0251565265833357080000000
TCGA-25-1628-01.2	118	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0251565265833357080000000
TCGA-24-2298-01.6	4	1_KEGG_ALZHEIMERS_DISEASE	148	3	0.0251748777832248340000000
TCGA-36-1578-01.10	60	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0251820130160428470000000
TCGA-25-2392-01.4	60	2_CELL_PROLIFERATION_GO_0008283	436	12	0.0251820130160428470000000
TCGA-61-2104-01.15	95	2_CELL_CYCLE_PHASE	146	9	0.0251970062449492940000000
TCGA-09-2051-01.26	142	2_DNA_BINDING	496	21	0.0252318412337874770000000
TCGA-36-1570-01.2	36	2_DNA_METABOLIC_PROCESS	218	7	0.0252385740721398560000000
TCGA-04-1542-01.4	141	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	11	0.0252519356299916970000000
TCGA-61-2016-01.10	50	1_KEGG_THYROID_CANCER	29	4	0.0252719619796143710000000
TCGA-04-1343-01.7	50	2_CHROMOSOMEPERICENTRIC_REGION	29	4	0.0252719619796143710000000
TCGA-24-1560-01.2	29	2_STRUCTURE_SPECIFIC_DNA_BINDING	50	4	0.0252719619796147220000000
TCGA-24-1436-01.1	49	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	12	0.0253063433578149600000000
TCGA-13-0904-01.6	105	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0253403710498536150000000
TCGA-61-2102-01.7	172	2_INTERPHASE	62	8	0.0253566782561533560000000
TCGA-61-1728-01.5	45	1_KEGG_CELL_CYCLE	114	6	0.0253674958097671490000000
TCGA-20-0991-01.12	166	2_INTERLEUKIN_RECEPTOR_ACTIVITY	19	5	0.0253787591255480310000000
TCGA-61-2104-01.15	95	0_HALLMARK_ANGIOGENESIS	32	5	0.0253797717489338060000000
TCGA-04-1364-01.3	163	1_KEGG_DNA_REPLICATION	32	6	0.0253986211963304830000000
TCGA-25-1625-01.6	38	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	6	0.0254485313318930370000000
TCGA-24-1416-01.4	38	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	6	0.0254485313318930370000000
TCGA-25-2404-01.5	58	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0254505297789305200000000
TCGA-13-0894-01.9	118	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0254800147563488430000000
TCGA-13-1489-01.11	118	0_HALLMARK_IL2_STAT5_SIGNALING	148	10	0.0254800147563488430000000
TCGA-13-1512-01.2	113	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0254903246062082070000000
TCGA-59-2355-01.2	14	2_PROTEIN_OLIGOMERIZATION	34	3	0.0254964473689403280000000
TCGA-29-2427-01.10	116	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	21	0.0254994806163281390000000
TCGA-24-2262-01.25	141	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	14	0.0255017311671788190000000
TCGA-25-1322-01.15	93	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0255082062308967550000000
TCGA-25-1627-01.4	75	2_CHROMOSOME	102	7	0.0255456508575831290000000
TCGA-13-0795-01.9	67	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	5	0.0255567305369540990000000
TCGA-25-1635-01.6	129	2_DNA_RECOMBINATION	40	6	0.0255621610541992420000000
TCGA-25-1623-01.7	111	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	7	0.0255645326126825930000000
TCGA-36-1575-01.9	193	2_ENZYME_BINDING	154	13	0.0255903199973804390000000
TCGA-25-1628-01.2	118	2_COLLAGEN_BINDING	13	4	0.0256125397567346260000000
TCGA-13-0897-01.2	61	2_METALLOENDOPEPTIDASE_ACTIVITY	24	4	0.0256412486886871130000000
TCGA-23-1031-01.17	142	2_REGULATION_OF_APOPTOSIS	309	16	0.0256486580429805130000000
TCGA-04-1530-01.2	90	1_KEGG_FOCAL_ADHESION	195	10	0.0256693386325300070000000
TCGA-25-1324-01.3	42	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	5	0.0257812358077501890000000
TCGA-24-2035-01.8	102	2_ION_BINDING	210	11	0.0258017649252587560000000
TCGA-25-1316-01.2	73	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0258264716721606470000000
TCGA-61-2109-01.13	122	1_KEGG_PROSTATE_CANCER	87	8	0.0258601306791724950000000
TCGA-13-1507-01.8	101	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0258649453626122700000000
TCGA-31-1959-01.7	101	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0258649453626122700000000
TCGA-13-1495-01.22	101	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0258649453626122700000000
TCGA-13-1498-01.13	104	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0258737046583639540000000
TCGA-13-1498-01.13	104	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0258737046583639540000000
TCGA-24-1436-01.1	49	2_AGING	10	3	0.0259180248147695100000000
TCGA-09-1662-01.6	49	2_AGING	10	3	0.0259180248147695100000000
TCGA-13-1510-01.20	82	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	11	0.0259248132591072540000000
TCGA-61-2092-01.12	209	2_ORGAN_MORPHOGENESIS	122	12	0.0259499629508874040000000
TCGA-13-0910-01.3	71	2_MICROTUBULE_BASED_PROCESS	72	6	0.0259548171918756180000000
TCGA-25-1324-01.3	42	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0259621855454138900000000
TCGA-13-0891-01.18	125	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0260103720104028460000000
TCGA-04-1362-01.4	35	1_KEGG_PROSTATE_CANCER	87	5	0.0260240377687215900000000
TCGA-24-2261-01.2	87	2_SPINDLE	35	5	0.0260240377687215900000000
TCGA-24-1469-01.6	123	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0260294255044958950000000
TCGA-59-2348-01.14	123	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0260294255044958950000000
TCGA-61-2104-01.15	95	2_APOPTOTIC_PROGRAM	54	6	0.0260759107062404210000000
TCGA-36-1568-01.22	80	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	8	0.0261138586153789980000000
TCGA-23-1030-01.10	58	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	7	0.0261397538559797640000000
TCGA-13-0924-01.5	68	2_ORGANELLE_PART	916	19	0.0261690479726924830000000
TCGA-24-1425-01.1	61	2_SKELETAL_DEVELOPMENT	84	6	0.0261785000842998450000000
TCGA-24-1557-01.13	106	2_CHROMOSOMEPERICENTRIC_REGION	29	5	0.0261896700587969520000000
TCGA-36-1568-01.22	80	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0262010499342078960000000
TCGA-36-1574-01.10	152	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0262608799439492290000000
TCGA-25-2042-01.3	63	0_HALLMARK_INFLAMMATORY_RESPONSE	170	8	0.0262656966614562590000000
TCGA-30-1853-01.4	111	2_INTRACELLULAR_SIGNALING_CASCADE	592	20	0.0262670495256920910000000
TCGA-24-1463-01.5	130	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0262857297629594260000000
TCGA-13-0912-01.2	55	1_KEGG_MAPK_SIGNALING_PATHWAY	258	9	0.0262971657059418890000000
TCGA-24-1470-01.7	76	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0263179255453654010000000
TCGA-24-0975-01.6	78	2_METALLOPEPTIDASE_ACTIVITY	39	5	0.0263208635184415920000000
TCGA-13-1506-01.5	113	2_REGULATION_OF_CELL_PROLIFERATION	265	13	0.0263346415602035350000000
TCGA-24-1469-01.6	123	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	13	0.0263395546473625400000000
TCGA-10-0931-01.12	59	1_KEGG_PROSTATE_CANCER	87	6	0.0263832818392616790000000
TCGA-04-1331-01.5	90	2_REGULATION_OF_MOLECULAR_FUNCTION	286	12	0.0264141072902829150000000
TCGA-13-0791-01.35	80	0_HALLMARK_MITOTIC_SPINDLE	175	9	0.0264660624390326070000000
TCGA-25-2401-01.5	119	2_COLLAGEN_BINDING	13	4	0.0264830752937252200000000
TCGA-13-0883-01.3	23	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	5	0.0265043000021544450000000
TCGA-61-2097-01.6	13	1_KEGG_MAPK_SIGNALING_PATHWAY	258	5	0.0265521288875863980000000
TCGA-13-0904-01.6	105	2_REGULATION_OF_MOLECULAR_FUNCTION	286	13	0.0265674753758959740000000
TCGA-24-1463-01.5	130	2_KINETOCHORE	24	5	0.0265862539407519490000000
TCGA-20-0990-01.17	133	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	22	0.0266561746889531530000000
TCGA-13-1482-01.7	62	2_CELL_CYCLE_ARREST_GO_0007050	49	5	0.0266610651030306410000000
TCGA-13-1410-01.9	115	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0266689651003901680000000
TCGA-13-0760-01.12	93	2_NUCLEUS	1110	26	0.0266883160052003230000000
TCGA-23-1031-01.17	142	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	16	0.0267000667937114040000000
TCGA-36-1580-01.1	65	2_CATION_BINDING	165	8	0.0267254396632694810000000
TCGA-23-1032-01.16	250	1_KEGG_MAPK_SIGNALING_PATHWAY	258	20	0.0267619616433756420000000
TCGA-30-1853-01.4	111	2_RESPONSE_TO_BIOTIC_STIMULUS	96	8	0.0267649224748973540000000
TCGA-13-0723-01.8	50	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0267740769833365800000000
TCGA-24-1562-01.4	36	1_KEGG_APOPTOSIS	85	5	0.0267815399688395160000000
TCGA-61-2111-01.16	56	2_TRANSITION_METAL_ION_BINDING	92	6	0.0268279878307545360000000
TCGA-31-1950-01.7	105	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	9	0.0268392972407205910000000
TCGA-09-2044-01.4	83	1_KEGG_GLIOMA	62	6	0.0268595375335749340000000
TCGA-04-1367-01.3	74	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	16	0.0268610149656003630000000
TCGA-24-1431-01.3	57	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0269047554932027620000000
TCGA-04-1347-01.15	187	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0269853296718623320000000
TCGA-23-1110-01.7	299	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0269936508774087400000000
TCGA-13-1481-01.3	78	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0269953923682883170000000
TCGA-25-1630-01.10	35	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0270137036842340480000000
TCGA-13-1408-01.1	45	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0270684197629888040000000
TCGA-23-1028-01.18	93	2_RESPONSE_TO_STRESS	427	15	0.0270749633012280920000000
TCGA-31-1959-01.7	101	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	14	0.0270753671548946000000000
TCGA-25-1322-01.15	93	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0272223048349787900000000
TCGA-13-0760-01.12	93	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0272223048349787900000000
TCGA-24-1614-01.5	86	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0272263981328453100000000
TCGA-13-0726-01.12	78	1_KEGG_MELANOGENESIS	99	7	0.0272290802471693750000000
TCGA-36-1576-01.8	124	1_KEGG_BLADDER_CANCER	42	6	0.0272633466179094640000000
TCGA-09-2056-01.6	63	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	7	0.0272895055096447630000000
TCGA-10-0926-01.2	45	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	8	0.0272927881812349390000000
TCGA-24-1563-01.15	100	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0272932014845755180000000
TCGA-24-1556-01.19	120	2_CONDENSED_CHROMOSOME	26	5	0.0272997336873295370000000
TCGA-13-0904-01.6	105	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	19	0.0273263941023257070000000
TCGA-09-1659-01.5	51	2_CHROMOSOMEPERICENTRIC_REGION	29	4	0.0273646972978547900000000
TCGA-24-1556-01.19	120	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0273752631260366400000000
TCGA-13-0795-01.9	67	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	12	0.0274313084202736510000000
TCGA-25-2404-01.5	58	2_MITOTIC_CELL_CYCLE	134	7	0.0274499442154947820000000
TCGA-24-1469-01.6	123	1_KEGG_PROSTATE_CANCER	87	8	0.0274535116473441370000000
TCGA-24-1562-01.4	36	2_REGULATION_OF_APOPTOSIS	309	8	0.0274826367250027780000000
TCGA-24-1426-01.7	63	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0274909874129441280000000
TCGA-13-1510-01.20	82	2_KINASE_BINDING	63	6	0.0274909874129441320000000
TCGA-23-1117-01.11	99	2_DNA_METABOLIC_PROCESS	218	11	0.0275184858691844000000000
TCGA-24-1549-01.21	158	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0275186164447632910000000
TCGA-13-0723-01.8	50	2_AGING	10	3	0.0275570072499012500000000
TCGA-61-2016-01.10	50	2_AGING	10	3	0.0275570072499012500000000
TCGA-04-1343-01.7	50	2_AGING	10	3	0.0275570072499012500000000
TCGA-25-1626-01.2	86	2_RESPONSE_TO_CHEMICAL_STIMULUS	252	11	0.0275672509209273500000000
TCGA-24-1614-01.5	86	2_RESPONSE_TO_CHEMICAL_STIMULUS	252	11	0.0275672509209273500000000
TCGA-25-1326-01.11	119	2_ORGAN_DEVELOPMENT	460	18	0.0275806347106491160000000
TCGA-24-1558-01.12	174	1_KEGG_GLIOMA	62	8	0.0275834948355460390000000
TCGA-24-1103-01.5	73	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0275865797821405540000000
TCGA-61-2092-01.12	209	2_REGULATION_OF_BODY_FLUID_LEVELS	52	8	0.0276302124253692720000000
TCGA-04-1336-01.28	106	2_CELL_CYCLE_ARREST_GO_0007050	49	6	0.0276389117007401350000000
TCGA-09-2051-01.26	142	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	14	0.0276522044649848320000000
TCGA-25-1625-01.6	38	2_REGULATION_OF_KINASE_ACTIVITY	138	6	0.0276618194647730710000000
TCGA-24-1416-01.4	38	2_REGULATION_OF_KINASE_ACTIVITY	138	6	0.0276618194647730710000000
TCGA-13-0890-01.2	48	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	10	0.0276621113169479950000000
TCGA-23-1031-01.17	142	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0277562112444601010000000
TCGA-23-1028-01.18	93	0_HALLMARK_P53_PATHWAY	151	9	0.0277724705369710410000000
TCGA-04-1346-01.10	75	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0277800387757445170000000
TCGA-13-0889-01.4	37	2_DNA_RECOMBINATION	40	4	0.0277977205017261380000000
TCGA-61-1995-01.4	102	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0278105922093832280000000
TCGA-59-2355-01.2	14	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	3	0.0278623611591894490000000
TCGA-04-1336-01.28	106	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0279333426486521420000000
TCGA-04-1364-01.3	163	2_AGING	10	4	0.0279497892458735190000000
TCGA-24-1471-01.4	49	2_REGULATION_OF_CELL_CYCLE	160	7	0.0279761866883245750000000
TCGA-09-1662-01.6	49	2_REGULATION_OF_CELL_CYCLE	160	7	0.0279761866883245750000000
TCGA-13-1487-01.3	79	2_BLOOD_COAGULATION	39	5	0.0280149775541015220000000
TCGA-13-1487-01.3	79	2_COAGULATION	39	5	0.0280149775541015220000000
TCGA-13-1492-01.2	162	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	24	0.0280238958363959660000000
TCGA-09-1659-01.5	51	2_CHROMOSOME	102	6	0.0280473690144621080000000
TCGA-23-1031-01.17	142	2_ORGAN_DEVELOPMENT	460	20	0.0280515273044715140000000
TCGA-13-0903-01.11	77	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0280586300642200750000000
TCGA-23-1122-01.11	77	2_DNA_RECOMBINATION	40	5	0.0280586300642200750000000
TCGA-24-2293-01.3	33	2_CARBOHYDRATE_BINDING	45	4	0.0280762569084504650000000
TCGA-24-1562-01.4	36	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	8	0.0281349323729413250000000
TCGA-24-1474-01.12	122	0_HALLMARK_SPERMATOGENESIS	88	8	0.0281420518875829110000000
TCGA-04-1347-01.15	187	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	58	8	0.0281784836507887810000000
TCGA-13-1404-01.13	117	0_HALLMARK_P53_PATHWAY	151	10	0.0281794043553331570000000
TCGA-20-0991-01.12	166	2_HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY	32	6	0.0281820822699877860000000
TCGA-25-1321-01.3	33	2_M_PHASE	94	5	0.0281831213111591520000000
TCGA-61-2102-01.7	172	2_DNA_REPLICATION	82	9	0.0282154433034696870000000
TCGA-24-1616-01.2	38	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0282213268303839260000000
TCGA-13-1509-01.9	117	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	16	0.0282282804135360020000000
TCGA-04-1517-01.4	44	1_KEGG_PANCREATIC_CANCER	70	5	0.0283310274345124520000000
TCGA-13-1492-01.2	162	1_KEGG_PROSTATE_CANCER	87	9	0.0283355535492849230000000
TCGA-24-1424-01.4	80	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0283444776846756630000000
TCGA-13-2060-01.10	86	2_REGULATION_OF_MITOSIS	36	5	0.0283568714299492170000000
TCGA-24-1614-01.5	86	2_REGULATION_OF_MITOSIS	36	5	0.0283568714299492170000000
TCGA-61-2002-01.1	118	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0283761332528697580000000
TCGA-13-0894-01.9	118	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0283761332528697580000000
TCGA-13-0883-01.3	23	2_REGULATION_OF_KINASE_ACTIVITY	138	5	0.0284512661301550740000000
TCGA-61-2094-01.6	63	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	14	0.0285430547861492520000000
TCGA-36-1575-01.9	193	2_INFLAMMATORY_RESPONSE	112	11	0.0285711693848760170000000
TCGA-24-2289-01.6	53	0_HALLMARK_KRAS_SIGNALING_UP	148	7	0.0286179754124872980000000
TCGA-04-1361-01.4	27	2_RESPONSE_TO_STRESS	427	8	0.0286276793776174160000000
TCGA-24-1104-01.2	18	1_KEGG_APOPTOSIS	85	4	0.0286620454700956020000000
TCGA-57-1583-01.20	185	1_KEGG_THYROID_CANCER	29	6	0.0286772668591886400000000
TCGA-24-1435-01.12	115	2_PROTEOLYSIS	154	10	0.0287499956828738690000000
TCGA-24-2030-01.8	161	2_REGULATION_OF_MITOTIC_CELL_CYCLE	20	5	0.0287663339554621730000000
TCGA-23-1116-01.7	84	1_KEGG_COLORECTAL_CANCER	62	6	0.0287788248906247590000000
TCGA-24-1418-01.16	84	2_INTERPHASE	62	6	0.0287788248906247590000000
TCGA-13-1482-01.7	62	2_SKELETAL_DEVELOPMENT	84	6	0.0287788248906247590000000
TCGA-23-1110-01.7	299	0_HALLMARK_IL2_STAT5_SIGNALING	148	16	0.0288073871107580870000000
TCGA-61-2003-01.4	45	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0288217215409141140000000
TCGA-13-0893-01.4	112	2_MICROTUBULE_MOTOR_ACTIVITY	14	4	0.0288892470791159780000000
TCGA-23-2072-01.9	74	2_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY	146	8	0.0288895127582366500000000
TCGA-25-1623-01.7	111	1_KEGG_FOCAL_ADHESION	195	11	0.0288936093958636410000000
TCGA-61-2111-01.16	56	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0288947070695707540000000
TCGA-61-2111-01.16	56	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0288947070695707540000000
TCGA-04-1336-01.28	106	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	9	0.0289840370599608040000000
TCGA-13-0900-01.8	90	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0290222530848110660000000
TCGA-13-0723-01.8	50	2_DOUBLE_STRANDED_DNA_BINDING	30	4	0.0290465491335663260000000
TCGA-23-1118-01.5	50	2_DOUBLE_STRANDED_DNA_BINDING	30	4	0.0290465491335663260000000
TCGA-04-1348-01.6	81	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0290732607566490730000000
TCGA-25-2392-01.4	60	1_KEGG_PROSTATE_CANCER	87	6	0.0290999898963653120000000
TCGA-57-1583-01.20	185	2_MICROTUBULE_CYTOSKELETON	117	11	0.0291064378761191340000000
TCGA-04-1342-01.12	104	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0291167311091839740000000
TCGA-13-0800-01.9	124	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	8	0.0291287314431298880000000
TCGA-13-0800-01.9	124	1_KEGG_PROSTATE_CANCER	87	8	0.0291287314431298880000000
TCGA-24-2030-01.8	161	2_CELL_CYCLE_ARREST_GO_0007050	49	7	0.0291335012816221870000000
TCGA-61-2102-01.7	172	2_DNA_DEPENDENT_DNA_REPLICATION	46	7	0.0291619975444649610000000
TCGA-23-2077-01.18	63	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	4	0.0291687094129766050000000
TCGA-04-1347-01.15	187	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	17	0.0291731568549872390000000
TCGA-61-2109-01.13	122	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0292259635827642890000000
TCGA-24-1474-01.12	122	2_KINESIN_COMPLEX	13	4	0.0292259635827642890000000
TCGA-24-1474-01.12	122	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0292259635827642890000000
TCGA-29-2427-01.10	116	2_CATION_HOMEOSTASIS	93	8	0.0292548814815764520000000
TCGA-09-1659-01.5	51	2_AGING	10	3	0.0292630089754799330000000
TCGA-09-1659-01.5	51	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	3	0.0292630089754799330000000
TCGA-24-1103-01.5	73	2_BIOPOLYMER_METABOLIC_PROCESS	1367	25	0.0292726501392553650000000
TCGA-23-2081-01.7	56	1_KEGG_FOCAL_ADHESION	195	8	0.0293019399549772770000000
TCGA-13-1497-01.7	59	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	7	0.0293140836385984080000000
TCGA-10-0931-01.12	59	1_KEGG_INSULIN_SIGNALING_PATHWAY	133	7	0.0293140836385984080000000
TCGA-25-1322-01.15	93	2_INTRACELLULAR_ORGANELLE_PART	912	23	0.0294094277204461490000000
TCGA-61-1728-01.5	45	2_MICROTUBULE_CYTOSKELETON	117	6	0.0294339635068329230000000
TCGA-23-1118-01.5	50	2_INTERPHASE	62	5	0.0294747755092108350000000
TCGA-24-1426-01.7	63	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0294800545329577180000000
TCGA-04-1343-01.7	50	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0294801146921205020000000
TCGA-24-2024-01.3	55	2_RECEPTOR_BINDING	331	10	0.0295195853905930760000000
TCGA-10-0930-01.3	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043940000000
TCGA-13-1409-01.1	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043940000000
TCGA-25-2396-01.6	42	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0295395153564356120000000
TCGA-25-2398-01.5	81	2_SYSTEM_DEVELOPMENT	694	18	0.0295443611718260970000000
TCGA-61-2109-01.13	122	2_CHROMOSOME_SEGREGATION	26	5	0.0295829764419537340000000
TCGA-24-1474-01.12	122	2_CONDENSED_CHROMOSOME	26	5	0.0295829764419537340000000
TCGA-24-1431-01.3	57	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0295918328926911170000000
TCGA-36-1575-01.9	193	2_INTEGRAL_TO_MEMBRANE	956	39	0.0296122087566754800000000
TCGA-24-1471-01.4	49	2_ORGAN_DEVELOPMENT	460	11	0.0296230129298267230000000
TCGA-13-1410-01.9	115	2_M_PHASE	94	8	0.0297095684081200990000000
TCGA-13-0884-01.11	68	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0297719763259489440000000
TCGA-25-1626-01.2	86	2_ENDOPEPTIDASE_ACTIVITY	91	7	0.0298215099403985750000000
TCGA-25-2399-01.16	103	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0298779211471220910000000
TCGA-20-0990-01.17	133	2_CELL_CYCLE_PROCESS	163	11	0.0298796751135595310000000
TCGA-61-2012-01.6	78	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0298878580071418770000000
TCGA-13-1512-01.2	113	2_G1_PHASE	14	4	0.0299238888691284840000000
TCGA-04-1331-01.5	90	1_KEGG_PROSTATE_CANCER	87	7	0.0299251443939151510000000
TCGA-24-1428-01.9	90	1_KEGG_PROSTATE_CANCER	87	7	0.0299251443939151510000000
TCGA-36-1568-01.22	80	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	16	0.0299989585899403010000000
TCGA-61-1919-01.9	87	2_REGULATION_OF_MITOSIS	36	5	0.0300035775437554430000000
TCGA-25-1625-01.6	38	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	6	0.0300282900575458800000000
TCGA-24-1416-01.4	38	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	6	0.0300282900575458800000000
TCGA-13-0903-01.11	77	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0300749821866524610000000
TCGA-23-1122-01.11	77	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0300749821866524610000000
TCGA-24-1548-01.8	141	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	7	0.0302294915261733630000000
TCGA-25-2404-01.5	58	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	7	0.0302337632371244940000000
TCGA-25-1313-01.2	13	2_CELL_CYCLE_GO_0007049	265	5	0.0302338807753113930000000
TCGA-61-1998-01.14	105	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0302415253716230220000000
TCGA-24-1558-01.12	174	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	19	0.0302440992944612750000000
TCGA-25-1634-01.4	75	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0302750996152205760000000
TCGA-04-1346-01.10	75	1_KEGG_PANCREATIC_CANCER	70	6	0.0302750996152205760000000
TCGA-25-1627-01.4	75	1_KEGG_PANCREATIC_CANCER	70	6	0.0302750996152205760000000
TCGA-24-1470-01.7	76	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	8	0.0302807514181686120000000
TCGA-25-1324-01.3	42	2_REGULATION_OF_MITOSIS	36	4	0.0302927376492192760000000
TCGA-36-1570-01.2	36	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0302927376492192760000000
TCGA-25-1630-01.10	35	1_KEGG_PATHWAYS_IN_CANCER	323	8	0.0303539612291946930000000
TCGA-61-2111-01.16	56	2_M_PHASE	94	6	0.0303562399138914210000000
TCGA-25-1627-01.4	75	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0303637784371043050000000
TCGA-13-0761-01.6	75	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0303637784371043050000000
TCGA-61-2002-01.1	118	0_HALLMARK_P53_PATHWAY	151	10	0.0303719348555589430000000
TCGA-13-0903-01.11	77	2_CHROMOSOME	102	7	0.0304104245576324630000000
TCGA-04-1367-01.3	74	1_KEGG_MELANOMA	71	6	0.0304131306854982970000000
TCGA-13-0883-01.3	23	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	5	0.0305082240693967210000000
TCGA-13-0889-01.4	37	2_DNA_METABOLIC_PROCESS	218	7	0.0305230994076179820000000
TCGA-13-0910-01.3	71	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0305283967936585860000000
TCGA-24-0968-01.9	71	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0305283967936585860000000
TCGA-61-1995-01.4	102	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	5	0.0305332161171193580000000
TCGA-13-0916-01.11	92	2_SPINDLE_POLE	17	4	0.0307365549727785480000000
TCGA-59-2348-01.14	123	2_CONDENSED_CHROMOSOME	26	5	0.0307791047740481120000000
TCGA-23-2079-01.14	85	2_INTERPHASE	62	6	0.0308073816639807890000000
TCGA-04-1357-01.6	22	1_KEGG_PANCREATIC_CANCER	70	4	0.0308869851306367400000000
TCGA-13-0891-01.18	125	1_KEGG_PROSTATE_CANCER	87	8	0.0308891351339018460000000
TCGA-04-1350-01.2	130	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0309455350581815530000000
TCGA-13-0905-01.7	160	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0309804677723755990000000
TCGA-59-2355-01.2	14	1_KEGG_CELL_CYCLE	114	4	0.0309856095880069320000000
TCGA-09-1669-01.10	81	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	13	0.0310066666512528320000000
TCGA-61-2113-01.15	99	0_HALLMARK_ANGIOGENESIS	32	5	0.0310313093865767530000000
TCGA-23-1117-01.11	99	0_HALLMARK_ANGIOGENESIS	32	5	0.0310313093865767530000000
TCGA-57-1993-01.8	52	2_APOPTOTIC_MITOCHONDRIAL_CHANGES	10	3	0.0310373207214403730000000
TCGA-24-1426-01.7	63	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0311049662267176220000000
TCGA-23-1023-01.1	93	2_MICROTUBULE_CYTOSKELETON	117	8	0.0311511017775587440000000
TCGA-36-1576-01.8	124	2_COLLAGEN_BINDING	13	4	0.0311673988290062790000000
TCGA-36-1568-01.22	80	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0312404718461895760000000
TCGA-13-0920-01.9	82	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0312661729692665370000000
TCGA-61-2111-01.16	56	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	5	0.0312683779295601370000000
TCGA-13-0730-01.8	83	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0312978680582279640000000
TCGA-09-2044-01.4	83	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0312978680582279640000000
TCGA-25-1633-01.1	71	0_HALLMARK_HYPOXIA	154	8	0.0313002338420932810000000
TCGA-24-1416-01.4	38	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0313024977239745180000000
TCGA-24-1435-01.4	3	2_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS	24	2	0.0313067792044568680000000
TCGA-61-1919-01.6	3	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	2	0.0313067792044568680000000
TCGA-13-1497-01.8	3	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	2	0.0313067792044568680000000
TCGA-24-1563-01.13	3	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	2	0.0313067792044568680000000
TCGA-09-1666-01.25	3	2_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION	24	2	0.0313067792044568680000000
TCGA-24-0975-01.3	3	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	2	0.0313067792044568680000000
TCGA-09-2044-01.3	3	2_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS	24	2	0.0313067792044568680000000
TCGA-23-2072-01.5	3	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	2	0.0313067792044568680000000
TCGA-20-0991-01.12	166	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0313096184167100670000000
TCGA-20-0990-01.17	133	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	8	0.0313603708020119480000000
TCGA-13-1483-01.3	66	2_DNA_METABOLIC_PROCESS	218	9	0.0313855265057100470000000
TCGA-04-1336-01.28	106	2_MITOCHONDRIAL_TRANSPORT	15	4	0.0313980385900671860000000
TCGA-25-1318-01.11	46	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0314359035907637650000000
TCGA-13-0761-01.6	75	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0314922806059099450000000
TCGA-24-2254-01.3	49	2_CELL_CYCLE_PROCESS	163	7	0.0315672613982454910000000
TCGA-25-1322-01.15	93	2_ORGANELLE_PART	916	23	0.0315737630185023090000000
TCGA-04-1362-01.4	35	2_ENZYME_BINDING	154	6	0.0315737683030786610000000
TCGA-25-1630-01.10	35	2_ENZYME_BINDING	154	6	0.0315737683030786610000000
TCGA-24-1549-01.21	158	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0315930083838310700000000
TCGA-23-1116-01.7	84	2_M_PHASE	94	7	0.0316049385261553540000000
TCGA-13-1412-01.8	113	1_KEGG_PANCREATIC_CANCER	70	7	0.0316173490768464630000000
TCGA-04-1362-01.4	35	2_NUCLEUS	1110	14	0.0316459761029886240000000
TCGA-10-0926-01.2	45	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	5	0.0316901438248445990000000
TCGA-23-2072-01.9	74	2_SYSTEM_DEVELOPMENT	694	17	0.0317383131334002460000000
TCGA-24-1413-01.6	34	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	3	0.0317921755638267830000000
TCGA-24-1413-01.6	34	2_MITOCHONDRIAL_TRANSPORT	15	3	0.0317921755638267830000000
TCGA-23-1026-01.5	65	0_HALLMARK_E2F_TARGETS	169	8	0.0318100662192251290000000
TCGA-24-2298-01.6	4	1_KEGG_HUNTINGTONS_DISEASE	160	3	0.0318266408848765020000000
TCGA-23-1032-01.16	250	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	9	0.0319271741656587320000000
TCGA-24-2019-01.10	192	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0320287310800627530000000
TCGA-25-1322-01.15	93	2_SPINDLE_POLE	17	4	0.0320824745127139470000000
TCGA-24-2289-01.6	53	2_SYSTEM_DEVELOPMENT	694	14	0.0320912123293856380000000
TCGA-13-0924-01.5	68	2_CHROMOSOMAL_PART	78	6	0.0320976818907939420000000
TCGA-13-1492-01.2	162	2_CELL_DEVELOPMENT	511	23	0.0321045988199128440000000
TCGA-13-0883-01.3	23	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	6	0.0321489042819138380000000
TCGA-04-1514-01.6	91	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	7	0.0321791937579073500000000
TCGA-24-1424-01.4	80	2_CHROMOSOME_ORGANIZATION_AND_BIOGENESIS	99	7	0.0321872941089029540000000
TCGA-24-1560-01.2	29	2_REGULATION_OF_MOLECULAR_FUNCTION	286	7	0.0321991692012533540000000
TCGA-25-2409-01.5	29	2_REGULATION_OF_MOLECULAR_FUNCTION	286	7	0.0321991692012533540000000
TCGA-23-1032-01.16	250	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	42	0.0322252312128740790000000
TCGA-24-1435-01.12	115	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0322856763259027690000000
TCGA-24-2298-01.7	138	2_BLOOD_COAGULATION	39	6	0.0323016467036097780000000
TCGA-24-2298-01.7	138	2_COAGULATION	39	6	0.0323016467036097780000000
TCGA-13-0792-01.8	64	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0323031244547066980000000
TCGA-13-0807-01.8	46	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	8	0.0323132245670760540000000
TCGA-09-1665-01.16	131	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	41	6	0.0323275882693487700000000
TCGA-36-1571-01.6	109	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0323465306341852170000000
TCGA-04-1514-01.6	91	1_KEGG_PRIMARY_IMMUNODEFICIENCY	35	5	0.0324075749362326210000000
TCGA-59-2350-01.1	62	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0324154930712469080000000
TCGA-04-1332-01.2	25	1_KEGG_GLIOMA	62	4	0.0324154930712469080000000
TCGA-36-1571-01.6	109	2_GROWTH_FACTOR_ACTIVITY	49	6	0.0324262670289291450000000
TCGA-20-0991-01.12	166	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	13	0.0324366938570508360000000
TCGA-24-2267-01.8	26	1_KEGG_PATHWAYS_IN_CANCER	323	7	0.0324474113634938550000000
TCGA-57-1584-01.8	54	0_HALLMARK_KRAS_SIGNALING_UP	148	7	0.0324531072531730540000000
TCGA-25-1329-01.5	43	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0324546124998672250000000
TCGA-24-1431-01.3	57	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0324972691981200300000000
TCGA-24-1469-01.6	123	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	11	0.0325847629773711390000000
TCGA-23-1124-01.17	107	2_MITOCHONDRIAL_TRANSPORT	15	4	0.0325868352274264890000000
TCGA-24-1464-01.5	2	2_MITOCHONDRIAL_MEMBRANE_PART	42	2	0.0326051386823529720000000
TCGA-04-1347-01.7	2	2_EMBRYONIC_DEVELOPMENT	42	2	0.0326051386823529720000000
TCGA-10-0937-01.2	2	2_MITOCHONDRIAL_MEMBRANE_PART	42	2	0.0326051386823529720000000
TCGA-23-2078-01.8	2	2_MITOCHONDRIAL_MEMBRANE_PART	42	2	0.0326051386823529720000000
TCGA-24-1466-01.11	2	2_MITOCHONDRIAL_MEMBRANE_PART	42	2	0.0326051386823529720000000
TCGA-24-1556-01.17	2	2_EMBRYONIC_DEVELOPMENT	42	2	0.0326051386823529720000000
TCGA-23-1031-01.17	142	2_COLLAGEN	23	5	0.0326795337600033350000000
TCGA-24-1470-01.7	76	1_KEGG_PANCREATIC_CANCER	70	6	0.0326796011329485090000000
TCGA-13-1504-01.4	48	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0327294862654636250000000
TCGA-24-1426-01.7	63	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	14	0.0327572190669304310000000
TCGA-20-0987-01.19	194	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	29	0.0327859920220127250000000
TCGA-24-2030-01.8	161	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0328487506992955480000000
TCGA-13-0894-01.9	118	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	25	0.0328528214418560840000000
TCGA-13-0730-01.8	83	2_DNA_METABOLIC_PROCESS	218	10	0.0328531401326671650000000
TCGA-25-1322-01.15	93	2_CYTOSKELETAL_PART	194	10	0.0328625244439642510000000
TCGA-13-0761-01.6	75	2_MITOSIS	71	6	0.0328631821829256720000000
TCGA-13-0923-01.5	53	2_AGING	10	3	0.0328812302044254950000000
TCGA-24-2289-01.6	53	2_AGING	10	3	0.0328812302044254950000000
TCGA-10-0934-01.11	145	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	11	0.0328931819805173140000000
TCGA-10-0933-01.2	97	2_DNA_REPAIR	113	8	0.0329237085578690590000000
TCGA-23-1026-01.5	65	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	11	0.0329360025329284500000000
TCGA-13-1494-01.4	65	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0329617911808577630000000
TCGA-04-1349-01.2	20	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0329627104430268780000000
TCGA-09-1661-01.1	20	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0329627104430268780000000
TCGA-13-0903-01.11	77	2_TRANSCRIPTION	667	17	0.0330350790827909640000000
TCGA-13-1494-01.4	65	2_METALLOENDOPEPTIDASE_ACTIVITY	24	4	0.0330411553015823240000000
TCGA-36-1580-01.1	65	2_METALLOENDOPEPTIDASE_ACTIVITY	24	4	0.0330411553015823240000000
TCGA-23-1026-01.5	65	2_METALLOENDOPEPTIDASE_ACTIVITY	24	4	0.0330411553015823240000000
TCGA-24-1558-01.12	174	2_CHEMICAL_HOMEOSTASIS	126	11	0.0330792665504284910000000
TCGA-13-0714-01.9	51	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0331119156892234760000000
TCGA-09-1659-01.5	51	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0331119156892234760000000
TCGA-24-2262-01.25	141	2_CHROMOSOMAL_PART	78	8	0.0331371763014245490000000
TCGA-04-1367-01.3	74	1_KEGG_FOCAL_ADHESION	195	9	0.0331406088536535110000000
TCGA-13-0755-01.6	16	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	7	0.0332046798198225720000000
TCGA-04-1525-01.7	52	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	17	0.0332166049052011540000000
TCGA-13-0723-01.8	50	2_SINGLE_STRANDED_DNA_BINDING	31	4	0.0332200503259448420000000
TCGA-61-2092-01.12	209	0_HALLMARK_COAGULATION	125	12	0.0332285909681732660000000
TCGA-25-2404-01.5	58	2_REGULATION_OF_KINASE_ACTIVITY	138	7	0.0332471864355281050000000
TCGA-25-2391-01.2	64	2_REGULATION_OF_MOLECULAR_FUNCTION	286	10	0.0332710071261027240000000
TCGA-24-1469-01.6	123	2_REGULATION_OF_MOLECULAR_FUNCTION	286	14	0.0332772446183472940000000
TCGA-57-1582-01.26	174	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0332902218556034440000000
TCGA-13-0905-01.7	160	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	8	0.0333951933258519120000000
TCGA-09-2053-01.14	121	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0334288325099080940000000
TCGA-10-0930-01.5	60	2_SYSTEM_DEVELOPMENT	694	15	0.0334298441930124670000000
TCGA-09-1669-01.10	81	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0335563086474521340000000
TCGA-25-2398-01.5	81	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0335563086474521340000000
TCGA-24-1431-01.3	57	2_M_PHASE	94	6	0.0336576551943130670000000
TCGA-13-0717-01.6	103	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	15	0.0336849390720721930000000
TCGA-24-1470-01.7	76	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0337209732501310010000000
TCGA-61-2102-01.7	172	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0337866284277696520000000
TCGA-25-2042-01.3	63	0_HALLMARK_COMPLEMENT	176	8	0.0337929929633233940000000
TCGA-13-1491-01.7	90	2_REGULATION_OF_CELL_CYCLE	160	9	0.0338174614869109770000000
TCGA-04-1350-01.2	130	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	11	0.0338177506599537450000000
TCGA-24-1424-01.4	80	2_DNA_RECOMBINATION	40	5	0.0338245535441902210000000
TCGA-25-1318-01.11	46	2_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	176	7	0.0338546548485325410000000
TCGA-23-1027-01.8	68	2_EXTRACELLULAR_REGION_PART	269	10	0.0338963507394493820000000
TCGA-13-1481-01.3	78	2_ORGAN_DEVELOPMENT	460	14	0.0339171809143525710000000
TCGA-25-1313-01.2	13	2_NON_MEMBRANE_BOUND_ORGANELLE	476	6	0.0339426326277942960000000
TCGA-25-1313-01.2	13	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	6	0.0339426326277942960000000
TCGA-25-1633-01.1	71	2_CARBOHYDRATE_BINDING	45	5	0.0339706816056931790000000
TCGA-13-0724-01.21	71	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	5	0.0339706816056931790000000
TCGA-13-0886-01.1	45	2_MITOSIS	71	5	0.0339706816056932060000000
TCGA-24-1470-01.7	76	2_CYTOSKELETON	293	11	0.0340090974445525360000000
TCGA-09-1665-01.16	131	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	31	0.0340690459311923380000000
TCGA-61-2088-01.7	150	2_RESPONSE_TO_BIOTIC_STIMULUS	96	9	0.0340845330514477560000000
TCGA-09-2049-01.8	96	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	9	0.0340845330514477630000000
TCGA-09-1665-01.16	131	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	5	0.0341115418121288180000000
TCGA-23-1110-01.7	299	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0341220272669287910000000
TCGA-57-1582-01.26	174	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0341721174340343940000000
TCGA-31-1959-01.7	101	0_HALLMARK_ANGIOGENESIS	32	5	0.0342019299126508080000000
TCGA-24-1616-01.2	38	2_KINASE_REGULATOR_ACTIVITY	41	4	0.0342231743145450240000000
TCGA-20-0987-01.19	194	1_KEGG_BLADDER_CANCER	42	7	0.0342532497399331140000000
TCGA-24-2298-01.6	4	0_HALLMARK_OXIDATIVE_PHOSPHORYLATION	164	3	0.0342786230836552370000000
TCGA-20-0990-01.17	133	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0342990088849607910000000
TCGA-09-2044-01.4	83	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	8	0.0342990088849607910000000
TCGA-09-2050-01.18	196	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	28	0.0343220443333181400000000
TCGA-24-1419-01.2	93	1_KEGG_FOCAL_ADHESION	195	10	0.0343609124483700640000000
TCGA-31-1950-01.7	105	1_KEGG_OOCYTE_MEIOSIS	105	8	0.0344019922091360690000000
TCGA-24-1560-01.2	29	2_APOPTOTIC_PROGRAM	54	4	0.0344107731203018160000000
TCGA-13-0889-01.4	37	1_KEGG_PROSTATE_CANCER	87	5	0.0344415550579599060000000
TCGA-20-0991-01.12	166	1_KEGG_PROSTATE_CANCER	87	9	0.0344419021459881760000000
TCGA-23-1022-01.10	170	1_KEGG_APOPTOSIS	85	9	0.0344651523415372770000000
TCGA-23-2077-01.18	63	2_CASPASE_ACTIVATION	25	4	0.0345515349516814230000000
TCGA-29-2427-01.10	116	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	20	0.0345730770784567560000000
TCGA-24-1553-01.7	26	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	126	5	0.0345953334385181100000000
TCGA-24-1557-01.13	106	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0346704605837740360000000
TCGA-13-1512-01.2	113	2_MITOSIS	71	7	0.0347325193968295800000000
TCGA-20-0990-01.17	133	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0347745014194906150000000
TCGA-61-1736-01.2	54	2_AGING	10	3	0.0347960221316959630000000
TCGA-13-0765-01.4	54	2_AGING	10	3	0.0347960221316959630000000
TCGA-04-1357-01.6	22	0_HALLMARK_P53_PATHWAY	151	5	0.0348719564547329830000000
TCGA-24-2280-01.10	58	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	16	0.0349915999307938640000000
TCGA-13-0760-01.12	93	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0350306139678670800000000
TCGA-04-1348-01.6	81	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0350338105019880950000000
TCGA-13-1488-01.17	109	2_MITOCHONDRIAL_TRANSPORT	15	4	0.0350635566582900990000000
TCGA-24-1418-01.16	84	2_REGULATION_OF_CELL_PROLIFERATION	265	11	0.0351321732392938170000000
TCGA-61-1995-01.4	102	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	6	0.0351355926199646980000000
TCGA-25-1634-01.4	75	0_HALLMARK_KRAS_SIGNALING_UP	148	8	0.0352379511720313230000000
TCGA-13-1409-01.6	122	2_RESPONSE_TO_OTHER_ORGANISM	66	7	0.0352697035173785490000000
TCGA-23-1026-01.5	65	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0353403099141801490000000
TCGA-36-1577-01.14	168	2_CONTRACTILE_FIBER_PART	20	5	0.0353497433101736670000000
TCGA-25-1318-01.11	46	1_KEGG_PANCREATIC_CANCER	70	5	0.0353514929489730230000000
TCGA-13-0900-01.8	90	2_REGULATION_OF_MITOSIS	36	5	0.0353948323043868990000000
TCGA-24-1428-01.9	90	2_REGULATION_OF_MITOSIS	36	5	0.0353948323043868990000000
TCGA-24-1435-01.12	115	1_KEGG_PANCREATIC_CANCER	70	7	0.0354517299721194700000000
TCGA-13-0905-01.7	160	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0355536784070067320000000
TCGA-13-0761-01.6	75	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	6	0.0356268446425774330000000
TCGA-59-2351-01.5	31	2_DNA_DAMAGE_CHECKPOINT	17	3	0.0356341912351645710000000
TCGA-13-0886-01.1	45	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0356768553128917680000000
TCGA-61-2003-01.4	45	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0356768553128917680000000
TCGA-25-2400-01.5	35	2_CELL_PROLIFERATION_GO_0008283	436	9	0.0356784707109506220000000
TCGA-04-1350-01.2	130	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0356989293322648930000000
TCGA-13-0727-01.1	29	2_DNA_REPAIR	113	5	0.0357386648118876990000000
TCGA-13-1492-01.2	162	2_REGULATION_OF_APOPTOSIS	309	17	0.0357689742459821530000000
TCGA-13-0903-01.11	77	1_KEGG_BLADDER_CANCER	42	5	0.0358160789092043590000000
TCGA-23-1122-01.11	77	1_KEGG_BLADDER_CANCER	42	5	0.0358160789092043590000000
TCGA-59-2363-01.3	89	2_CELL_CYCLE_PROCESS	163	9	0.0358203358290372570000000
TCGA-13-0793-01.8	97	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0358867389812064230000000
TCGA-09-2051-01.26	142	2_CHROMOSOME	102	9	0.0359073957959324950000000
TCGA-13-0800-01.9	124	2_CYTOKINE_BINDING	44	6	0.0359095155729975270000000
TCGA-61-2109-01.13	122	2_MEIOTIC_CELL_CYCLE	27	5	0.0359332058536077570000000
TCGA-04-1348-01.6	81	2_DNA_RECOMBINATION	40	5	0.0359385127648170140000000
TCGA-09-1669-01.10	81	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0359385127648170140000000
TCGA-13-0893-01.4	112	2_MICROTUBULE_BASED_PROCESS	72	7	0.0359531798281597090000000
TCGA-09-1659-01.5	51	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	4	0.0359648766807737080000000
TCGA-04-1337-01.2	31	2_EXTRACELLULAR_MATRIX_PART	51	4	0.0359648766807737220000000
TCGA-61-2092-01.12	209	2_CELL_DEVELOPMENT	511	27	0.0359771961238827400000000
TCGA-13-0906-01.5	66	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0360086931971543570000000
TCGA-13-1510-01.20	82	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0360086931971543570000000
TCGA-13-0760-01.12	93	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	5	0.0360255261646989440000000
TCGA-30-1862-01.13	91	2_ORGAN_MORPHOGENESIS	122	8	0.0360289524888820490000000
TCGA-57-1583-01.20	185	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	28	0.0360533855121334120000000
TCGA-23-2079-01.14	85	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0360568581273197490000000
TCGA-24-1614-01.5	86	2_KINASE_BINDING	63	6	0.0361547499231051410000000
TCGA-57-1582-01.26	174	2_AGING	10	4	0.0361738249966260940000000
TCGA-24-1549-01.21	158	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0361804609637620190000000
TCGA-23-1031-01.17	142	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	18	0.0361972430141735690000000
TCGA-24-2262-01.25	141	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0362368439545619480000000
TCGA-24-1471-01.4	49	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0362531161656280620000000
TCGA-23-1117-01.11	99	2_PATTERN_BINDING	33	5	0.0362704997016826470000000
TCGA-25-2399-01.16	103	2_EXTRACELLULAR_REGION	346	14	0.0362775954537609200000000
TCGA-24-2293-01.1	22	2_KINETOCHORE	24	3	0.0363177873470239070000000
TCGA-24-2293-01.1	22	2_MOTOR_ACTIVITY	24	3	0.0363177873470239070000000
TCGA-13-0919-01.5	50	2_ORGAN_DEVELOPMENT	460	11	0.0363383955376278130000000
TCGA-13-0920-01.9	82	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0363526006845447670000000
TCGA-24-1434-01.3	82	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0363526006845447670000000
TCGA-13-0886-01.1	45	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	5	0.0363770618874641530000000
TCGA-04-1364-01.3	163	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0364249912649053580000000
TCGA-04-1364-01.3	163	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0364249912649053580000000
TCGA-13-0807-01.8	46	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	7	0.0364253862351867420000000
TCGA-25-2404-01.5	58	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	7	0.0365047846075965340000000
TCGA-09-0369-01.9	109	2_STRUCTURE_SPECIFIC_DNA_BINDING	50	6	0.0365051678687964430000000
TCGA-59-2363-01.3	89	0_HALLMARK_DNA_REPAIR	125	8	0.0365194886663005520000000
TCGA-13-1497-01.7	59	2_MEIOTIC_CELL_CYCLE	27	4	0.0365453465675084630000000
TCGA-24-1425-01.1	61	0_HALLMARK_ADIPOGENESIS	133	7	0.0366219888858993970000000
TCGA-13-0714-01.9	51	2_REGULATION_OF_CELL_CYCLE	160	7	0.0366506423503783480000000
TCGA-24-1616-01.2	38	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	6	0.0366670150676522350000000
TCGA-24-1616-01.2	38	2_DNA_METABOLIC_PROCESS	218	7	0.0366890220040178430000000
TCGA-24-1552-01.5	54	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	5	0.0367080818747022450000000
TCGA-23-1122-01.11	77	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0367575968837064800000000
TCGA-13-0912-01.2	55	2_AGING	10	3	0.0367829782050281550000000
TCGA-25-2391-01.2	64	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0367893603088261730000000
TCGA-13-0720-01.5	32	0_HALLMARK_G2M_CHECKPOINT	174	6	0.0368297843687730160000000
TCGA-25-1628-01.2	118	2_POLYSACCHARIDE_BINDING	28	5	0.0368430241087347180000000
TCGA-09-1666-01.25	3	2_PATTERN_SPECIFICATION_PROCESS	26	2	0.0368596551300117080000000
TCGA-23-1124-01.17	107	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0368804442137501200000000
TCGA-13-0920-01.9	82	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0368863115072526340000000
TCGA-24-1466-01.15	82	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0368863115072526340000000
TCGA-13-0903-01.11	77	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0369051955859544600000000
TCGA-13-0765-01.4	54	0_HALLMARK_P53_PATHWAY	151	7	0.0369675288105156260000000
TCGA-09-1665-01.16	131	1_KEGG_GLIOMA	62	7	0.0369825135803019960000000
TCGA-13-0899-01.1	28	2_DNA_INTEGRITY_CHECKPOINT	19	3	0.0369845865525921730000000
TCGA-25-1634-01.4	75	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	9	0.0369964818360462020000000
TCGA-24-1555-01.3	10	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	4	0.0370009650442499270000000
TCGA-23-1028-01.18	93	2_REGULATION_OF_MOLECULAR_FUNCTION	286	12	0.0370519675570813170000000
TCGA-04-1525-01.7	52	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0370960567176352240000000
TCGA-23-1028-01.18	93	1_KEGG_PROSTATE_CANCER	87	7	0.0371092829234007660000000
TCGA-13-1488-01.17	109	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0371528021756706290000000
TCGA-13-0905-01.7	160	1_KEGG_PANCREATIC_CANCER	70	8	0.0371679656960253390000000
TCGA-25-2042-01.3	63	2_PEPTIDASE_ACTIVITY	129	7	0.0372213633889035620000000
TCGA-23-1030-01.10	58	2_M_PHASE	94	6	0.0372426031030402280000000
TCGA-13-0916-01.11	92	0_HALLMARK_SPERMATOGENESIS	88	7	0.0372644835170359500000000
TCGA-24-1105-01.8	52	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0372838713236208490000000
TCGA-57-1993-01.8	52	2_REGULATION_OF_MOLECULAR_FUNCTION	286	9	0.0372838713236208490000000
TCGA-13-1492-01.2	162	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	17	0.0372881550701189700000000
TCGA-09-1665-01.16	131	1_KEGG_BLADDER_CANCER	42	6	0.0372898992720676610000000
TCGA-25-2409-01.5	29	1_KEGG_CELL_CYCLE	114	5	0.0372986481006267470000000
TCGA-23-1026-01.5	65	0_HALLMARK_COAGULATION	125	7	0.0373272898236609310000000
TCGA-10-0930-01.6	9	2_CELL_PROLIFERATION_GO_0008283	436	5	0.0373421319394064980000000
TCGA-24-1558-01.12	174	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0373518580247289220000000
TCGA-23-1022-01.10	170	2_CONTRACTILE_FIBER_PART	20	5	0.0374312032262192480000000
TCGA-61-2088-01.7	150	0_HALLMARK_IL2_STAT5_SIGNALING	148	11	0.0374627326720843940000000
TCGA-20-0990-01.17	133	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0374654746148279370000000
TCGA-61-1998-01.9	5	1_KEGG_TIGHT_JUNCTION	125	3	0.0374790489256328770000000
TCGA-23-2078-01.17	5	1_KEGG_TIGHT_JUNCTION	125	3	0.0374790489256328770000000
TCGA-10-0930-01.3	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508260000000
TCGA-57-1993-01.8	52	2_DNA_METABOLIC_PROCESS	218	8	0.0374947149722011170000000
TCGA-24-1463-01.5	130	2_KINESIN_COMPLEX	13	4	0.0375642100522800210000000
TCGA-24-1463-01.5	130	2_SISTER_CHROMATID_SEGREGATION	13	4	0.0375642100522800210000000
TCGA-24-2271-01.3	44	0_HALLMARK_COAGULATION	125	6	0.0375897049054768690000000
TCGA-36-1575-01.9	193	2_INTRINSIC_TO_MEMBRANE	966	39	0.0376178229221721740000000
TCGA-23-1116-01.7	84	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0376743421186779140000000
TCGA-24-2030-01.8	161	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0376904687348221870000000
TCGA-24-1416-01.4	38	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0377168087823611180000000
TCGA-61-2101-01.2	38	1_KEGG_BLADDER_CANCER	42	4	0.0377168087823611180000000
TCGA-13-2060-01.10	86	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0377675453232514740000000
TCGA-13-0919-01.5	50	0_HALLMARK_ANGIOGENESIS	32	4	0.0378181414297504920000000
TCGA-61-2016-01.10	50	0_HALLMARK_ANGIOGENESIS	32	4	0.0378181414297504920000000
TCGA-24-1549-01.21	158	2_REGULATION_OF_MOLECULAR_FUNCTION	286	16	0.0378535449375516230000000
TCGA-36-1570-01.2	36	2_MITOCHONDRIAL_TRANSPORT	15	3	0.0378615399856587000000000
TCGA-10-0933-01.2	97	2_SPINDLE_POLE	17	4	0.0379041112923226290000000
TCGA-23-1022-01.10	170	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	9	0.0379061604668355850000000
TCGA-13-0804-01.5	78	1_KEGG_PANCREATIC_CANCER	70	6	0.0379509609778857370000000
TCGA-61-2012-01.6	78	1_KEGG_PANCREATIC_CANCER	70	6	0.0379509609778857370000000
TCGA-25-2398-01.5	81	2_RECEPTOR_BINDING	331	12	0.0380575460360302460000000
TCGA-13-0887-01.6	47	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	8	0.0380867579016463540000000
TCGA-13-1512-01.2	113	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0380967786344008140000000
TCGA-24-2262-01.25	141	2_REGULATION_OF_MOLECULAR_FUNCTION	286	15	0.0381051380925282800000000
TCGA-24-1567-01.3	141	2_REGULATION_OF_MOLECULAR_FUNCTION	286	15	0.0381051380925282800000000
TCGA-10-0937-01.9	40	2_DNA_RECOMBINATION	40	4	0.0381148518362490820000000
TCGA-25-1628-01.2	118	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	7	0.0381159738170452690000000
TCGA-24-1553-01.7	26	1_KEGG_COLORECTAL_CANCER	62	4	0.0381214758035259420000000
TCGA-13-1482-01.7	62	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0381214758035259420000000
TCGA-25-1625-01.6	38	2_CELL_CYCLE_PHASE	146	6	0.0381269355935530200000000
TCGA-25-2401-01.5	119	2_M_PHASE	94	8	0.0381332474878682270000000
TCGA-61-2012-01.6	78	1_KEGG_BLADDER_CANCER	42	5	0.0381443332177796160000000
TCGA-24-1466-01.15	82	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0381539788639522410000000
TCGA-13-1510-01.20	82	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0381539788639522410000000
TCGA-13-1510-01.20	82	2_CHEMOKINE_ACTIVITY	40	5	0.0381539788639522410000000
TCGA-24-2030-01.8	161	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0381597500670336760000000
TCGA-61-2092-01.12	209	2_CELL_CYCLE_GO_0007049	265	18	0.0382238082800492670000000
TCGA-24-1548-01.8	141	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0382298767033390770000000
TCGA-04-1542-01.4	141	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	58	7	0.0382298767033390770000000
TCGA-25-2396-01.6	42	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0382825776720029580000000
TCGA-09-1659-01.5	51	2_CYTOSKELETON	293	9	0.0383690998676217000000000
TCGA-13-1495-01.13	5	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0383870190988687060000000
TCGA-13-0920-01.9	82	2_INTRACELLULAR_ORGANELLE_PART	912	21	0.0383906587212927770000000
TCGA-13-1409-01.6	122	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0383942849371960510000000
TCGA-09-0366-01.5	32	2_SIGNAL_TRANSDUCTION	1442	15	0.0384360950609300210000000
TCGA-13-1483-01.3	66	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0386035930016442870000000
TCGA-13-1484-01.4	70	2_CELL_CYCLE_GO_0007049	265	10	0.0386659215528803520000000
TCGA-24-1556-01.19	120	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0387108799172127470000000
TCGA-23-2077-01.18	63	1_KEGG_ENDOMETRIAL_CANCER	52	5	0.0387177942573288870000000
TCGA-23-2077-01.18	63	2_REGULATION_OF_BODY_FLUID_LEVELS	52	5	0.0387177942573288870000000
TCGA-13-0897-01.2	61	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0387544892356942940000000
TCGA-24-2298-01.6	4	2_MITOCHONDRIAL_RESPIRATORY_CHAIN	19	2	0.0387603363653092480000000
TCGA-25-1634-01.4	75	0_HALLMARK_APOPTOSIS	150	8	0.0388398274309619750000000
TCGA-61-2111-01.16	56	2_AGING	10	3	0.0388433771246084260000000
TCGA-24-1422-01.10	56	2_AGING	10	3	0.0388433771246084260000000
TCGA-23-1022-01.10	170	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	20	0.0388486160186548720000000
TCGA-29-2427-01.10	116	2_CHEMICAL_HOMEOSTASIS	126	9	0.0388526547076666270000000
TCGA-24-2280-01.10	58	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0388682100514380140000000
TCGA-24-1557-01.13	106	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0389671262717228300000000
TCGA-61-2009-01.1	46	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0389721394509080220000000
TCGA-61-2092-01.12	209	0_HALLMARK_IL2_STAT5_SIGNALING	148	13	0.0390145794373783290000000
TCGA-24-2288-01.12	112	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0390351055496604910000000
TCGA-13-1405-01.4	69	2_ORGAN_DEVELOPMENT	460	13	0.0390513082916128310000000
TCGA-13-1409-01.6	122	2_ORGAN_DEVELOPMENT	460	18	0.0390561108514701150000000
TCGA-13-1505-01.13	60	2_MEIOTIC_CELL_CYCLE	27	4	0.0390794178115503600000000
TCGA-13-0791-01.35	80	2_CHROMOSOME	102	7	0.0391241471596968370000000
TCGA-30-1862-01.13	91	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	13	0.0391373525808263800000000
TCGA-24-0979-01.5	41	2_BIOPOLYMER_METABOLIC_PROCESS	1367	17	0.0391821341532130050000000
TCGA-13-1495-01.22	101	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0391922461142016270000000
TCGA-61-1998-01.14	105	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0392525669920328610000000
TCGA-13-0913-01.5	44	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	9	0.0392674193486076610000000
TCGA-61-2113-01.15	99	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0392719968393075090000000
TCGA-13-0923-01.5	53	2_INTERPHASE	62	5	0.0393233362533651350000000
TCGA-13-1411-01.7	96	2_MICROTUBULE_CYTOSKELETON	117	8	0.0393285697996088870000000
TCGA-13-0911-01.3	47	1_KEGG_PANCREATIC_CANCER	70	5	0.0393338188257138720000000
TCGA-24-1416-01.4	38	1_KEGG_PROSTATE_CANCER	87	5	0.0393741130655464460000000
TCGA-13-0916-01.11	92	2_REGULATION_OF_MITOSIS	36	5	0.0393885466368751740000000
TCGA-13-0912-01.2	55	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	8	0.0394035829469047070000000
TCGA-24-2262-01.25	141	1_KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	24	5	0.0394131879809178980000000
TCGA-20-0990-01.17	133	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0394927181769386750000000
TCGA-24-1552-01.5	54	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	4	0.0395369550407335540000000
TCGA-24-2261-01.2	87	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	4	0.0395372246175941660000000
TCGA-09-2050-01.18	196	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0396050791331492570000000
TCGA-13-0792-01.8	64	1_KEGG_ERBB_SIGNALING_PATHWAY	86	6	0.0396062790794132830000000
TCGA-13-1509-01.9	117	1_KEGG_PANCREATIC_CANCER	70	7	0.0396624062948363890000000
TCGA-13-1404-01.13	117	1_KEGG_PANCREATIC_CANCER	70	7	0.0396624062948363890000000
TCGA-09-2044-01.4	83	2_BIOPOLYMER_METABOLIC_PROCESS	1367	27	0.0396927615833805940000000
TCGA-61-2092-01.12	209	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0397228472626289170000000
TCGA-13-1499-01.1	22	2_CELL_CYCLE_GO_0007049	265	6	0.0397439704624228120000000
TCGA-10-0931-01.12	59	2_APOPTOSIS_GO	389	11	0.0398017938743132770000000
TCGA-24-1436-01.1	49	2_DNA_REPAIR	113	6	0.0398288497011568400000000
TCGA-10-0935-01.2	49	2_DNA_REPAIR	113	6	0.0398288497011568400000000
TCGA-10-0935-01.2	49	0_HALLMARK_E2F_TARGETS	169	7	0.0398991185298497170000000
TCGA-09-1665-01.16	131	1_KEGG_ERBB_SIGNALING_PATHWAY	86	8	0.0399058485206932740000000
TCGA-13-0886-01.1	45	2_REGULATION_OF_MITOSIS	36	4	0.0399973209703961970000000
TCGA-24-0979-01.5	41	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	6	0.0400063381288133100000000
TCGA-13-0726-01.12	78	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0400163965720893230000000
TCGA-09-2051-01.26	142	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0400217663553223830000000
TCGA-13-0919-01.5	50	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0400650563114578610000000
TCGA-61-2016-01.10	50	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0400650563114578610000000
TCGA-04-1343-01.7	50	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0400650563114578610000000
TCGA-61-2094-01.6	63	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	19	0.0400988160804577610000000
TCGA-24-2271-01.3	44	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0402937048782426170000000
TCGA-36-1568-01.22	80	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	6	0.0403957979171419570000000
TCGA-24-1436-01.1	49	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	12	0.0404391774727416440000000
TCGA-13-0730-01.8	83	2_DNA_RECOMBINATION	40	5	0.0404743550227065690000000
TCGA-24-1427-01.4	83	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0404743550227065690000000
TCGA-24-1474-01.12	122	2_MICROTUBULE_MOTOR_ACTIVITY	14	4	0.0405085993617142830000000
TCGA-13-1496-01.13	120	2_M_PHASE	94	8	0.0405268074586526210000000
TCGA-23-1120-01.10	57	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0405564569040093440000000
TCGA-25-1632-01.11	116	1_KEGG_THYROID_CANCER	29	5	0.0405775679675632050000000
TCGA-13-1487-01.3	79	1_KEGG_BLADDER_CANCER	42	5	0.0405887484043021340000000
TCGA-04-1338-01.7	85	2_RESPONSE_TO_STRESS	427	14	0.0405950345534223720000000
TCGA-13-0804-01.5	78	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	8	0.0405954727555050130000000
TCGA-25-1627-01.4	75	2_DNA_DEPENDENT_ATPASE_ACTIVITY	22	4	0.0406325603286582790000000
TCGA-25-2396-01.6	42	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	6	0.0406435766075259470000000
TCGA-13-0913-01.5	44	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	8	0.0406922126218312240000000
TCGA-25-2393-01.5	140	2_REGULATION_OF_CELL_CYCLE	160	11	0.0407005153378767330000000
TCGA-13-0905-01.7	160	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0407005153378767400000000
TCGA-25-1634-01.4	75	0_HALLMARK_P53_PATHWAY	151	8	0.0407536479541871710000000
TCGA-13-0761-01.6	75	0_HALLMARK_P53_PATHWAY	151	8	0.0407536479541871710000000
TCGA-10-0931-01.12	59	2_PROGRAMMED_CELL_DEATH	390	11	0.0407616650793761190000000
TCGA-20-0990-01.17	133	1_KEGG_COLORECTAL_CANCER	62	7	0.0408036410910208110000000
TCGA-20-0990-01.17	133	2_EXTRACELLULAR_MATRIX	85	8	0.0408736890777503110000000
TCGA-13-0730-01.8	83	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	9	0.0409507940283952430000000
TCGA-23-1026-01.5	65	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0410006288962179510000000
TCGA-13-0920-01.9	82	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0410071114150016150000000
TCGA-24-1466-01.15	82	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0410071114150016150000000
TCGA-13-0920-01.9	82	2_ORGANELLE_PART	916	21	0.0410162050779597150000000
TCGA-10-0935-01.2	49	2_APOPTOSIS_GO	389	10	0.0410414125233538730000000
TCGA-59-2352-01.5	34	2_SEQUENCE_SPECIFIC_DNA_BINDING	48	4	0.0410962826547597170000000
TCGA-13-0889-01.4	37	2_MITOCHONDRIAL_TRANSPORT	15	3	0.0411629762761719710000000
TCGA-04-1356-01.1	71	2_CHROMOSOMAL_PART	78	6	0.0411840708554659170000000
TCGA-24-2019-01.10	192	2_MICROTUBULE_CYTOSKELETON	117	11	0.0411876636290715580000000
TCGA-13-1499-01.1	22	2_CASPASE_ACTIVATION	25	3	0.0412079689059826610000000
TCGA-25-1633-01.1	71	2_REGULATION_OF_CELL_CYCLE	160	8	0.0412919909427273970000000
TCGA-13-0714-01.9	51	2_CELL_CYCLE_PROCESS	163	7	0.0413322736118436060000000
TCGA-13-1483-01.3	66	2_SKELETAL_DEVELOPMENT	84	6	0.0413471417339726370000000
TCGA-30-1891-01.4	84	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0413471417339731850000000
TCGA-09-2051-01.26	142	2_REGULATION_OF_MOLECULAR_FUNCTION	286	15	0.0414633780756326480000000
TCGA-13-1483-01.3	66	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0415824728347273310000000
TCGA-13-1409-01.6	122	2_INTEGRAL_TO_MEMBRANE	956	28	0.0417158036297096760000000
TCGA-09-1665-01.16	131	2_CONDENSED_CHROMOSOME	26	5	0.0417659746161445080000000
TCGA-59-2348-01.14	123	2_MICROTUBULE_MOTOR_ACTIVITY	14	4	0.0418345449775935910000000
TCGA-25-2398-01.5	81	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	9	0.0418502537493411420000000
TCGA-24-1603-01.3	69	2_KINETOCHORE	24	4	0.0419042232441097580000000
TCGA-13-0894-01.9	118	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0419176203249487720000000
TCGA-13-0923-01.5	53	2_REGULATION_OF_CELL_GROWTH	31	4	0.0419500464708244120000000
TCGA-13-0884-01.11	68	2_CELL_CYCLE_ARREST_GO_0007050	49	5	0.0419587621177783740000000
TCGA-23-1027-01.8	68	2_CELL_CYCLE_ARREST_GO_0007050	49	5	0.0419587621177783740000000
TCGA-10-0935-01.2	49	2_PROGRAMMED_CELL_DEATH	390	10	0.0419594902110690120000000
TCGA-09-2050-01.18	196	1_KEGG_MAPK_SIGNALING_PATHWAY	258	17	0.0419972212185254210000000
TCGA-10-0937-01.9	40	0_HALLMARK_WNT_BETA_CATENIN_SIGNALING	41	4	0.0421067696258996880000000
TCGA-24-0979-01.5	41	2_DNA_RECOMBINATION	40	4	0.0421067696258996880000000
TCGA-61-2002-01.1	118	2_CELL_CYCLE_GO_0007049	265	13	0.0421174890402531560000000
TCGA-13-0916-01.11	92	2_CYTOSKELETON	293	12	0.0421535046953020740000000
TCGA-25-1626-01.2	86	2_METALLOPEPTIDASE_ACTIVITY	39	5	0.0423891857047723610000000
TCGA-13-0762-01.2	68	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	14	0.0423959223861527720000000
TCGA-23-1027-01.8	68	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	14	0.0423959223861527720000000
TCGA-24-1548-01.8	141	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0424258878229750590000000
TCGA-13-0911-01.3	47	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0424857039874941350000000
TCGA-13-0887-01.6	47	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0424857039874941350000000
TCGA-24-1474-01.12	122	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0425263540042306180000000
TCGA-09-2056-01.6	63	2_CELL_DEVELOPMENT	511	13	0.0425289357486075550000000
TCGA-24-1423-01.5	27	1_KEGG_PATHWAYS_IN_CANCER	323	7	0.0425311094111926950000000
TCGA-24-1426-01.7	63	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	5	0.0425327088323615780000000
TCGA-36-1578-01.10	60	2_ANATOMICAL_STRUCTURE_MORPHOGENESIS	315	10	0.0426233548076427950000000
TCGA-25-2400-01.5	35	2_BASE_EXCISION_REPAIR	16	3	0.0426478195790247410000000
TCGA-13-0903-01.11	77	2_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0426574203685343230000000
TCGA-13-0903-01.11	77	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0426574203685343230000000
TCGA-24-1431-01.3	57	2_CELL_CYCLE_PHASE	146	7	0.0426633133498247260000000
TCGA-24-1431-01.3	57	1_KEGG_THYROID_CANCER	29	4	0.0427079545673176780000000
TCGA-13-0900-01.8	90	2_INTERPHASE	62	6	0.0427554789032944530000000
TCGA-13-0924-01.5	68	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0427836568980007260000000
TCGA-04-1514-01.6	91	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0428596936426507290000000
TCGA-24-1567-01.3	141	1_KEGG_OOCYTE_MEIOSIS	105	9	0.0428668786697324190000000
TCGA-24-1544-01.7	84	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0429031075061356080000000
TCGA-20-0987-01.19	194	2_BEHAVIOR	138	12	0.0429083608719901670000000
TCGA-23-1021-01.7	44	2_CELL_CYCLE_GO_0007049	265	8	0.0429736000811412610000000
TCGA-13-0913-01.5	44	2_REGULATION_OF_CELL_PROLIFERATION	265	8	0.0429736000811412610000000
TCGA-13-0885-01.6	44	2_REGULATION_OF_CELL_PROLIFERATION	265	8	0.0429736000811412610000000
TCGA-23-1122-01.11	77	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	10	0.0429815295745928780000000
TCGA-30-1862-01.13	91	0_HALLMARK_COAGULATION	125	8	0.0429872119097599380000000
TCGA-10-0930-01.5	60	2_ORGAN_DEVELOPMENT	460	12	0.0429887525925279760000000
TCGA-57-1583-01.20	185	1_KEGG_COLORECTAL_CANCER	62	8	0.0429977834573892350000000
TCGA-13-0890-01.2	48	2_MICROTUBULE_CYTOSKELETON	117	6	0.0430255038808756360000000
TCGA-04-1367-01.3	74	2_REGULATION_OF_APOPTOSIS	309	11	0.0430342713391101000000000
TCGA-13-1482-01.7	62	2_APOPTOTIC_PROGRAM	54	5	0.0431185462967767910000000
TCGA-24-2030-01.8	161	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0431383030665710500000000
TCGA-13-1507-01.8	101	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0431466608372673910000000
TCGA-04-1338-01.7	85	2_MITOTIC_CELL_CYCLE	134	8	0.0431538757051569200000000
TCGA-24-0979-01.5	41	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	5	0.0431590164266232590000000
TCGA-13-1510-01.20	82	2_CHEMOKINE_RECEPTOR_BINDING	41	5	0.0431590164266232590000000
TCGA-25-2404-01.5	58	2_AGING	10	3	0.0431896033186870350000000
TCGA-24-2030-01.8	161	1_KEGG_MELANOMA	71	8	0.0431927733395517380000000
TCGA-04-1530-01.2	90	2_CATION_BINDING	165	9	0.0432143986291221240000000
TCGA-25-2391-01.2	64	2_CONDENSED_CHROMOSOME	26	4	0.0432579457063312080000000
TCGA-24-0979-01.5	41	2_REGULATION_OF_MOLECULAR_FUNCTION	286	8	0.0432655508327803510000000
TCGA-31-1953-01.6	53	2_DNA_METABOLIC_PROCESS	218	8	0.0432940528416005320000000
TCGA-23-2079-01.14	85	0_HALLMARK_MITOTIC_SPINDLE	175	9	0.0434082092292083430000000
TCGA-09-1665-01.16	131	1_KEGG_PROSTATE_CANCER	87	8	0.0434405328884209030000000
TCGA-24-0979-01.5	41	2_REGULATION_OF_KINASE_ACTIVITY	138	6	0.0434621238991096810000000
TCGA-23-1116-01.7	84	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0434728486492918720000000
TCGA-24-1418-01.16	84	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0434728486492918720000000
TCGA-13-0890-01.2	48	0_HALLMARK_MITOTIC_SPINDLE	175	7	0.0435042849660947570000000
TCGA-25-1630-01.10	35	2_CELL_CYCLE_PROCESS	163	6	0.0435873966678595040000000
TCGA-04-1364-01.3	163	1_KEGG_PRIMARY_IMMUNODEFICIENCY	35	6	0.0435873966678595040000000
TCGA-61-2008-01.19	70	2_SEQUENCE_SPECIFIC_DNA_BINDING	48	5	0.0436564978482496470000000
TCGA-13-0807-01.8	46	2_REGULATION_OF_MITOSIS	36	4	0.0436879744405465060000000
TCGA-24-1557-01.13	106	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0437084813265087020000000
TCGA-24-2024-01.3	55	2_ION_BINDING	210	8	0.0437087833514523820000000
TCGA-13-1477-01.2	13	2_REGULATION_OF_MOLECULAR_FUNCTION	286	5	0.0437266836912025700000000
TCGA-13-1407-01.11	220	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	30	0.0438111395113525360000000
TCGA-13-1407-01.11	220	1_KEGG_APOPTOSIS	85	10	0.0439233278439577280000000
TCGA-36-1576-01.8	124	2_TRANSITION_METAL_ION_BINDING	92	8	0.0439317492642731030000000
TCGA-25-2392-01.4	60	2_EXTRACELLULAR_SPACE	192	8	0.0439936405481620510000000
TCGA-24-1544-01.7	84	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0440424601634705270000000
TCGA-13-0913-01.5	44	2_MEIOTIC_RECOMBINATION	13	3	0.0440948231906381700000000
TCGA-59-2354-01.2	44	2_COLLAGEN_BINDING	13	3	0.0440948231906381700000000
TCGA-23-1031-01.17	142	2_DNA_RECOMBINATION	40	6	0.0441604410118165360000000
TCGA-25-1316-01.2	73	1_KEGG_CELL_CYCLE	114	7	0.0441834775073852580000000
TCGA-24-0979-01.5	41	2_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0442292969122005250000000
TCGA-24-0979-01.5	41	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0442292969122005250000000
TCGA-36-1568-01.22	80	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	8	0.0442416558774304660000000
TCGA-36-1576-01.8	124	0_HALLMARK_APOPTOSIS	150	10	0.0442447069274193930000000
TCGA-59-2350-01.1	62	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0443322753891923490000000
TCGA-04-1367-01.3	74	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	11	0.0443405527207825290000000
TCGA-04-1361-01.4	27	1_KEGG_COLORECTAL_CANCER	62	4	0.0445320107214870750000000
TCGA-59-2350-01.1	62	2_MEIOTIC_CELL_CYCLE	27	4	0.0445320107214870750000000
TCGA-24-1464-01.5	2	2_MITOCHONDRIAL_INNER_MEMBRANE	49	2	0.0445338479563702760000000
TCGA-04-1347-01.7	2	2_REGULATION_OF_CELL_DIFFERENTIATION	49	2	0.0445338479563702760000000
TCGA-10-0937-01.2	2	2_MITOCHONDRIAL_INNER_MEMBRANE	49	2	0.0445338479563702760000000
TCGA-23-2078-01.8	2	2_MITOCHONDRIAL_INNER_MEMBRANE	49	2	0.0445338479563702760000000
TCGA-24-1466-01.11	2	2_MITOCHONDRIAL_INNER_MEMBRANE	49	2	0.0445338479563702760000000
TCGA-24-1556-01.17	2	2_REGULATION_OF_CELL_DIFFERENTIATION	49	2	0.0445338479563702760000000
TCGA-20-0990-01.17	133	1_KEGG_ERBB_SIGNALING_PATHWAY	86	8	0.0445381844081424870000000
TCGA-13-1489-01.11	118	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0445581317983772680000000
TCGA-61-2092-01.12	209	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	17	0.0445991385387651330000000
TCGA-25-1628-01.2	118	2_EXTRACELLULAR_SPACE	192	11	0.0446273564740583690000000
TCGA-24-0982-01.3	34	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0446356640859985610000000
TCGA-20-0990-01.17	133	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0447504738220565950000000
TCGA-23-1118-01.5	50	2_DNA_REPAIR	113	6	0.0448227256500713450000000
TCGA-25-1632-01.11	116	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0448338631447635290000000
TCGA-23-1028-01.18	93	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	8	0.0448347997320730770000000
TCGA-13-1477-01.2	13	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0448802122845950520000000
TCGA-24-1413-01.6	34	0_HALLMARK_E2F_TARGETS	169	6	0.0449636042431089260000000
TCGA-13-2060-01.10	86	2_DNA_METABOLIC_PROCESS	218	10	0.0450284761872923110000000
TCGA-24-0975-01.6	78	2_EXTRACELLULAR_SPACE	192	9	0.0450528780962984180000000
TCGA-24-2288-01.12	112	2_ORGAN_DEVELOPMENT	460	17	0.0451402398258511080000000
TCGA-61-2088-01.7	150	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	7	0.0451549891098207630000000
TCGA-13-1492-01.2	162	2_MITOSIS	71	8	0.0451664745399152290000000
TCGA-25-2391-01.2	64	0_HALLMARK_SPERMATOGENESIS	88	6	0.0451741988969724670000000
TCGA-25-1627-01.4	75	2_RESPONSE_TO_STRESS	427	13	0.0451760964653823150000000
TCGA-20-0990-01.17	133	2_EXTRACELLULAR_REGION	346	16	0.0452575554468199120000000
TCGA-24-2289-01.6	53	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	15	0.0453002149337387510000000
TCGA-10-0931-01.12	59	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0454026431995561000000000
TCGA-04-1338-01.7	85	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0454437657199110720000000
TCGA-36-1575-01.9	193	2_CYTOKINE_BINDING	44	7	0.0454553565395460980000000
TCGA-13-1497-01.7	59	2_AGING	10	3	0.0454779730206474050000000
TCGA-13-0920-01.9	82	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0455076359355763290000000
TCGA-24-1466-01.15	82	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0455076359355763290000000
TCGA-24-1549-01.21	158	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0455581098709805720000000
TCGA-10-0934-01.11	145	2_RESPONSE_TO_STRESS	427	19	0.0455591265167319330000000
TCGA-24-1558-01.12	174	2_LOCOMOTORY_BEHAVIOR	86	9	0.0456007945805938860000000
TCGA-13-0890-01.2	48	2_INTRACELLULAR_ORGANELLE_PART	912	15	0.0457301061265118910000000
TCGA-24-0979-01.5	41	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0457797573209215090000000
TCGA-13-0717-01.6	103	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	9	0.0458927985159566720000000
TCGA-09-1666-01.28	109	1_KEGG_ENDOMETRIAL_CANCER	52	6	0.0459027997238680500000000
TCGA-59-2355-01.2	14	2_CELL_CYCLE_GO_0007049	265	5	0.0459564986004090750000000
TCGA-24-1555-01.1	14	2_CELL_CYCLE_GO_0007049	265	5	0.0459564986004090750000000
TCGA-10-0938-01.2	102	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	7	0.0460046461317018050000000
TCGA-13-1494-01.4	65	2_GLYCOSAMINOGLYCAN_BINDING	26	4	0.0460085838849794500000000
TCGA-36-1580-01.1	65	2_GLYCOSAMINOGLYCAN_BINDING	26	4	0.0460085838849794500000000
TCGA-61-2002-01.1	118	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	7	0.0460264556196738550000000
TCGA-25-1324-01.3	42	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	6	0.0461264774068807990000000
TCGA-13-1495-01.22	101	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0461364994119350530000000
TCGA-24-1616-01.2	38	0_HALLMARK_P53_PATHWAY	151	6	0.0461475427248320480000000
TCGA-24-1552-01.5	54	1_KEGG_OOCYTE_MEIOSIS	105	6	0.0462227196937394430000000
TCGA-13-0890-01.2	48	2_MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS	35	4	0.0462264537294629350000000
TCGA-13-1510-01.20	82	1_KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	9	0.0462351910420907770000000
TCGA-04-1365-01.6	150	2_CONDENSED_NUCLEAR_CHROMOSOME	12	4	0.0462480914161413490000000
TCGA-04-1365-01.6	150	2_MITOTIC_SISTER_CHROMATID_SEGREGATION	12	4	0.0462480914161413490000000
TCGA-61-2088-01.7	150	2_MAP_KINASE_ACTIVITY	12	4	0.0462480914161413490000000
TCGA-13-1494-01.4	65	1_KEGG_PROSTATE_CANCER	87	6	0.0462784755818818200000000
TCGA-23-1124-01.17	107	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0463099637578670150000000
TCGA-25-1318-01.11	46	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	14	0.0463326153486982310000000
TCGA-09-0369-01.9	109	2_BASE_EXCISION_REPAIR	16	4	0.0463369044660466720000000
TCGA-23-2072-01.9	74	2_COLLAGEN	23	4	0.0463589992214815320000000
TCGA-13-1509-01.9	117	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0463774106265413610000000
TCGA-10-0931-01.12	59	2_RESPONSE_TO_BIOTIC_STIMULUS	96	6	0.0463795230010840830000000
TCGA-10-0937-01.9	40	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0463973559358683980000000
TCGA-23-1031-01.17	142	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0464515831264284900000000
TCGA-04-1347-01.15	187	1_KEGG_GLIOMA	62	8	0.0464601000517206390000000
TCGA-24-2293-01.1	22	2_CONDENSED_CHROMOSOME	26	3	0.0465126659447310520000000
TCGA-24-2293-01.1	22	2_CHROMOSOME_SEGREGATION	26	3	0.0465126659447310520000000
TCGA-61-2000-01.11	69	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	6	0.0465362008669551320000000
TCGA-04-1517-01.4	44	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	11	0.0466092369143121800000000
TCGA-13-0885-01.6	44	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	11	0.0466092369143121800000000
TCGA-13-1507-01.8	101	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0467118952685977790000000
TCGA-31-1959-01.7	101	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0467118952685977790000000
TCGA-13-1501-01.12	101	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0467118952685977790000000
TCGA-61-2092-01.12	209	2_EXTRACELLULAR_REGION_PART	269	18	0.0467141578792222010000000
TCGA-24-1563-01.15	100	2_TISSUE_DEVELOPMENT	115	8	0.0467494434352772600000000
TCGA-13-0884-01.11	68	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0468193929630172370000000
TCGA-13-1487-01.3	79	2_CELL_CYCLE_PHASE	146	8	0.0468597473572402930000000
TCGA-13-1491-01.7	90	1_KEGG_PPAR_SIGNALING_PATHWAY	63	6	0.0468972332662360090000000
TCGA-61-2110-01.3	37	1_KEGG_PATHWAYS_IN_CANCER	323	8	0.0469073411002343680000000
TCGA-13-0889-01.4	37	1_KEGG_PATHWAYS_IN_CANCER	323	8	0.0469073411002343680000000
TCGA-04-1356-01.1	71	2_KINETOCHORE	24	4	0.0469376215636570570000000
TCGA-24-1548-01.8	141	2_NUCLEUS	1110	34	0.0469532341267255220000000
TCGA-04-1348-01.6	81	1_KEGG_PANCREATIC_CANCER	70	6	0.0471234586552133140000000
TCGA-09-1669-01.10	81	1_KEGG_PANCREATIC_CANCER	70	6	0.0471234586552133140000000
TCGA-25-2398-01.5	81	1_KEGG_PANCREATIC_CANCER	70	6	0.0471234586552133140000000
TCGA-13-0919-01.5	50	1_KEGG_CELL_CYCLE	114	6	0.0471238078695843530000000
TCGA-24-1424-01.4	80	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	22	0.0471349173903249930000000
TCGA-24-0979-01.5	41	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	6	0.0471546968812984750000000
TCGA-13-0912-01.2	55	1_KEGG_GLIOMA	62	5	0.0471925026805698270000000
TCGA-13-0883-01.3	23	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	3	0.0473064289341581860000000
TCGA-24-2298-01.7	138	2_CATION_BINDING	165	11	0.0473892593123139000000000
TCGA-13-1477-01.2	13	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0475368859127874990000000
TCGA-36-1569-01.2	8	2_AGING	10	2	0.0475534190944951330000000
TCGA-24-1548-01.8	141	1_KEGG_INSULIN_SIGNALING_PATHWAY	133	10	0.0475971704667177280000000
TCGA-04-1542-01.4	141	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	10	0.0475971704667177280000000
TCGA-61-2003-01.4	45	0_HALLMARK_ALLOGRAFT_REJECTION	190	7	0.0478360003268892480000000
TCGA-24-2030-01.8	161	2_REGULATION_OF_MOLECULAR_FUNCTION	286	16	0.0478535249374305790000000
TCGA-24-1604-01.9	19	1_KEGG_PATHWAYS_IN_CANCER	323	6	0.0479331535315523430000000
TCGA-25-1628-01.2	118	1_KEGG_RENIN_ANGIOTENSIN_SYSTEM	15	4	0.0479597102578669670000000
TCGA-13-1497-01.7	59	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0480406212243636860000000
TCGA-24-1474-01.12	122	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	16	0.0480482519994972350000000
TCGA-13-0893-01.4	112	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	5	0.0480589705774225610000000
TCGA-13-2060-01.10	86	2_DNA_RECOMBINATION	40	5	0.0480999222548116540000000
TCGA-24-1614-01.5	86	2_DNA_RECOMBINATION	40	5	0.0480999222548116540000000
TCGA-13-1491-01.7	90	2_MITOCHONDRIAL_MEMBRANE_ORGANIZATION_AND_BIOGENESIS	7	3	0.0481007984264675840000000
TCGA-24-2254-01.3	49	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0481598512479340100000000
TCGA-13-0890-01.2	48	2_ORGANELLE_PART	916	15	0.0481687585638202880000000
TCGA-13-0920-01.9	82	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	16	0.0482316014553454410000000
TCGA-13-1510-01.20	82	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	16	0.0482316014553454410000000
TCGA-13-0795-01.9	67	1_KEGG_APOPTOSIS	85	6	0.0482505240236675430000000
TCGA-24-1436-01.1	49	1_KEGG_PANCREATIC_CANCER	70	5	0.0483395394740170000000000
TCGA-10-0933-01.2	97	2_CYTOKINESIS	18	4	0.0483511638870657150000000
TCGA-04-1367-01.3	74	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0484625483677363360000000
TCGA-13-0916-01.11	92	1_KEGG_COLORECTAL_CANCER	62	6	0.0484712421670811800000000
TCGA-20-0990-01.17	133	1_KEGG_PROSTATE_CANCER	87	8	0.0484741186988624440000000
TCGA-24-1417-01.14	94	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	8	0.0484772854977489340000000
TCGA-13-1506-01.5	113	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	9	0.0484992131844310250000000
TCGA-09-1659-01.5	51	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	10	0.0485170937550824730000000
TCGA-59-2355-01.2	14	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	3	0.0485725769563158660000000
TCGA-25-1324-01.3	42	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	5	0.0486597419324949210000000
TCGA-24-1548-01.8	141	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	5	0.0486781800861060130000000
TCGA-25-1321-01.3	33	2_REGULATION_OF_CELL_PROLIFERATION	265	7	0.0487436777856145240000000
TCGA-13-0717-01.6	103	2_REGULATION_OF_APOPTOSIS	309	13	0.0487819779759268920000000
TCGA-23-1032-01.16	250	1_KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	76	10	0.0488361071889124450000000
TCGA-36-1577-01.14	168	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0488844967783379700000000
TCGA-25-1627-01.4	75	1_KEGG_MISMATCH_REPAIR	23	4	0.0488918471932992750000000
TCGA-10-0934-01.11	145	2_DNA_METABOLIC_PROCESS	218	13	0.0489326690733731460000000
TCGA-24-1544-01.7	84	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0489444106243142540000000
TCGA-24-2281-01.10	107	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0489558944955318380000000
TCGA-30-1862-01.13	91	0_HALLMARK_PANCREAS_BETA_CELLS	38	5	0.0489806348795068580000000
TCGA-36-1577-01.14	168	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0490069754718707170000000
TCGA-13-1492-01.2	162	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	13	0.0490601044973222880000000
TCGA-24-1551-01.15	87	2_REGULATION_OF_MITOTIC_CELL_CYCLE	20	4	0.0490751513170891790000000
TCGA-13-0924-01.5	68	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	3	0.0490835948226540090000000
TCGA-13-0884-01.11	68	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0491088063335823610000000
TCGA-23-1027-01.8	68	2_SKELETAL_DEVELOPMENT	84	6	0.0491088063335823610000000
TCGA-25-1313-01.2	13	2_CYTOSKELETON	293	5	0.0491394904697961270000000
TCGA-57-1583-01.20	185	2_CHROMOSOME	102	10	0.0491775999186841380000000
TCGA-09-2053-01.14	121	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0493269987479670810000000
TCGA-61-2000-01.11	69	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	4	0.0496121030305689480000000
TCGA-61-2000-01.11	69	2_CASPASE_ACTIVATION	25	4	0.0496121030305689480000000
TCGA-61-1728-01.5	45	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0497021400134846080000000
TCGA-10-0926-01.2	45	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0497021400134846080000000
TCGA-24-1616-01.2	38	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0497745423989952790000000
TCGA-30-1853-01.4	111	2_CYTOKINE_SECRETION	16	4	0.0497812093006914370000000
TCGA-09-2044-01.4	83	2_CHROMOSOME	102	7	0.0498014572876719420000000
TCGA-25-1627-01.4	75	2_DNA_REPAIR	113	7	0.0498399002202374460000000
TCGA-24-1551-01.15	87	2_DNA_METABOLIC_PROCESS	218	10	0.0498644868282756700000000
TCGA-24-1603-01.3	69	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0498762512862392090000000
TCGA-13-1405-01.4	69	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0498762512862392090000000
TCGA-24-2288-01.12	112	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	20	0.0498858775060587390000000
TCGA-04-1342-01.12	104	2_SPINDLE_POLE	17	4	0.0499138416188039460000000
TCGA-13-0723-01.8	50	2_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0499206384384608540000000
TCGA-13-0723-01.8	50	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0499206384384608540000000
TCGA-23-1116-01.7	84	2_SYSTEM_DEVELOPMENT	694	18	0.0499264425889020400000000
TCGA-24-2035-01.8	102	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0499341027684240340000000
TCGA-09-2044-01.4	83	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	4	0.0499848113601646310000000
